WO2022226617A1 - Polynucleotide, pairs of primers, methods for detecting plant material, gene construct, kit for detecting presence in a sample of plant material, event ctc75064-3, insect-resistant plant, commodity product, method for producing an insect-resistant sugarcane plant and use of a plant, plant cell, part of a plant or seed - Google Patents

Polynucleotide, pairs of primers, methods for detecting plant material, gene construct, kit for detecting presence in a sample of plant material, event ctc75064-3, insect-resistant plant, commodity product, method for producing an insect-resistant sugarcane plant and use of a plant, plant cell, part of a plant or seed Download PDF

Info

Publication number
WO2022226617A1
WO2022226617A1 PCT/BR2022/050142 BR2022050142W WO2022226617A1 WO 2022226617 A1 WO2022226617 A1 WO 2022226617A1 BR 2022050142 W BR2022050142 W BR 2022050142W WO 2022226617 A1 WO2022226617 A1 WO 2022226617A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
plant
sugarcane
event
group
Prior art date
Application number
PCT/BR2022/050142
Other languages
French (fr)
Portuguese (pt)
Inventor
Antonio Adalberto KAUPERT NETO
Ana Carolina VIEIRA ZAKIR PEREIRA
Lucas CUTRI
Agustina GENTILE
Maria Lorena SERENO
Wladecir SALLES DE OLIVEIRA
Adriana CHEAVEGATTI GIANOTTO
Karina YANAGUI DE ALMEIDA
Original Assignee
Ctc - Centro De Tecnologia Canavieira S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc - Centro De Tecnologia Canavieira S.A. filed Critical Ctc - Centro De Tecnologia Canavieira S.A.
Publication of WO2022226617A1 publication Critical patent/WO2022226617A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H5/00Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/46Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325Bacillus thuringiensis crystal protein (delta-endotoxin)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • the present invention is related to the area of biotechnology. More precisely, a genetic construct and method for producing a transgenic plant event, especially a sugarcane event ( Saccharum spp.), which expresses the CrylAc toxin showing resistance to D/D pest infestation, is described. atraea saccharalis, popularly known as common borer, sugarcane borer or just borer.
  • the invention describes methods for detecting the event and material derived from the event resistant to sugarcane borer infestation, thus presenting initiator polynucleotides, probes and the flanking regions identifying such event.
  • Sugarcane (Saccharum spp.) is a grass plant belonging to the botanical family Poaceae, originating in Southeast Asia, more precisely in the great central region of New Guinea and Indonesia. It is one of the most important plant species cultivated in tropical and subtropical regions, with an area greater than 23 million hectares distributed in 121 countries (FAO Statistical Yearbook 2012 p. 233).
  • Sugarcane is a source of raw material for the production of sugar, wine, molasses, rum, cachaça (Brazil's national distillate). sil) and ethanol for fuel.
  • the bagasse that is produced after crushing the sugarcane can be used for baling and supplying heat energy, used in the mill, and electricity, which is typically sold to the consumer's electrical grid, or as raw material.
  • raw material for the production of second-generation ethanol (BR 11 2014 02385-1).
  • the sugarcane agroindustry responsible for generating millions of jobs in the area, is of great economic and social importance, generating foreign exchange through the commercialization of sugar and ethanol and the rational use of plant biomass.
  • Plant genetic engineering involves the transfer of genes of interest into plant cells (genetic transformation) in such a way that fertile and agronomically superior progeny maintain and stably express the gene responsible for the desired trait.
  • Sugarcane is considered a recalcitrant species for genetic transformation and, although several genetic engineering approaches have been evaluated for this species, there are still no standard protocols that guarantee the production of transgenic events. (Smith et al. 1992; Rathius & Birch. 1992.; Chen et al. 1987; Arencibia. 1998; Manickavasagam et al. 2004.; Elliott et al. 1998).
  • the genotypic complexity of sugarcane also significantly impacts the characterization of the events generated in order to guarantee the necessary characteristics for its commercialization.
  • the unequivocal identification of transgenic events is essential to ensure their traceability and monitoring, being a regulatory requirement for their commercialization.
  • the female sugarcane borer lays 200 to 400 eggs, on both sides and also in the sheaths of green leaves. After the eggs hatch, the neonate larvae feed on the leaf parenchyma, migrating to the sheath region in search of shelter. They remain in this region for 7 to 10 days, feeding by scraping the leaf sheath or the bark of young internodes. After an ecdysis, the caterpillars pierce the stem bark, penetrating its interior. The insect opens galleries inside the culms, usually in an upward direction, as it feeds. Inside the stalk, the caterpillar passes through approximately six ecdyses before becoming a winged adult (DINARDO-MIRANDA, 2014). This is the development phase ment in which the insect causes economic damage to the crop (Figure 1).
  • the attack of the sugarcane borer also causes serious secondary damage to the quality of the raw material used for the production of sugar and alcohol because the drilling of the sugarcane stalk by the borer creates conditions for the entry of fungi and opportunistic bacteria, especially Fusarium moniliforme and Colletotrichum falcatum, causing red rot.
  • the borer/red rot complex causes physiological, microbiological and technological deterioration of sugarcane. Bacteria associated with raw material with red rot produce undesirable fermentations, resulting in products foreign to the alcoholic fermentation of industrial processing.
  • these bacteria also produce organic acids and gums (dextrans) from the sugars contained in the must, which negatively affect the viability of yeast cells, requiring their replacement in the fermentation vats (PRECETTI and TER ⁇ N, 1983; PRECETTI et al. ai, 1988; BOTELHO and MACEDO, 2002).
  • Another problem arising from the presence of bacteria in the fermentation vats is the possibility of flocculation of the yeast.
  • the contaminating bacteria form a mucilage that aggregates the yeast cells, causing their flocculation.
  • plants attacked by borer/red rot also have high levels of phenolic compounds (METCALF and LUCKMANN, 1994; PRICE, 1997).
  • the crystal proteins Cry stand out for their specific toxicity to the larvae of species of Lepidoptera, Diptera and Coleoptera common as agricultural pests.
  • These proteins produced as protoxins (65-149 KDa), are solubilized and activated in the intestine of susceptible insects by proteolysis and bind to the membrane of intestinal cells, inducing osmotic lysis of the epithelium, which causes the death of the insect.
  • Cry proteins are classified into several groups according to the homology of their sequences, among them, the group of proteins classified as Cry1 has high specificity against lepidopteran insects, being an excellent candidate for genetic manipulation of sugarcane germplasm. -sugar for the production of varieties resistant to the sugarcane borer.
  • the heterologous expression of Cry1 proteins in sugarcane varieties despite being challenging, has great potential for controlling the sugarcane borer, reducing economic losses in the sugar-alcohol sector, as well as the release of chemical insecticides in the sugarcane industry. environment.
  • the genetically modified sugarcane event CTC75064-3 presented by the present invention aims to provide Brazilian sugarcane producers with a cultivar that has the genetic background of the cultivar RB 867515 (Certificate of protection of cultivar Ne 271) and is resistant to sugar cane borers.
  • the RB 867515 variety was planted on approximately 1,730,000 hectares in the Center-West region of Brazil. The cultivation of this variety in the northeast region of Brazil was approximately 57 thousand hectares. Considering the total area of sugarcane cultivated (CONAB, 2019), this variety has a market share in Brazil of around 21%.
  • the present invention describes a kit for detecting the presence of event CTC75064-3 in a sample of plant material.
  • the seventh objective of the present invention is to provide a commodity product.
  • An eighth objective of the present invention is through an insect resistant plant.
  • the invention further provides as a method of producing and cultivating an insect resistant sugarcane plant and/or using such a plant, plant cell, plant part or seed. Additionally, it provides a method for growing a sugarcane plant in an insect infestation environment, a method for controlling insects and a method for increasing sugarcane production in the field.
  • the first objective is achieved by using polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 22.
  • the second object of the invention is achieved by means of primer pairs wherein the sense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and the antisense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 7 and/or the sense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and the antisense primer can be having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 9.
  • the third objective is achieved by a method of detection of plant material derived from a genetically modified sugarcane plant of event CTC75064-3 characterized by comprising the steps of: a) obtaining a sample for analysis; b) extracting DNA from the sample; c) providing primer pairs comprising at least one sense and one antisense primer; d) amplification of the region that lies between the sites where the primers bind; and e) detecting the presence of amplification product.
  • the primer pairs of step c) are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • the present invention describes a method of detecting plant material derived from a genetically modified sugarcane plant of event CTC75064-3 characterized by comprising the steps of: a) obtaining a sample for analysis; b) extracting DNA or RNA from the sample; c) providing a probe designed or a combination of probes designed to bind at least one polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30 , SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 and SEQ ID NO 39; d) hybridizing said probe with the material extracted from the sample of step (I
  • the fourth objective of the invention is evidenced by means of a kit for detecting the presence in a sample of plant material derived from the event CTC75064-3 characterized by comprising a means for detecting the presence in a sample of a polynucleotide that comprises at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 and/or a Cry protein.
  • the fifth objective is achieved through genetic construction, characterized by the fact that it comprises at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO 2 and SEQ ID NO 14.
  • event CTC75064-3 which is characterized by the fact that it is a variety of sugarcane (Saccharum spp.) and comprises at least 14 contiguous nucleotides of the sequences selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 and SEQ ID NO 4. Additionally, event CTC75064-3 is characterized by the fact that it is a variety of sugarcane ( Saccharum spp.) and comprise at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22.
  • the invention also provides a plant, plant part, plant cell, plant tissue or sugarcane seed.
  • genetically modified sugar Saccharum spp.
  • genetically modified sugar comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 and SEQ ID NO 4.
  • a genetically modified plant part, plant cell, plant tissue or seed of sugarcane Saccharum spp. characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22;
  • the commodity product of the seventh object of the invention is achieved from the genetically modified sugarcane of the present invention.
  • the eighth object of the present invention provides a method for producing an insect resistant sugarcane plant comprising SEQ ID NO: 20 and SEQ ID NO: 21.
  • the invention also provides a method for producing a insect resistant sugarcane plant comprising crossing a first sugarcane plant with a second sugarcane plant comprising event CTC75064-3.
  • the present invention further provides a method for producing an insect resistant plant characterized in that it comprises introducing a genetic modification into a sugarcane plant ( Saccharum spp) comprising SEQ ID NO 5 or SEQ ID NO 22, to produce a genetically modified sugarcane plant (Saccharum spp ) from event CTC75064-3. Additionally, the present invention provides a method for producing a genetically modified insect resistant sugar cane plant comprising inserting a T DNA fragment at a specific site in the genome comprised among sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination. Preferably, said method is for producing a sugarcane plant of genetically modified insect resistant sugar from event CTC75064-3.
  • the tenth object of the invention describes the use of a plant, plant cell, plant part or seed characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product.
  • the invention describes the use of a plant, plant cell, plant part or seed characterized by comprising event CTC75064-3 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product.
  • the present invention describes a method for growing a genetically modified sugarcane plant comprising growing a sugarcane plant comprising SEQ ID NO 2 under conditions comprising insect infestation.
  • the present invention provides a method for controlling insects comprising providing a genetically modified plant, tissue, plant part, cells or seeds, characterized by comprising SEQ ID NO 2, for feeding to the insect. . Additionally, the invention further provides a method for increasing the production of sugarcane in the field, characterized in that it comprises cultivating a genetically modified sugarcane plant characterized by comprising SEQ ID NO 2.
  • Figure 1 exemplifies the damage to sugarcane plants caused by Diatrea saccharalis (sugarcane borer).
  • Figure 2 exemplifies the red rot-borer complex caused by Diatrea saccharalis (sugarcane borer) infestation.
  • Figure 3 represents the map of the T-DNA introduced in the event of the present invention.
  • Figure 4 represents the plasmid used as a basis for construction of the plasmid used in the present invention.
  • Figure 5 represents the resulting plasmid, used to obtain the event of interest.
  • Figure 6 represents one of the amplification graphs of qPCR via Taqman® (relative fluorescence x cycle) for the event of interest.
  • Figure 7 represents the melting curves of qPCR via SYBR GREENTM (relative fluorescence x temperature) for the event of interest.
  • the arrows indicate the specific amplification peak of the event of interest as well as the baseline indicative of absence of amplification for the other events and negative controls.
  • Figure 8 is the result of the comparison of means of CrylAc expression in leaves (Fresh Tissue) of event CTC75064-3 during the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ⁇ standard error, according to the results of the joint analysis.
  • Figure 9 is the result of the comparison of means of CrylAc expression in leaves (dry tissue) of event CTC75064-3 for the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ⁇ standard error, according to the results of the conjoint analysis.
  • Figure 10 is the result of the comparison of means of CrylAc expression in leaf, stem and root of event CTC75064-3 (fresh tissue and dry tissue). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. each bar represents the mean ⁇ standard error.
  • Figure 11 is the result of the comparison of means of Nptll expression in leaves (fresh tissue) of event CTC75064-3 for the sugarcane cycle.
  • Figure 12 is the result of the comparison of means of the expression of Nptll in leaves (Dry tissue) of the event CTC75064-3 for the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ⁇ standard error, according to the results of the joint analysis.
  • Figure 13 is the result of the comparison of means of Nptll expression in stem, leaf and root of event CTC75064-3 (fresh tissue and dry tissue). Bars followed by the same letter do not differ from each other by the t test at the 5% probability level. Each bar represents the mean ⁇ standard error.
  • Figure 14 is the result of the Western blot methodology to identify the CrylAc protein.
  • M Molecular weight marker (KDA).
  • R1 to R4 biological repeats of event CTC75064-3.
  • WT Negative control: total protein extracted from the parental cultivar RB867515.
  • CP Pasitive Control: 1ng CrylAc protein; WT+CP: 1ng of purified CrylAc protein diluted in total proteins extracted from the parental cultivar. 0: Empty well.
  • Figure 15 is the result of the Western blot methodology to identify the Nptll protein.
  • M molecular weight marker (kDa).
  • R1 and R2 biological repeats of event CTC75064-3.
  • CP control positive: 5 ng NptII protein;
  • WT+CP 5 ng of Nptll protein diluted in total proteins extracted from the parental cultivar.
  • WT total protein extracted from the parental cultivar.
  • Figure 16 represents A) infestation index (l.l.%), B) Relative length of damage in event CTC75064-3 and in controls (first cut plants). The letters represent the result of the analysis of variance by the T test and the bars refer to the standard error.
  • Figure 18 demonstrates A: larval mortality in leaf disc assay with plant material from the insect resistant event (sugar cane borer) CTC75064-3 compared to the parental material (no genetic modification) CTC75-TC (cultivate RB867515); B: Relative effectiveness of sugarcane borer control by CTC75-064-3; C: Examples of larval sizes (larval development) after seven days of feeding in the leaf disc assay. On the left are examples of larvae that fed on plant material resistant to event CTC75064-3, and on the right are examples of larvae that fed on plant material of the parental cultivar (without genetic modification) CTC75-TC ( cultivar RB867515).
  • FIG 19 shows examples of expression cassettes for generating event CTC75064-3 through genomic editing.
  • Cassette A comprises codon-optimized Cas9 for sugar cane with expression directed through the pZmUbi promoter and the T-35s terminator;
  • Cassette B comprises crRNA for Cas9 with expression driven by the wheat U3 promoter and
  • Cassette C comprises the HR template comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences). ) for site-specific integration.
  • Figure 20 represents an example of a genome editing construction comprising the cassettes “Cas 9” and “crRNA”.
  • Figure 21 demonstrates an example of a genome editing construct comprising the HR template CTC75064-3 comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences) for site-specific integration.
  • Figure 22 represents a genome-editing construct comprising all cassettes for generating event CTC75064-3: the cassette of Cas9 with codon-optimized sugar cane with expression directed through the pZmUbi promoter and the T-terminator. 35s; the crRNA cassette for Cas9 with expression driven by the wheat U3 promoter and the HR template cassette comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences) for site-specific integration.
  • Figure 23 A presents a schematic representation of the Southern blot strategy using two restriction enzymes Hindlll and EcoRV to identify the T-DNA inserted in event CTC75064-3. Gray lines below the schematic representation of the T-DNA indicate the expected sizes of the generated T-DNA fragments from event CTC75064-3.
  • B) is a schematic representation of the Southern blot strategy for detection of vector (backbone) fragments using the restriction enzyme Sph ⁇ .
  • Figure 24 shows Southern blot results using restriction enzymes Hindll (left) and EcoRV (right). Results for hybridization with the Cry probe that recognizes the crylAc gene.
  • M molecular weight marker
  • WT negative control
  • 1C positive control 1 copy.
  • T0 plant cane (first cut).
  • T1 punch 1 (second cut);
  • T2 stump (third cut) 2;
  • T3 clog 3 (fourth cut).
  • Figure 25 shows Southern blot results using restriction enzymes EcoRV (left) and Hind ⁇ (right). Results for the 35s probe that recognizes the 35s promoter.
  • M molecular weight marker
  • WT negative control
  • 1C positive control 1 copy.
  • T1 stump 1 (second cut); T2: stump (third cut) 2;
  • T3 clog 3 (fourth cut).
  • Figure 26 shows Southern blot results using the restriction enzymes Hind ⁇ (left) and EcoRV (right). Results for the nptll probe that recognizes the nptll gene.
  • M molecular weight marker
  • WT negative control
  • 1C positive control 1 copy.
  • T0 plant cane (first cut).
  • T1 stump 1 (second cut);
  • T2 stump (third cut) 2;
  • T3 clog 3 (fourth cut).
  • Figure 27 A represents Southern blot results using Sph ⁇ restriction enzymes and vector (backbone) probes BB1 and BB3.
  • M molecular weight marker
  • WT negative control
  • 1C positive control 1 copy with pCTC146
  • 1C * positive control 1 copy with pCTC302.
  • BB1 positive control with backbone probe 1;
  • BB2 positive control with backbone probe 2;
  • BB3 positive control with backbone probe 3. Red lines indicate two repetitions of event CTC75064-3.
  • Well (Lane) 1 other events.
  • M molecular weight marker
  • WT negative control
  • 1C positive control 1 copy with pCTC146
  • 1C * positive control 1 copy with pCTC302.
  • BB1 positive control with backbone probe 1;
  • BB2 positive control with the backbone probe 2;
  • BB3 positive control with backbone probe 3. Red lines indicate two repeats of event CTC75064-3.
  • Well (Lane) 1 other events.
  • Figure 28 demonstrates the confirmation of the integrity of the flanking regions of the T-DNA inserted in event CTC75064-3.
  • TEE Confirmation of the integrity of the left edge (5').
  • B Confirmation of the integrity of the right edge (3').
  • Event DNA from event CTC75064-3; WT: parental CT 7515 DNA (culture RB 867515); C-: negative control.
  • an "event” is considered to be the genetically modified plant produced by any method of genetic modification and/or transformation that significantly and constantly expresses the characteristic that was intended to be included in it, which is conferred by the introduced transgene. More particularly, in the present case, the genetically modified plant is considered an "event", preferably a genetically modified sugarcane plant (Saccharum spp.) which, after genetic modification, expresses the characteristic of resistance to pest, particularly Diatraea saccharalis (sugarcane borer).
  • genetically modified sugarcane produced by genetic transformation is designated “CTC75064-3” and may alternatively be referred to as “Event CTC75064-3”.
  • region LB is understood the left transfer edge of the T-DNA (5'), and by region RB is understood the right transfer edge of the T-DNA (3').
  • plant material means any and all plant tissue or its derivatives, such as, but not limited to, seeds, trunks, stems, stems, leaves, straws, bark, roots, cellu- them, molecules of vegetable origin, among others, and also any product of a plant or derivative thereof, for example, but not limited to, sap, sugar, ethanol, among others.
  • Recombinant DNA technology enabled the isolation of genes and their stable insertion into a host genome.
  • This technique also called genetic transformation, can be defined as the controlled introduction of nucleic acids ("DNA” or DNA) into a recipient genome, excluding introduction by fertilization. It is a controlled process, where normally only the defined fragment of DNA is introduced into the host genome, or receptor genome, and must be integrated into it.
  • the stable insertion of these molecules into a host genome gives rise to an individual equal or substantially equal to the receptor of the recombinant molecule, but with a new and particular characteristic.
  • substantially the same is meant an organism that has greater than 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to the recipient organism.
  • Indirect transfer is one in which exogenous DNA is inserted into the genome by the action of a biological vector or any other type of carrier molecule, and its insertion is facilitated by endogenous or exogenous mechanisms, while direct transfer is facilitated by endogenous or exogenous mechanisms. based mainly on physico-biochemical processes.
  • tissues and/or cells to be transformed may vary according to the genetic transformation techniques used and according to the species or genotype to be transformed. These tissues generally include, without limitation, embryogenic callus, callus, protoplasts, embryos, somatic embryos, meristematic tissues, and any part, tissue or plant cell that has a regenerative capacity.
  • the indirect transformation is mainly based on the system mediated by bacteria of the genus Agrobacterium and has been the most used method to obtain transgenic plants, as it has some advantages, such as the possibility of transferring DNA segments relatively long with no rearrangement and integration of low copy numbers of the transgenes, ensuring greater genotypic stability for the generated events.
  • Several species and strains of Agrobacterium, plasmids and protocols have been developed and adapted for the genetic transformation of different plant species.
  • the advantages of the Agrobacterium-mediated transformation method include the higher probability of single copy insertions, the stable integration and genetic inheritance of the introduced traits, as well as consistent gene expression across generations, in addition to lower chances of gene silencing. .
  • Agrobacterium tumefaciens and A. rhizogenes are phytopathogenic soil bacteria, gram negative, belonging to the family Rhizobiaceae, which cause diseases in dicots, known as crown gall and wig root, respectively.
  • T-DNA plant cell
  • the bacterium transfers T-DNA ("transferred DNA"), which is part of the bacterial plasmid called Ti (“tumour-inducing”), and it integrates into the genome of infected plant cells. .
  • T-DNA fragment that is transferred to the plant cell are the genes involved in the constitutive biosynthesis of phytohormones (auxins and cytokinins) that alter the program of normal development of infected tissue, causing tumor formation. Furthermore, it also contains oncogenes for the synthesis of sugars and amino acids called opines, which are responsible for the survival of the bacterium, which uses them as a source of carbon and nitrogen (Oger et al 1997). Repeated ends of 25 base pairs (bp) on the right and left edges delimit the T-DNA, and are essential for its transfer. Phenolic compounds released by injured plant tissues activate specific regions (vir regions), initiating the process of transferring T-DNA to the plant cell. Agrobacterium also has chromosomal genes ( chv ) that guarantee the connection between bacterial and host cells, allowing the formation of the passage pore of the complex containing the T-DNA (Sheng & Citovsky, 1996).
  • chv chromosomal genes
  • any sequence flanked by the edges can be transferred to a plant by means of agrobacteria, allowing the manipulation of these sequences for the transfer of coding sequences of interest.
  • the substitution or elimination of the coding regions of the wild-type T-DNA (oncogenes) allows the generation of non-oncogenic (disarmed) Agrobacterium strains that carry the sequences of interest, without prejudice to the transfer of the T-DNA to plants as long as the virulence genes (vir region) are maintained.
  • the indirect transformation system by Agrobacterium allows the use of artificial plasmid constructs for the transfer of genes to plants as long as they contain such T-DNA borders, allowing a great flexibility for the use of the tools molecular and material available and developed for other bacterial strains.
  • These artificial plasmid constructs have pro- motors of different origins, including plant gene promoters, viral, bacterial and/or chimeric promoters, in addition to genes that confer antibiotic resistance, herbicide resistance or that have enzymatic activity (phosphomannose isomerase (PMI)/mannose ( Man)) so that these markers can be used for the selection of transformed cells or plants.
  • plant gene promoters including plant gene promoters, viral, bacterial and/or chimeric promoters, in addition to genes that confer antibiotic resistance, herbicide resistance or that have enzymatic activity (phosphomannose isomerase (PMI)/mannose ( Man)) so that these markers can be used for the selection of transformed cells or plants.
  • PMI phosphomannose isomerase
  • Man mannose
  • these constructs may contain auxiliary genes that interfere in signaling pathways relevant to the morphogenesis of plant tissues, increasing the efficiency of the process of genetic modification and regeneration.
  • auxiliary genes that interfere in signaling pathways relevant to the morphogenesis of plant tissues, increasing the efficiency of the process of genetic modification and regeneration.
  • the foreign or exogenous DNA that will be introduced into the plant is cloned into a binary plasmid, between the left and right edge consensus sequences (T-DNA).
  • the binary plasmid is transferred into an Agrobacterium cell, which is subsequently used to infect plant tissue.
  • the region of the vector's T-DNA that comprises the exogenous DNA is inserted into the plant genome.
  • the expression cassette with the marker gene and the expression cassette with the trait gene can be present in the same region of the T-DNA, in different regions of the T-DNA in the same plasmid, or even in different regions of the plasmid.
  • the cassettes are present in the same region of the T-DNA.
  • One skilled in the art is familiar with methods of indirect transformation by Agrobacterium.
  • the direct transfer of DNA can be used to introduce DNA directly into a plant cell.
  • These methods offer an alternative for the integration of a gene of interest with minimal cellular toxicity at random locations in the genome.
  • the introduction of exogenous DNA is performed without the aid of a vector.
  • a suitable method of direct DNA transfer may be to bombard plant cells with a vector comprising the DNA for insertion using a particle gun (particle-mediated biolistics transformation).
  • Other methods for transforming plant cells include protoplast transformation (optionally in the presence of polyethylene glycols); ultrasound treatment of plant tissues, cells or protoplasts in a medium comprising the polynucleotide or vector; sonication, the microinjection of the polynucleotide or vector into plant material; macroinjection, electroporation of plant cells and the like, vacuum infiltration, use of silicon carbide fibers, chemical transformation mediated by polyethylene glycol (PEG), among others.
  • PEG polyethylene glycol
  • the genetic transformation can be carried out in a site-directed manner through homologous recombination aided by nucleases (genomic editing).
  • genomic editing technology based on the use of "engineered” or chimeric nucleases has gained prominence, enabling the generation of genetically modified organisms in a more precise and specific way.
  • the introduction of exogenous genes occurs through homologous recombination mechanisms through the introduction of a homologous recombination (HR) template containing the DNA of interest linked to a DNA fragment homologous to the genome of the recipient organism.
  • HR homologous recombination
  • CRISPR chimeric enzyme system
  • Cas Zinc finger nucleases
  • TALENs Zinc effector nucleases
  • CRISPR/Cas systems are enzymatic systems that comprise 2 main components: an endonuclease (Cas) and a guide RNA (single-guide RNA - sgRNA).
  • Guide RNA comprises 2 main parts: "crispr RNA” (crRNA), a 17-20 nucleotide sequence complementary to specific sites in genomic DNA; "tracr RNA”, a template for binding Cas nuclease, responsible for guiding the endonuclease to the specific cleavage site.
  • the specific cleavage performed by the endonuclease and directed by the guide RNA can be repaired through homologous recombination, integrating in a site-directed manner the exogenous DNA flanked by sequences homologous to the cleavage site.
  • the introduction of this enzymatic system into the cell can occur in different ways, using plasmids, through direct or indirect transformation, or even using proteins and other carrier molecules.
  • the expression of the components of the system can occur transiently or stably using the cellular machinery of the receptor organism or even be performed exogenously, in which case, the components of the system are delivered to the cell "ready to use” (endonucleases + sgRNAs transcribed in vitro and combined prior to their introduction into the cell).
  • the description presented here should not be considered exhaustive and, therefore, the use of such genomic editing methods within the scope of the present invention should not be limited to the description presented, and the application of variations of these systems and methods, as known in this - that of Art, as well as those that are yet to be discovered.
  • the transgenic plants must be regenerated starting from the transformed plant tissue and the progeny that has exogenous DNA selected using an appropriate marker such as resistance to kanamycin, geneticin or glufosinate ammonium.
  • an appropriate marker such as resistance to kanamycin, geneticin or glufosinate ammonium.
  • One skilled in the art is familiar with the composition of suitable regeneration media.
  • the genetic transformation is mediated through a bacterium of the genus Agrobacterium.
  • the genetic transformation is mediated by Agrobacterium tumefasciens.
  • Event CTC75064-3 displays a new genotype comprising two expression cassettes.
  • the first expression cassette comprises a promoter suitable for expression in plants operably linked to a gene encoding an insecticidal CrylAc toxin useful in controlling lepidopteran insect pests and a suitable polyadenylation signal.
  • the second expression cassette comprises a promoter suitable for expression in plants operably linked to a gene encoding a protein used as a selective marker in obtaining the event of the present invention.
  • Suitable promoters can be isolated or expressed, among other organisms, in plants. Several promoters have been isolated or developed, including constitutive, "on and off” promoters, responsive to abiotic stresses, tissue-specific, among others. Many of these promoters have intronic sequences described as relevant for proper gene expression.
  • the promoters are constitutive promoters and may be selected from the non-limiting group consisting of CaMV 35S, CoYMV (Commelina yellow mottle virus), FMV (Figwort mosaic virus) 35S, Ubiquitin, Rice Actin promoter 1 (Act-1), Rice Actin promoter 2 (Act-2), Nopaline synthase promoter (NOS), octopine synthase promoter ( OCS), corn alcohol dehydrogenase promoter (Adh-1), PvUbil, among others.
  • enhancer and driver sequences can also be incorporated into the expression cassette for the purpose of improving gene expression levels, for example transcriptional or translational enhancers such as the CaMV enhancers 35S, FMV 35S, Nos, supP, Wheat Major Chlorophyll a/b Binding Polypeptide a/b (L-Cab) non-transcribed leader sequences, kosak sequences 5' upstream of the translation start site, among others.
  • transcriptional or translational enhancers such as the CaMV enhancers 35S, FMV 35S, Nos, supP, Wheat Major Chlorophyll a/b Binding Polypeptide a/b (L-Cab) non-transcribed leader sequences, kosak sequences 5' upstream of the translation start site, among others.
  • the promoter is the Cauliflower Mosaic Virus 35s (CaMV 35Ss) promoter.
  • CaMV 35s promoter has the duplicated enhancer sequence (2xCaMV35s).
  • the sequence Kosak 5' upstream of the translation start site and the rice Actin 1 intron are contemplated in the CaMV 35s promoter region.
  • the L-Cab leader sequence is also contemplated in the CaMV 35s promoter region.
  • crylAc gene expression is regulated by the combination of elements selected from the group consisting of Cauliflower Mosaic Virus 35s promoter with duplicate enhancer sequence (2xCaMV35s), non-trans leader sequence - Wheat Major Chlorophyll a/b Binding Polypeptide a/b crita (L-Cab), Rice Actin 1 intron (Oryza sativa Actin 1 intron; OsACTI) and Kosak sequence 5' upstream from the translation start site.
  • elements selected from the group consisting of Cauliflower Mosaic Virus 35s promoter with duplicate enhancer sequence (2xCaMV35s), non-trans leader sequence - Wheat Major Chlorophyll a/b Binding Polypeptide a/b crita (L-Cab), Rice Actin 1 intron (Oryza sativa Actin 1 intron; OsACTI) and Kosak sequence 5' upstream from the translation start site.
  • crylAc gene expression is regulated by the promoter region of Cauliflower Mosaic Virus 35s with sequence Duplicated enhancer (2xCaMV35s), non-transcribed leader sequence of Wheat Major Chlorophyll a/b Binding Polypeptide (L-Cab), Rice Actin 1 intron (Oryza sativa Actin 1 introrr, OsACTI) and Kosak 5' sequence upstream from the translation start site.
  • the promoter region is the corn Ubiquitin gene (pUBI).
  • the promoter region is that of the corn Ubiquitin gene (pUBI) contains an intron in the 5' sequence of the leader RNA.
  • the promoter region ( UBI-1 ) of the present invention has 1992 base pairs which are subdivided into: promoter fragment (899 bases), first exon of the polyubiquitin-1 gene (83 bases) and first intron (1010 bases) .
  • the expression of the nptll gene is regulated by the corn ubiquitin promoter (pUBI).
  • the expression of the nptll gene is regulated by the corn ubiquitin promoter (pUBI) containing an intron in the 5' sequence of the leader RNA.
  • the expression of the nptll gene is regulated by the promoter region (UBI-1) of the present invention has 1992 base pairs that are subdivided into: promoter fragment (899 bases), first exon of the polyubiquitin-1 gene (83 bases) and first intron (1010 bases).
  • Terminator sequences are also contemplated in the expression cassette.
  • suitable and functional polyadenylation signals in plants include that from the nopaline synthase (nos) gene of Agrobacterium tumefaciens, that from the proteinase inhibitor II gene, rbcS (pea ribulose-1,5-bisphosphate carboxylase small subunit), Lhcbl (tobacco chlorophyll a/b-binding proteins), CaMV 35S, octopine synthase, the one from the alpha-tubulin gene, among others.
  • nos nopaline synthase
  • rbcS pea ribulose-1,5-bisphosphate carboxylase small subunit
  • Lhcbl tobacco chlorophyll a/b-binding proteins
  • CaMV 35S octopine synthase, the one from the alpha-tubulin gene, among others.
  • the polyadeny- lation is derived from the CaMV 35s gene (T35s).
  • the polyadenylation signal is that from the nopaline synthase (nos) gene of Agrobacterium tumefaciens.
  • the polyadenylation signal for the crylAc cassette is CaMV 35s terminator (T-35s) and the polyadenylation signal for the nptII gene is Agrobacterium tumefaciens nopaline synthase terminator - NOS.
  • the crylAc gene encodes a 615 amino acid toxin with an estimated molecular weight of 68 KDa, originating from Bacillus thuringiensis serovar kustaki (strain HD73) that confers resistance to D/atraea saccharalis (sugarcane borer).
  • the present invention contemplates gene modifications for the expression of only the active tryptic core of the native CrylAc protein.
  • the polynucleotide encoding the CrylAc protein is truncated, encoding the 52 kDa insecticidal tryptic core.
  • the CrylAc protein is SEQ ID NO 34.
  • the present invention also contemplates sequences comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity with SEQ ID NO: 34.
  • the tryptic nucleus is responsible for the insecticidal activity of the protein, binding to specific proteins of the insect intestine, leading to the disruption of the functional and anatomical integrity of this organ that alters the absorption of nutrients and rapid toxicity. - insect death and death.
  • the polynucleotide encoding the CrylAc protein may have codons optimized or otherwise altered to improve its expression in plant material. Such codon optimization can be used to alter the predicted secondary structure of the RNA transcript produced in any transformed cell or to destroy the cryptic RNA instability elements present in the unaltered transcription product. thereby improving the stability and/or availability of the transcription product in the transformed cell.
  • the crylAc gene present in the event of the invention corresponds to a synthetic DNA sequence, truncated and optimized with sugarcane preferred codons.
  • the crylAc gene has the sequence SEQ ID NO: 20.
  • the present invention also contemplates sequences comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 20.
  • marker genes for plant selection events have been characterized, including some that confer antibiotic tolerance and others that confer herbicide resistance.
  • marker genes examples include those that confer resistance or tolerance to hygromycin, kanamycin, gentamicin, glyphosate, glufosinate ammonium or resistance to toxins such as eutypine.
  • Other forms of selection are also available, such as hormone-based selection systems, visual selection through the expression of fluorescent proteins, mannose isomerase, xylose isomerase, among others.
  • the event selection marker gene of the present invention is one that confers tolerance to antibiotics of the aminoglycoside class. In one scope of the present invention, the event selection marker gene confers tolerance to kanamycin and geneticin.
  • the marker gene used in the second expression cassette is the nptII gene, which encodes the 265 amino acid neomycin phosphotransferase II (nptII) enzyme with an estimated molecular weight of 29.2KDa .
  • the nptll gene has the sequence SEQ ID NO 21. Neomycin phosphotransferase II confers resistance to propensity to antibiotics of the aminoglycoside class, such as kanamycin and geneticin.
  • the npt11 gene used as a selection marker in obtaining the transformed events is derived from the Tn5 transposon of Escherichia coli as described by BECK et al (1982).
  • the Nptll protein is produced by several prokaryotes widely found in the environment, both in aquatic and terrestrial habitats, as well as in human and animal intestinal microflora.
  • the Nptll protein inactivates aminoglycoside antibiotics such as neomycin, gentamicin, paromycin and kanamycins A, B and C, using adenosine triphosphate (ATP) to phosphorylate them, thus preventing them from causing injury to cells when exposed to mentioned antibiotics. This mechanism allows its use as a selection marker for transformed plants.
  • the Npt11 protein is SEQ ID NO 35.
  • the present invention also contemplates sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 35.
  • selection marker genes such as the nptll gene
  • HORSCH et al., 1985 The objective of inserting the nptll gene in the event of the present invention was, therefore, the selection of cells transformed with the crylAc gene.
  • additional expression cassettes are optionally comprised in event CTC75064-3.
  • the first and second expression cassettes comprised in event CTC75064-3 can be introduced into the plant on the same or different plasmids. If the first and second expression cassettes are present on the same plasmid and were introduced into the plant via an Agrobacterium-mediated transformation method, they may be present within the same or from different regions of the T-DNA. In one embodiment of the present invention, the first and second expression cassettes are present in the same region of the T-DNA.
  • the event of the present invention was obtained by Agrobacterium tumefasciens-mediated transformation with a genetic construct comprising a DNA fragment (T-DNA) containing the expression cassettes of the crylAc and nptll genes ( Figure 1).
  • the genetic construct of the present invention is characterized in that it comprises the nucleotide sequence having at least 80% identity to SEQ ID NO:1, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO:1.
  • the event of the present invention was obtained by Agrobacterium tumefasciens-mediated transformation comprising the T-DNA fragment as defined above (SEQ ID NO:1).
  • This T-DNA fragment was inserted into a binary plasmid that contains in its host spectrum the bacteria Escherichia coli and Agrobacterium tumefaciens.
  • the specific genetic elements, origins of the components of the original binary plasmid of the present invention are shown in Figure 4.
  • the binary plasmid comprising the construct of the present invention is represented in Figure 5.
  • the genetic construct of the present invention is characterized in that it comprises a nucleotide sequence having at least 80 %, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 14.
  • Said genetic construct is inserted by heat shock into the DH5a strain of Escherichia coli.
  • An isolated colony containing the construct (SEQ ID NO 14) was inoculated into liquid LB medium supplemented with 150 ⁇ g/mL spectinomycin and incubated at 37°C, with stirring at 250 rpm for a period of 16 hours.
  • Stocks containing bacterial suspension and 10% glycerol (v/v) were then prepared and stored in an ultrafreezer -80°C. Plasmid DNA was extracted from the same bacterial suspension using the QIAGEN Plasmid Giga Kit according to the manufacturer's recommendations (Qiagen, Germany).
  • the construct SEQ ID NO 14 was then transferred to a strain of Agrobacterium tumefaciens (vector) by means of techniques known to a person skilled in the art, such as electroporation, heat shock, among others.
  • the construct is transferred to a strain of Agrobacterium tumefaciens via electroporation.
  • An isolated colony of agrobacteria containing the construct is inoculated into liquid LB medium supplemented with 100 ⁇ g/ml of spectinomycin and 50 ⁇ g/ml of rifampicin and incubated at 28°C, shaking at 200 rpm for a period of 24 hours.
  • Stocks containing bacterial suspension and 10% glycerol (v/v) are prepared and stored in an ultrafreezer -80°C. These stocks are used in genetic transformation experiments.
  • the vector is an EHA105 strain of Agrobacterium tumefaciens.
  • a method for producing a genetically modified insect resistant sugarcane plant comprises the steps of: a) introducing the genetic construct into an Agrobacterium strain; b) Obtaining embryogenic calluses from palm hearts of a variety of sugarcane (Saccharum spp.); c) Co-cultivation of embryogenic calluses with Agrobacterium from stage I; d) Selection of transformed cells that contain the functional fragment in a culture medium containing aminoglycoside antibiotics; and e) Regeneration of transformed sugarcane plants.
  • the method for producing a genetically modified sugarcane plant is based on or identical to that described by BR 11 2017 005441, the teachings of which are incorporated into the present invention.
  • step a) of the method for producing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3 comprises introducing a genetic construct comprising SEQ ID NO 20 and SEQ ID 21 in an Agrobacterium strain.
  • step d) comprises the selection of transformed cells containing a functional fragment in a culture medium containing geneticin.
  • step e) of that method comprises regenerating transformed sugarcane plants, wherein the transformed sugarcane plants comprise SEQ ID NO 20 and SEQ ID NO 21.
  • the method for producing a plant of genetically modified sugarcane ( Saccharum spp ) described is for production of the event of interest, CTC75064-3.
  • the invention also contemplates a plant part, a plant cell, a plant tissue, or a seed of the genetically modified sugarcane plants produced by the method described above.
  • step b The person skilled in the art is familiar with the composition of suitable culture media for the generation of embryogenic callus (step b), as well as with the media of the co-cultivation stages (step c: co-cultivation + rest) , selection (step d) and regeneration (step e; regeneration + elongation).
  • the culture media used Lysates are based on compositions comprising ingredients such as MS salts (Murashige and Skoog, 1962), sucrose, vitamins B5 and, optionally: amino acids selected from the group comprising proline and asparagine; casein hydrolyzate; Citric acid; mannitol; copper sulfate; glycine; gelling agent; auxins; antibiotics; acetosyringone; and selection agents.
  • auxins in the means of embryogenic callus generation, co-culture and selection stands out, as well as geneticin in the selection medium.
  • the "co-cultivation” step refers to the incubation of infected or contacted plant tissue with Agrobacterium in order to allow the transfer of Agrobacterium T-DNA to plant cells. This stage corresponds to the period between the moment immediately after inoculation (contact of the Agrobacterium with the plant tissue) until the moment when the bacteria is removed or inactivated.
  • the inoculated tissue can be co-cultured for about 1 to 30 days, preferably 1 to 20, more preferably 1 to 10 days.
  • the temperature can be any suitable temperature for the target plant known in the art.
  • the temperature can range from about 15°C to about 30°C and from about 16°C to about 29°C.
  • the co-cultivation step takes place in the absence of light.
  • the medium is removed and the cells are transferred to a culture medium in the absence of Agrobacterium, being incubated in the dark, at a temperature of 20°C to about 26°C, for a period of 1 to 20 days.
  • the method provided herein further includes selecting cells comprising at least one copy of the genetic sequence of interest.
  • Select means the situation in which it is A selective agent for transformants is used, where said selective agent will allow the preferential growth of plant cells containing at least one copy of the marker gene positioned within the T-DNA and transferred by Agrobacterium to the detriment of those cells that have not been transformed .
  • any suitable selection marker can be used.
  • the selection marker gene used is the nptll gene, which encodes an enzyme that confers resistance to antibiotics of the aminoglycoside class, such as kanamycin and geneticin.
  • an agent that inhibits the growth of Agrobacterium is also added after step c.
  • Selection can occur under light or dark conditions, depending on the plant species being transformed, and the genotype, for example.
  • embryogenic callus or other tissues undergoing transformation can be subcultured at regular or irregular intervals in the same medium.
  • callus transformation it is possible to keep individual calluses separate to ensure that only one plant is regenerated per callus and therefore all regenerated plants are derived from independent transformation events.
  • the selection step takes place in the dark, for about 1 to 10 weeks, more preferably 2 to 5 weeks.
  • the plant tissue that continued to grow in the presence of the selection agent, and which, therefore, was genetically modified can be manipulated and regenerated, placing it in culture media and conditions suitable growth.
  • the transgenic plants thus obtained can be tested for the presence of the DNA of interest.
  • the term "regenerate”, for purposes of this invention refers to the formation of a plant, which includes a shoot and roots. Regenerated plants can be planted in substrate suitable, such as soil and be transferred to the greenhouse.
  • “genetically modified” or “transgenic” or “stably transformed” means a plant cell, plant part, plant tissue, or plant that comprises a DNA sequence of interest that is introduced into its genome via transformation.
  • the bacterium is of the genus Agrobacterium.
  • the bacterium is Agrobacterium tumefaciens.
  • the bacterium is an EHA105 strain of Agrobacterium tumefaciens.
  • the present invention also relates to the characterization of the selected event (CTC75064-3) and methods of detecting plant material derived therefrom.
  • Analytical methods for detecting and characterizing transgenic plants include indirect methods (protein-based detection methods) or direct methods (DNA-based detection methods)
  • the map of genetic insertions cas present in event CTC75064-3 is represented in Figure 3 (SEQ ID NO 2).
  • the flanking sequences of event CTC75064-3 are characterized by comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24.
  • the flanking sequences of event CTC75064-3 are characterized by SEQs ID NO 23 and SEQ ID NO 24.
  • a polynucleotide comprising at least 14 contiguous nucleotides of the sequence SEQ ID NO 18.
  • a polynucleotide comprising at least 15 contiguous nucleotides of SEQ is provided. ID NO 18.
  • a polynucleotide comprising at least 16 contiguous nucleotides of SEQ ID NO 18 is provided.
  • said polynucleotide comprises at least 17 contiguous nucleotides of SEQ ID NO 18.
  • said polynucleotide comprises at least 18 contiguous nucleotides of SEQ ID NO 18.
  • said polynucleotide comprises at least 19 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of SEQ ID NO 18.
  • said polynucleotide comprises at least 25 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises SEQ ID NO 18. In a further aspect of the invention, said poly - nucleotide is characterized by the fact that it comprises SEQ ID NO 13.
  • a polynucleotide comprising at least 14 contiguous nucleotides SEQ ID NO. 19. In one embodiment, a polynucleotide comprising at least 15 contiguous nucleotides of SEQ ID NO. 19. According to one aspect of the invention, there is provided a polynucleotide comprising at least 16 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, said polynucleotide comprises at least 17 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 18 contiguous nucleotides of SEQ ID NO 19.
  • said polynucleotide comprises at least 19 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of SEQ ID NO 19. In in one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of SEQ ID NO 19.
  • a polynucleotide comprising at least 25 contiguous nucleotides of SEQ ID NO. 19.
  • said polynucleotide comprises SEQ ID NO 19.
  • said polynucleotide is characterized in that it comprises SEQ ID NO 12.
  • a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 3.
  • a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 4.
  • a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 5.
  • a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 22.
  • a plant comprising at least 14 contiguous nucleotides of SEQ ID NO. 18. In one embodiment, a plant is provided that comprises at least 15 contiguous nucleotides of SEQ ID NO. 18. According to one aspect of the invention, there is provided a plant comprising at least 16 contiguous nucleotides of SEQ ID NO. 18. In one embodiment, the plant comprises at least 17 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 18 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 19 nucleotides - contiguous nucleotides of SEQ ID NO 18.
  • the plant comprises at least 20 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 21 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 22 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 23 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 24 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 25 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises SEQ ID NO 18. In a further embodiment, the plant comprises comprises SEQ ID NO 13.
  • a plant comprising at least 14 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, a plant is provided that comprises at least 15 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, a plant is provided that comprises at least 16 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, the plant comprises at least 17 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 18 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 19 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 20 contiguous nucleotides of SEQ ID NO 19.
  • the plant comprises at least 21 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 22 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 23 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least at least 24 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 24 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 25 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises SEQ ID NO 19. In an additional embodiment, the plant comprises SEQ ID NO 12.
  • said plant is a genetically modified sugar cane (Saccharum spp). Additionally, said plant is resistant to insects and is characterized by comprising a sequence with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO 5. In a further aspect, the insect resistant plant of the present invention is characterized by characterized by comprising a sequence having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 22. In one embodiment of the present invention, said plant is a sugarcane plant. In an additional embodiment, said plant is an insecticidal sugarcane plant which is event CTC75064-3 or a plant derived therefrom.
  • event CTC75064-3 is provided, characterized in that it is a variety of sugar cane ( Saccharum spp.) comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19. Additionally, event CTC75064-3 is characterized by the fact that it is a variety of sugarcane ( Saccharum spp.) comprising SEQ ID NO 5. In a further aspect, event CTC75064 -3 is characterized by the fact that it comprises SEQ ID NO 22.
  • a method for detection and unambiguous characterization of the event of interest is still desirable.
  • the present invention provides a specific method of detecting and identifying event CTC75064-3.
  • the invention provides a method of detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3, characterized by comprising the steps of: a) obtaining a sample of the plant material for analysis; b) extracting DNA from the sample; c) providing primer pairs comprising at least one sense and one antisense primer; d) amplifying the region between the sites where the primers bind; and e) detecting the presence of amplification product.
  • primer pairs (step c) according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO 2 and SEQ ID NO 36.
  • the primer pairs of step c) are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, where at least one (1) primer pair comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • the above primer pairs (step c) are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where at least in the 1(one) pair of primers comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • the primer pairs are designed to bind polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one (1) primer pair comprises at least 7 nucleotides contigs of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • primer pairs are designed to bind to polynucleotides comprising at least - in the 14 nucleotides c sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one (1) primer pair comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • primer pairs according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, where at least one (1) pair of primers consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising at least 14 contiguous nucleotides of selected sequences from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs as described in the detection method, are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein at least one (1) primer pair comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
  • primer pairs are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, where at least 1 (a) primer pair comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
  • primers are designed to bind to a polynucleotide and which comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein at least 1 (one) pair of primers comprises at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
  • the primer pairs as the detection method described, are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, where at least one (1) pair of ini - constructor comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
  • primer pairs according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO. :37, wherein at least one (1) primer pair consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs are designed to bind to polynucleotides comprising at least least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 3 contiguous nucleotides of sequence. those selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs are drawn to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 7 contiguous nucleotides of selected sequences from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • primer pairs are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ I D NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
  • the method of detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3 of the present invention comprises: a) obtaining a sample of plant material for analysis; b) extracting DNA from the sample; c) providing primer pairs designed to bind at least one polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29; d) amplification of the region that lies between the sites where initiators bind; and e) detecting the presence of the amplification product, wherein, the amplification product is characterized by comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33.
  • the primer pairs are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 , SEQ ID NO 29. Additionally, primer pairs are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where, the amplification product detected in step e) is characterized by comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33.
  • primer pairs are designed to bind at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where and, the amplification product detected in step e) is characterized in that it comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38 and SEQ ID NO 39.
  • the amplification product detected in step e) is characterized in that it comprises at least 104 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 038, SEQ ID NO 39.
  • the initiating pairs as per the method, detection whole described, are designed to bind to at least one polynucleotide comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37.
  • primer pairs as detection method described, are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37.
  • primer pairs are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein, the amplification product detected in step e) is characterized by comprise at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33.
  • the in The invention writes primer pairs designed to bind at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein, the amplification product detected in step e) is characterized in that it comprises at least 104 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38, SEQ ID NO 39.
  • primer pairs are provided by the present invention and characterized in that they are selected from the group consisting of sequences with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9.
  • the primer pairs used in step c) of the event-derived plant material detection method CTC75064-3 are characterized in that they are selected from the group consisting of sequences with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9.
  • primer pairs used in step c) of the method for detecting plant material derived from event CTC75064-3 comprise sequences selected from the group consisting of SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9. Further, in a preferred embodiment, primer pairs are provided, where the sense primer consists of SEQ ID NO: 6 and the antisense of SEQ ID NO: 7 and/or, the sense primer consists of SEQ ID NO: 8 and the antisense of SEQ ID NO: 9.
  • pairs of primers are provided for the detection of plant material derived from the event of genetically modified sugar cane CTC75064-3 characterized by the fact that the sense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and the antisense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 7 and/or the sense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and the antisense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 9.
  • primer pairs are characterized by the sense primer comprising SEQ ID NO: 6 and the antisense primer comprising SEQ ID NO: 7 and/or the sense primer comprising SEQ ID NO: 8 and the antisense primer co comprising SEQ ID NO:9.
  • the amplification product (or amplicom) produced by the primers of the described detection is between 100 and 1000 base pairs in length.
  • the amplicon produced by the primers of the described detection method is between 100 and 300 base pairs in length.
  • the amplicom is obtained using primer pairs comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and SEQ ID NO: 7 is characterized by comprising SEQ ID NO 12 and the amplification product (or amplicon) produced by the primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 8 and SEQ ID NO: 9 is characterized by comprising SEQ ID NO 13.
  • DNA molecule is made up of two chains or strands of nucleotides that are held together by hydrogen bonds between the bases of the nucleotides. Pairing occurs according to the complementarity of the bases, following the general rule of: Adenine with Thymine and Cytosine with Guanine.
  • Adenine with Thymine and Cytosine with Guanine.
  • Methods for obtaining samples for DNA extraction for molecular analysis are widely known to a person skilled in the art and include the collection of any plant material derived from the transgenic event CTC75064-3, such as stems, roots and leaves . Preferably, the samples are obtained from intact leaves.
  • Methods of extracting plant DNA include, without limitation, those based on the use of CTAB detergent (Alianabi et al, 1999), followed or not by further purification of the sample with cesium chloride or ammonium acetate, in addition to commercially available methods.
  • Primer pairs suitable for use in this detection method can be designed using parameters well known to those skilled in the art of molecular biology now that the SEQ IDs of the present invention have become available, in particular SEQ IDs Nos 2, 3, 4, 5.18, 19, 22, 23, 24, 29, 30, 31.32, 33, 36, 37, 38 and 39.
  • one or both of the primers in the pair can be designed to be construct specific, trait gene specific, promoter specific, sequence specific for the junction between the inserted DNA and the genomic DNA and/or specific to flanking sequences.
  • PCR polymerase chain reaction
  • One of the embodiments of the present invention uses variations of the PCR principle such as, for example, quantitative real-time PCR, nested PCR (nested PCR), inverse PCR (iPCR), digital PCR, Long PCR, Touchdown PCR, Hot Start PCR, Multiplex PCR, among others.
  • the amplification product can also be detected by different methodologies, which are contemplated in the present invention, such as, for example, the SYBR GreenTM system, which emits fluorescence when this reagent binds to DNA strand.
  • dual and the Taqman® system where detection is based on the interaction of fluorescent probes.
  • the Taqman® methodology uses a probe that is complementary to the intended PCR product segment, located between between the reaction initiators.
  • single-stranded nucleotide sequences complementary to polynucleotides comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO 3, SEQ ID NO. 4, SEQ ID NO 5, SEQ ID NO. 12, SEQ ID NO 13, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 29, SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32, SEQ ID NO. 33, SEQ ID NO. 36, SEQ ID NO. 37, SEQ ID NO. 38 and SEQ ID NO. 39.
  • the probe is bound to the target DNA, and during the extension of the Taq polymerase, through its 5'-exonuclease activity, it removes the probe, releasing the presenting fluorochrome, allowing the emission of its fluorescence.
  • Additional embodiments of this aspect of the present invention include, but are not limited to: loop-mediated isothermal amplification ("LAMP”), capillary gel electrophoresis (“CGE”), "microarray” , Luminex technology, "DNA walking” and “Next Generation Sequencing (NGS), Sanger method, Illumina, among others.
  • LAMP loop-mediated isothermal amplification
  • CGE capillary gel electrophoresis
  • microarray microarray
  • Luminex technology Luminex technology
  • DNA walking and “Next Generation Sequencing (NGS), Sanger method, Illumina, among others.
  • NGS Next Generation Sequencing
  • the detection of amplification products (or amplicons) obtained through the use of primer pairs selected from the group having at least 80%, preferably 85%, 90%, 95%, 98 %, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9 is performed by hybridizing probe selected from the group consisting of, respectively, SEQ ID NO 10 and SEQ ID NO 11.
  • the amplification product (or amplicom) produced by primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7 is visualized through a labeled probe comprising the sequence SEQ ID NO. 10.
  • the amplification product (or amplicom) produced by primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and SEQ ID NO: 9 is visualized through a labeled probe comprising the sequence SEQ ID NO. 11.
  • detection of the amplification product obtained using primers SEQ ID NO: 6 and SEQ ID NO: 7 and/or SEQ ID NO: 8 and SEQ ID NO: 9 is carried out via hybridization with a probe comprising the sequences SEQ ID NO: 10 or SEQ ID NO: 11.
  • Figures 6 (specific detection reaction for the event of the invention via Taqman ® ) and 7 (assay via SYBR GREENTM), represent the validation of both Methods.
  • primers and probes described in the present invention can be used in combination to detect event CTC75064-3.
  • an additional embodiment of the present invention involves the use of multiplex PCR to identify plant material from event CTC75064-3.
  • event CTC75064-3 can be detected from plant material by hybridizing DNA samples with the probes.
  • the present invention describes a method for the detection of plant material derived from a genetically modified sugarcane plant of event CTC75064-3, which comprises: a) obtaining a sample for analysis; b) extracting DNA or RNA from the sample; c) providing a probe or combination of probes designed to bind to at least one polynucleotide comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 and SEQ ID NO 39, wherein said polynucleo
  • the detection method through the use of probes contemplates an additional step (b1) comprising obtaining amplification product from the material of Step b) through the primers described by the present invention.
  • Such an amplification product is used in the later stages of hybridization and detection of the hybridized probe (c - e).
  • step c) of the described method a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO is provided : 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) of the described method is ca- characterized in that it comprises providing a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 15 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 16 contiguous nucleotides of a sequence. selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least at least one polynucleotide comprising at least 17 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • the step c) comprises a probe or combination of probes designed to read to at least one polynucleotide comprising at least 18 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind at least one polynucleotide comprising at least 19 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 20 contiguous nucleotides of a sequence selected from the group consisting of in SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide that comprises at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind at least one polynucleotide comprising at least 22 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 23 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least a polynucleotide comprising at least 24 contiguous nucleotides of a sequence selected from the group consisting of See SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 25 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 26 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33.
  • the probe can be, for example, a PCR product or a restriction digest fragment.
  • the probe as described herein may be labeled with a fluorescent, radioactive, enzymatic, or other suitable label to enable that hybridization can be detected.
  • a fluorescent, radioactive, enzymatic, or other suitable label to enable that hybridization can be detected.
  • a method of hybridizing a probe to the sample under stringent conditions is provided.
  • Stringent hybridization conditions are well known to those skilled in the art and comprise for example: hybridization at a temperature of approximately 65°C in a solution containing 6x SSC, 0.01% SDS and 0.25% desiccated milk powder. - swimming, followed by washing at the same temperature in a solution containing 0.2 x SSC and 0.1% SDS.
  • Suitable techniques for the specific detection of plant material derived from event CTC75064-3 based on the hybridization principle include, but are not limited to Southern Blots and in situ hybridization. One skilled in the art is familiar with techniques such as these.
  • these involve incubating a probe with a sample, washing to remove the unbound probe, and detecting that the probe has hybridized.
  • Said detection method is dependent on the type of demarcation attached to the probe - for example - a radioactively labeled probe can be detected through exposure to and development of the X-ray film.
  • an enzyme-labeled probe can be detected by converting a substrate to effect a color change.
  • another aspect of the invention contemplates a method for detecting plant material derived from event CTC75064-3 which comprises obtaining a sample for analysis; the provision of an antibody designed to bind to a Cry or Nptll protein contained within a plant that comprises at least 14 contiguous nucleotides of a selected sequence from the group consisting of SEQ ID NO. 18 and/or SEQ ID NO 19; incubating said antibody with the sample; and detecting that the antibody has bound.
  • said Cry protein is encoded by the nucleotide sequence SEQ ID NO 20 and the Nptll protein is encoded by the nucleotide sequence SEQ ID NO 21.
  • the Cry protein comprises SEQ ID NO: 34 and the Nptll protein comprises SEQ ID NO: 35.
  • Suitable methods for the detection of plant material derived from event CTC75064-3 based on said antibody binding include, but are not limited to western blots, ELISA ("Enzyme-Linked ImmunoSorbent Assays") and to mass spectrometry (SELDI - "Surface-enhanced laser desorption/ionization” or MALDI - "matrix-assisted laser desorption/ionization”).
  • ELISA Enzyme-Linked ImmunoSorbent Assays
  • MALDI matrix-assisted laser desorption/ionization
  • Typical steps include incubating a sample with an antibody that binds to Cry or NptII protein, washing to remove unbound antibody, and detecting that the antibody has bound.
  • Many such detection methods rely on enzymatic reactions - for example, the antibody can be linked with an enzyme such as peroxidase and on application of a suitable substrate, a color change is detected.
  • Such antibodies may be monoclonal or polyclonal
  • the invention contemplates a method for detecting plant material derived from event CTC75064-3 which comprises obtaining a sample for analysis; providing a protein extract from the sample; the provision of test strips designed to detect the presence of a Cry or Nptll protein contained within a plant comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO. 18 and SEQ ID NO. 19; incubation of test strips with the sample; and detection.
  • said Cry protein is encoded by the nucleotide sequence SEQ ID NO 20 and the Nptll protein is encoded by the nucleotide sequence SEQ ID NO 21.
  • the Cry protein comprises SEQ ID NO: 34 and the Nptll protein comprises SEQ ID NO: 35.
  • a method for detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3 comprising the obtaining a sample derived from event CTC75064-3 and a sample of a non-transgenic sugarcane species for analysis (control); subjecting one or more insects of the species Diatraea saccharallis (susceptible to CrylAc) to the samples; to detect the insecticidal effect on the insects in the samples.
  • “Insecticide” refers to any inhibitory effect on the insect, including, but not limited to, reduced feeding, retarded growth, reduced fecundity, paralysis, death.
  • the method of detecting event CTC75064-3 plant material includes, but is not limited to, leaf feeding biological assays in which a leaf or other suitable part of the event CTC75064-3 plant or any plant material derived from the event CTC75064-3, is infested with one or more insect pests. Detection can be done by evaluating leaf or plant damage after set periods of time, evaluating mortality or other insecticidal effect on insects. Such biological assays can be carried out in the field or in a greenhouse and can be submitted to natural or artificial infestation of insects.
  • kits for detecting the presence in a sample of plant material derived from event CTC75064-3 which comprises a means for detecting the presence of a polynucleotide comprising at least 14 nu- contiguous cleotides of a sequence selected from the group consisting of SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 32 and SEQ ID NO. 33 and/or a Cry protein.
  • said kit may comprise DNA amplification detection technology such as PCR, qPCR or Taqman ® .
  • said kit may comprise detection technology by hybridization of probes such as Southern Blots or In situ Hybridization.
  • detecting the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein comprises primer pairs designed to bind at least one polynucleotide comprising nucleotide contiguous genes of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29.
  • detection of the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein comprises primer pairs designed to bind at least one polynucleotide comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one primer comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
  • detecting the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein comprises a probe comprising sequences selected from the group consisting of SEQ ID NO 10 and SEQ ID NO 11.
  • said kit may comprise antibody-binding detection technology such as western blots, ELISAs, in addition to mass spectrometry (SELDI or MALDI) or test strips.
  • said kit may comprise insect bioassay detection technology such as leaf feeding biological assays or biological mortality assays.
  • said kit may comprise any combination of the detection technologies mentioned above.
  • the transgenic event as described in the present invention has an effect on insects of one or more species of the group comprising insects of the order Lepidoptera. As a result, a reduced number of insecticidal sprays are required during the cultivation of said plant compared to a non-GM sugarcane plant of the same variety.
  • the present invention is not bound by itself to event CTC75064-3, but is further extended to include any plant material derived therefrom, including seed, provided they contain at least one of the polynucleotides of the present invention.
  • the present invention comprises a plant part, a plant cell, a plant tissue, or a seed of a genetically modified sugarcane plant (Saccharum spp.), wherein said plant, part of plant, plant cell, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19.
  • the invention comprises plant, plant part, cell of plant, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13. Additionally, the invention includes plant, part of plant, plant cell, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22.
  • the present invention includes, but is not limited to, plants that are derived from crosses from lines with event CTC75064-3 or a derivative thereof through conventional breeding or other methods.
  • an embodiment of the present invention relates to the use of a plant, plant cell, plant part or seed of a genetically modified sugarcane plant (Saccharum spp.), as described above, characterized by comprising at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19, for regenerating a plant, planting or cultivating a field of plants, or producing a plant product.
  • the invention describes the use of a plant, plant cell, plant part or seed characterized by comprising event CTC75064-3 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product.
  • the present invention describes a method for growing a genetically modified sugarcane plant, comprising growing a sugarcane plant comprising at least one sequence selected from the group consisting of SEQ ID NO 2 under conditions comprising infestation of insects.
  • the present invention describes a method for growing a genetically modified sugarcane plant, comprising growing a sugarcane plant characterized by comprising SEQ ID NO 5 and/or SEQ ID NO 22, under conditions comprising insect infestation.
  • the invention features a method for growing a genetically modified sugarcane plant of event CTC75064-3, comprising growing a sugarcane plant characterized by comprising SEQ ID NO 5 e/ or SEQ ID NO 22, under conditions comprising insect infestation.
  • the insect is Dia trea Saccharalis.
  • the present invention provides a method for controlling insects comprising providing a plant, tissue, plant part, cells or seeds of genetically modified sugar cane from event CTC75064-3 for feeding to the insect. .
  • the present invention further provides a method for controlling insects comprising providing a genetically modified sugarcane plant, tissue, plant part, cells or seeds characterized by comprising SEQ ID NO 2 for feeding to the insect.
  • said method comprises providing a genetically modified sugarcane plant, tissue, plant part, cells or seeds characterized by comprising SEQ ID NO 5 and/or SEQ ID NO 22 for feeding the insect.
  • the insect is Diatrea Saccharalis.
  • the invention further provides a method for increasing the production of sugarcane in the field characterized by culturing a genetically modified sugarcane plant of event CTC75064-3.
  • the present invention further provides a method for increasing the production of sugarcane in the field characterized by cultivating a genetically modified sugarcane plant characterized by comprising SEQ ID NO 2.
  • a method for increasing the production of sugarcane field sugar characterized in that it comprises cultivating a genetically modified sugar cane plant characterized in that it comprises SEQ ID NO 5 and/or SEQ ID NO 22.
  • the insect is Diatrea Saccharalis.
  • the present invention also contemplates the tissue culture of a genetically modified sugarcane plant (Sac-charum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19.
  • tissue culture of a genetically modified sugar cane plant ( Saccharum spp.) comprising at least one selected sequence from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13.
  • tissue culture tissue culture of a genetically modified sugar cane plant Saccharum spp.
  • tissue culture tissue culture of a genetically modified sugar cane plant comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22.
  • a genetically modified sugar cane plant regenerated from the tissue culture described above is also included in the present invention, wherein the regenerated plant comprises at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19.
  • plant cells, plant parts include, but are not limited to: suspension cells, callus, somatic embryos, t meristematic acid, upper stem or stem, stem or stem, stem, leaf, leaf disc, shoots, among others.
  • Another aspect contemplates a method for producing an insect resistant sugarcane plant, characterized in that it comprises crossing a first sugarcane plant with a second sugarcane plant. comprising event CTC75064-3 and producing an offspring of insect resistant sugarcane plants.
  • the plant comprising event CTC75064-3 is a genetically modified sugar cane plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19.
  • the present invention also includes a sugarcane plant (Saccharum spp.) and part of the plant, cells, tissues and seeds of the same generated by the method of producing an insect resistant sugarcane, as described above.
  • the present invention provides a method for producing an insect resistant sugarcane plant comprising inserting at least one fragment of T DNA in a specific site of the genome comprised between the sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination.
  • the invention provides a method for producing an insect resistant sugarcane plant comprising inserting at least one T DNA fragment selected from the group consisting of a sequence having at least 80% identity with any of SEQ ID NO 2, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with any one of SEQ ID NO 2, at a specific site in the genome comprised among the selected sequences of the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination.
  • the insertion of the T-DNA fragment as described above occurs so as to comprise, after insertion, at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
  • the present invention also contemplates a sugarcane plant (Saccharum spp.) and part of the plant, cells, tissues and seeds thereof generated by the method of producing an insect resistant sugarcane as described above.
  • said method is for producing a genetically modified sugarcane plant resistant to event CTC75064-3.
  • the present invention provides a commodity product, characterized in that it is produced from a sugarcane plant comprising event CTC75064-3.
  • the invention includes a commodity product, produced from a genetically modified sugarcane plant (Saccharum spp.) comprising at least one sequence selected from the group. po consisting of SEQ ID NO: 18 and SEQ ID NO: 19.
  • the present invention contemplates a commodity product, produced from a genetically modified plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13.
  • a commodity product produced from a genetically modified plant (Saccharum spp.) comprising at least one sequence selected from the group consisting of having SEQ ID NO: 5 and SEQ ID NO: 22.
  • commodity products include, but are not limited to: bagasse, sugar cane juice, syrup, first generation ethanol (produced from from sugar cane), second-generation ethanol (cellulosic ethanol produced from biomass), biomass, sugar, raw sugar, refined sugar, molasses, vinasse and fiber.
  • the invention further includes plant material derived from event CTC75064-3 which may comprise additional, modified or shorter polynucleotide sequences compared to event CTC75064-3 or exhibit other phenotypic characteristics. For example, it may be desirable to transform plant material derived from event CTC75064-3 to generate a new event that has an additional trait, such as a second insect resistance gene. This process is known as gene stacking.
  • the second insect resistance gene can encode, for example, insecticidal lectins, insecticidal protease inhibitors and other insecticidal proteins derived from Bacillus thuringiensis species.
  • the present invention further provides a method of controlling insects that comprises the provision of plant material derived from event CTC75064-3 in a place where said insects feed.
  • the invention still further provides a method of controlling insects which comprises providing plant material derived from CTC75064-3 at the place where said insects feed and the application of other agrochemical or biological reagents to said plant material such as herbicides, fungicides and others.
  • the invention describes a method for producing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3, comprising introducing a genetic modification to a sugarcane plant ( Saccharum spp. .) comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22 to produce a genetically modified sugar cane plant ( Saccharum spp.) from event CTC75064-3, where the sugarcane plant (Saccharum spp.) genetically modified sugar cane ( Sac charum spp.) has improved insect resistance when compared to a sugar cane plant ( Sac charum spp.) without the genetic modification.
  • the invention provides a method for growing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3, comprising growing a genetically modified sugarcane plant ( Saccharum spp.) comprising at least a sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22 under conditions comprising insect infestation, wherein the genetically modified sugar cane plant (Saccharum spp.) has increased insect resistance compared to a sugarcane plant (Saccharum spp.) without genetic modification growing under the same conditions.
  • the invention also provides a genetically modified sugar cane plant (Saccharum spp.) characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
  • the invention contemplates a genetically modified sugarcane plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO 12 and SEQ ID NO 13.
  • the invention features a genetically modified sugar cane plant ( Saccharum spp .) comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22, where the plant is insect resistant.
  • the genetically modified sugarcane plant (Saccharum spp.) is from event CTC75064-3.
  • Transgenic Sugarcane CTC75064-3 The plants of the transgenic sugarcane event 'CTC75064-3' are substantially genetically equivalent and phenotypically similar to the parental variety 'RB 867515' (Certificate of protection of cultivar Ne 271 ), but with a new and particular characteristic (CrylAc expression.), which guarantees resistance to the sugarcane borer, Diatrea saccharalis (Lepidoptera).
  • CTC75064-3 is a modern sugarcane hybrid that has many desirable agronomic characteristics such as genetic potential for high ratoon cane sprouting vigor, high productivity, excellent tillering, medium-late maturity, high sucrose content and tolerances to scald, blight and sugarcane mosaic.
  • the plants of the event 'CTC75064-3' are characterized by purple culms when exposed to the sun and purple-green when in the shade.
  • 'CTC75064-3' plants exhibit medium to long curved internodes and medium width greenish yellow growth rings.
  • the internodes are smooth in appearance and without growth cracks, with medium waxiness.
  • Plants 'CTC75064-3' exhibit obovate-shaped buds with pubescence in the apical position of the bud.
  • the leaf architecture is erect with curved tips.
  • the middle auricle is lanceolate, with a ligule in crescent shape.
  • Agronomic and phenotypic characteristics of plants of event CTC75064-3 were evaluated in comparison to the parental variety RB ' 867515' and three commercial reference cultivars, in 6 representative locations of the parental variety's cultivation area.
  • the average plant height (measurements performed at 330 days after planting - DAP, except in Juazeiro, where the measurement was performed at 210 DAP), stem diameter (measurements performed at 330 days after planting - DAP, except in Juazeiro, where the measurement was performed at 210 DAP); number of offspring (measurements carried out at 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 and 330 DAP; test not carried out in Juazeiro-BA), plot weight (measurements carried out at 330 Days after planting - DAP, except in Juazeiro, where the measurement was carried out at 210 DAP), sugar content (BRIX %; measurements carried out at 330 Days after planting - DAP, except in Juazeiro, where the measurement was carried
  • compositional studies were carried out and also demonstrate that 'CTC75064-3' is similar to its parental variety ('RB 867515') [compositional parameters related to nutrition and use of sugar cane in the diet, as defined by the OECD Guidance Document (OECD, 2011)].
  • Event CTC75064-3 was obtained by genetic transformation mediated by Agrobacterium tumefasciens of the cultivar RB 867515.
  • the cultivar RB 867515 is a commercial hybrid that is a genotype donor for event CTC75064-3 (genetic background) ; thus, it represents the reference untransformed manifold for event CTC75064-3. This cultivar has medium to late maturation and has been planted especially in south-central Brazil. Thus, like other commercial hybrids, it is a material with high ploidy and many chromosomes derived from two parental varieties: S. officinarum and S. spontaneum (DANIELS and ROACH, 1987; SREENIVASAN et al., 1987).
  • Event CTC75064-3 has the crylAc gene, which expresses a toxin to control D. saccharalis, and the nptll gene, used as a selection marker during the genetic modification process.
  • the development of event CTC75064-3 was proposed to control the sugarcane borer. It is expected that after the hatching of the larvae from the eggs in the leaves of the event CTC75064-3, the young larvae begin to feed and, when ingesting the CrylAc protein, they are controlled before penetrating the stem of the plants of the event CTC75064-3, avoiding the economic damage of the pest to the crop.
  • the crylAc gene expression is regulated by the promoter region comprising CaMV 35s promoter with duplicated enhacer (2xCaMV35s), wheat L-Cab leader sequence, rice actin intron (OsACTI) and Kosak sequence 5' upstream from the transcription start site.
  • the expression of the nptll gene is regulated by the corn ubiquitin gene promoter - UBI-1 (which has an endogenous intron).
  • the crylAc expression cassette uses the CaMV 35S terminator and the nptll cassette uses the no- paline synthase from Agrobacterium tumefaciens (nos).
  • the construction of the present invention was developed by joining the 2xCaMV35s-cry1Ac-T35s and UBI-nptlITNOS cassettes.
  • the T-DNA containing both cassettes was transferred by traditional cloning to the base plasmid ( Figure 4; binary plasmid vector, which contains the bacteria Escherichia coli and Agrobacterium tumefaciens in its host spectrum), generating the plasmid bi - nary containing the construct of the present invention ( Figure 5; SEQ ID NO 14).
  • the construct of the present invention was then transferred from E. coli to Agrobacterium tumefaciens strain EHA105 by isolating and purifying the plasmid DNA and transforming the Agrobacterium by electroporation.
  • An isolated colony of agrobacteria containing the desired vector was inoculated into liquid LB medium supplemented with 100 ⁇ g/ml of spectinomycin and 50 ⁇ g/ml of rifampicin and incubated at 28°C, with agitation at 200 rpm for a period of 24 h. - ras.
  • Stocks containing bacterial suspension and 10% glycerol (v/v) were then prepared and stored in an ultrafreezer -80°C. These stocks were used in the genetic transformation experiments that gave rise to event CTC75064-3.
  • the Agrobacterium culture comprising the EHA105 strain transformed with the binary plasmid of the present invention, was started from a glycerol stock and kept in the dark at 28°C for two to three days.
  • the Agrobacterium suspension to infect the plant material was prepared by resuspending the culture in MS liquid medium plus acetosyringone, adjusting to a final ODeoo of 0.1-1.0 (MS salts, sucrose and vitamins B5).
  • the calluses were separated from the Agrobacterium suspension and the excess suspension was removed. Then, the calluses were cultured for 1-5 days in semi-solid (MS salts, sucrose, vitamins B5, citric acid, gelling agent, 2,4D and acetosyringone) at 22°C in the dark.
  • the calluses were transferred to DT resting medium (MS salts; sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, citric acid, copper sulfate, glycine , gelling agent, 2,4D, thimetine]) and kept for 5-14 days at 26°C in the dark.
  • MS salts sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, citric acid, copper sulfate, glycine , gelling agent, 2,4D, thimetine
  • the transformed cells were selected by successive subcultures in a selection culture medium containing phytoregulators and the selective agent, geneticin (selection medium with geneticin, MS Salts; sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, copper sulfate, glycine, gelling agent, 2,4D, thimetine).
  • geneticin selection medium with geneticin, MS Salts; sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, copper sulfate, glycine, gelling agent, 2,4D, thimetine.
  • the calluses were transferred to the regeneration medium (equivalent to the selection medium without 2,4D) and later to the elongation medium (MS salts; sucrose, vitamins B5, casein hydrolyzate, gelling agent, timetine), and for a photoperiod of 16 hours at 4000 lux. Plants regenerated in the presence of the antibiotic used as a selective agent were multiplied, rooted and acclimatized before being transferred to a greenhouse, including the clone that later gave rise to event CTC75064-3, for which the methods for its characterization.
  • MS salts sucrose, vitamins B5, casein hydrolyzate, gelling agent, timetine
  • the sugarcane polyubiquitin gene was used [Initiator sense: 5 'ACCATTACCCTGGAGGTTGAGA 3 ' (SEQ ID NO: 15); antisense primer: 5' GTCCT GGAT CTT CGCCTT CA 3' (SEQ ID NO: 16); probe: VIC -5 'CTCTGACACCATCGAC 3'-MGB (SEQ ID NO:17)], in a multiplex mode.
  • the qPCR reactions used 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 300 nM of each primer and 200 nM of the corresponding probes.
  • the cycling used was: one cycle of 50°C for 2 minutes for activation of uracil-N-glycosylase, one cycle of 95°C for 20 seconds for activation of DNA polymerase, 40 cycles of 95°C for 3 seconds (denaturation) and 60°C for 30 seconds (annealing and extension).
  • results of the assays indicate the presence of 1 copy of the crylAc gene and 1 copy of the nptll gene present in the genome of the CTC75064-3 event.
  • genomic DNA from event CTC75064-3 was digested separately with different restriction enzymes (EcoRV, Hindlll and Shpl), followed by the probe cold labeling procedure (Digoxigenin - DIG). Briefly, genomic DNAs from event CTC75064-3 and from the parental variety RB 867515 were extracted using NucleoSpin® Plant II kit in tubes, following the manufacturer's recommendations (Macherey-Nagel GmbH & Co. KG, Germany).
  • the quality of the extracted DNA was verified on a 1% agarose gel in 1X TAE buffer (Tris-Acetate EDTA) and 10 ⁇ g of DNA was digested using 100 units of restriction enzyme (10 U/ ⁇ g of gDNA) per sample, in a final volume of 400 ⁇ l of reaction. [00223] The enzymatic reaction was performed according to the manufacturer's instructions (Thermo Fisher, USA). The digestion product was precipitated in 2 volumes of ethanol and 10% 7.5M ammonium acetate, and incubated for 48 h at -20°C. The precipitated DNA was centrifuged at 14,000 x g for 30 min and the formed pellet was resuspended in 35 ⁇ l milli-Q water until complete dissolution.
  • Probes were designed to detect the crylAc gene (CrylAc probe - 1.079 bp), nptII gene (nptII probe 579 bp), and CaMV 35s promoter region (CaMV 35s promoter and OsACT intron; 35S probe - 904 bp), present in event CTC75064-3.
  • the probes to detect fragments of the vector (backbone) were designed through the vector, covering ⁇ 98% of the backbone (probe BB1 - 1875 bp; probe BB2 -2305 bp; probe BB3 -2282 bp; Figure 23 B).
  • Probes were prepared and used to detect targets using PCR reagents from the DIG Probe Synthesis Kit (Roche, cat # 11636090910, Switzerland). About 100 ⁇ g of the linearized vector were used as a template for amplification of regions of interest and incorporation of the digoxigenin molecule (DIG; labeling) by PCR for use as a probe.
  • DIG digoxigenin molecule
  • the primers used to produce the probes, the annealing temperatures (Thyb) and the expected size of each amplicon are listed in Table 04.
  • DNA from the RB 867515 variety was used as a negative control.
  • plasmid DNA containing the construct used to obtain event CTC75064-3 was added to the genomic DNA of RB 867515.
  • the plasmid DNA was previously linearized with the restriction enzyme used in each assay.
  • the Prehybridization treatment consists of incubating the membrane with DIG Easy Hyb solution (Roche # 11603558001, Switzerland) at 40 °C for 3 hours, with denatured salmon sperm DNA at a final concentration of 100 ⁇ g. ml_-1 and constant rotation (0.5 x g). Afterwards, hybridization was performed with the same Prehybridization solution (DIG Easy Hyb with salmon sperm DNA) added to the DIG-labeled and denatured probe. The concentration used for the probes was 65 ⁇ g.ml_-1. The annealing temperature was 50°C.
  • Hybridization was performed in a hybridization oven for approximately 16 hours with constant rotation (0.5 xg). Hybridized membranes were washed and blocked. Afterwards, the blocking solution was discarded and the membrane was covered with a new blocking solution with Anti-Digoxigenin AP fragments (Roche # 11093274910, Switzerland) diluted in a ratio of 1:20,000. The membrane was then incubated for 30 min at room temperature and gently shaken. The antibody solution was discarded and the membrane was washed and incubated with Detection buffer (Roche # 11585762001, Switzerland) plus CDP-Star ready to use (Roche # 12041677001, Switzerland) at a final concentration of 1X, according to the manufacturer's instructions.
  • Detection buffer Roche # 11585762001, Switzerland
  • CDP-Star ready to use Roche # 12041677001, Switzerland
  • iPCR Reverse PCR assays were performed for am- at the ends of the T-DNA in order to isolate and clone the flanking regions of the insert.
  • the iPCR methodology is based on the digestion of genomic DNA using enzymes that cleave the T-DNA sequence and a random sequence of the event's genome. The cleavage products are circularized and subjected to multiple cycles of nested PCR (nested PCR), using primers for known regions of the T-DNA (TABLE 5). From the isolation, sequencing and analysis of the amplified bands in the iPCR reactions by Sanger methodology, a consensus sequence of the flanking regions was defined (SEQ ID NO: 23 and SEQ ID NO: 24).
  • primers Two specific amplification primers (primers) were designed to generate information about the T-DNA insertions in both methodologies, so that, for each primer pair, one primer anchors in the spacer region and one second primer anchors in the genome.
  • primers For the use of Taqman ® technology, specific probes were designed between the primers.
  • the primers designed are characterized as defined in SEQ ID Nos: 6 to 9, where Primer SEQ ID NO: 6 is the right edge sense primer and the sequence primer SEQ ID NO: 7 is the right edge antisense primer, the SEQ ID NO: 8 primer is the left edge sense primer, and the sequence primer SEQ ID NO: 9 is the left edge antisense primer (Table 06).
  • the probe employed in the PCR via Taqman ® technology to identify the CTC75064-3 event comprises the SEQ ID NO: 10 in the right border (RB border) and/or the SEQ ID NO: 11 on the left border (LB border).
  • the qPCR reactions used 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 150 nM of each specific primer for the event of the invention and 100 nM of the corresponding probe, 300 nM of the primers for the gene endogenous poly-ubiquitin and 200 nM of your probe, 100-200 ng of DNA and enough water to complete the volume of 20 ⁇ L.
  • the cycling used was: one cycle of 50°C for 2 minutes for activation of uracil-N-glycosylase, one cycle of 95°C for 20 seconds for activation of DNA polymerase, 40 cycles of 95°C for 3 seconds (denaturation) and 60°C for 1 minute (annealing and extension).
  • the cycling parameters used were: a cycle of DNA denaturation at 95°C for 5 minutes, 35 cycles of primer annealing and amplification at 95°C for 15 seconds and 60°C for 1 minute and a cycle of dissociation to generate the "melting peak" (95°C for 15 sec, 60°C for 1 min, 95°C for 15 sec).
  • the reaction with SYBR safe does not allow the use of multiplex, requiring the preparation of a new endogenous gene amplification reaction, using the same DNA, to eliminate false negatives.
  • Taqman® technology probes specifically bind to DNA and are released during DNA amplification, generating a fluorescence signal captured by the equipment during the process.
  • the CTC75064-3 event can be generated using genomic editing (GE) tools, recreating the event initially developed through an Agrobacterium-mediated genetic transformation method, as presented by the present invention.
  • GE genomic editing
  • the event CTC75064-3 is recreated by inserting the CrylAc gene at the same location in the genome of the cultivar RB 867515 as described for the event CTC75064-3.
  • the expression of the CrylAc gene is regulated by a promoter or a promoter region and a terminator capable of driving the expression of the CrylAc protein to levels sufficient to control the infestation of the target pest.
  • a marker gene or a selection system is also inserted (transiently or stably) to allow selection of the event.
  • the T-DNA of the present invention (SEQ ID NO: 2) is inserted into the genome-specific site(s) as described for event CTC75064-3.
  • the CTC75064-3 event is recreated with the insertion of the crylAc gene, which expresses the toxin that controls D. saccharalis, and the nptll gene.
  • THE crylAc expression by the promoter region comprising CaMV35s promoter with duplicated enhancer, wheat L-Cab leader sequence, OsACTI intron and Kosak sequence 5' upstream from the transcription start site.
  • the expression of nptll genes is regulated by the maize ubiquitin 1 (UBI-1) promoter, which has an endogenous intron.
  • the crylAc expression cassette has CaMV35s terminator (T35s) and the nptII expression cassette uses Agrobacterium tumefaciens nopaline synthase terminator (nos).
  • GE strategy defined for the generation of the CTC75064-3 event results in a low efficiency of T-DNA integration at the specific insertion site of CTC75064-3
  • developmental genes, morphogens or other regulatory elements may be used in conjunction with Genomic Editing (GE) reagents to improve integration efficiency.
  • GE reagents can be delivered in multiple constructs (plasmids), each comprising an element of the enzyme complex (endonuclease, crRNA or guide RNA, and the homologous recombination template-HR).
  • plasmids each comprising an element of the enzyme complex (endonuclease, crRNA or guide RNA, and the homologous recombination template-HR).
  • the construct of the homologous recombination (RH or HR) template comprises the T-DNA (SEQ ID NO 2), flanked by DNA fragments homologous to the flanking sequences of event CTC75064-3 (SEQ ID Nos: 23 and SEQ ID Nos: 24), located on both sides of the T-DNA.
  • a construction comprising the T-DNA sequence selected from the group consisting of SEQ ID NO: 2 and flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences characterizing event CTC75064-3, which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID Nos: 24.
  • the orientation of the sequences is defined by the orientation of the T-DNA in the genome of the event CTC75064-3 such that the homologous recombination template is characterized by comprising an identical or substantially identical sequence. to SEQ ID NO 22.
  • the homologous recombination (HR) template construct comprises SEQ ID NO: 26 ( Figure 21).
  • the invention also comprises a second construct comprising an endonuclease expression cassette.
  • the endonuclease expression cassette comprises the sequence of a Cas9 endonuclease.
  • the endonuclease sequence is codon optimized for expression in sugar cane.
  • a third construct is also contemplated by the present invention comprising only the guide RNA/crRNA expression cassette is also contemplated by the present invention.
  • the Cas 9 endonuclease-containing construct additionally comprises the guide RNA/crRNA sequence.
  • the Cas9 construct comprises the crRNA sequence SEQ ID NO: 28.
  • the Cas9 construct comprises SEQ ID NO: 27 ( Figure 20).
  • a third construct comprising only the guide RNA expression cassette is also contemplated in the present invention and comprises SEQ ID NO: 28 [00255] ) which comprises the endonuclease expression cassettes, the guide RNA (sgRNA) and the homologous recombination template containing the sequence(s) sequences of interest.
  • the single construct comprises the T-DNA sequence of the present invention (SEQ ID NO: 2), flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences that characterize event CTC75064-3 , which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID No 24 located at both ends of the T-DNA.
  • the construct comprises SEQ ID NO: 25 ( Figure 22).
  • the orientation of the sequences is defined by the orientation of the T-DNA in the genome of event CTC75064-3 such that the homologous recombination template is characterized by comprising sequence identical or substantially identical to the sequence selected from the group consisting of SEQ ID NO 22.
  • the constructs also comprise selection/fluorescent markers and/or other genetic engineering systems for removing selection markers and/or nuclease cassettes, such as the Cre homologous recombination system /loxP of bacteriophage P1.
  • selection/fluorescent markers and/or other genetic engineering systems for removing selection markers and/or nuclease cassettes, such as the Cre homologous recombination system /loxP of bacteriophage P1.
  • the marker/nuclease expression cassette which must be deleted, is flanked by LoxP regions, while the Cre recombinase removes this fragment during its transient expression.
  • the event of the invention is generated using methodologies for the direct delivery of proteins, RNA or plasmids.
  • Methodologies for direct delivery are selected from the group consisting of particle bombardment, electroporation, lipofection and protoplast transfection; however, other methodologies known to one skilled in the art may also be used.
  • the event of the present invention can be generated using ribonucleoproteins (RNP) or the direct delivery of sgRNA to the cells or plant tissue to be transformed.
  • RNP ribonucleoproteins
  • the direct delivery of the RNP/sgRNA complex are the bombardment of sugarcane callus particles and the transfection of protoplasts, without, however, being limited to these, being possible to use other methods.
  • methodologies for the transmembrane transport of molecules as is known in the State of the Art.
  • other cell types can be used for transformation, including, but not limited to: leaf discs, meristem, callus, and suspension cells.
  • the endonucleases and the crRNA or guide RNA are delivered directly to the plant cell in the form of an RNP, separated from the homologous recombination (RH) template, which is delivered through a plasmid.
  • RNP homologous recombination
  • the guide RNA must be preliminarily produced by in vitro transcription or be chemically synthesized as a ribooligonucleotide, while the corresponding nuclease can be produced in vivo and later purified (bacterial expression) or purchased from the manufacturer of these products.
  • the nuclease is Cas9.
  • RNP ribonucleoprotein
  • event CTC75064-3 is recreated through the direct delivery of plasmids containing the sequences necessary for the expression of the components of CRISPR-Cas systems and provision of the template for homologous recombination using the machinery of the cell/plant tissue itself, which must be expressed transiently for the synthesis of the complement. enzyme capable of performing site-specific cleavage for homologous recombination.
  • the methodologies for the delivery of plasmids are selected from the group consisting of particle bombardment (biolistics) of sugarcane callus and transformation of protoplasts with polyethylene glycol; however, other transformation methodologies known in the state of the art can be used, as well as other tissues besides callus, such as: protoplasts, leaf discs, meristems, fine cells in suspension, among others.
  • the event of the invention can be generated through the use of plasmids, where the components of the enzymatic complex are stably inserted in the genome of the recipient organism (RB 867515), being expressed and needed. excised after transformation through, for example, the use of a Cre/Lox system or equivalent. The choice of this alternative can generate the permanence of LoxP sites inserted in the plant genome.
  • Other DNA excision strategies known from the prior art can be used to remove the EG reagent from the DNA of the plant genome of event CTC75064-3.
  • Genome editing reagents can be delivered in multiple plasmids, but are preferably delivered in a single plasmid, which comprises LoxP sites, a selection marker, the endonuclease sequence, sgRNA, and the homologous recombination template. .
  • the event of the present invention is generated using indirect plasmid delivery methodologies, such as, for example, Agrobacterium-mediated transformation.
  • Agrobacterium tumefaciens and Agrobacterium rhizogenes can be used.
  • Plant viruses can also be used for indirect delivery of plasmids to plant cells and tissues.
  • geminivirus ge- netically modified genes make it possible to achieve a high efficiency of transformation, especially if the considered strategy does not contemplate the stable insertion of the constructs in the genome.
  • different tissues and cell types can be used for transformation including, but not limited to: calus, protoplasts, leaf discs, meristems, and calus-derived suspension cells.
  • Agrobacterium-mediated transformation is carried out as described in Example 1.
  • the event of the invention is generated through delivery of the plasmid by Agrobacterium-mediated transformation, where the EG reagents are expressed in a transient manner, achieving site-directed integration of CTC75064 -3 without the integration of additional transgenes associated with the EG strategy.
  • EG reagents can be delivered on multiple plasmids, but preferably, on a single plasmid.
  • the construct is SEQ ID NO: 25 and comprises a selectable marker, a nuclease, the guide RNA/crRNA, and the homologous recombination template (RH; Figure 22).
  • the homologous recombination template comprises a T-DNA sequence selected from the group consisting of SEQ ID NO: 2 and flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences that characterize event CTC75064-3, the which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID Nos: 24 and located on either side of the T-DNA.
  • the orientation of the sequences is defined by the orientation of the T-DNA in the genome of event CTC75064-3 such that the homologous recombination template is characterized by comprising sequence identical or substantially identical to the sequence selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24.
  • the event of the invention is generated using indirect delivery through plasmids where EG reagents are stably expressed, thus necessitating excision of EG reagents and/or selection markers integrated through, for example - by the Cre/Lox system.
  • the choice of this alternative can generate the permanence of LoxP sites inserted in the plant genome.
  • Other DNA excision strategies known from the prior art can be used to remove the EG reagent from the plant genome DNA of event CTC75064-3.
  • Morphogenetic genes or other regulatory elements can be included in any of the strategies described above, enabling improvements in transformation efficiency (delivery and genomic integration).
  • the resulting transformed cells will be regenerated to form a plant identical or substantially identical to the event of the present invention.
  • PCR reactions use 0.2 mM primers (Table 7), 20ng DNA, 1X Dream Taq- Thermo Fisher buffer (Thermo Fisher Scientific Inc - USA), Taq polymerase (final volume 20 mI_). Reaction conditions: 1 cycle at 94°C for 1 min; 35 cycles at 94°C for 30 seconds, 65°C for 45 seconds and 72°C for 3 min; and 1 extension cycle at 72°C for 7 minutes.
  • the reactions are performed with 1U of Takara LA Taq enzyme - Takara (Takara Bio Inc- USA), 1 X LA PCR Buffer (Takara Bio Inc - USA), 2.5 mM MgCl2, 2 .5 mM dNTP, 0.5 mM primers and 200 ng DNA (50 ⁇ l final volume).
  • Leaf samples were collected in plots of experimental treatments in AGRO/PHENO trials at 100, 200, 300 and 330DAP. Stems and roots were collected only at 330 DAP. The 330DAP samples were collected at 210 DAP in Juazeiro. After collection, samples were sent for ELISA analysis to determine the expression of CrylAc and Nptll proteins in event CTC75064-3.
  • Leaf Samples 30 cm of tissue were collected from the tip of 5 to 10 "diagnosis" leaves in lines 2 and 3 in a zigzag pattern, avoiding diseased leaves. After removing the midrib, the leaves were chopped into pieces, homogenized and placed in previously identified plastic ziplock bags.
  • Stem samples 10 whole canes were collected in a zigzag pattern. After removing the dry leaves and shoots, the canes were cut into small pieces, homogenized and packed in previously identified packages.
  • Root samples a representative clump of lines 2 and 3 of the experimental plot was collected. The soil was crumbled and the roots washed with clean water to remove excess soil. Then, the clean roots were chopped into pieces, homogenized and placed in previously identified plastic bags. [00282] All tissue samples (leaf, stem and roots) were transferred to the styrofoam box with dry ice within 15 min after collection. The genetic identity of all clumps sampled was confirmed by an event-specific assay as described in the present invention.
  • CrylAc protein For the analysis of CrylAc protein, 30 ⁇ 1 mg of leaf, 200 ⁇ 1 mg of stem and 20 ⁇ 1 mg of roots frozen in dry ice or liquid nitrogen were used. Maceration was performed on the TissueLyser equipment. To the leaf macerated tissue was added 750 ⁇ l of phosphate saline extraction buffer (PBS) supplemented with Tween20 (0.138 M NaCl; 0.027 mM KCl; 200.05% Tween, pH 7.4) diluted according to the instructions of the manufacturer (EnvirologixTM USA). In the case of stems, 375 ml of the same buffer were used, and for roots 1,500 ml of the same buffer.
  • PBS phosphate saline extraction buffer
  • the standards used to obtain the calibration curve for protein quantification were commercial standards already diluted (Albumin Standard Thermo Scientific, cat#23209). Calibrators at the concentration of 2000, 1000, 500, 250, 125 and 0 ⁇ g/mL (prepared in PBST buffer) were used. 10 pL of each calibrator standard was added in triplicate to the wells on the plates. In total, 6 curves were generated from independent dilutions. For the samples, 10pL of 3 individual protein extractions were used in each well. Subsequently, 200pL of Coomassie Plus Reagent Solution was added to each well containing the calibrators and samples. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device, US).
  • Total proteins were obtained in triplicates for each sample studied. After the quantification of total proteins, the sample with the smallest variation of the median value of the quantification was chosen. After quantification, the leaf samples were diluted as follows: leaf samples for CrylAc analysis were diluted 2500x, except for the 100 DAP samples which were diluted 3500x; stem samples for CrylAc analysis were diluted 2,500x; while root samples for CrylAc analysis were diluted 200x. All samples (leaf, root, and stem) for Nptll analysis were diluted 8x.
  • the average concentration of CrylAc in sheets of the event of the invention at 100 DAP is lower than the average concentration at 200 and 300 DAP.
  • Nptll the average expression in leaves throughout the sugarcane cycle remains constant.
  • the standards used to obtain the calibration curve were commercial standards already diluted of BSA (Pre- Diluted Protein Assay Standards: Bovine Serum Albumin (BSA) set-23208, (Thermo Scientific, USA) at a concentration of 2,000, 1,500, 1000, 750, 500, 250, 125 and 0 ⁇ g/ml, prepared in PBST buffer. 10 ml of each calibrator standard was added in triplicate wells on the plate. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device).
  • BSA Pre- Diluted Protein Assay Standards: Bovine Serum Albumin (BSA) set-23208, (Thermo Scientific, USA) at a concentration of 2,000, 1,500, 1000, 750, 500, 250, 125 and 0 ⁇ g/ml, prepared in PBST buffer. 10 ml of each calibrator standard was added in triplicate wells on the plate. The plates were covered and
  • the membrane was blocked for 16 hours at 4°C, under constant agitation, in blocking solution [5% skimmed milk powder (Bio-Rad, USA) and TBS/T (20mM Tris, 150mM NaCI, 1% Tween20] to prevent possible unspecific binding to the membrane.
  • the membrane was incubated with the primary antibody for 90 minutes to detect and confirm the presence and integrity of the CrylAc and Nptll proteins.
  • the polyclonal antibodies used in this assay were Anti-Cry1Ab (Fitzgerald, USA) produced in rabbit and which reacts with CrylAc and CrylAb proteins; and Anti-NptII (Rhea, BRA IM0770-18088), also produced in rabbit, and which reacts with NptII protein, diluted at a concentration of 1:500 in TBS/T (v/v).
  • the membrane was washed in 3 cycles of 5 minutes (3x5) in TBS/T and incubated with secondary Anti-Rabbit antibody conjugated to HRP produced in goats (Sigma), at a concentration of 1:20,000 or Fitzgerald, at a concentration of 1:5,000 - v/v) for 60 minutes. After the incubations, the membrane was washed again with TBS/T (3x5 minutes) and the enzyme immunoreaction was verified on Amersham Hyperfilm ECL X-ray films (GE Healthcare, USA) by reacting with Clarit Western ECL Substrate Kit (Biorad, USA), from according to the manufacturer's instructions. Exposure of the X-ray film to the membrane ranged from 15 seconds to 3 minutes.
  • WT+CP it is commonly known as doublet and is accepted as a product of intracellular proteolytic cleavages of Cry protein in plant leaves, usually produced through the removal of terminal amino acid residues by proteases released during tissue processing. vegetal, as well as the other bands of smaller molecular weights ( ⁇ 20 and 10 kDa) visualized in the samples.
  • Bioassays with the target pest of the crop, D. saccharalis (sugarcane borer), can also be used for the detection and characterization of event CTC75064-3, demonstrating the control effectiveness provided by the CrylAc insecticidal protein expressed.
  • D. saccharalis sucgarcane borer
  • Different Bioassays can be contemplated within the scope of the present invention, such as, for example, Leaf Disc Assay, Telado Efficacy Assays, Tissue Dilution Assays, among others.
  • leaf samples from event CTC75064-3 are collected, cut into discs and then kept moist. Then, the leaf discs are distributed in culture plates containing solid medium (agar), infested with neonatal caterpillars (0-24h of age) of D. saccharalis and incubated at a temperature of 27 ⁇ 1°C, relative humidity 60 ⁇ 10% and photoperiod 12:12 (light:dark), for a period of 7 days. At the end of incubation, evaluate larval mortality and inhibition of larval development of surviving individuals, and the relative efficiency is calculated from this using the formula:
  • each 16-cell quadrant received a sample diluted 25x with MS diet (Multiple Species), filling approximately 1 ml per cell. For infestation, 2 neonate larvae (0-24h of age) were transferred into each cell (32 larvae per quadrant).
  • event CTC75064-3 presented relative efficacy in the control of infestation by D. saccharalis of 98.8% and control of damage to the stems (length) greater than 99.9% in relation to the non-transgenic parental variety RB 867515 (Control).
  • the damage caused by D. saccharalis in the culms of event CTC75064-3 was noticeably lower than in conventional non-transgenic sugarcane RB 867515.
  • the observation and analysis of artificial or natural infestations in planting areas also allow the characterization of the effectiveness of materials against D. saccharalis.
  • the l.l (Intensity of infestation) for example, can be calculated through the evaluation of natural infestations by defining an experimental area for the collection of culms and longitudinal opening to count the total internodes and the brocade internodes ( with damage caused by the borer), thus obtaining the infestation index (l.l).

Abstract

The present invention pertains to the field of biotechnology. More precisely, a gene construct and method are described for the production of a transgenic plant event, especially a sugarcane (Saccharum spp.) event, which is resistant to infestation by the pest Diatraea saccharalis, popularly known as the common borer, sugarcane borer or simply borer. The invention describes the event, methods for identifying the event, and also methods for detecting the insertions on the basis of the junction regions between the insert and the host genome and the flanking regions characterizing same.

Description

Relatório Descritivo da Patente de Invenção para "POLI- NUCLEOTÍDEO, PARES DE INICIADORES, MÉTODOS DE DETEC- ÇÃO DE MATERIAL VEGETAL, CONSTRUÇÃO GENÉTICA, KIT PARA DETECÇÃO DA PRESENÇA EM UMA AMOSTRA DE MATE- RIAL VEGETAL, EVENTO CTC75064-3, PLANTA RESISTENTE A INSETOS, PRODUTO DE COMÓDITE, MÉTODO PARA PRODUZIR UMA PLANTA DE CANA-DE-AÇÚCAR RESISTENTE A INSETO E USO DE UMA PLANTA, CÉLULA DE PLANTA, PARTE DE PLANTA OU SEMENTE". Descriptive Report of the Patent of Invention for "POLYNUCLEOTIDE, PAIRS OF INITIATORS, METHODS OF DETECTION OF PLANT MATERIAL, GENETIC CONSTRUCTION, KIT FOR DETECTION OF THE PRESENCE IN A SAMPLE OF PLANT MATERIAL, EVENT CTC75064-3, PLANT RESISTANT TO INSECTS, COMMODITY PRODUCT, METHOD FOR PRODUCING AN INSECT-RESISTANT SUGARCANE PLANT AND USE OF A PLANT, PLANT CELL, PLANT PART OR SEED".
Campo Técnico Technical Field
[001] A presente invenção está relacionada à área de biotecnolo- gia. Mais precisamente, é descrita uma construção genética e método para a produção de um evento de planta transgênica, especialmente de um evento de cana-de-açúcar ( Saccharum spp.), o qual expressa a toxina CrylAc apresentando resistência à infestação pela praga D/a- traea saccharalis, popularmente conhecida como broca comum, broca- da-cana ou apenas broca. A invenção descreve métodos para detec- ção do evento e de material derivado do evento resistente à infestação por broca-da-cana, assim apresenta polinucleotídeos iniciadores, son- das e as regiões flanqueadoras identificadoras de tal evento. [001] The present invention is related to the area of biotechnology. More precisely, a genetic construct and method for producing a transgenic plant event, especially a sugarcane event ( Saccharum spp.), which expresses the CrylAc toxin showing resistance to D/D pest infestation, is described. atraea saccharalis, popularly known as common borer, sugarcane borer or just borer. The invention describes methods for detecting the event and material derived from the event resistant to sugarcane borer infestation, thus presenting initiator polynucleotides, probes and the flanking regions identifying such event.
Descrição do Estado da Técnica Description of the State of the Technique
[002] A cana-de-açúcar ( Saccharum spp.) é uma planta gramínea pertencente à família botânica Poaceae, sendo originária do Sudeste Asiático, mais precisamente da grande região central da Nova Guiné e Indonésia. Ela é uma das mais importantes espécies vegetais cultiva- das nas regiões tropicais e subtropicais, com uma área maior que 23 milhões de hectares distribuídos em 121 países (FAO Statistical Year- book 2012 p. 233). [002] Sugarcane (Saccharum spp.) is a grass plant belonging to the botanical family Poaceae, originating in Southeast Asia, more precisely in the great central region of New Guinea and Indonesia. It is one of the most important plant species cultivated in tropical and subtropical regions, with an area greater than 23 million hectares distributed in 121 countries (FAO Statistical Yearbook 2012 p. 233).
[003] A cana-de-açúcar é fonte de matéria prima para a produção de açúcar, vinho, melaço, rum, cachaça (o destilado nacional do Bra- sil) e etanol para combustível. O bagaço que produzido após a moa- gem da cana-de-açúcar pode ser utilizado para enfardamento e forne- cimento de energia calorífica, usada no moinho, e eletricidade, que é tipicamente vendida para a grade elétrica do consumidor, ou ainda como matéria prima para produção de etanol de segunda geração (BR 11 2014 02385-1). Desta forma, a agroindústria canavieira, responsá- vel por gerar milhões de empregos na área, tem uma grande impor- tância económica e social, com geração de divisas por meio da co- mercialização de açúcar e etanol e pelo aproveitamento racional da biomassa vegetal. [003] Sugarcane is a source of raw material for the production of sugar, wine, molasses, rum, cachaça (Brazil's national distillate). sil) and ethanol for fuel. The bagasse that is produced after crushing the sugarcane can be used for baling and supplying heat energy, used in the mill, and electricity, which is typically sold to the consumer's electrical grid, or as raw material. raw material for the production of second-generation ethanol (BR 11 2014 02385-1). In this way, the sugarcane agroindustry, responsible for generating millions of jobs in the area, is of great economic and social importance, generating foreign exchange through the commercialization of sugar and ethanol and the rational use of plant biomass.
[004] Mais recentemente, com o advento do tema aquecimento global e uso de fontes alternativas a combustíveis fósseis (biocombus- tíveis), o interesse mundial por cana-de-açúcar tem aumentado de maneira significativa. O uso do etanol derivado da cana de açúcar co- mo fonte de energia renovável tem sido considerado de extrema im- portância para redução dos gases de efeito estufa e da dependência aos combustíveis fósseis, tendo sido considerado uma das peças cha- ves dentre os esforços para controle das mudanças climáticas mundi- ais (Savage, 2011). [004] More recently, with the advent of global warming and the use of alternative sources to fossil fuels (biofuels), world interest in sugarcane has increased significantly. The use of ethanol derived from sugar cane as a source of renewable energy has been considered of extreme importance to reduce greenhouse gases and dependence on fossil fuels, having been considered one of the key pieces among the efforts for controlling global climate change (Savage, 2011).
[005] Devido à importância económica e social da cana-de- açúcar, observa-se um grande esforço em pesquisas com o objetivo de definir melhores práticas agrícolas para o seu cultivo e de melhorar a qualidade das variedades cultivadas. Os esforços para melhoramen- to das características agronómicas da cana de açúcar têm focado no aumento da produção e acúmulo de açúcares, aumento da tolerância a estresses bióticos e abióticos, resistência e tolerância a pragas e pa- tógenos, e desenvolvimento de tecnologias alternativas para a produ- ção de etanol a partir da biomassa lignocelulósica (PI 0802153-8; PI 0904538-4; PI 1101295-1). [005] Due to the economic and social importance of sugarcane, there is a great effort in research with the objective of defining better agricultural practices for its cultivation and to improve the quality of the cultivated varieties. Efforts to improve the agronomic characteristics of sugarcane have focused on increasing the production and accumulation of sugars, increasing tolerance to biotic and abiotic stresses, resistance and tolerance to pests and pathogens, and the development of alternative technologies for the production of ethanol from lignocellulosic biomass (PI 0802153-8; PI 0904538-4; PI 1101295-1).
[006] A complexidade do genoma poliploide e aneuploide das variedades modernas de cana-de-açúcar, somada a sua base genética relativamente restrita e a baixa fertilidade, impõem grandes dificulda- des e inúmeras limitações na seleção das plantas com as característi- cas agronómicas desejáveis por técnicas do melhoramento convenci- onal (Souza et al, 2011; D'Hont & Glaszmann, 2005, Basel, v. 109, n. 1-3, p. 27-33; Cheavegatti-Gianotto et al., 2011), demandando grandes investimentos, mão de obra intensiva e prazos muito longos para se- rem considerados razoáveis considerando o contexto e demanda atual do mercado global. [006] The complexity of the polyploid and aneuploid genome of modern sugarcane varieties, added to their relatively restricted genetic base and low fertility, impose great difficulties and innumerable limitations in the selection of plants with the desirable agronomic characteristics by conventional breeding techniques (Souza et al. al, 2011; D'Hont & Glaszmann, 2005, Basel, v. 109, n. 1-3, p. 27-33; Cheavegatti-Gianotto et al., 2011), demanding large investments, intensive labor and deadlines too long to be considered reasonable considering the context and current demand of the global market.
[007] O aumento da produção de cana de açúcar observada nos últimos 20 anos é resultado não apenas do aumento da produtividade dos canaviais, mas também da diversificação das variedades cultiva- das, o que permitiu a expansão da área cultivada de cana de açúcar para outras regiões geográficas. Essa expansão geográfica demanda o desenvolvimento de variedades adaptadas a diferentes condições edafoclimáticas, garantindo a sustentabilidade do mercado de cana de açúcar através do fornecimento contínuo de novos germoplasmas me- lhor adaptados às condições locais e capazes de controlar doenças e pragas. [007] The increase in sugarcane production observed in the last 20 years is the result not only of the increase in sugarcane productivity, but also of the diversification of cultivated varieties, which allowed the expansion of the sugarcane cultivated area to other geographic regions. This geographic expansion demands the development of varieties adapted to different soil and climatic conditions, ensuring the sustainability of the sugarcane market through the continuous supply of new germplasm, better adapted to local conditions and capable of controlling diseases and pests.
[008] O melhoramento convencional é importante para o supri- mento contínuo de variedades, mas não suficiente para atender o mercado atual já que parte das características desejáveis e necessá- rias para os cultivos modernos não pode ser encontrada no background genético das espécies, sendo fundamental o desenvolvi- mento de técnicas para a introdução de genes exógenos. Devido às limitações dos métodos de melhoramento convencional e da necessi- dade crescente de incorporar com celeridade e eficiência característi- cas desejáveis em diferentes variedades, o uso de técnicas de enge- nharia genética (biotecnologia) nos programas de melhoramento gené- tico de cana-de-açúcar ganhou destaque, em especial devido ao su- cesso comercial da incorporação de características agronómicas dese- jáveis por meio de engenharia genética em outras espécies vegetais (soja, milho, canola, beterraba e algodão, por exemplo). [008] Conventional breeding is important for the continuous supply of varieties, but not enough to meet the current market since part of the desirable and necessary characteristics for modern crops cannot be found in the genetic background of the species, being the development of techniques for the introduction of exogenous genes is fundamental. Due to the limitations of conventional breeding methods and the growing need to quickly and efficiently incorporate desirable traits into different varieties, the use of genetic engineering techniques (biotechnology) in cane genetic improvement programs of sugar gained prominence, especially due to the commercial process of incorporating desirable agronomic traits through genetic engineering into other plant species (soybean, corn, canola, sugar beet and cotton, for example).
[009] A engenharia genética de plantas envolve a transferência de genes de interesse para dentro de células vegetais (transformação genética), de tal maneira que uma progénie fértil e agronomicamente superior mantenha e expresse de forma estável o gene responsável pela característica desejada. [009] Plant genetic engineering involves the transfer of genes of interest into plant cells (genetic transformation) in such a way that fertile and agronomically superior progeny maintain and stably express the gene responsible for the desired trait.
[0010] Apesar de comprovada a possibilidade de alteração genéti- ca (incorporação de características desejáveis) de cana-de-açúcar por meio de engenharia genética [resistência a vírus (Guo et ai, 2015; Zhu et al., 2011), insetos (Kalunke, Kolge, Babu, & Prasad, 2009; Weng et ai, 2011), herbicidas (Enriquez-Obregon, Vazquez-Padron, Prieto- Samsonov, De la Riva, & Selman- Housein, 1998; van der Vyver, Con- radie, Kossmann, & Lloyd, 2013), tolerância a seca (Molinari et ai, 2007; Reis et ai, 2014), salinidade (Kumar, Uzma, Khan, Abbas, & Ali, 2014) e toxicidade a alumínio (Ribeiro, 2016), aumento da produção e acúmulo de açúcar (Bewg, Poovaiah, Lan, Ralph, & Coleman, 2016; Mudge et ai, 2013)], essa abordagem também é limitada por caracte- rísticas intrínsecas da cana-de-açúcar, que apresenta respostas genó- tipo-dependentes à aplicação de técnicas de cultura de tecidos, baixa taxa de indução e regeneração de calos embriogênicos, além da im- possibilidade de usar o embrião zigótico como tecido alvo na transfor- mação genética, ao contrário de milho, arroz, trigo e outros cereais comerciais [(Anderson & Birch, 2012; Basnayake, Moyle, & Birch, 2011 ; Molinari et ai, 2007)]. É frequente a obtenção de uma baixa taxa de eficiência de transformação, sendo observado alta variabilidade en- tre genótipos, havendo ainda inúmeros desafios a serem transpostos para a incorporação de características agronómicas desejáveis por meio de engenharia genética em cana-de-açúcar. [0011] A cana-de-açúcar é tida como uma espécie recalcitrante para transformação genética e, apesar de terem sido avaliadas diver- sas abordagens de engenharia genética para essa espécie, ainda não há protocolos padrões que garantam a produção de eventos transgê- nicos (Smith et al. 1992; Rathius & Birch. 1992.; Chen et al. 1987; Arencibia. 1998; Manickavasagam etal. 2004.; Elliott etal. 1998). [0012] Somada às limitações inerentes da espécie para a aplica- ção das técnicas existentes de engenharia genética devido à comple- xidade do genoma da cana-de-açúcar (alto grau de ploidia, aliado à presença de aneuploidia), não existem programas de introgressão de características de interesse agronómico em cultivares de cana de açú- car através de retrocruzamentos (reconstituição de um genótipo espe- cífico), como é comumente realizado em outras culturas de interesse comercial. Desta forma, para a "introdução" de uma mesma caracterís- tica em mais de um germoplasma, possibilitando ganhos em produtivi- dade em diferentes regiões de cultivo, é necessário realizar nova transformação genética, incorrendo nos mesmos custos e riscos asso- ciados ao primeiro evento obtido para aquela característica. Ainda hoje há muito pouca previsibilidade de sucesso para a introdução de uma mesma característica em diferentes variedades de cana de açúcar, sendo um processo extremamente genótipo-dependente, o que torna desafiador a construção de um portfólio de produtos geneticamente modificados para esta espécie. [0010] Despite the proven possibility of genetic alteration (incorporation of desirable characteristics) of sugarcane through genetic engineering [virus resistance (Guo et al., 2015; Zhu et al., 2011), insects (Kalunke, Kolge, Babu, & Prasad, 2009; Weng et al, 2011), herbicides (Enriquez-Obregon, Vazquez-Padron, Prieto-Samsonov, De la Riva, & Selman-Housein, 1998; van der Vyver, Con- radie, Kossmann, & Lloyd, 2013), drought tolerance (Molinari et al, 2007; Reis et al, 2014), salinity (Kumar, Uzma, Khan, Abbas, & Ali, 2014) and aluminum toxicity (Ribeiro, 2016). ), increased production and sugar accumulation (Bewg, Poovaiah, Lan, Ralph, & Coleman, 2016; Mudge et al, 2013)], this approach is also limited by the intrinsic characteristics of sugarcane, which has genotype-dependent responses to the application of tissue culture techniques, low rate of induction and regeneration of embryogenic callus, in addition to the impossibility of using the zygotic embryo as te target in genetic transformation, unlike corn, rice, wheat and other commercial cereals [(Anderson & Birch, 2012; Basnayake, Moyle, & Birch, 2011 ; Molinari et al, 2007)]. It is common to obtain a low rate of transformation efficiency, with high variability between genotypes being observed, and there are still numerous challenges to be overcome in order to incorporate desirable agronomic traits through genetic engineering in sugarcane. [0011] Sugarcane is considered a recalcitrant species for genetic transformation and, although several genetic engineering approaches have been evaluated for this species, there are still no standard protocols that guarantee the production of transgenic events. (Smith et al. 1992; Rathius & Birch. 1992.; Chen et al. 1987; Arencibia. 1998; Manickavasagam et al. 2004.; Elliott et al. 1998). [0012] Added to the inherent limitations of the species for the application of existing techniques of genetic engineering due to the complexity of the sugarcane genome (high degree of ploidy, allied to the presence of aneuploidy), there are no programs of introgression of traits of agronomic interest in sugarcane cultivars through backcrosses (reconstitution of a specific genotype), as is commonly performed in other crops of commercial interest. Thus, for the "introduction" of the same trait in more than one germplasm, enabling gains in productivity in different growing regions, it is necessary to carry out a new genetic transformation, incurring the same costs and risks associated with the first one. event obtained for that feature. Even today there is very little predictability of success for the introduction of the same trait in different varieties of sugarcane, being an extremely genotype-dependent process, which makes the construction of a portfolio of genetically modified products for this species challenging.
[0013] A complexidade genotípica da cana de açúcar também im- pacta significativamente a caracterização dos eventos gerados de for- ma a garantir as características necessárias para a sua comercializa- ção. A identificação inequívoca dos eventos transgênicos é fundamen- tal para assegurar a sua rastreabilidade e monitoramento, sendo exi- gência regulatória para sua comercialização. A alta poliploidia do ge- noma da cana-de-açúcar e o alto número de regiões repetidas, asso- ciado a pouca informação existente sobre a sua organização e estrutu- ra, constituem desafios para a caracterização dos eventos transgêni- cos gerados. [0013] The genotypic complexity of sugarcane also significantly impacts the characterization of the events generated in order to guarantee the necessary characteristics for its commercialization. The unequivocal identification of transgenic events is essential to ensure their traceability and monitoring, being a regulatory requirement for their commercialization. The high polyploidy of the sugarcane genome and the high number of repeated regions, as- Due to the little information available about its organization and structure, they constitute challenges for the characterization of the transgenic events generated.
[0014] Existem diversos desafios técnicos a serem transpostos no campo do melhoramento genético de cana-de-açúcar para aumento da previsibilidade sobre os resultados esperados, mesmo quando aplica- das técnicas convencionais e/ou moleculares/genéticas amplamente conhecidas. Ainda assim, não restam dúvidas da urgência na obten- ção de variedades melhoradas que apresentem características que impactem significativamente a produtividade da cultura e, portanto, o seu mercado. [0014] There are several technical challenges to be overcome in the field of genetic improvement of sugarcane to increase the predictability of the expected results, even when widely known conventional and/or molecular/genetic techniques are applied. Even so, there is no doubt about the urgency of obtaining improved varieties that present characteristics that significantly impact the crop's productivity and, therefore, its market.
[0015] Historicamente, as pragas agrícolas são um dos principais fatores que acarretam prejuízos na agricultura. No Brasil, a principal praga da cana-de-açúcar é a espécie Diatraea saccharalis Fabricius, 1794 (Lepidoptera: Crambidae), popularmente conhecida como broca comum, broca-da-cana ou apenas broca. Esta é encontrada em prati- camente toda extensão cultivada da cultura, cuja área é de aproxima- damente 10 milhões de hectares na atual safra 2019/20 (CONAB, 2019). [0015] Historically, agricultural pests are one of the main factors that cause losses in agriculture. In Brazil, the main pest of sugarcane is the species Diatraea saccharalis Fabricius, 1794 (Lepidoptera: Crambidae), popularly known as common borer, sugarcane borer or just borer. This is found in practically the entire cultivated area of the crop, whose area is approximately 10 million hectares in the current 2019/20 crop (CONAB, 2019).
[0016] Após o acasalamento, a fêmea da broca-da-cana deposita de 200 a 400 ovos, em ambas faces e também nas bainhas das folhas verdes. Após a eclosão dos ovos, as larvas neonatas alimentam-se do parênquima foliar, migrando para a região da bainha à procura de abrigo. Permanecem nesta região por 7 a 10 dias, alimentando-se pela raspagem da bainha da folha ou da casca dos entrenós jovens. Após uma ecdise, as lagartas perfuram a casca do colmo, penetrando em seu interior. O inseto abre galerias no interior dos colmos, geralmente no sentido ascendente, à medida que se alimenta. No interior do colmo a lagarta passa por, aproximadamente, seis ecdises antes de se tornar adulto alado (DINARDO-MIRANDA, 2014). Esta é a fase do desenvol- vimento em que o inseto provoca os danos económicos à cultura (Fi- gura 1). [0016] After mating, the female sugarcane borer lays 200 to 400 eggs, on both sides and also in the sheaths of green leaves. After the eggs hatch, the neonate larvae feed on the leaf parenchyma, migrating to the sheath region in search of shelter. They remain in this region for 7 to 10 days, feeding by scraping the leaf sheath or the bark of young internodes. After an ecdysis, the caterpillars pierce the stem bark, penetrating its interior. The insect opens galleries inside the culms, usually in an upward direction, as it feeds. Inside the stalk, the caterpillar passes through approximately six ecdyses before becoming a winged adult (DINARDO-MIRANDA, 2014). This is the development phase ment in which the insect causes economic damage to the crop (Figure 1).
[0017] O ataque da broca-da-cana também causa graves danos secundários à qualidade da matéria-prima utilizada para a produção do açúcar e do álcool pois a perfuração do colmo da cana-de-açúcar pela broca cria condições para entrada de fungos e bactérias oportunistas, especialmente Fusarium moniliforme e Colletotríchum falcatum, cau- sando a podridão vermelha. O complexo broca/podridão vermelha provocam deterioração fisiológica, microbiológica e tecnológica da ca- na-de-açúcar. As bactérias associadas à matéria-prima com podridão- vermelha produzem fermentações indesejáveis, resultando em produ- tos estranhos à fermentação alcoólica do processamento industrial. Além disso, estas bactérias também produzem ácidos orgânicos e gomas (dextranas) a partir dos açúcares contidos no mosto, que afe- tam negativamente a viabilidade das células de leveduras, requerendo sua substituição nas dornas de fermentação (PRECETTI e TERÁN, 1983; PRECETTI et ai, 1988; BOTELHO e MACEDO, 2002). Outro problema decorrente da presença de bactérias nas dornas de fermen- tação é a possibilidade de ocorrência de floculação do fermento. Neste caso, as bactérias contaminantes formam uma mucilagem que agrega as células da levedura, provocando sua floculação. Além da perda de leveduras e da produtividade de açúcar, plantas atacadas por bro- ca/podridão-vermelha também apresentam altos teores de compostos fenólicos (METCALF e LUCKMANN, 1994; PRICE, 1997). [0017] The attack of the sugarcane borer also causes serious secondary damage to the quality of the raw material used for the production of sugar and alcohol because the drilling of the sugarcane stalk by the borer creates conditions for the entry of fungi and opportunistic bacteria, especially Fusarium moniliforme and Colletotrichum falcatum, causing red rot. The borer/red rot complex causes physiological, microbiological and technological deterioration of sugarcane. Bacteria associated with raw material with red rot produce undesirable fermentations, resulting in products foreign to the alcoholic fermentation of industrial processing. In addition, these bacteria also produce organic acids and gums (dextrans) from the sugars contained in the must, which negatively affect the viability of yeast cells, requiring their replacement in the fermentation vats (PRECETTI and TERÁN, 1983; PRECETTI et al. ai, 1988; BOTELHO and MACEDO, 2002). Another problem arising from the presence of bacteria in the fermentation vats is the possibility of flocculation of the yeast. In this case, the contaminating bacteria form a mucilage that aggregates the yeast cells, causing their flocculation. In addition to the loss of yeast and sugar productivity, plants attacked by borer/red rot also have high levels of phenolic compounds (METCALF and LUCKMANN, 1994; PRICE, 1997).
[0018] Utilizando valores médios de perdas agrícola e no processo industrial de produção de açúcar e etanol causadas pela broca, e um índice de Intensidade de Infestação de 4%, muito comum nos canavi- ais brasileiros, somados aos custos de controle usados, estima-se que esta praga causa perdas económicas da ordem de mais de R$ 5 bi- lhões por ano ao setor sucroenergético brasileiro. [0019] A broca da cana-de-açúcar é uma praga de difícil controle por inseticidas químicos, devido ao comportamento alimentar da larva no colmo, impedindo o contato efetivo do inseticida com o inseto. Al- ternativamente aos inseticidas químicos, as proteínas inseticidas, iden- tificadas principalmente a partir da bactéria Bacillus thuringiensis (Bt), têm sido utilizadas com grande efetividade para o controle de pragas agrícolas, dentre elas Diatraea sp. Dentre as proteínas inseticidas de- rivadas de cepas Bt, as proteínas cristalinas Cry destacam-se pela to- xicidade específica às larvas de espécies de lepidópteros, dípteros e coleópteros comuns como pragas agrícolas. Essas proteínas, produzi- das como protoxinas (65-149 KDa), são solubilizadas e ativadas no intestino dos insetos suscetíveis por proteólise e se ligam à membrana das células intestinais, induzindo à lise osmótica do epitélio, o que ocasiona a morte do inseto. [0018] Using average values of agricultural losses and in the industrial process of sugar and ethanol production caused by the borer, and an Infestation Intensity Index of 4%, very common in Brazilian sugarcane plantations, added to the control costs used, estimates It is known that this plague causes economic losses of more than R$ 5 billion per year to the Brazilian sugar-energy sector. [0019] The sugarcane borer is a pest difficult to control by chemical insecticides, due to the feeding behavior of the larva in the stem, preventing the effective contact of the insecticide with the insect. As an alternative to chemical insecticides, insecticidal proteins, identified mainly from the bacterium Bacillus thuringiensis (Bt), have been used with great effectiveness to control agricultural pests, among them Diatraea sp. Among the insecticidal proteins derived from Bt strains, the crystal proteins Cry stand out for their specific toxicity to the larvae of species of Lepidoptera, Diptera and Coleoptera common as agricultural pests. These proteins, produced as protoxins (65-149 KDa), are solubilized and activated in the intestine of susceptible insects by proteolysis and bind to the membrane of intestinal cells, inducing osmotic lysis of the epithelium, which causes the death of the insect.
[0020] As proteínas Cry são classificadas em diversos grupos de acordo com a homologia de suas sequências, dentre eles, o grupo de proteínas classificado como Cry1 apresenta alta especificidade contra insetos lepidópteros, sendo um excelente candidato para manipulação genética dos germoplasmas de cana-de-açúcar para produção de va- riedades resistentes à broca da cana. A expressão heteróloga de pro- teínas Cry1 em variedades de cana-de-açúcar, apesar de desafiadora, possui grande potencial para o controle da broca da cana, reduzindo as perdas económicas do setor sucroalcooleiro, assim como a libera- ção de inseticidas químicos no meio ambiente. [0020] Cry proteins are classified into several groups according to the homology of their sequences, among them, the group of proteins classified as Cry1 has high specificity against lepidopteran insects, being an excellent candidate for genetic manipulation of sugarcane germplasm. -sugar for the production of varieties resistant to the sugarcane borer. The heterologous expression of Cry1 proteins in sugarcane varieties, despite being challenging, has great potential for controlling the sugarcane borer, reducing economic losses in the sugar-alcohol sector, as well as the release of chemical insecticides in the sugarcane industry. environment.
[0021] Persiste, portanto, a necessidade de desenvolvimento de estratégias para mitigar os danos causados à cultivos de cana-de- açúcar pela infestação de pragas, principalmente pela infestação pela praga broca-da-cana. Ao oferecer aos produtores de cana-de-açúcar variedades de alto potencial de produção para diferentes ambientes edafoclimáticos, aliada a uma característica de resistência à broca, a biotecnologia agrícola confere importante contribuição ao setor sucro- energético e aos plantadores de cana-de-açúcar. [0021] There remains, therefore, the need to develop strategies to mitigate the damage caused to sugarcane crops by pest infestation, mainly by infestation by the sugarcane borer pest. By offering sugarcane producers varieties with high production potential for different soil and climatic environments, combined with a characteristic of resistance to the borer, the agricultural biotechnology makes an important contribution to the sugar-energy sector and sugarcane growers.
[0022] O evento de cana-de-açúcar geneticamente modificado CTC75064-3 apresentado pela presente invenção tem como objetivo fornecer aos produtores de cana-de-açúcar brasileiros uma cultivar que possui o background genético da cultivar RB 867515 (Certificado de proteção de cultivar Ne 271) e é resistente à broca da cana de açú- car. Na safra 2018/2109, a variedade RB 867515 foi plantada em aproximadamente 1.730 mil hectardes na região Centro-Oeste do Bra- sil. O cultivo dessa variedade na região nordeste do Brasil foi de apro- ximadamente 57 mil hectares. Considerando a área total de cana culti- vada (CONAB, 2019), essa variedade possui um market share no Bra- sil de cerca de 21%. [0022] The genetically modified sugarcane event CTC75064-3 presented by the present invention aims to provide Brazilian sugarcane producers with a cultivar that has the genetic background of the cultivar RB 867515 (Certificate of protection of cultivar Ne 271) and is resistant to sugar cane borers. In the 2018/2109 harvest, the RB 867515 variety was planted on approximately 1,730,000 hectares in the Center-West region of Brazil. The cultivation of this variety in the northeast region of Brazil was approximately 57 thousand hectares. Considering the total area of sugarcane cultivated (CONAB, 2019), this variety has a market share in Brazil of around 21%.
Objetivos da invenção Objectives of the invention
[0023] É um primeiro objetivo prover polinucleotídeos que identifi- quem de maneira inequívoca o evento CTC75064-3. [0023] It is a first objective to provide polynucleotides that unequivocally identify the event CTC75064-3.
[0024] É um segundo objetivo descrever pares de iniciadores e sondas capazes de identificar os polinucleotídeos que caracterizam o evento CTC75064-3. [0024] It is a second objective to describe pairs of primers and probes capable of identifying the polynucleotides that characterize the CTC75064-3 event.
[0025] É um terceiro objetivo fornecer métodos de detecção de material vegetal derivado de uma planta de cana de açúcar genetica- mente modificada do evento CTC75064-3. [0025] It is a third objective to provide methods for detecting plant material derived from a genetically modified sugarcane plant from event CTC75064-3.
[0026] Como um quarto objetivo a presente invenção descreve um kit para detecção da presença do evento CTC75064-3 em uma amos- tra de material vegetal. [0026] As a fourth objective, the present invention describes a kit for detecting the presence of event CTC75064-3 in a sample of plant material.
[0027] Como um quinto objetivo da presente invenção, descreve- se uma construção genética capaz de conferir a uma planta de cana- de-açúcar ( Saccharum spp.), resistência à infestação por inseto, parti- cularmente pela praga Diatraea saccharalis. [0027] As a fifth objective of the present invention, a genetic construct capable of conferring resistance to insect infestation, particularly by the pest Diatraea saccharalis, to a sugarcane plant (Saccharum spp.) is described.
[0028] É um sexto objetivo da invenção prover uma cana-de- açúcar geneticamente modificada, uma parte de planta, uma célula de planta, um tecido de planta ou uma semente compreendendo a cons- trução genética de interesse localizada em sítios definidos no genoma da planta de cana de açúcar transformada, caracterizada por sequên- cias flanqueadoras específicas. [0028] It is a sixth object of the invention to provide a sugarcane genetically modified sugar, a plant part, a plant cell, a plant tissue or a seed comprising the genetic construct of interest located at defined sites in the genome of the transformed sugarcane plant, characterized by specific flanking sequences .
[0029] O sétimo objetivo da presente invenção é prover um produ- to de comódite. [0029] The seventh objective of the present invention is to provide a commodity product.
[0030] Um oitavo objetivo da presente invenção se dá por meio de uma planta resistente à insetos. [0030] An eighth objective of the present invention is through an insect resistant plant.
[0031] Finalmente, como um nono e décimo objetivos, a invenção ainda fornece como um método de produção e cultivo de uma planta de cana-de-açúcar resistente a inseto e/ou uso de tal planta, célula de planta, parte de planta ou semente. Adicionalmente, provê um método para cultivar uma planta de cana de açúcar em um ambiente de infes- tação de insetos, um método para controle de insetos e um método para aumentar a produção de cana de açúcar no campo. [0031] Finally, as a ninth and tenth object, the invention further provides as a method of producing and cultivating an insect resistant sugarcane plant and/or using such a plant, plant cell, plant part or seed. Additionally, it provides a method for growing a sugarcane plant in an insect infestation environment, a method for controlling insects and a method for increasing sugarcane production in the field.
Breve Descrição da Invenção Brief Description of the Invention
[0032] O primeiro objetivo é alcançado por meio de polinucleotí- deos que compreendem pelo menos 14 nucleotídeos contíguos de se- quências selecionadas do grupo consistindo em SEQ ID NO: 5, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 18, SEQ ID NO: 19, e SEQ ID NO: 22. [0032] The first objective is achieved by using polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 22.
[0033] O segundo objetivo da invenção é alcançado por meio de pares de iniciadores em que o iniciador senso possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de iden- tidade com a SEQ ID NO: 6 e o iniciador antissenso possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 7 e/ou o iniciador senso possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 8 e o iniciador antissenso pos- suindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 9. [0033] The second object of the invention is achieved by means of primer pairs wherein the sense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and the antisense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 7 and/or the sense primer having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and the antisense primer can be having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 9.
[0034] O terceiro objetivo é alcançado por um método de detec- ção de material vegetal derivado de uma planta de cana de açúcar ge- neticamente modificada do evento CTC75064-3 caracterizado por compreender as etapas de: a) a obtenção de uma amostra para análise; b) a extração do DNA da amostra; c) o fornecimento de pares de iniciadores compreendendo pelo menos um iniciador senso e outro antissenso; d) a amplificação da região que fica entre os sítios em que os iniciadores se ligam; e e) detecção da presença de produto da amplificação. [0034] The third objective is achieved by a method of detection of plant material derived from a genetically modified sugarcane plant of event CTC75064-3 characterized by comprising the steps of: a) obtaining a sample for analysis; b) extracting DNA from the sample; c) providing primer pairs comprising at least one sense and one antisense primer; d) amplification of the region that lies between the sites where the primers bind; and e) detecting the presence of amplification product.
[0035] Ainda para atingir o terceiro objetivo, os pares de iniciado- res da etapa c) são desenhados para se ligarem a um polinucleotídeo compreendendo nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um par de iniciadores compreende nucleotídeos contíguos de sequências selecionados do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. [0035] Still to achieve the third objective, the primer pairs of step c) are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
[0036] Em continuidade para alcançar o terceiro objetivo, a pre- sente invenção descreve um método de detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3 caracterizado por compreender as etapas de: a) obter uma amostra para análise; b) extrair o DNA ou RNA da amostra; c) fornecer uma sonda planejada ou uma combinação de sondas planejadas para se ligar a pelo menos um polinucleotídeo que compreende nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 e SEQ ID NO 39; d) hibridizar a dita sonda com o material extraído da amos- tra da etapa (II), e e) detectar a sonda hibridizada. [0036] Continuing to achieve the third objective, the present invention describes a method of detecting plant material derived from a genetically modified sugarcane plant of event CTC75064-3 characterized by comprising the steps of: a) obtaining a sample for analysis; b) extracting DNA or RNA from the sample; c) providing a probe designed or a combination of probes designed to bind at least one polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30 , SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 and SEQ ID NO 39; d) hybridizing said probe with the material extracted from the sample of step (II), and ee) detecting the hybridized probe.
[0037] O quarto objetivo da invenção evidencia-se por meio de um kit para detecção da presença em uma amostra de material vegetal derivado do evento CTC75064-3 caracterizado por compreender um meio para detecção da presença em uma amostra de um polinucleotí- deo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33 e/ou uma proteína Cry. [0038] O quinto objetivo é alcançado através de construção gené- tica, caracterizado pelo fato de que compreende pelo menos 80%, pre- ferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com sequências selecionadas do grupo consistindo em SEQ ID NO: 1, SEQ ID NO 2 e SEQ ID NO 14. [0037] The fourth objective of the invention is evidenced by means of a kit for detecting the presence in a sample of plant material derived from the event CTC75064-3 characterized by comprising a means for detecting the presence in a sample of a polynucleotide that comprises at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33 and/or a Cry protein. [0038] The fifth objective is achieved through genetic construction, characterized by the fact that it comprises at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO 2 and SEQ ID NO 14.
[0039] Já o sexto objetivo concretiza-se por meio do evento CTC75064-3, o qual é caracterizado pelo fato de ser uma variedade de cana-de-açúcar ( Saccharum spp.) e compreender pelo menos 14 nu- cleotídeos contíguos das sequências selecionadas do grupo consistin- do em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 e SEQ ID NO 4. Adicionalmente, o evento CTC75064-3 é caracterizado pelo fato de ser uma variedade de cana-de-açúcar ( Saccharum spp.) e compreender pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 22. [0039] The sixth objective is achieved through event CTC75064-3, which is characterized by the fact that it is a variety of sugarcane (Saccharum spp.) and comprises at least 14 contiguous nucleotides of the sequences selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 and SEQ ID NO 4. Additionally, event CTC75064-3 is characterized by the fact that it is a variety of sugarcane ( Saccharum spp.) and comprise at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22.
[0040] Adicionalmente, a invenção também provê uma planta, par- te da planta, célula da planta, tecido da planta ou semente de cana-de- açúcar ( Saccharum spp.) geneticamente modificada compreendendo pelo menos 14 nucleotídeos contíguos das sequências selecionadas do grupo consistindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 e SEQ ID NO 4. Adicionalmente, a invenção também provê uma plan- ta, parte da planta, célula da planta, tecido da planta ou semente de cana-de-açúcar ( Saccharum spp.) geneticamente modificada caracte- rizada pelo fato de compreender pelo menos uma sequência selecio- nada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 22; [0040] Additionally, the invention also provides a plant, plant part, plant cell, plant tissue or sugarcane seed. genetically modified sugar ( Saccharum spp.) comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 3 and SEQ ID NO 4. a genetically modified plant part, plant cell, plant tissue or seed of sugarcane ( Saccharum spp.) characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22;
[0041] O produto de comódite do sétimo objetivo da invenção é alcançado a partir da cana-de-açúcar geneticamente modificada da presente invenção. [0041] The commodity product of the seventh object of the invention is achieved from the genetically modified sugarcane of the present invention.
[0042] O oitavo objetivo da presente invenção provê um método para produzir uma planta de cana-de-açúcar resistente a inseto com- preendendo a SEQ ID NO: 20 e SEQ ID NO: 21. A invenção também provê um método para produzir uma planta de cana-de-açúcar resis- tente a inseto compreendendo cruzar uma primeira planta de cana-de- açúcar com uma segunda planta de cana-de-açúcar compreendendo o evento CTC75064-3. [0042] The eighth object of the present invention provides a method for producing an insect resistant sugarcane plant comprising SEQ ID NO: 20 and SEQ ID NO: 21. The invention also provides a method for producing a insect resistant sugarcane plant comprising crossing a first sugarcane plant with a second sugarcane plant comprising event CTC75064-3.
[0043] A presente invenção ainda fornece um método para produ- zir uma planta resistente a inseto caracterizado por compreender in- troduzir uma modificação genética em uma planta de cana de açúcar ( Saccharum spp) compreendendo SEQ ID NO 5 ou SEQ ID NO 22, para produzir uma planta de cana de açúcar geneticamente modificada (Saccharum spp ) do evento CTC75064-3. Adicionalmente, a presente invenção provê um método para produzir uma planta de cana de açú- car geneticamente modificada resistente a inseto compreendendo in- serir um fragmento de T DNA em sítio específico do genoma compre- endido entre as sequências selecionadas do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24 através de recombinação homóloga. Preferivelmente, o referido método é para produzir uma planta de cana de açúcar geneticamente modificada resistente a inseto do evento CTC75064-3. [0043] The present invention further provides a method for producing an insect resistant plant characterized in that it comprises introducing a genetic modification into a sugarcane plant ( Saccharum spp) comprising SEQ ID NO 5 or SEQ ID NO 22, to produce a genetically modified sugarcane plant (Saccharum spp ) from event CTC75064-3. Additionally, the present invention provides a method for producing a genetically modified insect resistant sugar cane plant comprising inserting a T DNA fragment at a specific site in the genome comprised among sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination. Preferably, said method is for producing a sugarcane plant of genetically modified insect resistant sugar from event CTC75064-3.
[0044] Por fim, o décimo objetivo da invenção descreve o uso de uma planta, célula de planta, parte de planta ou semente caracterizada por compreender pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19 para regenerar uma planta, plantar ou cultivar um campo de plantas ou produzir um produ- to de planta. Preferivelmente, a invenção descreve o uso de uma plan- ta, célula de planta, parte de planta ou semente caracterizada por compreender o evento CTC75064-3 para regenerar uma planta, plan- tar ou cultivar um campo de plantas ou produzir um produto de planta. Adicionalmente, a presente invenção descreve um método para culti- var uma planta de cana de açúcar geneticamente modificada compre- endendo crescer uma planta de cana de açúcar compreendendo a SEQ ID NO 2 sob condições compreendendo infestação de insetos. Adicionalmente, a presente invenção fornece um método para controle de insetos compreendendo disponibilizar uma planta, tecido, parte da planta, células ou sementes de cana de açúcar geneticamente modifi- cada, caracterizada por compreender a SEQ ID NO 2, para alimenta- ção do inseto. Adicionalmente, a invenção ainda fornece um método para aumentar a produção de cana de açúcar no campo, caracterizado por compreender cultivar uma planta de cana de açúcar geneticamen- te modificada caracterizada por compreender a SEQ ID NO 2. Descrição sumarizada das Figuras [0044] Finally, the tenth object of the invention describes the use of a plant, plant cell, plant part or seed characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product. Preferably, the invention describes the use of a plant, plant cell, plant part or seed characterized by comprising event CTC75064-3 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product. . Additionally, the present invention describes a method for growing a genetically modified sugarcane plant comprising growing a sugarcane plant comprising SEQ ID NO 2 under conditions comprising insect infestation. Additionally, the present invention provides a method for controlling insects comprising providing a genetically modified plant, tissue, plant part, cells or seeds, characterized by comprising SEQ ID NO 2, for feeding to the insect. . Additionally, the invention further provides a method for increasing the production of sugarcane in the field, characterized in that it comprises cultivating a genetically modified sugarcane plant characterized by comprising SEQ ID NO 2. Summary Description of the Figures
[0045] A Figura 1 exemplifica o dano as plantas de cana de açúcar causado pela Diatrea saccharalis (broca da cana). [0045] Figure 1 exemplifies the damage to sugarcane plants caused by Diatrea saccharalis (sugarcane borer).
[0046] A Figure 2 exemplifica o complexo da broca-podridão ver- melha causado pela infestação de Diatrea saccharalis (broca da cana). [0047] A Figura 3 representa o mapa do T-DNA introduzido no evento da presente invenção. [0048] A Figura 4 representa o plasmídeo utilizado como base pa- ra construção do plasmídeo utilizado na presente invenção. [0046] Figure 2 exemplifies the red rot-borer complex caused by Diatrea saccharalis (sugarcane borer) infestation. [0047] Figure 3 represents the map of the T-DNA introduced in the event of the present invention. [0048] Figure 4 represents the plasmid used as a basis for construction of the plasmid used in the present invention.
[0049] A Figura 5 representa o plasmídeo resultante, utilizado para a obtenção do evento de interesse. [0049] Figure 5 represents the resulting plasmid, used to obtain the event of interest.
[0050] A Figura 6 representa um dos gráficos de amplificação da qPCR via Taqman® (fluorescência relativa x ciclo) para o evento de interesse. [0050] Figure 6 represents one of the amplification graphs of qPCR via Taqman® (relative fluorescence x cycle) for the event of interest.
[0051] A Figura 7 representa as curvas de melting da qPCR via SYBR GREEN™ (fluorescência relativa x temperatura) para o evento de interesse. As setas indicam o pico específico de amplificação do evento de interesse bem como as linhas basais indicativas de ausên- cia de amplificação para os demais eventos e controles negativos. [0052] A Figura 8 é o resultado da comparação de médias da ex- pressão de CrylAc em folhas (Tecido Fresco) do evento CTC75064-3 durante o ciclo da cana de açúcar. Análise conjunta para Barrinha, Pi- racicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) e Ju- azeiro (BA). Barras seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de 5% de probabilidade. Cada barra representa a média ± erro padrão, conforme resultados da análise conjunta. [0051] Figure 7 represents the melting curves of qPCR via SYBR GREEN™ (relative fluorescence x temperature) for the event of interest. The arrows indicate the specific amplification peak of the event of interest as well as the baseline indicative of absence of amplification for the other events and negative controls. [0052] Figure 8 is the result of the comparison of means of CrylAc expression in leaves (Fresh Tissue) of event CTC75064-3 during the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ± standard error, according to the results of the joint analysis.
[0053] A Figura 9 é o resultado da comparação de médias da ex- pressão de CrylAc em folhas (tecido seco) do evento CTC75064-3 para ciclo da cana de açúcar. Análise conjunta para Barrinha, Piraci- caba, Valparaiso (SP), Quirinópolis (GO), Mandaguaçu (PR) e Juazei- ro (BA). Barras seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de 5% de probabilidade. Cada barra representa a mé- dia ± erro padrão, conforme resultados da análise conjunta. [0053] Figure 9 is the result of the comparison of means of CrylAc expression in leaves (dry tissue) of event CTC75064-3 for the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ± standard error, according to the results of the conjoint analysis.
[0054] A Figura 10 é o resultado da comparação de médias da ex- pressão de CrylAc em folha, colmo e raiz do evento CTC75064-3 (te- cido fresco e tecido seco). Barras seguidas pela mesma letra não dife- rem entre si pelo Teste t ao nível de 5% de probabilidade. Cada barra representa a média ± erro padrão. [0054] Figure 10 is the result of the comparison of means of CrylAc expression in leaf, stem and root of event CTC75064-3 (fresh tissue and dry tissue). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. each bar represents the mean ± standard error.
[0055] A Figura 11 é o resultado da comparação de médias da ex- pressão de Nptll em folhas (tecido fresco) do evento CTC75064-3 para ciclo de cana. Análise conjunta para Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (GO), Mandaguaçu (PR) e Juazeiro (BA). Barras seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de 5% de probabilidade. Cada barra representa a média ± erro padrão, conforme resultados da análise conjunta. [0055] Figure 11 is the result of the comparison of means of Nptll expression in leaves (fresh tissue) of event CTC75064-3 for the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ± standard error, according to the results of the joint analysis.
[0056] A Figura 12 é o resultado da comparação de médias da ex- pressão de Nptll em folhas (Tecido seco) do evento CTC75064-3 para ciclo de cana de açúcar. Análise conjunta para Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) e Juazeiro (BA). Barras seguidas pela mesma letra não diferem entre si pelo Tes- te t ao nível de 5% de probabilidade. Cada barra representa a média ± erro padrão, conforme resultados da análise conjunta. [0056] Figure 12 is the result of the comparison of means of the expression of Nptll in leaves (Dry tissue) of the event CTC75064-3 for the sugarcane cycle. Joint analysis for Barrinha, Piracicaba, Valparaiso (SP), Quirinópolis (-GO), Mandaguaçu (PR) and Juazeiro (BA). Bars followed by the same letter do not differ from each other by the t Test at the 5% probability level. Each bar represents the mean ± standard error, according to the results of the joint analysis.
[0057] A Figura 13 é o resultado da comparação de médias da ex- pressão de Nptll em colmo, folha e raiz do evento CTC75064-3 (tecido fresco e tecido seco). Barras seguidas pela mesma letra não diferem entre si pelo teste de t ao nível de 5% de probabilidade. Cada barra representa a média ± erro padrão. [0057] Figure 13 is the result of the comparison of means of Nptll expression in stem, leaf and root of event CTC75064-3 (fresh tissue and dry tissue). Bars followed by the same letter do not differ from each other by the t test at the 5% probability level. Each bar represents the mean ± standard error.
[0058] A Figura 14 é o resultado da metodologia Western blot para identificação da proteína CrylAc. M: Marcador de peso molecular (KDA). R1 a R4: repetições biológicas do evento CTC75064-3. WT (Controle negativo): proteína total extraída da cultivar parental RB867515. CP (Controle positivo): 1ng de proteína CrylAc; WT+CP: 1ng de proteína CrylAc purificada diluída em proteínas totais extraídas da cultivar parental. 0: Poço vazio. [0058] Figure 14 is the result of the Western blot methodology to identify the CrylAc protein. M: Molecular weight marker (KDA). R1 to R4: biological repeats of event CTC75064-3. WT (Negative control): total protein extracted from the parental cultivar RB867515. CP (Positive Control): 1ng CrylAc protein; WT+CP: 1ng of purified CrylAc protein diluted in total proteins extracted from the parental cultivar. 0: Empty well.
[0059] A Figura 15 é o resultado da metodologia Western blot para identificação da proteína Nptll. M: marcador de peso molecular (kDa). R1 e R2: repetições biológicas do evento CTC75064-3. CP (controle positivo): 5 ng de proteína Nptll; WT+CP: 5 ng de proteína Nptll diluída em proteínas totais extraídas da cultivar parental. WT: proteína total extraída da cultivar parental. [0059] Figure 15 is the result of the Western blot methodology to identify the Nptll protein. M: molecular weight marker (kDa). R1 and R2: biological repeats of event CTC75064-3. CP (control positive): 5 ng NptII protein; WT+CP: 5 ng of Nptll protein diluted in total proteins extracted from the parental cultivar. WT: total protein extracted from the parental cultivar.
[0060] A Figura 16 representa A) índice de infestação (l.l.%), B) Comprimento relativo do dano no evento CTC75064-3 e nos controles (plantas de primeiro corte). As letras representam o resultado da análi- se de variância pelo teste T e as barras se referem ao erro padrão. [0061] A Figura 17 representa Eficácia relativa do controle da bro- ca pelo evento CTC75-064-3 em 4 locais (l.l% = índice de infestação). As barras se referem ao erro padrão da análise. [0060] Figure 16 represents A) infestation index (l.l.%), B) Relative length of damage in event CTC75064-3 and in controls (first cut plants). The letters represent the result of the analysis of variance by the T test and the bars refer to the standard error. [0061] Figure 17 represents the relative effectiveness of the borer control by the event CTC75-064-3 in 4 places (l.l% = infestation index). The bars refer to the standard error of the analysis.
[0062] A Figura 18 demonstra A: mortalidade larval no ensaio de disco foliar com material vegetal do evento resistente a inseto (broca da cana de açúcar) CTC75064-3 em comparação com o material pa- rental (sem modificação genética) CTC75-TC (cultivar RB867515); B: Eficácia relativa do controle da broca da cana de açúcar pelo CTC75- 064-3; C: exemplos de tamanhos de larvas (desenvolvimento larval) após sete dias de alimentação no ensaio de disco foliar. Na esquerda estão exemplos de larvas que se alimentaram com material vegetal de planta resistentes a inseto do evento CTC75064-3, e na direita estão exemplos de larvas que se alimentaram com material vegetal de planta da cultivar parental (sem modificação genética) CTC75-TC (cultivar RB867515). [0062] Figure 18 demonstrates A: larval mortality in leaf disc assay with plant material from the insect resistant event (sugar cane borer) CTC75064-3 compared to the parental material (no genetic modification) CTC75-TC (cultivate RB867515); B: Relative effectiveness of sugarcane borer control by CTC75-064-3; C: Examples of larval sizes (larval development) after seven days of feeding in the leaf disc assay. On the left are examples of larvae that fed on plant material resistant to event CTC75064-3, and on the right are examples of larvae that fed on plant material of the parental cultivar (without genetic modification) CTC75-TC ( cultivar RB867515).
[0063] Figura 19 apresenta exemplos de cassetes de expressão para geração do evento CTC75064-3 através de edição genômica. O cassete A compreende Cas9 com códon otimizados para cana de açú- car com expressão dirigida através do promotor pZmUbi e pelo termi- nator T-35s; o Cassete B compreende crRNA para Cas9 com a ex- pressão dirigida pelo promotor U3 de trigo e o Cassete C compreende o molde HR compreendendo a região de T-DNA do evento CTC75064- 3 (SEQ ID NO 2) com braços homólogos (sequências flanqueadoras) para integração sítio específica. [0063] Figure 19 shows examples of expression cassettes for generating event CTC75064-3 through genomic editing. Cassette A comprises codon-optimized Cas9 for sugar cane with expression directed through the pZmUbi promoter and the T-35s terminator; Cassette B comprises crRNA for Cas9 with expression driven by the wheat U3 promoter and Cassette C comprises the HR template comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences). ) for site-specific integration.
[0064] Figura 20 representa um exemplo de construção de edição genômica compreendendo os cassetes “Cas 9” e “crRNA”. [0064] Figure 20 represents an example of a genome editing construction comprising the cassettes “Cas 9” and “crRNA”.
[0065] A Figura 21 demonstra um exemplo de construção de edi- ção genômica compreendendo o molde HR CTC75064-3 compreen- dendo a região de T-DNA do evento CTC75064-3 (SEQ ID NO 2) com braços homólogos (sequências flanqueadoras) para integração sítio específica. [0065] Figure 21 demonstrates an example of a genome editing construct comprising the HR template CTC75064-3 comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences) for site-specific integration.
[0066] A Figura 22 representa uma construção de edição genômi- ca compreendendo todos os cassetes para a geração do evento CTC75064-3: o cassete do Cas9 com códon otimizados para cana de açúcar com expressão dirigida através do promotor pZmUbi e pelo terminador T-35s; o cassete crRNA para Cas9 com a expressão dirigi- da pelo promotor U3 de trigo e o cassete do molde HR compreenden- do a região de T-DNA do evento CTC75064-3 (SEQ ID NO 2) com braços homólogos (sequências flanqueadoras) para integração sítio específica. [0066] Figure 22 represents a genome-editing construct comprising all cassettes for generating event CTC75064-3: the cassette of Cas9 with codon-optimized sugar cane with expression directed through the pZmUbi promoter and the T-terminator. 35s; the crRNA cassette for Cas9 with expression driven by the wheat U3 promoter and the HR template cassette comprising the T-DNA region of event CTC75064-3 (SEQ ID NO 2) with homologous arms (flanking sequences) for site-specific integration.
[0067] A Figura 23 A) apresenta uma representação esquemática da estratégia de Southern blot utilizando duas enzimas de restrição Hindlll e EcoRV para identificação do T-DNA inserido no evento CTC75064-3. Linhas cinzas abaixo da representação esquemática do T-DNA indicam os tamanhos esperados dos fragmentos de T-DNA do evento CTC75064-3 gerados. B) é uma representação esquemática da estratégia de Southern blot para detecção de fragmentos do vetor (backbone) usando a enzima de restrição Sph\. [0067] Figure 23 A) presents a schematic representation of the Southern blot strategy using two restriction enzymes Hindlll and EcoRV to identify the T-DNA inserted in event CTC75064-3. Gray lines below the schematic representation of the T-DNA indicate the expected sizes of the generated T-DNA fragments from event CTC75064-3. B) is a schematic representation of the Southern blot strategy for detection of vector (backbone) fragments using the restriction enzyme Sph\.
[0068] A Figura 24 apresenta resultados de Southern blot utilizan- do as enzimas de restrição Hindlll (esquerda) e EcoRV (direita). Resul- tados para a hibridização com a sonda Cry que reconhece o gene crylAc. M: marcador de peso molecular; WT: controle negativo; 1C: controle positivo 1 cópia. T0: cana planta (primeiro corte). T1: soca 1 (segundo corte); T2: soca (terceiro corte) 2; T3: soca 3 (quarto corte). [0069] A Figura 25 apresenta resultados de Southern blot utilizan- do as enzimas de restrição EcoRV (esquerda) e Hind\\\ (direita). Resul- tados para a sonda 35s que reconhece o promotor 35s. M: marcador de peso molecular; WT: controle negativo; 1C: controle positivo 1 có- pia. TO: cana planta (primeiro corte). T1: soca 1 (segundo corte); T2: soca (terceiro corte) 2; T3: soca 3 (quarto corte). [0068] Figure 24 shows Southern blot results using restriction enzymes Hindll (left) and EcoRV (right). Results for hybridization with the Cry probe that recognizes the crylAc gene. M: molecular weight marker; WT: negative control; 1C: positive control 1 copy. T0: plant cane (first cut). T1: punch 1 (second cut); T2: stump (third cut) 2; T3: clog 3 (fourth cut). [0069] Figure 25 shows Southern blot results using restriction enzymes EcoRV (left) and Hind\\\ (right). Results for the 35s probe that recognizes the 35s promoter. M: molecular weight marker; WT: negative control; 1C: positive control 1 copy. TO: plant cane (first cut). T1: stump 1 (second cut); T2: stump (third cut) 2; T3: clog 3 (fourth cut).
[0070] A Figura 26 apresenta resultados de Southern blot utilizan- do as enzimas de restrição Hind\\\ (esquerda) e EcoRV (direita). Resul- tados para a sonda nptll que reconhece o gene nptll. M: marcador de peso molecular; WT: controle negativo; 1C: controle positivo 1 cópia. T0: cana planta (primeiro corte). T1: soca 1 (segundo corte); T2: soca (terceiro corte) 2; T3: soca 3 (quarto corte). [0070] Figure 26 shows Southern blot results using the restriction enzymes Hind\\\ (left) and EcoRV (right). Results for the nptll probe that recognizes the nptll gene. M: molecular weight marker; WT: negative control; 1C: positive control 1 copy. T0: plant cane (first cut). T1: stump 1 (second cut); T2: stump (third cut) 2; T3: clog 3 (fourth cut).
[0071] Figura 27 A) representa os resultados de Southern blot usando as enzimas de restrição Sph\ e as sondas do vetor ( backbone ) BB1 e BB3. M: marcador de peso molecular; WT: controle negativo; 1C: controle positivo 1 cópia com pCTC146; 1C*: controle positivo 1 cópia com pCTC302. BB1: controle positivo com a sonda backbone 1; BB2: controle positivo com a sonda backbone 2; BB3: controle positivo com a sonda backbone 3. As linhas vermelhas indicam duas repeti- ções do evento CTC75064-3. Poço (Lane) 1: outros eventos. B) usan- do as enzimas de restrição Sph\ e a sonda do vetor (backbone) BB2. M: marcador de peso molecular; WT: controle negativo; 1C: controle positivo 1 cópia com pCTC146; 1C*: controle positivo 1 cópia com pCTC302. BB1: controle positivo com a sonda backbone 1; BB2: con- trole positivo com a sonda backbone 2; BB3: controle positivo com a sonda backbone 3. As linhas vermelhas indicam duas repetições do evento CTC75064-3. Poço (Lane) 1: outros eventos. [0071] Figure 27 A) represents Southern blot results using Sph\ restriction enzymes and vector (backbone) probes BB1 and BB3. M: molecular weight marker; WT: negative control; 1C: positive control 1 copy with pCTC146; 1C * : positive control 1 copy with pCTC302. BB1: positive control with backbone probe 1; BB2: positive control with backbone probe 2; BB3: positive control with backbone probe 3. Red lines indicate two repetitions of event CTC75064-3. Well (Lane) 1: other events. B) using SphI restriction enzymes and the BB2 vector (backbone) probe. M: molecular weight marker; WT: negative control; 1C: positive control 1 copy with pCTC146; 1C * : positive control 1 copy with pCTC302. BB1: positive control with backbone probe 1; BB2: positive control with the backbone probe 2; BB3: positive control with backbone probe 3. Red lines indicate two repeats of event CTC75064-3. Well (Lane) 1: other events.
[0072] Figura 28 demonstra a confirmação de integridade das re- giões flanqueadoras do T-DNA inserido no evento CTC75064-3. (A) Confirmação da integridade da borda esquerda (5'). (B) Confirmação da integridade da borda direita (3'). Evento: DNA do evento CTC75064-3; WT: DNA CT 7515 parental (cultivar RB 867515); C-: controle negativo. [0072] Figure 28 demonstrates the confirmation of the integrity of the flanking regions of the T-DNA inserted in event CTC75064-3. (THE) Confirmation of the integrity of the left edge (5'). (B) Confirmation of the integrity of the right edge (3'). Event: DNA from event CTC75064-3; WT: parental CT 7515 DNA (culture RB 867515); C-: negative control.
Descrição Detalhada da Invenção Detailed Description of the Invention
[0073] Inicialmente, considera-se como "evento" a planta geneti- camente modificada produzida por qualquer método de modificação e/ou transformação genética que expresse de forma significativa e constante a característica que se desejava incluir nesta, a qual é con- ferida pelo transgene introduzido. Mais particularmente, no presente caso, considera-se "evento" a planta geneticamente modificada, prefe- rencialmente uma planta geneticamente modificada de cana-de-açúcar ( Saccharum spp.) que, após modificação genética, expressa a caracte- rística de resistência à praga, particularmente à praga Diatraea sac- charalis (broca-da-cana). Em um escopo preferido, a cana de açúcar geneticamente modificada produzida por transformação genética é de- signada “CTC75064-3” e pode alternativamente ser referida como “evento CTC75064-3”. [0073] Initially, an "event" is considered to be the genetically modified plant produced by any method of genetic modification and/or transformation that significantly and constantly expresses the characteristic that was intended to be included in it, which is conferred by the introduced transgene. More particularly, in the present case, the genetically modified plant is considered an "event", preferably a genetically modified sugarcane plant (Saccharum spp.) which, after genetic modification, expresses the characteristic of resistance to pest, particularly Diatraea saccharalis (sugarcane borer). In a preferred scope, genetically modified sugarcane produced by genetic transformation is designated “CTC75064-3” and may alternatively be referred to as “Event CTC75064-3”.
[0074] Ainda, para fins de referência, a não ser que expressamen- te mencionado ao contrário, por região LB entende-se a borda esquer- da de transferência do T-DNA (5'), e por região RB entende-se a borda direita de transferência do T-DNA (3'). [0074] Also, for reference purposes, unless expressly mentioned to the contrary, by region LB is understood the left transfer edge of the T-DNA (5'), and by region RB is understood the right transfer edge of the T-DNA (3').
[0075] Adicionalmente, todas as sequências biológicas aqui descri- tas, exceto onde explicitamente mencionado o contrário, englobam também sequências possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as sequências a que se referem. [0075] Additionally, all biological sequences described herein, unless explicitly stated otherwise, also encompass sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with the sequences to which they refer.
[0076] Por fim, por material vegetal entende-se todo e qualquer tecido vegetal ou derivado deste, tais como, mas não limitados a, se- mentes, troncos, caules, colmos, folhas, palhas, cascas, raízes, célu- las, moléculas de origem vegetal, entre outros, e ainda todo e qualquer produto de uma planta ou derivado deste, por exemplo, mas não limi- tado a, seiva, açúcar, etanol, entre outros. [0076] Finally, plant material means any and all plant tissue or its derivatives, such as, but not limited to, seeds, trunks, stems, stems, leaves, straws, bark, roots, cellu- them, molecules of vegetable origin, among others, and also any product of a plant or derivative thereof, for example, but not limited to, sap, sugar, ethanol, among others.
[0077] A tecnologia do DNA recombinante possibilitou o isolamen- to de genes e sua inserção estável em um genoma hospedeiro. Esta técnica, também chamada de transformação genética, pode ser defini- da como a introdução controlada de ácidos nucleicos ("DNA" ou ADN) em um genoma receptor, excluindo-se a introdução por fecundação. É um processo controlado, onde normalmente apenas o fragmento defi- nido de DNA é introduzido no genoma do hospedeiro, ou genoma re- ceptor, devendo ser a ele integrado. A inserção estável dessas molé- culas em um genoma hospedeiro dá origem a um indivíduo igual ou substancialmente igual ao receptor da molécula recombinante, porém acrescido de característica nova e particular. Por "substancialmente igual" entende-se como um organismo que possui mais do que 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade em relação ao organismo receptor. [0077] Recombinant DNA technology enabled the isolation of genes and their stable insertion into a host genome. This technique, also called genetic transformation, can be defined as the controlled introduction of nucleic acids ("DNA" or DNA) into a recipient genome, excluding introduction by fertilization. It is a controlled process, where normally only the defined fragment of DNA is introduced into the host genome, or receptor genome, and must be integrated into it. The stable insertion of these molecules into a host genome gives rise to an individual equal or substantially equal to the receptor of the recombinant molecule, but with a new and particular characteristic. By "substantially the same" is meant an organism that has greater than 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to the recipient organism.
[0078] Existem diversas técnicas de transformação genética de plantas, as quais podem, de maneira geral, serem agrupadas em duas categorias principais: transferência indireta e direta de genes. A trans- ferência indireta é aquela em que o DNA exógeno é inserido no geno- ma pela ação de um vetor biológico ou qualquer outro tipo de molécula carreadora, sendo a sua inserção facilitada por mecanismos endóge- nos ou exógenos, enquanto que a direta é baseada principalmente em processos físico-bioquímicos. [0078] There are several techniques for genetic transformation of plants, which can, in general, be grouped into two main categories: indirect and direct gene transfer. Indirect transfer is one in which exogenous DNA is inserted into the genome by the action of a biological vector or any other type of carrier molecule, and its insertion is facilitated by endogenous or exogenous mechanisms, while direct transfer is facilitated by endogenous or exogenous mechanisms. based mainly on physico-biochemical processes.
[0079] Os tecidos e/ou células a serem transformados podem vari- ar de acordo com técnicas de transformação genética utilizada e de acordo com a espécie ou genótipo a ser transformado. De maneira ge- ral, esses tecidos incluem, sem limitação, calos embriogênicos, calos, protoplastos, embriões, embriões somáticos, tecidos meristemáticos, e qualquer parte, tecido ou célula vegetal que possui capacidade rege- nerativa. [0079] The tissues and/or cells to be transformed may vary according to the genetic transformation techniques used and according to the species or genotype to be transformed. These tissues generally include, without limitation, embryogenic callus, callus, protoplasts, embryos, somatic embryos, meristematic tissues, and any part, tissue or plant cell that has a regenerative capacity.
[0080] A transformação indireta baseia-se principalmente no sis- tema mediado por bactérias do gênero Agrobacterium e tem sido o método mais utilizado para obtenção de plantas transgênicas, por apresentar algumas vantagens como, por exemplo, a possiblidade de transferência de segmentos de DNA relativamente longos com ne- nhum rearranjo e integração de baixo número de cópias dos transge- nes, garantindo maior estabilidade genotípica para os eventos gera- dos. Diversas espécies e linhagens de Agrobacterium, plasmídeos e protocolos têm sido desenvolvidos e adaptados para a transformação genética de diversas espécies de plantas. As vantagens do método de transformação mediado por Agrobacterium incluem a maior probabili- dade de inserções cópia única, a integração estável e herança genéti- ca das características introduzidas, assim como expressão gênica consistente através das gerações, além de menores chances de silen- ciamento gênico. [0080] The indirect transformation is mainly based on the system mediated by bacteria of the genus Agrobacterium and has been the most used method to obtain transgenic plants, as it has some advantages, such as the possibility of transferring DNA segments relatively long with no rearrangement and integration of low copy numbers of the transgenes, ensuring greater genotypic stability for the generated events. Several species and strains of Agrobacterium, plasmids and protocols have been developed and adapted for the genetic transformation of different plant species. The advantages of the Agrobacterium-mediated transformation method include the higher probability of single copy insertions, the stable integration and genetic inheritance of the introduced traits, as well as consistent gene expression across generations, in addition to lower chances of gene silencing. .
[0081] Agrobacterium tumefaciens e A. rhizogenes são bactérias fitopatogênicas de solo, gram negativas, pertencentes à família Rhizo- biaceae, que causam doenças em dicotiledôneas, conhecidas como galhas da coroa e raiz em cabeleira, respectivamente. Nesta interação planta-patógeno ocorre um processo de transferência natural de genes entre a agrobactéria e a célula vegetal, quando fragmentos de DNA bacteriano são transferidos para dentro da célula vegetal (T-DNA), in- tegrando-se ao genoma nuclear. Em sua forma natural, a bactéria transfere o T-DNA ("transferred DNA"), que é parte do plasmídeo bac- teriano denominado Ti ("tumour-inducing"), e este se integra ao geno- ma das células de plantas infectadas. No fragmento de T-DNA que é transferido para a célula vegetal estão os genes envolvidos na biossín- tese constitutiva de fitohormônios (auxinas e citocininas) que alteram o programa de desenvolvimento normal do tecido infectado, ocasionan- do a formação do tumor. Além disso, contém também oncogenes para a síntese de açúcares e aminoácidos denominados de opinas, que são responsáveis pela sobrevivência da bactéria, que os utilizam como fonte de carbono e nitrogénio (Oger et ai 1997). Extremidades repeti- das de 25 pares de base (pb) nas bordas direita e esquerda delimitam o T-DNA, e são imprescindíveis para sua transferência. Compostos fenólicos liberados pelos tecidos vegetais lesionados ativam regiões especificas (regiões vir), iniciando o processo de transferência do T- DNA para a célula vegetal. A Agrobacterium possui também genes cromossomais ( chv ) que garantem a ligação entre as células bacteria- na e hospedeira, permitindo a formação do poro de passagem do complexo contendo o T-DNA (Sheng & Citovsky. 1996). [0081] Agrobacterium tumefaciens and A. rhizogenes are phytopathogenic soil bacteria, gram negative, belonging to the family Rhizobiaceae, which cause diseases in dicots, known as crown gall and wig root, respectively. In this plant-pathogen interaction, a process of natural gene transfer occurs between the agrobacteria and the plant cell, when bacterial DNA fragments are transferred into the plant cell (T-DNA), integrating the nuclear genome. In its natural form, the bacterium transfers T-DNA ("transferred DNA"), which is part of the bacterial plasmid called Ti ("tumour-inducing"), and it integrates into the genome of infected plant cells. . In the T-DNA fragment that is transferred to the plant cell are the genes involved in the constitutive biosynthesis of phytohormones (auxins and cytokinins) that alter the program of normal development of infected tissue, causing tumor formation. Furthermore, it also contains oncogenes for the synthesis of sugars and amino acids called opines, which are responsible for the survival of the bacterium, which uses them as a source of carbon and nitrogen (Oger et al 1997). Repeated ends of 25 base pairs (bp) on the right and left edges delimit the T-DNA, and are essential for its transfer. Phenolic compounds released by injured plant tissues activate specific regions (vir regions), initiating the process of transferring T-DNA to the plant cell. Agrobacterium also has chromosomal genes ( chv ) that guarantee the connection between bacterial and host cells, allowing the formation of the passage pore of the complex containing the T-DNA (Sheng & Citovsky, 1996).
[0082] Uma vez que o segmento a ser transferido (transgene) é definido por suas bordas, qualquer sequência flanqueada pelas bordas pode ser transferida para uma planta por meio da agrobacteria, possi- bilitando a manipulação dessas sequências para transferência de se- quências codificadoras de interesse. A substituição ou eliminação das regiões codificadoras do T-DNA do tipo selvagem (oncogenes), permi- tem a geração de linhagens de Agrobacterium não oncogênicas (de- sarmadas) e carreadoras das sequências de interesse, sem prejuízo a transferência do T-DNA para as plantas desde que os genes de viru- lência (região vir) sejam mantidos. [0082] Once the segment to be transferred (transgene) is defined by its edges, any sequence flanked by the edges can be transferred to a plant by means of agrobacteria, allowing the manipulation of these sequences for the transfer of coding sequences of interest. The substitution or elimination of the coding regions of the wild-type T-DNA (oncogenes) allows the generation of non-oncogenic (disarmed) Agrobacterium strains that carry the sequences of interest, without prejudice to the transfer of the T-DNA to plants as long as the virulence genes (vir region) are maintained.
[0083] Adicionalmente, o sistema de transformação indireta por Agrobacterium permite o uso de construções artificiais de plasmídeos para a transferência de genes para as plantas desde que os mesmos contenham tais bordas de T-DNA, possibilitando uma grande flexibili- dade para uso das ferramentas moleculares e materiais disponíveis e desenvolvidos para outras cepas bacterianas. [0083] Additionally, the indirect transformation system by Agrobacterium allows the use of artificial plasmid constructs for the transfer of genes to plants as long as they contain such T-DNA borders, allowing a great flexibility for the use of the tools molecular and material available and developed for other bacterial strains.
[0084] Estas construções artificiais de plasmídeos possuem pro- motores de diversas origens, entre eles promotores de genes de plan- tas, promotores virais, bacterianos e/ou quiméricos, além de genes que conferem resistência a antibióticos, resistência a herbicidas ou que possuam atividade enzimática ( phosphomannose isomerase (PMI)/mannose (Man)) de forma a fazer com que estes marcadores possam ser usados para a seleção de células ou plantas transforma- das. [0084] These artificial plasmid constructs have pro- motors of different origins, including plant gene promoters, viral, bacterial and/or chimeric promoters, in addition to genes that confer antibiotic resistance, herbicide resistance or that have enzymatic activity (phosphomannose isomerase (PMI)/mannose ( Man)) so that these markers can be used for the selection of transformed cells or plants.
[0085] Adicionalmente, essas construções podem conter genes auxiliares que interferem em vias de sinalização relevantes para a morfogênese de tecidos vegetais, aumentando a eficiência do proces- so de modificação genética e regeneração. Destacam-se, sem limita- ções: LEAFY COTYLEDON1 (Lotan et ai, 1998), Lec1 (Lowe et ai, 2002), LEAFY COTYLEDON2 (Stone et ai, 2001), WUSCHEL (WUS; Zuo et ai, 2002), e BABY BOOM (BBM; Boutilier et ai, 2002), entre outros. [0085] Additionally, these constructs may contain auxiliary genes that interfere in signaling pathways relevant to the morphogenesis of plant tissues, increasing the efficiency of the process of genetic modification and regeneration. The following stand out, without limitations: LEAFY COTYLEDON1 (Lotan et al, 1998), Lec1 (Lowe et al, 2002), LEAFY COTYLEDON2 (Stone et al, 2001), WUSCHEL (WUS; Zuo et al, 2002), and BABY BOOM (BBM; Boutilier et al, 2002), among others.
[0086] Em um primeiro aspecto da presente invenção, o DNA es- tranho ou exógeno que será introduzido na planta é clonado em um plasmídeo binário, entre as sequências consenso das bordas esquer- da e direita (T-DNA). O plasmídeo binário é transferido para uma célu- la de Agrobacterium, que é subsequentemente utilizada para infectar o tecido vegetal. A região do T-DNA do vetor que compreende o DNA exógeno é inserida no genoma da planta. O cassete de expressão com o gene marcador e o cassete de expressão com o gene da carac- terística podem estar presentes na mesma região do T-DNA, em regi- ões diferentes do T-DNA no mesmo plasmídeo, ou ainda em regiões diferentes do T-DNA em plasmídeos diferentes. Em uma modalidade da presente invenção, os cassetes estão presentes na mesma região do T-DNA. O versado na técnica está familiarizado com os métodos de transformação indireta por Agrobacterium. [0086] In a first aspect of the present invention, the foreign or exogenous DNA that will be introduced into the plant is cloned into a binary plasmid, between the left and right edge consensus sequences (T-DNA). The binary plasmid is transferred into an Agrobacterium cell, which is subsequently used to infect plant tissue. The region of the vector's T-DNA that comprises the exogenous DNA is inserted into the plant genome. The expression cassette with the marker gene and the expression cassette with the trait gene can be present in the same region of the T-DNA, in different regions of the T-DNA in the same plasmid, or even in different regions of the plasmid. T-DNA on different plasmids. In one embodiment of the present invention, the cassettes are present in the same region of the T-DNA. One skilled in the art is familiar with methods of indirect transformation by Agrobacterium.
[0087] Ainda de modo alternativo, a transferência direta do DNA pode ser utilizada para introduzir o DNA diretamente em uma célula vegetal. Esses métodos oferecem uma alternativa para a integração de um gene de interesse com toxicidade celular mínima em locais ale- atórios do genoma. Nesses casos a introdução do DNA exógeno é realizada sem o auxílio de um vetor. Um método adequado de transfe- rência direta do DNA pode ser o bombardeio de células vegetais com um vetor que compreende o DNA para a inserção utilizando uma pisto- la de partículas (transformação por biolística mediada por partículas). Outros métodos para transformação de células vegetais incluem a transformação de protoplastos (opcionalmente na presença de polieti- lenoglicóis); o tratamento com ultra-som de tecidos, células ou proto- plastos vegetais em um meio compreendendo o polinucleotídeo ou o vetor; sonicação, a microinjeção do polinucleotídeo ou do vetor no material vegetal; macroinjeção, eletroporação de células vegetais e similares, infiltração a vácuo, uso de fibras de carboneto de silício, transformação química mediada por polietileno glicol (PEG), entre ou- tros. Dentre as desvantagens associadas aos métodos de transforma- ção direta estão os desafios relacionadas a regeneração e baixa ex- pressão dos transgenes. [0087] Still alternatively, the direct transfer of DNA can be used to introduce DNA directly into a plant cell. These methods offer an alternative for the integration of a gene of interest with minimal cellular toxicity at random locations in the genome. In these cases, the introduction of exogenous DNA is performed without the aid of a vector. A suitable method of direct DNA transfer may be to bombard plant cells with a vector comprising the DNA for insertion using a particle gun (particle-mediated biolistics transformation). Other methods for transforming plant cells include protoplast transformation (optionally in the presence of polyethylene glycols); ultrasound treatment of plant tissues, cells or protoplasts in a medium comprising the polynucleotide or vector; sonication, the microinjection of the polynucleotide or vector into plant material; macroinjection, electroporation of plant cells and the like, vacuum infiltration, use of silicon carbide fibers, chemical transformation mediated by polyethylene glycol (PEG), among others. Among the disadvantages associated with direct transformation methods are the challenges related to regeneration and low expression of transgenes.
[0088] Ainda de modo alternativo, a transformação genética pode ser realizada de maneira sítio dirigida através da recombinação homó- loga auxiliada por nucleases (edição genômica). Nos últimos anos, a tecnologia de edição genômica baseada no uso de nucleases "enge- nheiradas" ou quiméricas tem ganhado destaque, possibilitando a ge- ração de organismos geneticamente modificados de maneira mais precisa e específica. Nesse caso, a introdução de genes exógenos ocorre através de mecanismos de recombinação homóloga através da introdução de um molde de recombinação homóloga (HR) contendo o DNA de interesse ligado a um fragmento de DNA homólogo ao geno- ma do organismo receptor. Dentre as ferramentas disponíveis estão o sistema enzimático quimérico CRISPR (clustered, regularly interspa- ced, short palindromic repeats) - Cas, além das nucleases Zinc finger (ZFN) e TAL effector nucleases (TALENs). Os sistemas CRISPR/Cas são sistemas enzimáticos que compreendem 2 componentes princi- pais: uma endonuclease (Cas) e um RNA guia (single-guide RNA - sgRNA). O RNA guia compreende 2 partes principais: "crispr RNA" (crRNA), uma sequência de 17-20 nucleotídeos complementar a sítios específicos no DNA genômico; "tracr RNA", um molde para ligação da nuclease Cas, responsável por guiar a endonuclease para o local es- pecífico de clivagem. A clivagem específica realizada pela endonu- clease e direcionada pelo RNA guia pode ser reparada através de re- combinação homóloga, integrando de maneira sítio dirigida o DNA exógeno flanqueado por sequências homólogas ao sítio de clivagem. A introdução desse sistema enzimático na célula pode ocorrer de di- versas maneiras, utilizando plasmídeos, através de transformação di- reta ou indireta, ou ainda utilizando-se de proteínas e outras moléculas carregadoras. A expressão dos componentes do sistema pode ocorrer de forma transiente ou estável utilizando a maquinaria celular do orga- nismo receptor ou ainda ser realizada de maneira exógena, e nesse caso, os componentes do sistema são entregues na célula "prontos para uso" (endonucleases + sgRNAs transcritos in vitro e combinados antes da sua introdução na célula). A descrição aqui apresentada não deve ser considerada exaustiva e, portanto, o uso de tais métodos de edição genômica dentro do escopo da presente invenção não deve ser limitado à descrição apresentada, estando contemplado a aplicação de variações desses sistemas e métodos, conforme conhecidas no Esta- do da Arte, bem como aquelas que ainda estão por serem descober- tas. [0088] Still alternatively, the genetic transformation can be carried out in a site-directed manner through homologous recombination aided by nucleases (genomic editing). In recent years, genomic editing technology based on the use of "engineered" or chimeric nucleases has gained prominence, enabling the generation of genetically modified organisms in a more precise and specific way. In this case, the introduction of exogenous genes occurs through homologous recombination mechanisms through the introduction of a homologous recombination (HR) template containing the DNA of interest linked to a DNA fragment homologous to the genome of the recipient organism. Among the tools available are the chimeric enzyme system CRISPR (clustered, regularly interspaced, short palindromic repeats) - Cas, in addition to Zinc finger nucleases (ZFN) and TAL effector nucleases (TALENs). CRISPR/Cas systems are enzymatic systems that comprise 2 main components: an endonuclease (Cas) and a guide RNA (single-guide RNA - sgRNA). Guide RNA comprises 2 main parts: "crispr RNA" (crRNA), a 17-20 nucleotide sequence complementary to specific sites in genomic DNA; "tracr RNA", a template for binding Cas nuclease, responsible for guiding the endonuclease to the specific cleavage site. The specific cleavage performed by the endonuclease and directed by the guide RNA can be repaired through homologous recombination, integrating in a site-directed manner the exogenous DNA flanked by sequences homologous to the cleavage site. The introduction of this enzymatic system into the cell can occur in different ways, using plasmids, through direct or indirect transformation, or even using proteins and other carrier molecules. The expression of the components of the system can occur transiently or stably using the cellular machinery of the receptor organism or even be performed exogenously, in which case, the components of the system are delivered to the cell "ready to use" (endonucleases + sgRNAs transcribed in vitro and combined prior to their introduction into the cell). The description presented here should not be considered exhaustive and, therefore, the use of such genomic editing methods within the scope of the present invention should not be limited to the description presented, and the application of variations of these systems and methods, as known in this - that of Art, as well as those that are yet to be discovered.
[0089] Após a transformação, as plantas transgênicas devem ser regeneradas partindo do tecido vegetal transformado e a progénie que possui DNA exógeno selecionada utilizando um marcador apropriado tal como a resistência à canamicina, geneticina ou glufosinato de amónio. O versado na técnica está familiarizado com a composição de meios de regeneração adequados. [0089] After the transformation, the transgenic plants must be regenerated starting from the transformed plant tissue and the progeny that has exogenous DNA selected using an appropriate marker such as resistance to kanamycin, geneticin or glufosinate ammonium. One skilled in the art is familiar with the composition of suitable regeneration media.
[0090] Alternativamente, outros métodos de seleção podem ser aplicados, sem a necessidade da introdução no organismo receptor de um marcador de seleção conforme acima exemplificado. [0090] Alternatively, other selection methods can be applied, without the need to introduce a selection marker into the recipient organism as exemplified above.
[0091] Em uma modalidade preferida, a transformação genética é mediada por meio de uma bactéria do gênero Agrobacterium. [0091] In a preferred embodiment, the genetic transformation is mediated through a bacterium of the genus Agrobacterium.
[0092] Em uma modalidade ainda mais preferida, a transformação genética é mediada por Agrobacterium tumefasciens. [0092] In an even more preferred embodiment, the genetic transformation is mediated by Agrobacterium tumefasciens.
[0093] O evento CTC75064-3 exibe um novo genótipo que com- preende dois cassetes de expressão. O primeiro cassete de expressão compreende um promotor adequado para a expressão em plantas li- gado de forma operacional a um gene que codifica uma toxina insetici- da CrylAc, útil no controle de pragas de insetos lepidópteros e um si- nal de poliadenilação adequados. O segundo cassete de expressão compreende um promotor adequado para a expressão em plantas li- gado de forma operacional a um gene que codifica uma proteína utili- zada como marcador seletivo na obtenção do evento da presente in- venção. [0093] Event CTC75064-3 displays a new genotype comprising two expression cassettes. The first expression cassette comprises a promoter suitable for expression in plants operably linked to a gene encoding an insecticidal CrylAc toxin useful in controlling lepidopteran insect pests and a suitable polyadenylation signal. The second expression cassette comprises a promoter suitable for expression in plants operably linked to a gene encoding a protein used as a selective marker in obtaining the event of the present invention.
[0094] Os promotores adequados podem ser isolados ou expres- sos, entre outros organismos, em plantas. Vários promotores foram isolados ou desenvolvidos incluindo promotores constitutivos, do tipo "liga e desliga", responsivos a estresses abióticos, específicos aos te- cidos, entre outros. Muitos desses promotores possuem sequências intrônicas descritas como relevantes para uma expressão adequada dos genes. Em um aspecto preferido da invenção, os promotores são promotores constitutivos e podem ser selecionados do grupo não limi- tante consistindo em CaMV 35S, CoYMV (Commelina yellow mottle virus), FMV (Figwort mosaic virus) 35S, Ubiquitina, promotor de Actina de arroz 1 (Act-1), promotor de Actina de arroz 2 (Act-2), promotor da nopalina sintase (NOS), promotor da octopina sintase (OCS), promotor da desidrogenase alcoólica de milho (Adh-1), PvUbil, entre outros. [0095] Elementos adicionais tais como sequências intensificadoras e direcionadores (transportadores) também podem ser incorporadas no cassete de expressão com a finalidade de melhorar os níveis de expressão genica, por exemplo, intensificadores de transcrição ou tra- dução, tais como, os intensificadores CaMV 35S, FMV 35S, Nos, supP, sequências líderes não transcritas do Polipeptídeo de ligação a Clorofila a/b principal de trigo (L-Cab), sequências kosak 5' upstream do sítio de início da tradução, entre outras. [0094] Suitable promoters can be isolated or expressed, among other organisms, in plants. Several promoters have been isolated or developed, including constitutive, "on and off" promoters, responsive to abiotic stresses, tissue-specific, among others. Many of these promoters have intronic sequences described as relevant for proper gene expression. In a preferred aspect of the invention, the promoters are constitutive promoters and may be selected from the non-limiting group consisting of CaMV 35S, CoYMV (Commelina yellow mottle virus), FMV (Figwort mosaic virus) 35S, Ubiquitin, Rice Actin promoter 1 (Act-1), Rice Actin promoter 2 (Act-2), Nopaline synthase promoter (NOS), octopine synthase promoter ( OCS), corn alcohol dehydrogenase promoter (Adh-1), PvUbil, among others. [0095] Additional elements such as enhancer and driver sequences (transporters) can also be incorporated into the expression cassette for the purpose of improving gene expression levels, for example transcriptional or translational enhancers such as the CaMV enhancers 35S, FMV 35S, Nos, supP, Wheat Major Chlorophyll a/b Binding Polypeptide a/b (L-Cab) non-transcribed leader sequences, kosak sequences 5' upstream of the translation start site, among others.
[0096] Em uma modalidade da invenção, o promotor é o promotor do Vírus do Mosaico da Couve-flor 35s (CaMV 35Ss). Em uma modali- dade ainda mais preferida, o promotor CaMV 35s possui a sequência enhancer duplicada (2xCaMV35s). [0096] In one embodiment of the invention, the promoter is the Cauliflower Mosaic Virus 35s (CaMV 35Ss) promoter. In an even more preferred embodiment, the CaMV 35s promoter has the duplicated enhancer sequence (2xCaMV35s).
[0097] Em um escopo da invenção, a sequência Kosak 5' upstre am do sítio de início da tradução e o intron de Actina 1 de arroz ( Oryza sativa Actin 1 introrr, OsACTI) são contemplados na região promotora CaMV 35s. Adicionalmente, a sequência líder L-Cab também está con- templada na região promotora CaMV 35s. [0097] In a scope of the invention, the sequence Kosak 5' upstream of the translation start site and the rice Actin 1 intron ( Oryza sativa Actin 1 introrr, OsACTI) are contemplated in the CaMV 35s promoter region. Additionally, the L-Cab leader sequence is also contemplated in the CaMV 35s promoter region.
[0098] Em um escopo preferido, a expressão gênica do crylAc é regulada pela combinação de elementos selecionado do grupo consis- tindo em promotor do Vírus do Mosaico da Couve-flor 35s com se- quência enhancer duplicada (2xCaMV35s), sequência líder não trans- crita do Polipeptídeo de ligação a Clorofila a/b principal de trigo (L- Cab), intron de Actina 1 de arroz ( Oryza sativa Actin 1 intron ; OsACTI) e sequência Kosak 5' upstream do sítio de início da tradução. Em um escopo preferido, a expressão gênica do crylAc é regulada pela regi- ão promotora do Vírus do Mosaico da Couve-flor 35s com sequência enhancer duplicada (2xCaMV35s), sequência líder não transcrita do Polipeptídeo de ligação a Clorofila a/b principal de trigo (L-Cab), intron de Actina 1 de arroz ( Oryza sativa Actin 1 introrr, OsACTI) e sequên- cia Kosak 5' upstream do sítio de início da tradução. [0098] In a preferred scope, crylAc gene expression is regulated by the combination of elements selected from the group consisting of Cauliflower Mosaic Virus 35s promoter with duplicate enhancer sequence (2xCaMV35s), non-trans leader sequence - Wheat Major Chlorophyll a/b Binding Polypeptide a/b crita (L-Cab), Rice Actin 1 intron (Oryza sativa Actin 1 intron; OsACTI) and Kosak sequence 5' upstream from the translation start site. In a preferred scope, crylAc gene expression is regulated by the promoter region of Cauliflower Mosaic Virus 35s with sequence Duplicated enhancer (2xCaMV35s), non-transcribed leader sequence of Wheat Major Chlorophyll a/b Binding Polypeptide (L-Cab), Rice Actin 1 intron (Oryza sativa Actin 1 introrr, OsACTI) and Kosak 5' sequence upstream from the translation start site.
[0099] Em um outro escopo, a região promotora é a do gene da Ubiquitina de milho (pUBI). Em um escopo preferido, a região promoto- ra é a do gene da Ubiquitina de milho (pUBI) contém um intron na se- quência 5' do RNA líder. [0099] In another scope, the promoter region is the corn Ubiquitin gene (pUBI). In a preferred scope, the promoter region is that of the corn Ubiquitin gene (pUBI) contains an intron in the 5' sequence of the leader RNA.
[00100] A região promotora ( UBI-1 ) da presente invenção possui 1992 pares de bases que são subdivididas em: fragmento promotor (899 bases), primeiro éxon do gene da poliubiquitina-1 (83 bases) e primeiro intron (1.010 bases). [00100] The promoter region ( UBI-1 ) of the present invention has 1992 base pairs which are subdivided into: promoter fragment (899 bases), first exon of the polyubiquitin-1 gene (83 bases) and first intron (1010 bases) .
[00101] Em um escopo, a expressão do gene nptll é regulada pelo promotor da ubiquitina de milho (pUBI). Em um escopo preferido, a expressão do gene nptll é regulada pelo promotor da ubiquitina de mi- lho (pUBI) contendo um intron na sequência 5' do RNA líder. Em um escopo específico, a expressão do gene nptll é regulada pela região promotora ( UBI-1 ) da presente invenção possui 1992 pares de bases que são subdivididas em: fragmento promotor (899 bases), primeiro éxon do gene da poliubiquitina-1 (83 bases) e primeiro intron (1.010 bases). [00101] In one scope, the expression of the nptll gene is regulated by the corn ubiquitin promoter (pUBI). In a preferred scope, the expression of the nptll gene is regulated by the corn ubiquitin promoter (pUBI) containing an intron in the 5' sequence of the leader RNA. In a specific scope, the expression of the nptll gene is regulated by the promoter region (UBI-1) of the present invention has 1992 base pairs that are subdivided into: promoter fragment (899 bases), first exon of the polyubiquitin-1 gene (83 bases) and first intron (1010 bases).
[00102] As sequências terminadoras também estão contempladas no cassete de expressão. Exemplos de sinais de poliadenilação ade- quados e funcionais nas plantas incluem o proveniente do gene da no- palina sintase (nos) de Agrobacterium tumefaciens, o proveniente do gene do inibidor II da proteinase, rbcS ( pea ribulose-1 ,5-bisphosphate carboxylase small subunit ), Lhcbl ( tobacco chlorophyll a/b-binding pro- teins ), CaMV 35S, octopina sintase, o proveniente do gene da alfa- tubulina, entre outros. [00102] Terminator sequences are also contemplated in the expression cassette. Examples of suitable and functional polyadenylation signals in plants include that from the nopaline synthase (nos) gene of Agrobacterium tumefaciens, that from the proteinase inhibitor II gene, rbcS (pea ribulose-1,5-bisphosphate carboxylase small subunit), Lhcbl (tobacco chlorophyll a/b-binding proteins), CaMV 35S, octopine synthase, the one from the alpha-tubulin gene, among others.
[00103] Em um escopo da presente invenção, o sinal de poliadeni- lação é derivado do gene CaMV 35s (T35s). Em uma modalidade da presente invenção, o sinal de poliadenilação é aquele proveniente do gene nopalina sintase (nos) de Agrobacterium tumefaciens. [00103] In a scope of the present invention, the polyadeny- lation is derived from the CaMV 35s gene (T35s). In one embodiment of the present invention, the polyadenylation signal is that from the nopaline synthase (nos) gene of Agrobacterium tumefaciens.
[00104] Preferivalmente, o sinal de poliadenilaçãopara o cassete crylAc é o terminador CaMV 35s (T-35s) e o sinal de poliadenilação para o gene nptll é terminador de nopalina sintase de Agrobacterium tumefaciens - NOS. [00104] Preferably, the polyadenylation signal for the crylAc cassette is CaMV 35s terminator (T-35s) and the polyadenylation signal for the nptII gene is Agrobacterium tumefaciens nopaline synthase terminator - NOS.
[00105] O gene crylAc codifica uma toxina de 615 aminoácidos com peso molecular estimado de 68 KDa, originária de Bacillus thurin- giensis serovar kustaki (estirpe HD73) que confere resistência à D/a- traea saccharalis (broca-da-cana). A presente invenção contempla modificações do gene para a expressão apenas do núcleo tríptico ativo da proteína CrylAc nativa. Assim, em uma modalidade preferida da presente invenção, o polinucleotídeo que codifica a proteína CrylAc é truncado, codificando o núcleo tríptico inseticida de 52 KDa. Em uma modalidade preferida, a proteína CrylAc é a SEQ ID NO 34. A presen- te invenção também contempla sequências compreendendo pelo me- nos 80%, preferivelmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com SEQ ID NO: 34. O núcleo tríptico é responsável pela atividade inseticida da proteína, ligando-se a proteínas específicas do intestino do inseto levando à disrupção da integridade funcional e ana- tômica deste órgão que altera a absorção de nutrientes e rápida toxici- dade e morte do inseto. [00105] The crylAc gene encodes a 615 amino acid toxin with an estimated molecular weight of 68 KDa, originating from Bacillus thuringiensis serovar kustaki (strain HD73) that confers resistance to D/atraea saccharalis (sugarcane borer). The present invention contemplates gene modifications for the expression of only the active tryptic core of the native CrylAc protein. Thus, in a preferred embodiment of the present invention, the polynucleotide encoding the CrylAc protein is truncated, encoding the 52 kDa insecticidal tryptic core. In a preferred embodiment, the CrylAc protein is SEQ ID NO 34. The present invention also contemplates sequences comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% of identity with SEQ ID NO: 34. The tryptic nucleus is responsible for the insecticidal activity of the protein, binding to specific proteins of the insect intestine, leading to the disruption of the functional and anatomical integrity of this organ that alters the absorption of nutrients and rapid toxicity. - insect death and death.
[00106] De acordo com a invenção, o polinucleotídeo que codifica a proteína CrylAc pode ter códons otimizados ou alterados de outra maneira para melhora da sua expressão no material vegetal. Tal otimi- zação de códons pode ser utilizada para alterar a estrutura secundária prevista do produto da transcrição de RNA produzido em qualquer cé- lula transformada ou para destruir os elementos da instabilidade crípti- cos de RNA presentes no produto da transcrição não alterado, aumen- tando assim a estabilidade e/ou a disponibilidade do produto da trans- crição na célula transformada. [00106] In accordance with the invention, the polynucleotide encoding the CrylAc protein may have codons optimized or otherwise altered to improve its expression in plant material. Such codon optimization can be used to alter the predicted secondary structure of the RNA transcript produced in any transformed cell or to destroy the cryptic RNA instability elements present in the unaltered transcription product. thereby improving the stability and/or availability of the transcription product in the transformed cell.
[00107] Preferivelmente, o gene crylAc presente no evento da in- venção corresponde a uma sequência de DNA sintética, truncada e otimizada com códons preferidos de cana-de-açúcar. Em um aspecto ainda mais preferido da presente invenção, o gene crylAc apresenta a sequência SEQ ID NO: 20. A presente invenção também contempla sequências compreendendo pelo menos 80%, preferivelmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com SEQ ID NO: 20. [00108] Vários genes marcadores para seleção de eventos em plantas já foram caracterizados, incluindo alguns que conferem tole- rância a antibióticos e outros que conferem resistência a herbicidas. Exemplos de genes marcadores que podem ser selecionados para uso na presente invenção incluem aqueles que conferem resistência ou tolerância a higromicina, canamicina, gentamicina, glifosato, glufosina- to de amónio ou resistência a toxinas tais como a eutipina. Também estão disponíveis outras formas de seleção tais como os sistemas de seleção baseados em hormônio, seleção visual através da expressão de proteínas fluorescentes, manose isomerase, xilose isomerase, en- tre outros. Em uma modalidade da presente invenção, o gene marca- dor para seleção do evento da presente invenção é um que confere tolerância à antibióticos da classe dos aminoglicosídeos. Em um esco- po da presente invenção, o gene do marcador de seleção do evento confere tolerância a kanamicina e geneticina. [00107] Preferably, the crylAc gene present in the event of the invention corresponds to a synthetic DNA sequence, truncated and optimized with sugarcane preferred codons. In an even more preferred aspect of the present invention, the crylAc gene has the sequence SEQ ID NO: 20. The present invention also contemplates sequences comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 20. [00108] Several marker genes for plant selection events have been characterized, including some that confer antibiotic tolerance and others that confer herbicide resistance. Examples of marker genes that may be selected for use in the present invention include those that confer resistance or tolerance to hygromycin, kanamycin, gentamicin, glyphosate, glufosinate ammonium or resistance to toxins such as eutypine. Other forms of selection are also available, such as hormone-based selection systems, visual selection through the expression of fluorescent proteins, mannose isomerase, xylose isomerase, among others. In one embodiment of the present invention, the event selection marker gene of the present invention is one that confers tolerance to antibiotics of the aminoglycoside class. In one scope of the present invention, the event selection marker gene confers tolerance to kanamycin and geneticin.
[00109] Em uma modalidade preferida da invenção, o gene marca- dor utilizado no segundo cassete de expressão é o gene nptll, o qual codifica a enzima neomicina fosfotransferase II (nptll) de 265 aminoá- cidos com peso molecular estimado de 29,2KDa. Em um aspecto ain- da mais preferido da presente invenção, o gene nptll apresenta a se- quência SEQ ID NO 21. A neomicina fosfotransferase II confere resis- tência a antibióticos da classe dos aminoglicosídeos, como a canami- cina e a geneticina. O gene nptll utilizado como marcador de seleção na obtenção dos eventos transformados é derivado do transposon Tn5 de Escherichia coli como descrito por BECK et ai (1982). A proteína Nptll é produzida por vários procariontes amplamente encontrados no meio ambiente, tanto em habitats aquáticos e terrestres, como na mi- croflora intestinal humana e animal. A proteína Nptll inativa antibióticos aminoglicosídicos como neomicina, gentamicina, paromicina e cana- micinas A, B e C utilizando-se de adenosina-trifosfato (ATP) para fos- forilá-los, evitando assim que causem injúrias às células quando ex- postas aos antibióticos mencionados. Esse mecanismo possibilita seu uso como marcador de seleção de plantas transformadas. Em uma modalidade preferida, a proteína Nptll é a SEQ ID NO 35. A presente invenção também contempla sequências possuindo pelo menos 80%, preferivelmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 35. [00109] In a preferred embodiment of the invention, the marker gene used in the second expression cassette is the nptII gene, which encodes the 265 amino acid neomycin phosphotransferase II (nptII) enzyme with an estimated molecular weight of 29.2KDa . In an even more preferred aspect of the present invention, the nptll gene has the sequence SEQ ID NO 21. Neomycin phosphotransferase II confers resistance to propensity to antibiotics of the aminoglycoside class, such as kanamycin and geneticin. The npt11 gene used as a selection marker in obtaining the transformed events is derived from the Tn5 transposon of Escherichia coli as described by BECK et al (1982). The Nptll protein is produced by several prokaryotes widely found in the environment, both in aquatic and terrestrial habitats, as well as in human and animal intestinal microflora. The Nptll protein inactivates aminoglycoside antibiotics such as neomycin, gentamicin, paromycin and kanamycins A, B and C, using adenosine triphosphate (ATP) to phosphorylate them, thus preventing them from causing injury to cells when exposed to mentioned antibiotics. This mechanism allows its use as a selection marker for transformed plants. In a preferred embodiment, the Npt11 protein is SEQ ID NO 35. The present invention also contemplates sequences having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 35.
[00110] O uso de genes marcadores de seleção, como o gene nptll, é importante para selecionar as células transformadas no processo de modificação genética (HORSCH et al., 1985). O objetivo da inserção do gene nptll no evento da presente invenção foi, portanto, a seleção de células transformadas com o gene crylAc. [00110] The use of selection marker genes, such as the nptll gene, is important to select transformed cells in the process of genetic modification (HORSCH et al., 1985). The objective of inserting the nptll gene in the event of the present invention was, therefore, the selection of cells transformed with the crylAc gene.
[00111] Além dos cassetes de expressão descritos, cassetes de expressão adicionais são opcionalmente compreendidos no evento CTC75064-3. [00111] In addition to the expression cassettes described, additional expression cassettes are optionally comprised in event CTC75064-3.
[00112] O primeiro e segundo cassetes de expressão compreendi- dos no evento CTC75064-3 podem ser introduzidos na planta no mesmo ou em plasmídeos diferentes. Se o primeiro e segundo casse- tes de expressão estiverem presentes no mesmo plasmídeo e foram introduzidos na planta por meio de um método de transformação me- diado por Agrobacterium, podem estar presentes dentro das mesmas ou de regiões diferentes do T-DNA. Em uma modalidade da presente invenção, o primeiro e o segundo cassete de expressão estão presen- tes na mesma região do T-DNA. [00112] The first and second expression cassettes comprised in event CTC75064-3 can be introduced into the plant on the same or different plasmids. If the first and second expression cassettes are present on the same plasmid and were introduced into the plant via an Agrobacterium-mediated transformation method, they may be present within the same or from different regions of the T-DNA. In one embodiment of the present invention, the first and second expression cassettes are present in the same region of the T-DNA.
[00113] Mais particularmente, o evento da presente invenção foi obtido por transformação mediada por Agrobacterium tumefasciens com uma construção genética compreendendo um fragmento de DNA (T-DNA) contendo os cassetes de expressão dos genes crylAc e nptll (Figura 1). Preferivelmente, a construção genética da presente inven- ção é caracterizada pelo fato de que compreende a sequência nucleo- tídica possuindo pelo menos 80% de identidade com a SEQ ID NO:1, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO:1. [00113] More particularly, the event of the present invention was obtained by Agrobacterium tumefasciens-mediated transformation with a genetic construct comprising a DNA fragment (T-DNA) containing the expression cassettes of the crylAc and nptll genes (Figure 1). Preferably, the genetic construct of the present invention is characterized in that it comprises the nucleotide sequence having at least 80% identity to SEQ ID NO:1, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO:1.
[00114] O evento da presente invenção foi obtido por transforma- ção mediada por Agrobacterium tumefasciens compreendendo o frag- mento de T- DNA conforme definido acima (SEQ ID NO:1). [00114] The event of the present invention was obtained by Agrobacterium tumefasciens-mediated transformation comprising the T-DNA fragment as defined above (SEQ ID NO:1).
[00115] Este fragmento de T-DNA foi inserido dentro de um plasmí- deo binário que contém em seu espectro de hospedeiro as bactérias Escherichia coli e Agrobacterium tumefaciens. Os elementos genéticos específicos, as origens dos componentes do plasmídeo binário original da presente invenção são apresentadas na Figura 4. [00115] This T-DNA fragment was inserted into a binary plasmid that contains in its host spectrum the bacteria Escherichia coli and Agrobacterium tumefaciens. The specific genetic elements, origins of the components of the original binary plasmid of the present invention are shown in Figure 4.
[00116] O plasmídeo binário compreendendo a construção da pre- sente invenção é representado na Figure 5. Em uma modalidade pre- ferida, a construção genética da presente invenção é caracterizada pelo fato de que compreende uma sequência de nucleotídeos pos- suindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 14. [00116] The binary plasmid comprising the construct of the present invention is represented in Figure 5. In a preferred embodiment, the genetic construct of the present invention is characterized in that it comprises a nucleotide sequence having at least 80 %, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 14.
[00117] A referida construção genética é inserida por choque térmi- co na cepa de DH5a de Escherichia coli. Uma colónia isolada conten- do a construção (SEQ ID NO 14) foi inoculada em meio LB líquido su- plementado com 150 μg/mL de espectinomicina e incubada a 37°C, com agitação à 250 rpm por um período de 16 horas. Prepararam-se, então, estoques contendo suspensão bacteriana e glicerol 10% (v/v) que foram armazenados em ultrafreezer -80°C. A partir da mesma suspenção bacteriana extraiu-se DNA plasmidial utilizando-se QIA- GEN Plasmid Giga Kit segundo as recomendações do fabricante (Qia- gen, Alemanha). [00117] Said genetic construct is inserted by heat shock into the DH5a strain of Escherichia coli. An isolated colony containing the construct (SEQ ID NO 14) was inoculated into liquid LB medium supplemented with 150 μg/mL spectinomycin and incubated at 37°C, with stirring at 250 rpm for a period of 16 hours. Stocks containing bacterial suspension and 10% glycerol (v/v) were then prepared and stored in an ultrafreezer -80°C. Plasmid DNA was extracted from the same bacterial suspension using the QIAGEN Plasmid Giga Kit according to the manufacturer's recommendations (Qiagen, Germany).
[00118] A construção SEQ ID NO 14 foi então transferida para uma cepa de Agrobacterium tumefaciens (vetor) por meio de técnicas co- nhecidas por um técnico no assunto, como por exemplo, eletropora- ção, choque térmico, entre outras. Preferivelmente, a construção é transferida para uma cepa de Agrobacterium tumefaciens por meio de eletroporação. Uma colónia isolada de agrobactéria contendo a cons- trução é inoculada em meio LB líquido suplementado com 100 μg/ml de espectinomicina e 50 μg/ml de rifampicina e incubada a 28°C, com agitação de 200 rpm por um período de 24 horas. Estoques contendo suspensão bacteriana e glicerol 10% (v/v) são preparados e armaze- nados em ultrafreezer -80°C. Esses estoques são utilizados nos expe- rimentos de transformação genética. [00118] The construct SEQ ID NO 14 was then transferred to a strain of Agrobacterium tumefaciens (vector) by means of techniques known to a person skilled in the art, such as electroporation, heat shock, among others. Preferably, the construct is transferred to a strain of Agrobacterium tumefaciens via electroporation. An isolated colony of agrobacteria containing the construct is inoculated into liquid LB medium supplemented with 100 μg/ml of spectinomycin and 50 μg/ml of rifampicin and incubated at 28°C, shaking at 200 rpm for a period of 24 hours. Stocks containing bacterial suspension and 10% glycerol (v/v) are prepared and stored in an ultrafreezer -80°C. These stocks are used in genetic transformation experiments.
[00119] Em uma modalidade ainda mais preferida, o vetor é uma cepa EHA105 de Agrobacterium tumefaciens. [00119] In an even more preferred embodiment, the vector is an EHA105 strain of Agrobacterium tumefaciens.
[00120] É ainda descrito um método para produção de uma planta de cana de açúcar (Saccharum spp) geneticamente modificada resis- tente a inseto. Em uma modalidade preferida, o referido método com- preende as etapas de: a) Introdução da construção genética em uma cepa de Agrobacterium ; b) Obtenção de calos embriogênicos de palmitos de uma variedade de cana-de-açúcar ( Saccharum spp.); c) Co-cultivo dos calos embriogênicos com a Agrobacterium da etapa I; d) Seleção de células transformadas que contém o frag- mento funcional em meio de cultura contendo antibióticos aminoglico- sídicos; e e) Regeneração de plantas de cana-de-açúcar transforma- das. [00120] A method for producing a genetically modified insect resistant sugarcane plant (Saccharum spp) is also described. In a preferred embodiment, said method comprises the steps of: a) introducing the genetic construct into an Agrobacterium strain; b) Obtaining embryogenic calluses from palm hearts of a variety of sugarcane (Saccharum spp.); c) Co-cultivation of embryogenic calluses with Agrobacterium from stage I; d) Selection of transformed cells that contain the functional fragment in a culture medium containing aminoglycoside antibiotics; and e) Regeneration of transformed sugarcane plants.
[00121] Em um aspecto da presente invenção, o método para a produção de uma planta de cana de açúcar geneticamente modificada (Saccharum spp..) é baseado ou idêntico ao descrito pelo BR 11 2017 005441, cujos ensinamentos são incorporados à presente invenção. Em um aspecto adicional, a etapa a) do método para a produção de uma planta de cana de açúcar geneticamente modificada ( Saccharum spp.) do evento CTC75064-3 compreende a introdução de uma cons- trução genética compreendendo a SEQ ID NO 20 e SEQ ID 21 em uma linhagem de Agrobacterium. Em um outro aspecto, a etapa d) compreende a seleção de células transformadas contendo um frag- mento funcional em um meio de cultura contendo geneticina. Adicio- nalmente, a etapa e) desse método compreende regenerar plantas de cana de açúcar transformadas, onde as plantas de cana de açúcar transformadas compreendem SEQ ID NO 20 e SEQ ID NO 21. Preferi- velmente, o método para a produção de uma planta de cana de açúcar geneticamente modificada ( Saccharum spp ) descrito é para produção do evento de interesse, CTC75064-3. A invenção também contempla uma parte de planta, uma célula de planta, um tecido de planta, ou uma semente das plantas de cana de açúcar geneticamente modifica- das produzidas pelo método descrito acima. [00121] In one aspect of the present invention, the method for producing a genetically modified sugarcane plant (Saccharum spp..) is based on or identical to that described by BR 11 2017 005441, the teachings of which are incorporated into the present invention. In a further aspect, step a) of the method for producing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3 comprises introducing a genetic construct comprising SEQ ID NO 20 and SEQ ID 21 in an Agrobacterium strain. In another aspect, step d) comprises the selection of transformed cells containing a functional fragment in a culture medium containing geneticin. Additionally, step e) of that method comprises regenerating transformed sugarcane plants, wherein the transformed sugarcane plants comprise SEQ ID NO 20 and SEQ ID NO 21. Preferably, the method for producing a plant of genetically modified sugarcane ( Saccharum spp ) described is for production of the event of interest, CTC75064-3. The invention also contemplates a plant part, a plant cell, a plant tissue, or a seed of the genetically modified sugarcane plants produced by the method described above.
[00122] O versado na técnica está familiarizado com a composição de meios de cultura adequados para a geração de calos embriogêni- cos (etapa b), assim como dos meios das etapas de co-cultivo (etapa c: co-cultivo + descanso), seleção (etapa d) e regeneração (etapa e; regeneração + elongação). Preferencialmente, os meios de cultura uti- lizados são baseados em composições compreendo ingredientes tais como, os sais MS (Murashige e Skoog, 1962), sacarose, vitaminas B5 e, opcionalmente: aminoácidos selecionados do grupo compreenden- do prolina e asparagina; hidrolisado de caseína; ácido cítrico; manitol; sulfato de cobre; glicina; agente gelificante; auxinas; antibióticos; ace- toseringona; e agentes de seleção. Destaca-se o uso de auxinas nos meios de geração de calos embriogênicos, co-cultivo e seleção, assim como geneticina no meio de seleção. [00122] The person skilled in the art is familiar with the composition of suitable culture media for the generation of embryogenic callus (step b), as well as with the media of the co-cultivation stages (step c: co-cultivation + rest) , selection (step d) and regeneration (step e; regeneration + elongation). Preferably, the culture media used Lysates are based on compositions comprising ingredients such as MS salts (Murashige and Skoog, 1962), sucrose, vitamins B5 and, optionally: amino acids selected from the group comprising proline and asparagine; casein hydrolyzate; Citric acid; mannitol; copper sulfate; glycine; gelling agent; auxins; antibiotics; acetosyringone; and selection agents. The use of auxins in the means of embryogenic callus generation, co-culture and selection stands out, as well as geneticin in the selection medium.
[00123] A etapa de "co-cultivo" refere-se à incubação do tecido de planta infectado ou que entrou em contato com Agrobacterium, de forma a permitir a transferência de T-DNA da Agrobacterium para as células de plantas. Esta etapa corresponde ao período entre o momen- to logo após a inoculação (contato da Agrobacterium com o tecido ve- getal) até o momento em que a bactéria é retirada ou inativada. [00123] The "co-cultivation" step refers to the incubation of infected or contacted plant tissue with Agrobacterium in order to allow the transfer of Agrobacterium T-DNA to plant cells. This stage corresponds to the period between the moment immediately after inoculation (contact of the Agrobacterium with the plant tissue) until the moment when the bacteria is removed or inactivated.
[00124] O tecido inoculado pode ser co-cultivado por cerca de 1 a 30 dias, preferencialmente de 1 a 20, mais preferencialmente de 1 a 10 dias. [00124] The inoculated tissue can be co-cultured for about 1 to 30 days, preferably 1 to 20, more preferably 1 to 10 days.
[00125] Durante a etapa de co-cultivo, a temperatura pode ser qualquer temperatura adequada para a planta alvo conhecida na téc- nica. Ilustrativamente, para cana-de-açúcar, a temperatura pode variar entre cerca de 15°C a cerca de 30°C e de cerca de 16°C a cerca de 29°C. Em algumas concretizações, a etapa de co-cultivo ocorre na au- sência de luz. [00125] During the co-cultivation step, the temperature can be any suitable temperature for the target plant known in the art. Illustratively, for sugar cane, the temperature can range from about 15°C to about 30°C and from about 16°C to about 29°C. In some embodiments, the co-cultivation step takes place in the absence of light.
[00126] Após o co-cultivo com Agrobacterium, o meio é retirado e as células são transferidas para um meio de cultura na ausência de Agrobacterium, sendo incubadas no escuro, à temperatura de 20°C a cerca de 26°C, por um período de 1 a 20 dias. [00126] After co-cultivation with Agrobacterium, the medium is removed and the cells are transferred to a culture medium in the absence of Agrobacterium, being incubated in the dark, at a temperature of 20°C to about 26°C, for a period of 1 to 20 days.
[00127] O método aqui provido ainda inclui selecionar as células compreendendo pelo menos uma cópia da sequência genética de inte- resse. "Selecionar", como aqui utilizado, significa a situação em que é utilizado um agente seletivo para os transformantes, onde o dito agen- te seletivo irá permitir o crescimento preferencial de células de plantas contendo pelo menos uma cópia do gene marcador posicionado dentro do T-DNA e transferido pela Agrobacterium em detrimento daquelas células que não foram transformadas. Como indicado acima, qualquer marcador de seleção adequado pode ser utilizado. Preferencialmente, o gene marcador de seleção é utilizado é o gene nptll, o qual codifica uma enzima que confere resistência a antibióticos da classe dos ami- noglicosídeos, como a canamicina e a geneticina. [00127] The method provided herein further includes selecting cells comprising at least one copy of the genetic sequence of interest. "Select", as used herein, means the situation in which it is A selective agent for transformants is used, where said selective agent will allow the preferential growth of plant cells containing at least one copy of the marker gene positioned within the T-DNA and transferred by Agrobacterium to the detriment of those cells that have not been transformed . As indicated above, any suitable selection marker can be used. Preferably, the selection marker gene used is the nptll gene, which encodes an enzyme that confers resistance to antibiotics of the aminoglycoside class, such as kanamycin and geneticin.
[00128] Em algumas concretizações, é adicionado também um agente que inibe o crescimento de Agrobacterium após a etapa c. [00129] A seleção pode ocorrer em condições de claro ou escuro, dependendo da espécie de planta sendo transformada, e do genótipo, por exemplo. Em alguns casos, os calos embriogênicos ou outros teci- dos submetidos à transformação podem ser sub-cultivados em interva- los regulares ou irregulares no mesmo meio. No caso de transforma- ção de calos, é possível manter calos individuais separados para ga- rantir que apenas uma planta seja regenerada por calo e, portanto, to- das as plantas regeneradas são derivadas de eventos de transforma- ção independentes. Em uma concretização preferida, a etapa de sele- ção ocorre no escuro, por cerca de 1 a 10 semanas, mais preferenci- almente de 2 a 5 semanas. [00128] In some embodiments, an agent that inhibits the growth of Agrobacterium is also added after step c. [00129] Selection can occur under light or dark conditions, depending on the plant species being transformed, and the genotype, for example. In some cases, embryogenic callus or other tissues undergoing transformation can be subcultured at regular or irregular intervals in the same medium. In the case of callus transformation, it is possible to keep individual calluses separate to ensure that only one plant is regenerated per callus and therefore all regenerated plants are derived from independent transformation events. In a preferred embodiment, the selection step takes place in the dark, for about 1 to 10 weeks, more preferably 2 to 5 weeks.
[00130] Após o período de seleção, o tecido vegetal que continuou crescendo em presença do agente de seleção, e que, portanto, foi ge- neticamente modificado, pode ser manipulado e regenerado, colocan- do-o em meios de cultura e condições de crescimento adequados. As plantas transgênicas assim obtidas podem ser testadas para a presen- ça do DNA de interesse. O termo "regenerar", para fins desta inven- ção, refere-se à formação de uma planta, que inclui uma parte aérea e raízes. As plantas regeneradas podem ser plantadas em substrato adequado, como por exemplo, solo e serem transferidas para a casa de vegetação. Como aqui usado, "geneticamente modificado" ou "transgênico" ou "estavelmente transformado" significa uma célula de planta, parte de planta, tecido de planta ou planta que compreende uma sequência de DNA de interesse que é introduzida dentro do seu genoma por meio de transformação. [00130] After the selection period, the plant tissue that continued to grow in the presence of the selection agent, and which, therefore, was genetically modified, can be manipulated and regenerated, placing it in culture media and conditions suitable growth. The transgenic plants thus obtained can be tested for the presence of the DNA of interest. The term "regenerate", for purposes of this invention, refers to the formation of a plant, which includes a shoot and roots. Regenerated plants can be planted in substrate suitable, such as soil and be transferred to the greenhouse. As used herein, "genetically modified" or "transgenic" or "stably transformed" means a plant cell, plant part, plant tissue, or plant that comprises a DNA sequence of interest that is introduced into its genome via transformation.
[00131] Em uma modalidade, a bactéria é do gênero Agrobacte rium. [00131] In one embodiment, the bacterium is of the genus Agrobacterium.
[00132] Em uma modalidade mais preferida, a bactéria é a Agrobacterium tumefaciens. [00132] In a more preferred embodiment, the bacterium is Agrobacterium tumefaciens.
[00133] Em uma modalidade ainda mais preferida, a bactéria é uma cepa EHA105 de Agrobacterium tumefaciens. [00133] In an even more preferred embodiment, the bacterium is an EHA105 strain of Agrobacterium tumefaciens.
[00134] A presente invenção também se refere a caracterização do evento selecionado (CTC75064-3) e métodos de detecção de material vegetal derivado do mesmo. Os métodos analíticos para detecção e caracterização de plantas transgênicas incluem métodos indiretos (mé- todos de detecção baseados em proteínas) ou métodos diretos (méto- dos de detecção baseados em DNA) [00134] The present invention also relates to the characterization of the selected event (CTC75064-3) and methods of detecting plant material derived therefrom. Analytical methods for detecting and characterizing transgenic plants include indirect methods (protein-based detection methods) or direct methods (DNA-based detection methods)
[00135] A definição do sítio de integração estável do T-DNA no ge- noma das células hospedeiras e caracterização das sequências flan- queadoras é necessária para o desenvolvimento e validação de meto- dologias para a identificação e caracterização inequívoca do evento. [00136] Para identificar as regiões flanqueadoras das extremidades dos insertos de T-DNA presentes no evento CTC75064-3, foram reali- zados vários experimentos de amplificação e sequenciamento de DNA. Ensaios de PCR reverso (iPCR) foram realizados para ambas extremidades das sequências de T-DNA com o objetivo de isolar e clonar as regiões flanqueadoras dos insertos. Posteriormente, os fra- gmentos obtidos e isolados foram sequenciados por Sanger para vali- dação dos resultados obtidos por iPCR. O mapa das inserções genéti- cas presentes no evento CTC75064-3 é representado na Figura 3 (SEQ ID NO 2). As sequências flanqueadoras do evento CTC75064-3 são caracterizadas por compreender nucleotídeos contíguos das se- quências selecionadas do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24. Em um escopo preferido, as sequências flanqueadoras do evento CTC75064-3 são caracterizadas pelas SEQ ID NO 23 e SEQ ID NO 24. [00135] The definition of the site of stable integration of the T-DNA in the genome of the host cells and characterization of the flanking sequences is necessary for the development and validation of methodologies for the identification and unequivocal characterization of the event. [00136] To identify the flanking regions of the ends of the T-DNA inserts present in the CTC75064-3 event, several DNA amplification and sequencing experiments were performed. Reverse PCR (iPCR) assays were performed for both ends of the T-DNA sequences in order to isolate and clone the flanking regions of the inserts. Subsequently, the obtained and isolated fragments were sequenced by Sanger to validate the results obtained by iPCR. The map of genetic insertions cas present in event CTC75064-3 is represented in Figure 3 (SEQ ID NO 2). The flanking sequences of event CTC75064-3 are characterized by comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24. In a preferred scope, the flanking sequences of event CTC75064-3 are characterized by SEQs ID NO 23 and SEQ ID NO 24.
[00137] De acordo com um aspecto da invenção, é fornecido um polinucleotídeo que compreende pelo menos 14 nucleotídeos contí- guos da sequência SEQ ID NO 18. Em uma modalidade, é fornecido um polinucleotídeo que compreende pelo menos 15 nucleotídeos con- tíguos da SEQ ID NO 18. Em uma modalidade, é fornecido um polinu- cleotídeo que compreende pelo menos 16 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreen- de pelo menos 17 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 18 nucleo- tídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito poli- nucleotídeo compreende pelo menos 19 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreen- de pelo menos 20 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 21 nucleo- tídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito poli- nucleotídeo compreende pelo menos 22 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreen- de pelo menos 23 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 24 nucleo- tídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito poli- nucleotídeo compreende pelo menos 25 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, o dito polinucleotídeo compreen- de a SEQ ID NO 18. Em um aspecto adicional da invenção, o dito poli- nucleotídeo é caracterizado pelo fato de que compreende a SEQ ID NO 13. [00137] In accordance with one aspect of the invention, there is provided a polynucleotide comprising at least 14 contiguous nucleotides of the sequence SEQ ID NO 18. In one embodiment, a polynucleotide comprising at least 15 contiguous nucleotides of SEQ is provided. ID NO 18. In one embodiment, a polynucleotide comprising at least 16 contiguous nucleotides of SEQ ID NO 18 is provided. In one embodiment, said polynucleotide comprises at least 17 contiguous nucleotides of SEQ ID NO 18. embodiment, said polynucleotide comprises at least 18 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 19 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises at least 25 contiguous nucleotides of SEQ ID NO 18. In one embodiment, said polynucleotide comprises SEQ ID NO 18. In a further aspect of the invention, said poly - nucleotide is characterized by the fact that it comprises SEQ ID NO 13.
[00138] De acordo com um aspecto da invenção, é fornecido um polinucleotídeo que compreende pelo menos 14 nucleotídeos contí- guos SEQ ID NO. 19. Em uma modalidade, é fornecido um polinucleo- tídeo que compreende pelo menos 15 nucleotídeos contíguos da SEQ ID NO. 19. De acordo com um aspecto da invenção, é fornecido um polinucleotídeo que compreende pelo menos 16 nucleotídeos contí- guos da SEQ ID NO. 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 17 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 18 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 19 nucleotídeos contí- guos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 20 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 21 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 22 nucleotídeos contí- guos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 23 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, o dito polinucleotídeo compreende pelo menos 24 nucleotídeos contíguos da SEQ ID NO 19. De acordo com um as- pecto da invenção, é fornecido um polinucleotídeo que compreende pelo menos 25 nucleotídeos contíguos da SEQ ID NO. 19. Em uma modalidade, o dito polinucleotídeo compreende a SEQ ID NO 19. Em um aspecto da invenção, o dito polinucleotídeo é caracterizado pelo fato de que compreende a SEQ ID NO 12. [00138] According to one aspect of the invention, there is provided a polynucleotide comprising at least 14 contiguous nucleotides SEQ ID NO. 19. In one embodiment, a polynucleotide comprising at least 15 contiguous nucleotides of SEQ ID NO. 19. According to one aspect of the invention, there is provided a polynucleotide comprising at least 16 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, said polynucleotide comprises at least 17 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 18 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 19 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 20 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 21 contiguous nucleotides of SEQ ID NO 19. In in one embodiment, said polynucleotide comprises at least 22 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 23 contiguous nucleotides of SEQ ID NO 19. In one embodiment, said polynucleotide comprises at least 24 contiguous nucleotides of SEQ ID NO 19. In accordance with one aspect of the invention, there is provided a polynucleotide comprising at least 25 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, said polynucleotide comprises SEQ ID NO 19. In one aspect of the invention, said polynucleotide is characterized in that it comprises SEQ ID NO 12.
[00139] Em um aspecto adicional da presente invenção é fornecido um polinucleotídeo que compreende pelo menos 80%, preferencial- mente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 3. Em um mesmo aspecto da presente invenção é fornecido um polinucleotídeo que compreende pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 4. Em um aspecto adicional é fornecido um polinucleotídeo que com- preende pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 5. Ainda em um aspec- to adicional da presente invenção é fornecido um polinucleotídeo que compreende pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 22. [00139] In a further aspect of the present invention there is provided a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 3. In a single aspect of the present invention there is provided a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 4. a further aspect is provided a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 5. In a still further aspect of the present invention there is provided a polynucleotide comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 22.
[00140] De acordo com um aspecto da invenção, é fornecido uma planta que compreende pelo menos 14 nucleotídeos contíguos da SEQ ID NO. 18. Em uma modalidade, é fornecido uma planta que compreende pelo menos 15 nucleotídeos contíguos da SEQ ID NO. 18. De acordo com um aspecto da invenção, é fornecido uma planta que compreende pelo menos 16 nucleotídeos contíguos da SEQ ID NO. 18. Em uma modalidade, a planta compreende pelo menos 17 nu- cleotídeos contíguos SEQ ID NO 18. Em uma modalidade, a planta compreende pelo menos 18 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compreende pelo menos 19 nucleotí- deos contíguos da SEQ ID NO 18. Em uma modalidade, a planta com- preende pelo menos 20 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compreende pelo menos 21 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compre- ende pelo menos 22 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compreende pelo menos 23 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compre- ende pelo menos 24 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compreende pelo menos 25 nucleotídeos contíguos da SEQ ID NO 18. Em uma modalidade, a planta compre- ende a SEQ ID NO 18. Em uma modalidade adicional, a planta com- preende a SEQ ID NO 13. [00140] According to one aspect of the invention, there is provided a plant comprising at least 14 contiguous nucleotides of SEQ ID NO. 18. In one embodiment, a plant is provided that comprises at least 15 contiguous nucleotides of SEQ ID NO. 18. According to one aspect of the invention, there is provided a plant comprising at least 16 contiguous nucleotides of SEQ ID NO. 18. In one embodiment, the plant comprises at least 17 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 18 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 19 nucleotides - contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 20 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 21 contiguous nucleotides of SEQ ID NO 18. In one embodiment , the plant comprises at least 22 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 23 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 24 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises at least 25 contiguous nucleotides of SEQ ID NO 18. In one embodiment, the plant comprises SEQ ID NO 18. In a further embodiment, the plant comprises comprises SEQ ID NO 13.
[00141] De acordo com um aspecto da invenção, é fornecido uma planta que compreende pelo menos 14 nucleotídeos contíguos da SEQ ID NO. 19. Em uma modalidade, é fornecido uma planta que compreende pelo menos 15 nucleotídeos contíguos da SEQ ID NO. 19. Em uma modalidade, é fornecido uma planta que compreende pelo menos 16 nucleotídeos contíguos da SEQ ID NO. 19. Em uma modali- dade, a planta compreende pelo menos 17 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, a planta compreende pelo me- nos 18 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalida- de, a planta compreende pelo menos 19 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, a planta compreende pelo me- nos 20 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalida- de, a planta compreende pelo menos 21 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, a planta compreende pelo me- nos 22 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalida- de, a planta compreende pelo menos 23 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, a planta compreende pelo me- nos 24 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalida- de, a planta compreende pelo menos 24 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalidade, a planta compreende pelo me- nos 25 nucleotídeos contíguos da SEQ ID NO 19. Em uma modalida- de, a planta compreende a SEQ ID NO 19. Em uma modalidade adici- onal, a planta compreende a SEQ ID NO 12. [00141] According to one aspect of the invention, there is provided a plant comprising at least 14 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, a plant is provided that comprises at least 15 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, a plant is provided that comprises at least 16 contiguous nucleotides of SEQ ID NO. 19. In one embodiment, the plant comprises at least 17 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 18 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 19 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 20 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 21 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 22 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 23 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least at least 24 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 24 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises at least 25 contiguous nucleotides of SEQ ID NO 19. In one embodiment, the plant comprises SEQ ID NO 19. In an additional embodiment, the plant comprises SEQ ID NO 12.
[00142] Adicionalmente, a dita planta é uma cana de açúcar geneti- camente modificada ( Saccharum spp ). Adicionalmente, a dita planta é resistente a insetos e é caracterizada por compreender uma sequência com pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 5. Ainda em um aspecto adicional, a planta resistente a insetos da presente invenção é caracte- rizada por compreender uma sequência com pelo menos 80%, prefe- rencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO 22. Em uma modalidade da presente invenção, a dita planta é uma planta de cana-de-açúcar. Em uma modalidade adicio- nal, a dita planta é uma planta de cana-de-açúcar inseticida que é o evento CTC75064-3 ou uma planta derivada da mesma. [00142] Additionally, said plant is a genetically modified sugar cane (Saccharum spp). Additionally, said plant is resistant to insects and is characterized by comprising a sequence with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO 5. In a further aspect, the insect resistant plant of the present invention is characterized by characterized by comprising a sequence having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO 22. In one embodiment of the present invention, said plant is a sugarcane plant. In an additional embodiment, said plant is an insecticidal sugarcane plant which is event CTC75064-3 or a plant derived therefrom.
[00143] Em um aspecto da invenção, é fornecido o evento CTC75064-3 caracterizado pelo fato de ser uma variedade de cana- de-açúcar ( Saccharum spp.) compreendendo pelo menos 14 nucleotí- deos contíguos das sequências selecionadas do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. Adicionalmente, o evento CTC75064- 3 é caracterizado pelo fato de ser uma variedade de cana-de-açúcar ( Saccharum spp.) compreendendo a SEQ ID NO 5. Em um aspecto adicional, o evento CTC75064-3 é caracterizado pelo fato de compre- ender a SEQ ID NO 22. [00143] In one aspect of the invention, event CTC75064-3 is provided, characterized in that it is a variety of sugar cane ( Saccharum spp.) comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19. Additionally, event CTC75064-3 is characterized by the fact that it is a variety of sugarcane ( Saccharum spp.) comprising SEQ ID NO 5. In a further aspect, event CTC75064 -3 is characterized by the fact that it comprises SEQ ID NO 22.
[00144] É ainda desejável um método para detecção e caracteriza- ção inequívoca do evento de interesse (evento específico). Em um as- pecto, a presente invenção fornece um método específico de detecção e identificação do evento CTC75064-3. [00144] A method for detection and unambiguous characterization of the event of interest (specific event) is still desirable. In one aspect, the present invention provides a specific method of detecting and identifying event CTC75064-3.
[00145] Em um aspecto, a invenção fornece um método de detec- ção de material vegetal derivado de uma planta de cana de açúcar ge- neticamente modificada do evento CTC75064-3, caracterizado por compreender as etapas de: a) obter uma amostra do material vegetal para análise; b) extrair o DNA da amostra; c) fornecer pares de iniciadores compreendendo pelo me- nos um iniciador senso e outro antissenso; d) amplificar a região que fica entre os sítios em que os ini- ciadores se ligam; e e) detectar a presença de produto da amplificação. [00146] Em um escopo, pares de iniciadores (etapa c) de acordo com o método de detecção descrito são desenhados para se ligarem a polinucleotídeos compreendendo nucleotídeos contíguos de sequência selecionada do grupo consistindo em SEQ ID NO 2 e SEQ ID NO 36. [00147] Em um outro escopo, os pares de iniciadores da etapa c) são desenhados para se ligarem a polinucleotídeos compreendendo nucleotídeos contíguos de sequências selecionadas do grupo consis- tindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um (1) par de iniciadores compreende nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. [00145] In one aspect, the invention provides a method of detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3, characterized by comprising the steps of: a) obtaining a sample of the plant material for analysis; b) extracting DNA from the sample; c) providing primer pairs comprising at least one sense and one antisense primer; d) amplifying the region between the sites where the primers bind; and e) detecting the presence of amplification product. [00146] In one scope, primer pairs (step c) according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO 2 and SEQ ID NO 36. [00146] 00147] In another scope, the primer pairs of step c) are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, where at least one (1) primer pair comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
[00148] Em um escopo, os pares de iniciadores acima (etapa c) are desenhados para se ligarem a polinucleotídeos compreendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo me- nos 1(um) par de iniciadores compreende pelo menos 3 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. Em um escopo, os pares de iniciadores são desenhados para se ligarem a po- linucleotídeos compreendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo menos 1(um) par de iniciador compreende pelo menos 7 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. Adicionalmente, os pares de iniciadores são dese- nhados para se ligarem a polinucleotídeos compreendendo pelo me- nos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo menos 1(um) par de iniciador compreende pelo menos 14 nucleotídeos con- tíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. [00148] In one scope, the above primer pairs (step c) are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where at least in the 1(one) pair of primers comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. In one scope, the primer pairs are designed to bind polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one (1) primer pair comprises at least 7 nucleotides contigs of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. Additionally, primer pairs are designed to bind to polynucleotides comprising at least - in the 14 nucleotides c sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one (1) primer pair comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
[00149] Ainda em um aspecto adicional, pares de iniciadores de acordo com o método de detecção descrito são desenhados para se ligarem a polinucleotídeos compreendendo nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31 e um segundo inici- ador compreendendo nucleotídeos contíguos de sequências selecio- nadas do grupo consistindo em SEQ ID NO: 2 e SEQ ID NO: 36. [00150] Em um aspecto, pares de iniciadores de acordo com o mé- todo de detecção descrito são desenhados para se ligarem a polinu- cleotídeos compreendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo pelo menos 3 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31 e um se- gundo iniciador compreendendo pelo menos 3 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 2 e SEQ ID NO: 36. Ainda em um aspecto adicional, pares de iniciadores de acordo com o método de detecção descrito são desenhados para se ligarem a polinucleotídeos compreendendo pelo menos 14 nucleo- tídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo pelo menos 7 nucleotídeos contíguos de sequências selecionadas do gru- po consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31 e um segundo iniciador compreendendo pelo menos 7 nucleotídeos contíguos de sequências selecionadas do grupo consis- tindo em SEQ ID NO: 2 e SEQ ID NO: 36. Adicionalmente, pares de iniciadores de acordo com o método de detecção descrito são dese- nhados para se ligarem a polinucleotídeos compreendendo pelo me- nos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreen- dendo pelo menos 14 nucleotídeos contíguos de sequências selecio- nadas do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31 e um segundo iniciador compreendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 2 e SEQ ID NO: 36. [00149] In yet a further aspect, primer pairs according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, where at least one (1) pair of primers consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. [00150] In one aspect, primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In a still further aspect, primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. Additionally, primer pairs according to the described detection method are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one (1) pair of primers consists of a first primer comprising at least 14 contiguous nucleotides of selected sequences from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
[00151] Em uma modalidade, os pares de iniciadores, conforme o método de detecção descrito, são planejados para se ligarem a um polinucleotídeo que compreende nucleotídeos contíguos de sequên- cias selecionadas do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde pelo menos 1(um) par de iniciador compreende nucleotí- deos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39. Em um aspecto, os pares de iniciadores, conforme o método de detecção descrito, são planejados para se ligarem a um polinucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde pelo menos 1(um) par de iniciador compreende pelo menos 3 nucleotídeos contíguos de sequências selecionadas do grupo consis- tindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39. Adicionalmente, os pares de iniciadores são planejados para se ligarem a um polinucleotídeo que compreende pelo menos 14 nucleo- tídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde pelo menos 1(um) par de inicia- dor compreende pelo menos 7 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39. Em um aspecto, os pares de inicia- dores, conforme o método de detecção descrito, são planejados para se ligarem a um polinucleotídeo que compreende pelo menos 14 nu- cleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde pelo menos 1(um) par de ini- ciador compreende pelo menos 14 nucleotídeos contíguos de sequên- cias selecionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39. [00151] In one embodiment, primer pairs, as described in the detection method, are designed to bind to a polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein at least one (1) primer pair comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. In one aspect, primer pairs, according to the detection method described, are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, where at least 1 (a) primer pair comprises at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. primers are designed to bind to a polynucleotide and which comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein at least 1 (one) pair of primers comprises at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39. In one aspect, the primer pairs, as the detection method described, are designed to bind to a polynucleotide comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, where at least one (1) pair of ini - constructor comprises at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
[00152] Em um aspecto, pares de iniciadores de acordo com o mé- todo de detecção descrito são desenhados para se ligarem a polinu- cleotídeos compreendendo nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo nucleotídeos contíguos de sequências sele- cionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39 e um segundo iniciador compreendendo nucleotídeos contíguos de sequências selecionadas do grupo consis- tindo em SEQ ID NO: 2 e SEQ ID NO: 36. Em um aspecto adicional, pares de iniciadores são desenhados para se ligarem a polinucleotí- deos compreendendo pelo menos 14 nucleotídeos contíguos de se- quências selecionadas do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo pelo menos 3 nucleotídeos contí- guos de sequências selecionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39 e um segundo iniciador compreendendo pelo menos 3 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 2 e SEQ ID NO: 36. Em um aspecto, pares de iniciadores são desenhados para se ligarem a polinucleotídeos compreendendo pelo menos 14 nu- cleotídeos contíguos de sequências selecionadas do grupo consistin- do em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um (1) par de iniciadores consiste em um primeiro iniciador compreendendo pelo menos 7 nucleotídeos contíguos de sequências selecionadas do gru- po consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 e um segundo iniciador compreendendo pelo menos 7 nucleotídeos contíguos de sequências selecionadas do grupo consis- tindo em SEQ ID NO: 2 e SEQ ID NO: 36. Adicionalmente, pares de iniciadores são desenhados para se ligarem a polinucleotídeos com- preendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um (1) par de iniciadores consiste em um primei- ro iniciador compreendendo pelo menos 14 nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39 e um segundo inicia- dor compreendendo pelo menos 14 nucleotídeos contíguos de se- quências selecionadas do grupo consistindo em SEQ ID NO: 2 e SEQ ID NO: 36. [00152] In one aspect, primer pairs according to the described detection method are designed to bind to polynucleotides comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO. :37, wherein at least one (1) primer pair consists of a first primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In a further aspect, primer pairs are designed to bind to polynucleotides comprising at least least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 3 contiguous nucleotides of sequence. those selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 3 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. In one aspect, primer pairs are drawn to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 7 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 7 contiguous nucleotides of selected sequences from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36. Additionally, primer pairs are designed to bind to polynucleotides comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one (1) pair of primers consists of a first primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ I D NO: 38 and SEQ ID NO: 39 and a second primer comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 36.
[00153] Preferivelmente, o método de detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3 da presente invenção compreende: a) a obtenção de uma amostra de material vegetal para análise; b) a extração do DNA da amostra; c) o fornecimento de pares de iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende nucleo- tídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29; d) a amplificação da região que fica entre os sítios em que os iniciadores se ligam; e e) detecção da presença do produto da amplificação, onde, o produto de amplificação é caracterizado por compreender nu- cleotídeos contíguos de uma sequência selecionada do grupo consis- tindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 e SEQ ID NO 33. [00153] Preferably, the method of detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3 of the present invention comprises: a) obtaining a sample of plant material for analysis; b) extracting DNA from the sample; c) providing primer pairs designed to bind at least one polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29; d) amplification of the region that lies between the sites where initiators bind; and e) detecting the presence of the amplification product, wherein, the amplification product is characterized by comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33.
[00154] Conforme o método de detecção descrito, os pares inicia- dores (etapa c) são planejados para se ligarem a pelo menos um poli- nucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 22, SEQ ID NO 29. Adicionalmente, os pares iniciadores são planeja- dos para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde, o pro- duto de amplificação detectado na etapa e) é caracterizado por com- preender pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 e SEQ ID NO 33. Em um aspecto adicional, os pares iniciadores são planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde, o produto de amplificação detectado na etapa e) é caracterizado por compreender nucleotídeos contíguos de uma se- quência selecionada do grupo consistindo em SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38 e SEQ ID NO 39. Em um aspecto relacionado, o produto de amplificação detectado na etapa e) é caracterizado por compreender pelo menos 104 nucleotídeos contíguos de uma sequên- cia selecionada do grupo consistindo em SEQ ID NO 3, SEQ ID NO 4, SEQ ID N038, SEQ ID NO 39. [00154] According to the detection method described, the primer pairs (step c) are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 , SEQ ID NO 29. Additionally, primer pairs are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where, the amplification product detected in step e) is characterized by comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33. In a further aspect, primer pairs are designed to bind at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, where and, the amplification product detected in step e) is characterized in that it comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38 and SEQ ID NO 39. In one aspect related, the amplification product detected in step e) is characterized in that it comprises at least 104 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 038, SEQ ID NO 39.
[00155] Em uma modalidade, os pares iniciadores, conforme o mé- todo de detecção descrito, são planejados para se ligarem a pelo me- nos um polinucleotídeo que compreende nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37. Em uma modalidade adicional, os pares iniciadores, conforme o método de detecção descrito, são planejados para se liga- rem a pelo menos um polinucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo con- sistindo em SEQ ID NO 5 e SEQ ID NO 37. Adicionalmente, os pares iniciadores são planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde, o produto de amplificação detectado na etapa e) é caracterizado por compreender pelo menos 14 nucleotídeos contí- guos de uma sequência selecionada do grupo consistindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 e SEQ ID NO 33. Em mais uma modalidade, a invenção escreve pares iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 37, onde, o produto de amplificação detectado na etapa e) é caracterizado por compreender pelo menos 104 nucleotídeos contíguos de uma sequência seleciona- da do grupo consistindo em SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38, SEQ ID NO 39. [00155] In one embodiment, the initiating pairs, as per the method, detection whole described, are designed to bind to at least one polynucleotide comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37. In an additional embodiment, primer pairs, as detection method described, are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37. Additionally, primer pairs are designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein, the amplification product detected in step e) is characterized by comprise at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33. In a further embodiment, the in The invention writes primer pairs designed to bind at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 37, wherein, the amplification product detected in step e) is characterized in that it comprises at least 104 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38, SEQ ID NO 39.
[00156] Em uma modalidade, pares de iniciadores são fornecidos pela presente invenção e caracterizados pelo fato de serem seleciona- dos do grupo consistindo em sequências com pelo menos 80%, prefe- rencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as SEQ ID NO: 6 e SEQ ID NO: 7; SEQ ID NO: 8 e SEQ ID NO: 9. Em um aspecto particular, os pares de iniciadores utilizados na etapa c) do método de detecção de material vegetal derivado do evento CTC75064-3 são caracterizados pelo fato de serem selecionados do grupo consistindo em sequências com pelo menos 80%, preferencial- mente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as SEQ ID NO: 6 e SEQ ID NO: 7; SEQ ID NO: 8 e SEQ ID NO: 9. Adici- onalmente, os pares de iniciadores utilizados na etapa c) do método de detecção de material vegetal derivado do evento CTC75064-3 compreendem sequências selecionadas do grupo consistindo em SEQ ID NO: 6 e SEQ ID NO: 7; SEQ ID NO: 8 e SEQ ID NO: 9. Ainda, em uma modalidade preferida, pares de iniciadores são fornecidos, onde o iniciador sense consiste em SEQ ID NO: 6 e o antisense de SEQ ID NO: 7 e/ou, o iniciador sense consiste em SEQ ID NO: 8 e o antisense de SEQ ID NO: 9. [00156] In one embodiment, primer pairs are provided by the present invention and characterized in that they are selected from the group consisting of sequences with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9. In a particular aspect, the primer pairs used in step c) of the event-derived plant material detection method CTC75064-3 are characterized in that they are selected from the group consisting of sequences with at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9. Additionally, the primer pairs used in step c) of the method for detecting plant material derived from event CTC75064-3 comprise sequences selected from the group consisting of SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9. Further, in a preferred embodiment, primer pairs are provided, where the sense primer consists of SEQ ID NO: 6 and the antisense of SEQ ID NO: 7 and/or, the sense primer consists of SEQ ID NO: 8 and the antisense of SEQ ID NO: 9.
[00157] Em uma modalidade da presente invenção, são fornecidos pares de iniciadores para a detecção de material vegetal derivado do evento de cana de açúcar geneticamente modificado CTC75064-3 ca- racterizados pelo fato de que o iniciador senso possui pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de iden- tidade com a SEQ ID NO: 6 e o iniciador antissenso possui pelo me- nos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 7 e/ou o iniciador senso possui pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 8 e o iniciador antissenso possui pe- lo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com a SEQ ID NO: 9. Em uma modalidade prefe- rida, os pares de iniciadores são caracterizados pelo iniciador senso compreender a SEQ ID NO: 6 e o iniciador antissenso compreender a SEQ ID NO: 7 e/ou o iniciador senso compreender a SEQ ID NO: 8 e o iniciador antissenso compreender a SEQ ID NO:9. [00157] In one embodiment of the present invention, pairs of primers are provided for the detection of plant material derived from the event of genetically modified sugar cane CTC75064-3 characterized by the fact that the sense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and the antisense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 7 and/or the sense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and the antisense primer has at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 9. In a preferred embodiment - rida, primer pairs are characterized by the sense primer comprising SEQ ID NO: 6 and the antisense primer comprising SEQ ID NO: 7 and/or the sense primer comprising SEQ ID NO: 8 and the antisense primer co comprising SEQ ID NO:9.
[00158] Em uma modalidade ainda mais específica, o produto de amplificação (ou amplicom) produzido pelos iniciadores do método de detecção descrito está entre 100 e 1000 pares de base de comprimen- to. Em um escopo preferido, o amplicon produzido pelos iniciadores do método de detecção descrito está entre 100 e 300 pares de base de comprimento. Ainda mais preferivelmente, o amplicom obtido utilizan- do pares de iniciadores compreendendo pelo menos 80%, preferenci- almente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as SEQ ID NO: 6 e SEQ ID NO: 7 caracteriza-se por compreender a SEQ ID NO 12 e o produto de amplificação (ou amplicon) produzido pelos iniciadores possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as SEQ ID NO: 8 e SEQ ID NO: 9 caracteriza-se por compreender a SEQ ID NO 13. [00158] In an even more specific embodiment, the amplification product (or amplicom) produced by the primers of the described detection is between 100 and 1000 base pairs in length. In a preferred scope, the amplicon produced by the primers of the described detection method is between 100 and 300 base pairs in length. Even more preferably, the amplicom is obtained using primer pairs comprising at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 6 and SEQ ID NO: 7 is characterized by comprising SEQ ID NO 12 and the amplification product (or amplicon) produced by the primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with SEQ ID NO: 8 and SEQ ID NO: 9 is characterized by comprising SEQ ID NO 13.
[00159] É de conhecimento geral, em especial aos versados na técnica, que a molécula de DNA (ou ADN) é constituída por duas ca- deias ou fitas de nucleotídeos que se mantêm unidas por pontes de hidrogénio entre as bases dos nucleotídeos. O pareamento ocorre de acordo com a complementariedade das bases, seguindo a regra geral de: Adenina com Timina e Citosina com Guanina. Assim, apesar da representação das sequências nucleotídicas ser realizada apenas para uma das fitas, a sua fita complementar ou sequência complementar está incluída no escopo dessa invenção, sendo considerada para a definição das sequências iniciadoras e sondas aqui descritas. [00159] It is common knowledge, especially those skilled in the art, that the DNA molecule (or DNA) is made up of two chains or strands of nucleotides that are held together by hydrogen bonds between the bases of the nucleotides. Pairing occurs according to the complementarity of the bases, following the general rule of: Adenine with Thymine and Cytosine with Guanine. Thus, although the representation of the nucleotide sequences is performed only for one of the strands, its complementary strand or complementary sequence is included in the scope of this invention, being considered for the definition of the primers and probes described herein.
[00160] Os métodos para obtenção de amostras para extração de DNA para análises moleculares são amplamente conhecidos por um técnico no assunto e incluem a coleta de qualquer material vegetal de- rivado do evento transgênico CTC75064-3, como por exemplo colmo, raízes e folhas. Preferencialmente, as amostras são obtidas de folhas intactas. Métodos de extração de DNA vegetal incluem, sem limitação, aqueles baseados no uso do detergente CTAB (Alianabi et ai, 1999), seguidos ou não de purificação posterior da amostra com cloreto de césio ou acetato de amónio, além dos métodos comerciais disponíveis. [00161] Pares de iniciadores adequados para uso neste método de detecção podem ser planejados utilizando parâmetros bem- conhecidos pelos versados na técnica da biologia molecular agora que as SEQs IDs da presente invenção ficaram disponíveis, em especial, as SEQ IDs Nos 2, 3, 4, 5,18, 19, 22, 23, 24, 29, 30, 31,32, 33, 36, 37, 38 e 39. [00160] Methods for obtaining samples for DNA extraction for molecular analysis are widely known to a person skilled in the art and include the collection of any plant material derived from the transgenic event CTC75064-3, such as stems, roots and leaves . Preferably, the samples are obtained from intact leaves. Methods of extracting plant DNA include, without limitation, those based on the use of CTAB detergent (Alianabi et al, 1999), followed or not by further purification of the sample with cesium chloride or ammonium acetate, in addition to commercially available methods. [00161] Primer pairs suitable for use in this detection method can be designed using parameters well known to those skilled in the art of molecular biology now that the SEQ IDs of the present invention have become available, in particular SEQ IDs Nos 2, 3, 4, 5.18, 19, 22, 23, 24, 29, 30, 31.32, 33, 36, 37, 38 and 39.
[00162] Por exemplo, um ou ambos os iniciadores do par podem ser planejados para serem específicos a construção, específicos ao gene da característica, específicos ao promotor, específicos à sequên- cia da junção entre o DNA inserido e o DNA genômico e/ou específi- cos às sequências flanqueadoras. [00162] For example, one or both of the primers in the pair can be designed to be construct specific, trait gene specific, promoter specific, sequence specific for the junction between the inserted DNA and the genomic DNA and/or specific to flanking sequences.
[00163] Há muitos métodos de amplificação que podem ser utiliza- dos de acordo com este aspecto da invenção. O princípio básico, uma das técnicas conhecida pelos versados na arte, é a reação em cadeia da polimerase (PCR). O produto da amplificação de uma reação da PCR pode ser visualizado através da coloração da cadeia nucleotídica, com, por exemplo, brometo de etídio, e a excitação com luz UV, tipi- camente após a separação em tamanhos utilizando a eletroforese em gel de agarose. [00163] There are many amplification methods that can be used in accordance with this aspect of the invention. The basic principle, one of the techniques known to those skilled in the art, is the polymerase chain reaction (PCR). The amplification product of a PCR reaction can be visualized by staining the nucleotide chain with, for example, ethidium bromide, and excitation with UV light, typically after size separation using agarose gel electrophoresis. .
[00164] Uma das modalidades da presente invenção usa variações do princípio da PCR como, por exemplo, PCR quantitativo em tempo real, PCR aninhadas (nested PCR), PCR inversa (iPCR), PCR digital, Long PCR, Touchdown PCR, Hot Start PCR, Multiplex PCR, entre ou- tros. O produto da amplificação também pode ser detectado por dife- rentes metodologias, as quais estão contempladas na presente inven- ção, como por exemplo, o sistema de SYBR Green™, o qual emite flu- orescência quando este reagente se liga ao DNA de fita dupla e o sis- tema Taqman®, onde a detecção é baseado na interação de sondas fluorescentes. A metodologia Taqman® usa uma sonda que é com- plementar ao segmento do produto da PCR pretendido, localizada en- tre os iniciadores da reação. Desta forma, também é considerado co- mo um aspecto da presente invenção sequências de nucleotídeos de filamento único, complementares a polinucleotídeos compreendendo nucleotídeos contíguos de sequência selecionada do grupo consistin- do em SEQ ID NO. 2, SEQ ID NO 3, SEQ ID NO. 4, SEQ ID NO 5, SEQ ID NO. 12, SEQ ID NO 13, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 29, SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32, SEQ ID NO. 33, SEQ ID NO. 36, SEQ ID NO. 37, SEQ ID NO. 38 e SEQ ID NO. 39. Durante a etapa de hibridização do ciclo da PCR a sonda está ligada ao DNA-alvo, e durante a extensão da Taq polimerase, através da sua atividade de 5'- exonuclease, remove a sonda, liberando o fluorocromo apresentador, permitindo a emissão de sua fluorescência. Modalidades adicionais desse aspecto da presente invenção incluem, mas não são limitadas a: amplificação isotermal em loop ("loop-mediated isothermal amplifica- tion - LAMP"), eletroforese capilar em gel ("capillary gel electrophoresis - CGE"), "microarray", tecnologia Luminex, "DNA walking" e "Next Ge- neration Sequencing (NGS), método de Sanger, lllumina, entre outros. [00165] A presente invenção descreve uma metodologia de detec- ção específica baseada na técnica de PCR quantitativo em tempo real (qPCR) conhecida como "Plus-Minus" ou "Presença-Ausência", sendo apresentado duas variações da metodologia: via SYBR GREEN™ e via tecnologia Taqman®. [00164] One of the embodiments of the present invention uses variations of the PCR principle such as, for example, quantitative real-time PCR, nested PCR (nested PCR), inverse PCR (iPCR), digital PCR, Long PCR, Touchdown PCR, Hot Start PCR, Multiplex PCR, among others. The amplification product can also be detected by different methodologies, which are contemplated in the present invention, such as, for example, the SYBR Green™ system, which emits fluorescence when this reagent binds to DNA strand. dual and the Taqman® system, where detection is based on the interaction of fluorescent probes. The Taqman® methodology uses a probe that is complementary to the intended PCR product segment, located between between the reaction initiators. Accordingly, single-stranded nucleotide sequences complementary to polynucleotides comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO. 2, SEQ ID NO 3, SEQ ID NO. 4, SEQ ID NO 5, SEQ ID NO. 12, SEQ ID NO 13, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 24, SEQ ID NO. 29, SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32, SEQ ID NO. 33, SEQ ID NO. 36, SEQ ID NO. 37, SEQ ID NO. 38 and SEQ ID NO. 39. During the hybridization step of the PCR cycle, the probe is bound to the target DNA, and during the extension of the Taq polymerase, through its 5'-exonuclease activity, it removes the probe, releasing the presenting fluorochrome, allowing the emission of its fluorescence. Additional embodiments of this aspect of the present invention include, but are not limited to: loop-mediated isothermal amplification ("LAMP"), capillary gel electrophoresis ("CGE"), "microarray" , Luminex technology, "DNA walking" and "Next Generation Sequencing (NGS), Sanger method, Illumina, among others. [00165] The present invention describes a specific detection methodology based on the technique of quantitative PCR in time. (qPCR) known as "Plus-Minus" or "Presence-Absence", with two variations of the methodology being presented: via SYBR GREEN™ and via Taqman® technology.
[00166] Assim, é um aspecto da presente invenção que a detecção dos produtos de amplificação (ou amplicons) obtidos através do uso dos pares de iniciadores selecionados do grupo possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de iden- tidade com as SEQ ID NO: 6 e SEQ ID NO: 7; SEQ ID NO: 8 e SEQ ID NO: 9 é realizada através da hibridização de sonda selecionada do grupo consistindo em, respectivamente, SEQ ID NO 10 e SEQ ID NO 11. Adicionalmente, o produto de amplificação (ou amplicom) produzi- do pelos iniciadores possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com as SEQ ID NO: 6 e SEQ ID NO: 7 é visualizado através de uma sonda marcada compreendendo a sequência SEQ ID NO. 10. O produto de amplifica- ção (ou amplicom) produzido pelos iniciadores possuindo pelo menos 80%, preferencialmente 85%, 90%, 95%, 98%, 99% ou 100% de iden- tidade com as SEQ ID NO: 8 e SEQ ID NO: 9 é visualizado através de uma sonda marcada compreendendo a sequência SEQ ID NO. 11. Ainda é um aspecto da presente invenção que a detecção do produto de amplificação obtido com o uso dos iniciadores SEQ ID NO: 6 eSEQ ID NO: 7 e/ou SEQ ID NO: 8 e SEQ ID NO: 9 é realizada através da hibridização com uma sonda compreendendo as sequências SEQ ID NO: 10 ou SEQ ID NO: 11. [00166] Thus, it is an aspect of the present invention that the detection of amplification products (or amplicons) obtained through the use of primer pairs selected from the group having at least 80%, preferably 85%, 90%, 95%, 98 %, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9 is performed by hybridizing probe selected from the group consisting of, respectively, SEQ ID NO 10 and SEQ ID NO 11. Additionally, the amplification product (or amplicom) produced by primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 6 and SEQ ID NO: 7 is visualized through a labeled probe comprising the sequence SEQ ID NO. 10. The amplification product (or amplicom) produced by primers having at least 80%, preferably 85%, 90%, 95%, 98%, 99% or 100% identity to SEQ ID NO: 8 and SEQ ID NO: 9 is visualized through a labeled probe comprising the sequence SEQ ID NO. 11. It is a further aspect of the present invention that detection of the amplification product obtained using primers SEQ ID NO: 6 and SEQ ID NO: 7 and/or SEQ ID NO: 8 and SEQ ID NO: 9 is carried out via hybridization with a probe comprising the sequences SEQ ID NO: 10 or SEQ ID NO: 11.
[00167] As Figuras 6 (reação de detecção específica para o evento da invenção via Taqman®) e 7 (ensaio via SYBR GREEN™), represen- tam a validação de ambos os Métodos. [00167] Figures 6 (specific detection reaction for the event of the invention via Taqman ® ) and 7 (assay via SYBR GREEN™), represent the validation of both Methods.
[00168] Os iniciadores e sondas descritos na presente invenção podem ser utilizados em combinação para detectar o evento CTC75064-3. Assim, uma modalidade adicional da presente invenção envolve o uso de PCR multiplex para identificação do material vegetal do evento CTC75064-3. [00168] The primers and probes described in the present invention can be used in combination to detect event CTC75064-3. Thus, an additional embodiment of the present invention involves the use of multiplex PCR to identify plant material from event CTC75064-3.
[00169] Iniciadores e sondas alternativos para auxiliar a detecção e caracterização do evento CTC75064-3 estão incluídos na invenção. Esses e outras variações podem ser utilizados com qualquer um dos métodos de detecção direta descritos acima, mas não limitados a es- tes. [00169] Alternative primers and probes to aid in the detection and characterization of event CTC75064-3 are included in the invention. These and other variations can be used with any of the direct detection methods described above, but not limited to these.
[00170] Adicionalmente, o evento CTC75064-3 pode ser detectado de material vegetal através da hibridização de amostras de DNA com as sondas. Especificamente, a presente invenção descreve um méto- do para detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3 que compreende: a) a obtenção de uma amostra para análise; b) a extração do DNA ou RNA da amostra; c) o fornecimento de uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo compre- endendo nucleotídeos contíguos de sequência selecionada do grupo consistindo em SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 e SEQ ID NO 39, onde o dito polinucleotídeo possui filamento simples; d) a hibridização da dita sonda ou combinação de sondas com a amostra, e e) a detecção da sonda hibridizada ou combinação de son- das. [00170] Additionally, event CTC75064-3 can be detected from plant material by hybridizing DNA samples with the probes. Specifically, the present invention describes a method for the detection of plant material derived from a genetically modified sugarcane plant of event CTC75064-3, which comprises: a) obtaining a sample for analysis; b) extracting DNA or RNA from the sample; c) providing a probe or combination of probes designed to bind to at least one polynucleotide comprising contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 and SEQ ID NO 39, wherein said polynucleotide is single-stranded; d) hybridizing said probe or combination of probes with the sample, and ee) detecting the hybridized probe or combination of probes.
[00171] Opcionalmente, o método de detecção através do uso de sondas contempla uma etapa adicional (b1) compreendendo a obten- ção de produto de amplificação do material da Etapa b) através dos iniciadores descritos pela presente invenção. Tal produto de amplifica- ção é utilizado nas etapas posteriores de hibridização e detecção da sonda hibridizada (c - e). [00171] Optionally, the detection method through the use of probes contemplates an additional step (b1) comprising obtaining amplification product from the material of Step b) through the primers described by the present invention. Such an amplification product is used in the later stages of hybridization and detection of the hybridized probe (c - e).
[00172] Em um escopo preferido, na etapa c) do método descrito é fornecido uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Adicionalmente, a etapa c) do método descrito é ca- racterizada por compreender o fornecimento de uma sonda ou combi- nação de sondas planejadas para se ligarem a pelo menos um polinu- cleotídeo que compreende pelo menos 15 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em outro aspecto, a etapa c) compreende uma sonda ou combinação de sondas planeja- das para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 16 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 17 nucleotí- deos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 18 nucleotídeos contíguos de uma se- quência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 19 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 20 nucleotídeos con- tíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 21 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compre- ende uma sonda ou combinação de sondas planejadas para se liga- rem a pelo menos um polinucleotídeo que compreende pelo menos 22 nucleotídeos contíguos de uma sequência selecionada do grupo con- sistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compreende uma sonda ou com- binação de sondas planejadas para se ligarem a pelo menos um poli- nucleotídeo que compreende pelo menos 23 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspec- to, a etapa c) compreende uma sonda ou combinação de sondas pla- nejadas para se ligarem a pelo menos um polinucleotídeo que com- preende pelo menos 24 nucleotídeos contíguos de uma sequência se- lecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. Em um aspecto, a etapa c) compre- ende uma sonda ou combinação de sondas planejadas para se liga- rem a pelo menos um polinucleotídeo que compreende pelo menos 25 nucleotídeos contíguos de uma sequência selecionada do grupo con- sistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. De acprdp com outro aspecto, a etapa c) compreende uma sonda ou combinação de sondas planejadas para se ligarem a pelo menos um polinucleotídeo que compreende pelo menos 26 nucleotí- deos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 e SEQ ID NO: 33. [00173] A sonda pode ser, por exemplo, um produto da PCR ou um fragmento da digestão de restrição. Em uma modalidade adicional, a sonda como descrito aqui pode ser marcada com uma marcação fluo- rescente, radioativa, enzimática, ou outra adequada para possibilitar que a hibridização possa ser detectada. O versado na técnica saberá agora como planejar sonda adequadas, agora que possui vantagem da presente divulgação. [00172] In a preferred scope, in step c) of the described method a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO is provided : 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. Additionally, step c) of the described method is ca- characterized in that it comprises providing a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 15 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In another aspect, step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 16 contiguous nucleotides of a sequence. selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least at least one polynucleotide comprising at least 17 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, the step c) comprises a probe or combination of probes designed to read to at least one polynucleotide comprising at least 18 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In an aspect , step c) comprises a probe or combination of probes designed to bind at least one polynucleotide comprising at least 19 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 20 contiguous nucleotides of a sequence selected from the group consisting of in SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide that comprises at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind at least one polynucleotide comprising at least 22 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 23 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least a polynucleotide comprising at least 24 contiguous nucleotides of a sequence selected from the group consisting of See SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. In one aspect, step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 25 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. Of acprdp with another aspect , step c) comprises a probe or combination of probes designed to bind to at least one polynucleotide comprising at least 26 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 32 and SEQ ID NO: 33. [00173] The probe can be, for example, a PCR product or a restriction digest fragment. In an additional embodiment, the probe as described herein may be labeled with a fluorescent, radioactive, enzymatic, or other suitable label to enable that hybridization can be detected. One skilled in the art will now know how to design suitable probes now that he has taken advantage of the present disclosure.
[00174] Em uma modalidade adicional, é fornecido um método de hibridização de uma sonda à amostra sob condições estringentes (alta especificidade). As condições de hibridização estringentes são bem conhecidas pelo versado na técnica e compreendem por exemplo: a hibridização a uma temperatura de aproximadamente 65°C em uma solução contendo 6x SSC, 0,01% de SDS e 0,25% de leite em pó des- natado, seguida pela lavagem na mesma temperatura em uma solução contendo 0,2 x SSC e 0,1% de SDS. [00174] In an additional embodiment, a method of hybridizing a probe to the sample under stringent conditions (high specificity) is provided. Stringent hybridization conditions are well known to those skilled in the art and comprise for example: hybridization at a temperature of approximately 65°C in a solution containing 6x SSC, 0.01% SDS and 0.25% desiccated milk powder. - swimming, followed by washing at the same temperature in a solution containing 0.2 x SSC and 0.1% SDS.
[00175] As técnicas adequadas para a detecção específica do ma- terial vegetal derivado do evento CTC75064-3 com base no princípio de hibridização incluem, mas não estão limitadas a Southern Blots e à hibridização in situ. O versado na técnica está familiarizado com técni- cas tais como estas. [00175] Suitable techniques for the specific detection of plant material derived from event CTC75064-3 based on the hybridization principle include, but are not limited to Southern Blots and in situ hybridization. One skilled in the art is familiar with techniques such as these.
[00176] Tipicamente, estes envolvem a incubação de uma sonda com uma amostra, a lavagem para remoção da sonda não ligada e a detecção do fato da sonda ter se hibridizado. O dito método de detec- ção é dependente do tipo demarcação ligada à sonda - por exemplo - uma sonda marcada radioativamente pode ser detectada através da exposição a e do desenvolvimento do filme de raios-X. Alternativamen- te, uma sonda marcada enzimaticamente pode ser detectada através da conversão de um substrato para efetuar uma alteração de cor. [00177] Adicionalmente, outro aspecto da invenção contempla um método para detecção do material vegetal derivado do evento CTC75064-3 que compreende a obtenção de uma amostra para análi- se; o fornecimento de um anticorpo planejado para se ligar a uma pro- teína Cry ou Nptll contida dentro de uma planta que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO. 18 e/ou SEQ ID NO 19; a incuba- ção do dito anticorpo com a amostra; e a detecção do fato do anticorpo ter se ligado. Em uma modalidade da presente invenção, a dita proteí- na Cry é codificada pela sequência nucleotídica SEQ ID NO 20 e a proteína Nptll é codificada pela sequência nucleotídica SEQ ID NO 21. Em um aspecto adicional, a proteína Cry compreende a SEQ ID NO: 34 e a proteínas Nptll compreende a SEQ ID NO: 35. [00176] Typically, these involve incubating a probe with a sample, washing to remove the unbound probe, and detecting that the probe has hybridized. Said detection method is dependent on the type of demarcation attached to the probe - for example - a radioactively labeled probe can be detected through exposure to and development of the X-ray film. Alternatively, an enzyme-labeled probe can be detected by converting a substrate to effect a color change. [00177] Additionally, another aspect of the invention contemplates a method for detecting plant material derived from event CTC75064-3 which comprises obtaining a sample for analysis; the provision of an antibody designed to bind to a Cry or Nptll protein contained within a plant that comprises at least 14 contiguous nucleotides of a selected sequence from the group consisting of SEQ ID NO. 18 and/or SEQ ID NO 19; incubating said antibody with the sample; and detecting that the antibody has bound. In one embodiment of the present invention, said Cry protein is encoded by the nucleotide sequence SEQ ID NO 20 and the Nptll protein is encoded by the nucleotide sequence SEQ ID NO 21. In a further aspect, the Cry protein comprises SEQ ID NO: 34 and the Nptll protein comprises SEQ ID NO: 35.
[00178] Os métodos adequados para a detecção do material vege- tal derivado do evento CTC75064-3 baseados na dita ligação de anti- corpos incluem, mas não estão limitados a western blots, a ELISA ("Enzyme-Linked ImmunoSorbent Assays") e à espectrometria de massa (SELDI - "Surface-enhanced laser desorption/ionization" ou MALDI - "matrix-assisted laser desorption/ionization"). O versado na técnica está familiarizado a estas técnicas imunológicas. As etapas típicas incluem a incubação de uma amostra com um anticorpo que se liga a proteína Cry ou Nptll, a lavagem para a remoção de anticorpo não ligado e a detecção do fato do anticorpo ter se ligado. Muitos de tais métodos de detecção se baseiam em reações enzimáticas - por exemplo, o anticorpo pode estar ligado com uma enzima tal como a peroxidase e na aplicação de um substrato adequado, é detectada uma modificação da cor. Tais anticorpos podem ser monoclonais ou policlonais. [00178] Suitable methods for the detection of plant material derived from event CTC75064-3 based on said antibody binding include, but are not limited to western blots, ELISA ("Enzyme-Linked ImmunoSorbent Assays") and to mass spectrometry (SELDI - "Surface-enhanced laser desorption/ionization" or MALDI - "matrix-assisted laser desorption/ionization"). One of skill in the art is familiar with these immunological techniques. Typical steps include incubating a sample with an antibody that binds to Cry or NptII protein, washing to remove unbound antibody, and detecting that the antibody has bound. Many such detection methods rely on enzymatic reactions - for example, the antibody can be linked with an enzyme such as peroxidase and on application of a suitable substrate, a color change is detected. Such antibodies may be monoclonal or polyclonal.
[00179] Em um outro aspecto a invenção contempla um método pa- ra detecção do material vegetal derivado do evento CTC75064-3 que compreende a obtenção de uma amostra para análise; o fornecimento de um extrato de proteínas da amostra; o fornecimento de tiras de tes- te planejadas para detectar a presença de uma proteína Cry ou Nptll contida dentro de uma planta que compreende pelo menos 14 nucleo- tídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO. 18 e SEQ ID NO. 19; a incubação das tiras de teste com a amostra; e a detecção. Em uma modalidade da presente inven- ção, a dita proteína Cry é codificada pela sequência nucleotídica SEQ ID NO 20 e a proteína Nptll é codificada pela sequência nucleotídica SEQ ID NO 21. Em um aspecto adicional, a proteína Cry compreende a SEQ ID NO: 34 e a proteínas Nptll compreende a SEQ ID NO: 35. [00180] Em uma modalidade da invenção, é fornecido um método para a detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3 que compreende a obtenção de uma amostra derivada do evento CTC75064-3 e uma amostra de uma espécie não transgênica de cana- de-açúcar para análise (controle); submeter um ou mais insetos da es- pécie Diatraea saccharallis (susceptível à CrylAc) às amostras; detec- tar nas amostras efeito inseticida sobre os insetos. Nesse aspecto da invenção, "Inseticida" se refere a qualquer efeito inibidor sobre o inse- to, incluindo, mas não se limitando à alimentação reduzida, ao cresci- mento retardado, à fecundidade reduzida, à paralisia, à morte. [00179] In another aspect the invention contemplates a method for detecting plant material derived from event CTC75064-3 which comprises obtaining a sample for analysis; providing a protein extract from the sample; the provision of test strips designed to detect the presence of a Cry or Nptll protein contained within a plant comprising at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO. 18 and SEQ ID NO. 19; incubation of test strips with the sample; and detection. In one embodiment of the present invention, said Cry protein is encoded by the nucleotide sequence SEQ ID NO 20 and the Nptll protein is encoded by the nucleotide sequence SEQ ID NO 21. In a further aspect, the Cry protein comprises SEQ ID NO: 34 and the Nptll protein comprises SEQ ID NO: 35. [00180] In one embodiment of the invention, there is provided a method for detecting plant material derived from a genetically modified sugar cane plant of event CTC75064-3 comprising the obtaining a sample derived from event CTC75064-3 and a sample of a non-transgenic sugarcane species for analysis (control); subjecting one or more insects of the species Diatraea saccharallis (susceptible to CrylAc) to the samples; to detect the insecticidal effect on the insects in the samples. In this aspect of the invention, "Insecticide" refers to any inhibitory effect on the insect, including, but not limited to, reduced feeding, retarded growth, reduced fecundity, paralysis, death.
[00181] O método de detecção do material vegetal do evento CTC75064-3 inclui, mas não está limitado aos ensaios biológicos de alimentação com folhas em que uma folha ou outra parte adequada da planta do evento CTC75064-3 ou qualquer material vegetal derivado do evento CTC75064-3, é infestado com uma ou mais pragas de inse- tos. A detecção pode ser feita através da avaliação dos danos na folha ou na parte vegetal após períodos de tempo ajustados, da avaliação da mortalidade ou de um outro efeito inseticida sobre os insetos. Tais ensaios biológicos podem ser realizados no campo ou em estufa e po- dem ser submetidos à infestação natural ou artificial de insetos. [00181] The method of detecting event CTC75064-3 plant material includes, but is not limited to, leaf feeding biological assays in which a leaf or other suitable part of the event CTC75064-3 plant or any plant material derived from the event CTC75064-3, is infested with one or more insect pests. Detection can be done by evaluating leaf or plant damage after set periods of time, evaluating mortality or other insecticidal effect on insects. Such biological assays can be carried out in the field or in a greenhouse and can be submitted to natural or artificial infestation of insects.
[00182] Em um outro aspecto da invenção, é fornecido um kit para detecção da presença em uma amostra de material vegetal derivado do evento CTC75064-3 que compreende um meio para a detecção da presença de um polinucleotídeo que compreende pelo menos 14 nu- cleotídeos contíguos de uma sequência selecionada do grupo consis- tindo em SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 32 e SEQ ID NO. 33 e/ou uma proteína Cry. Em uma modalidade da presente in- venção, o dito kit pode compreender a tecnologia de detecção por am- plificação do DNA tal como a PCR, qPCR ou Taqman®. Em uma mo- dalidade adicional da presente invenção, o dito kit pode compreender a tecnologia de detecção por hibridização de sondas tais como Southern Blots ou a Hibridização in situ. Em um aspecto, a detecção da presença em uma amostra de material vegetal derivado de uma cana de açúcar transgênica compreendendo a proteína CrylAc (even- to CTC75064-3) compreende pares de iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende nucleotí- deos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29. Adicionalmente, a detecção da presença em uma amostra de material vegetal derivado de uma cana de açúcar transgênica compreendendo a proteína CrylAc (evento CTC75064-3) compreende pares de iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende nucleotí- deos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo menos um iniciador compreende nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. Adicionalmente, a detecção da tal amostra com- preende pares de iniciadores onde o iniciador senso compreende SEQ ID NO: 6 e o iniciador antissenso compreende SEQ ID NO: 7, ou o ini- ciador senso compreende SEQ ID NO: 8 e o iniciador antissenso com- preende SEQ ID NO: 9. Em um outro aspecto, a detecção da presença em uma amostra de material vegetal derivado de uma cana de açúcar transgênica compreendendo a proteína CrylAc (evento CTC75064-3) compreende uma sonda compreendendo sequências selecionados do grupo consistindo em SEQ ID NO 10 e SEQ ID NO 11. Em uma outra modalidade da presente invenção, o dito kit pode compreender a tec- nologia de detecção por ligação a anticorpos tais como western blots, ELISAs, além de espectrometria de massa (SELDI ou MALDI) ou tiras de teste. Em uma modalidade adicional da presente invenção, o dito kit pode compreender a tecnologia de detecção por ensaio biológico com insetos tais como os ensaios biológicos de alimentação com fo- lhas ou ensaios biológicos de mortalidade. Em uma modalidade adici- onal da presente invenção, o dito kit pode compreender qualquer com- binação das tecnologias de detecção mencionadas acima. [00182] In another aspect of the invention, there is provided a kit for detecting the presence in a sample of plant material derived from event CTC75064-3 which comprises a means for detecting the presence of a polynucleotide comprising at least 14 nu- contiguous cleotides of a sequence selected from the group consisting of SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 32 and SEQ ID NO. 33 and/or a Cry protein. In one embodiment of the present invention, said kit may comprise DNA amplification detection technology such as PCR, qPCR or Taqman ® . In a further embodiment of the present invention, said kit may comprise detection technology by hybridization of probes such as Southern Blots or In situ Hybridization. In one aspect, detecting the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein (CTC75064-3 event) comprises primer pairs designed to bind at least one polynucleotide comprising nucleotide contiguous genes of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29. Additionally, detection of the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein (event CTC75064-3) comprises primer pairs designed to bind at least one polynucleotide comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one primer comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31. Additionally, detection of such a sample comprises pair primers where the sense primer comprises SEQ ID NO: 6 and the antisense primer comprises SEQ ID NO: 7, or the sense primer comprises SEQ ID NO: 8 and the antisense primer comprises SEQ ID NO: 9. In In another aspect, detecting the presence in a sample of plant material derived from a transgenic sugar cane comprising the CrylAc protein (event CTC75064-3) comprises a probe comprising sequences selected from the group consisting of SEQ ID NO 10 and SEQ ID NO 11. In another embodiment of the present invention, said kit may comprise antibody-binding detection technology such as western blots, ELISAs, in addition to mass spectrometry (SELDI or MALDI) or test strips. In a further embodiment of the present invention, said kit may comprise insect bioassay detection technology such as leaf feeding biological assays or biological mortality assays. In a further embodiment of the present invention, said kit may comprise any combination of the detection technologies mentioned above.
[00183] O evento transgênico como descrito na presente invenção, possui um efeito sobre insetos de uma ou mais espécies do grupo que compreende insetos da ordem Lepidoptera. Como um resultado, um número reduzido de sprays inseticidas é necessário durante o cultivo da dita planta comparado com uma planta de cana-de-açúcar não- transgênica da mesma variedade. [00183] The transgenic event as described in the present invention has an effect on insects of one or more species of the group comprising insects of the order Lepidoptera. As a result, a reduced number of insecticidal sprays are required during the cultivation of said plant compared to a non-GM sugarcane plant of the same variety.
[00184] A presente invenção não está vinculada por si só ao evento CTC75064-3, mas é adicionalmente estendida para incluir qualquer material vegetal derivado do mesmo, incluindo semente, contanto que contenham pelo menos um dos polinucleotídeos da presente invenção. Em um aspecto, a presente invenção compreende uma parte de plan- ta, uma célula de planta, um tecido de planta, ou uma semente de uma planta de cana de açúcar geneticamente modificada ( Saccharum spp.), onde a dita planta, parte de planta, célula de planta, tecido de planta, ou semente compreendendo pelo menos uma sequência sele- cionada do grupo consistindo em SEQ ID NO: 18 e SEQ ID NO: 19. Em um escopo, a invenção compreende planta, parte de planta, célula de planta, tecido de planta, ou semente compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 12 e SEQ ID NO: 13. Adicionalmente, a invenção inclui planta, parte de planta, célula de planta, tecido de planta, ou semente compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 22. A presente invenção inclui, mas não está limitada às plantas que são derivadas de cruzamentos de linhagens com o evento CTC75064-3 ou um derivado do mesmo através de mé- todos de cruzamento convencional ou outros. Assim, uma modalidade da presente invenção refere-se ao uso de uma planta, célula de planta, parte de planta ou semente de uma planta de cana de açúcar geneti- camente modificada (Saccharum spp.), como descrito acima, caracte- rizada por compreender pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19, para regenerar uma planta, plantar ou cultivar um campo de plantas ou produzir um produto de planta. Preferivelmente, a invenção descreve o uso de uma planta, célula de planta, parte de planta ou semente caracterizada por compreender o evento CTC75064-3 para regenerar uma planta, plan- tar ou cultivar um campo de plantas ou produzir um produto de planta. [00185] Adicionalmente, a presente invenção descreve um método para cultivar uma planta de cana de açúcar geneticamente modificada, compreendendo crescer uma planta de cana de açúcar compreenden- do pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 2 sob condições compreendendo infestação de insetos. Preferivelmente, a presente invenção descreve um método para culti- var uma planta de cana de açúcar geneticamente modificada, compre- endendo crescer uma planta de cana de açúcar caracteriza por com- preender a SEQ ID NO 5 e/ou a SEQ ID NO 22, sob condições com- preendendo infestação de insetos. Em um aspecto ainda mais preferi- do, a invenção apresenta um método para cultivar uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3, compre- endendo crescer uma planta de cana de açúcar caracterizada por compreender a SEQ ID NO 5 e/ou SEQ ID NO 22, sob condições compreendendo infestação de insetos. Preferivelmente, o inseto é Dia trea Saccharalis. [00184] The present invention is not bound by itself to event CTC75064-3, but is further extended to include any plant material derived therefrom, including seed, provided they contain at least one of the polynucleotides of the present invention. In one aspect, the present invention comprises a plant part, a plant cell, a plant tissue, or a seed of a genetically modified sugarcane plant (Saccharum spp.), wherein said plant, part of plant, plant cell, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19. In one scope, the invention comprises plant, plant part, cell of plant, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13. Additionally, the invention includes plant, part of plant, plant cell, plant tissue, or seed comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22. The present invention includes, but is not limited to, plants that are derived from crosses from lines with event CTC75064-3 or a derivative thereof through conventional breeding or other methods. Thus, an embodiment of the present invention relates to the use of a plant, plant cell, plant part or seed of a genetically modified sugarcane plant (Saccharum spp.), as described above, characterized by comprising at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19, for regenerating a plant, planting or cultivating a field of plants, or producing a plant product. Preferably, the invention describes the use of a plant, plant cell, plant part or seed characterized by comprising event CTC75064-3 to regenerate a plant, plant or cultivate a field of plants, or produce a plant product. [00185] Additionally, the present invention describes a method for growing a genetically modified sugarcane plant, comprising growing a sugarcane plant comprising at least one sequence selected from the group consisting of SEQ ID NO 2 under conditions comprising infestation of insects. Preferably, the present invention describes a method for growing a genetically modified sugarcane plant, comprising growing a sugarcane plant characterized by comprising SEQ ID NO 5 and/or SEQ ID NO 22, under conditions comprising insect infestation. In an even more preferred aspect, the invention features a method for growing a genetically modified sugarcane plant of event CTC75064-3, comprising growing a sugarcane plant characterized by comprising SEQ ID NO 5 e/ or SEQ ID NO 22, under conditions comprising insect infestation. Preferably, the insect is Dia trea Saccharalis.
[00186] Em um aspecto, a presente invenção fornece um método para controle de insetos compreendendo disponibilizar uma planta, tecido, parte da planta, células ou sementes de cana de açúcar geneti- camente modificada do evento CTC75064-3 para alimentação do inse- to. A presente invenção ainda fornece um método para controle de in- setos compreendendo disponibilizar uma planta, tecido, parte da plan- ta, células ou sementes de cana de açúcar geneticamente modificada caracterizada por compreender a SEQ ID NO 2 para alimentação do inseto. Em um escopo preferido, o referido método compreende dispo- nibilizar uma planta, tecido, parte da planta, células ou sementes de cana de açúcar geneticamente modificada caracterizada por compre- ender a SEQ ID NO 5 e/ou SEQ ID NO 22 para alimentação do inseto. Preferivelmente, o inseto é Diatrea Saccharalis. [00186] In one aspect, the present invention provides a method for controlling insects comprising providing a plant, tissue, plant part, cells or seeds of genetically modified sugar cane from event CTC75064-3 for feeding to the insect. . The present invention further provides a method for controlling insects comprising providing a genetically modified sugarcane plant, tissue, plant part, cells or seeds characterized by comprising SEQ ID NO 2 for feeding to the insect. In a preferred scope, said method comprises providing a genetically modified sugarcane plant, tissue, plant part, cells or seeds characterized by comprising SEQ ID NO 5 and/or SEQ ID NO 22 for feeding the insect. Preferably, the insect is Diatrea Saccharalis.
[00187] A invenção ainda fornece um método para aumentar a pro- dução de cana de açúcar no campo caracterizado por compreender cultivar uma planta cana de açúcar geneticamente modificada do evento CTC75064-3. A presente invenção ainda fornece um método para aumentar a produção de cana de açúcar no campo caracterizado por compreender cultivar uma planta cana de açúcar geneticamente modificada caracterizada por compreender a SEQ ID NO 2. Em um escopo preferido, método para aumentar a produção de cana de açú- car no campo caracterizado por compreender cultivar uma planta cana de açúcar geneticamente modificada caracterizada por compreender a SEQ ID NO 5 e/ou SEQ ID NO 22. Preferivelmente, o inseto é Diatrea Saccharalis. [00187] The invention further provides a method for increasing the production of sugarcane in the field characterized by culturing a genetically modified sugarcane plant of event CTC75064-3. The present invention further provides a method for increasing the production of sugarcane in the field characterized by cultivating a genetically modified sugarcane plant characterized by comprising SEQ ID NO 2. In a preferred scope, a method for increasing the production of sugarcane field sugar characterized in that it comprises cultivating a genetically modified sugar cane plant characterized in that it comprises SEQ ID NO 5 and/or SEQ ID NO 22. Preferably, the insect is Diatrea Saccharalis.
[00188] A presente invenção também contempla a cultura de tecido de uma planta de cana de açúcar geneticamente modificada ( Sac - charum spp .) compreendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 18 e SEQ ID NO: 19. Em um esco- po adicional, a presente invenção contempla a cultura de tecido de uma planta de cana de açúcar geneticamente modificada ( Saccharum spp.) compreendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 12 e SEQ ID NO: 13. Também contem- plado na presente invenção está a cultura de tecidos cultura de tecido de uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada compreendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 22. Adicionalmen- te, uma planta de cana de açúcar geneticamente modificada regene- rada da cultura de tecidos descrita acima também está incluída na presente invenção, onde a planta regenerada compreende pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 18 e SEQ ID NO: 19. Exemplos de células de plantas, partes de plantas, incluem, mas nã estão limitados a: células em suspensão, calos, em- briões somáticos, tecido meristemático, haste ou colmo superior, haste ou colmo, caule, folha, disco foliar, brotos, entre outros. Um outro as- pecto contempla um método para produzir uma planta de cana-de- açúcar resistente a inseto, caracterizado pelo fato de que compreende cruzar uma primeira planta de cana-de-açúcar com uma segunda plan- ta de cana-de-açúcar compreendendo o evento CTC75064-3 e produ- zir uma prole de plantas de cana de açúcar resistente a insetos. A planta compreendendo o evento CTC75064-3 é uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada compreenden- do pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 18 e SEQ ID NO: 19. A presente invenção também con- templa uma planta de cana de açúcar ( Saccharum spp.) e parte da planta, células, tecidos e sementes da mesma geradas pelo método de produzir uma cana de açúcar resistente a insetos, conforme acima descrito. [00189] Ainda sob esse aspecto, a presente invenção provê um mé- todo para produzir uma planta de cana de açúcar resistente a inseto compreendendo inserir pelo menos um fragmento de T DNA em sítio específico do genoma compreendido entre as sequências seleciona- das do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24 através de recombinação homóloga. Adicionalmente, a invenção fornece um método para produzir uma planta de cana de açúcar resistente a inse- to compreendendo inserir pelo menos um fragmento de T DNA seleci- onado do grupo consistindo em uma sequência possuindo pelo menos 80% de identidade com qualquer uma das SEQ ID NO 2, preferenci- almente 85%, 90%, 95%, 98%, 99% ou 100% de identidade com qual- quer uma das SEQ ID NO 2, em sítio específico do genoma compre- endido entre as sequências selecionadas do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24 através de recombinação homóloga. Em um aspecto adicional, a inserção do fragmento de T-DNA confor- me acima descrito ocorre de maneira a compreender, após a inserção, pelo menos 14 nucleotídeos contíguos das sequências selecionadas do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. A presente invenção também contempla uma planta de cana de açúcar ( Sac - charum spp .) e parte da planta, células, tecidos e sementes da mesma geradas pelo método de produzir uma cana de açúcar resistente a in- setos, conforme acima descrito. Preferivelmente, o referido método é para produzir uma planta de cana de açúcar geneticamente modificada resistente a inseto do evento CTC75064-3. [00188] The present invention also contemplates the tissue culture of a genetically modified sugarcane plant (Sac-charum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19. In a further scope, the present invention contemplates the tissue culture of a genetically modified sugar cane plant ( Saccharum spp.) comprising at least one selected sequence from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13. Also contemplated in the present invention is tissue culture tissue culture of a genetically modified sugar cane plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22. Additionally, a genetically modified sugar cane plant regenerated from the tissue culture described above is also included in the present invention, wherein the regenerated plant comprises at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19. Examples of plant cells, plant parts, include, but are not limited to: suspension cells, callus, somatic embryos, t meristematic acid, upper stem or stem, stem or stem, stem, leaf, leaf disc, shoots, among others. Another aspect contemplates a method for producing an insect resistant sugarcane plant, characterized in that it comprises crossing a first sugarcane plant with a second sugarcane plant. comprising event CTC75064-3 and producing an offspring of insect resistant sugarcane plants. The plant comprising event CTC75064-3 is a genetically modified sugar cane plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 18 and SEQ ID NO: 19. The present invention also includes a sugarcane plant (Saccharum spp.) and part of the plant, cells, tissues and seeds of the same generated by the method of producing an insect resistant sugarcane, as described above. [00189] Still in this aspect, the present invention provides a method for producing an insect resistant sugarcane plant comprising inserting at least one fragment of T DNA in a specific site of the genome comprised between the sequences selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination. Additionally, the invention provides a method for producing an insect resistant sugarcane plant comprising inserting at least one T DNA fragment selected from the group consisting of a sequence having at least 80% identity with any of SEQ ID NO 2, preferably 85%, 90%, 95%, 98%, 99% or 100% identity with any one of SEQ ID NO 2, at a specific site in the genome comprised among the selected sequences of the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination. In a further aspect, the insertion of the T-DNA fragment as described above occurs so as to comprise, after insertion, at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19. The present invention also contemplates a sugarcane plant (Saccharum spp.) and part of the plant, cells, tissues and seeds thereof generated by the method of producing an insect resistant sugarcane as described above. Preferably, said method is for producing a genetically modified sugarcane plant resistant to event CTC75064-3.
[00190] Em uma modalidade adicional, a presente invenção fornece um produto de comódite, caracterizado pelo fato de que é produzido a partir de uma planta de cana-de-açúcar compreendendo o evento CTC75064-3. Assim, a invenção inclui um produto comódite, produzido a partir de uma planta de cana geneticamente modificada ( Saccharum spp.) compreendendo pelo menos uma sequência selecionada do gru- po consistindo em SEQ ID NO: 18 e SEQ ID NO: 19. Em um escopo adicional, a presente invenção contempla um produto comódite, pro- duzido a partir de uma planta geneticamente modificada ( Saccharum spp.) compreendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 12 e SEQ ID NO: 13. Também contem- plado na presente invenção está um produto comódite, produzido a partir de uma planta geneticamente modificada ( Saccharum spp.) compreendo pelo menos uma sequência selecionada do grupo consis- tindo em SEQ ID NO: 5 e SEQ ID NO: 22. Exemplos de produtos co- módite incluem, mas não se limitam a: bagaço, suco de cana de açú- car, xarope, etanol de primeira geração (produzido a partir do suco da cana de açúcar), etanol de segunda geração (etanol celulósico produ- zido a parti da biomassa), biomassa, açúcar, açúcar bruto, açúcar refi- nado, melaço, vinhaça e fibra. [00190] In an additional embodiment, the present invention provides a commodity product, characterized in that it is produced from a sugarcane plant comprising event CTC75064-3. Thus, the invention includes a commodity product, produced from a genetically modified sugarcane plant (Saccharum spp.) comprising at least one sequence selected from the group. po consisting of SEQ ID NO: 18 and SEQ ID NO: 19. In a further scope, the present invention contemplates a commodity product, produced from a genetically modified plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO: 12 and SEQ ID NO: 13. Also contemplated in the present invention is a commodity product, produced from a genetically modified plant (Saccharum spp.) comprising at least one sequence selected from the group consisting of having SEQ ID NO: 5 and SEQ ID NO: 22. Examples of commodity products include, but are not limited to: bagasse, sugar cane juice, syrup, first generation ethanol (produced from from sugar cane), second-generation ethanol (cellulosic ethanol produced from biomass), biomass, sugar, raw sugar, refined sugar, molasses, vinasse and fiber.
[00191] A invenção inclui ainda material vegetal derivado do evento CTC75064-3 que pode compreender sequências de polinucleotídeos adicionais, modificadas ou menores comparado com o evento CTC75064-3 ou exibir outras características fenotípicas. Por exemplo, pode ser desejável transformar o material vegetal derivado do evento CTC75064-3 para gerar um novo evento que possui uma característica adicional, tal como um segundo gene de resistência a insetos. Este processo é conhecido como empilhamento de genes. O segundo gene de resistência a insetos pode codificar, por exemplo, lectinas insetici- das, inibidores da protease inseticidas e outras proteínas inseticidas derivadas das espécies de Bacillus thuringiensis. [00191] The invention further includes plant material derived from event CTC75064-3 which may comprise additional, modified or shorter polynucleotide sequences compared to event CTC75064-3 or exhibit other phenotypic characteristics. For example, it may be desirable to transform plant material derived from event CTC75064-3 to generate a new event that has an additional trait, such as a second insect resistance gene. This process is known as gene stacking. The second insect resistance gene can encode, for example, insecticidal lectins, insecticidal protease inhibitors and other insecticidal proteins derived from Bacillus thuringiensis species.
[00192] A presente invenção fornece ainda um método de controle de insetos que compreende o fornecimento do material vegetal deriva- do do evento CTC75064-3 em um local onde os ditos insetos se ali- mentam. A invenção fornece ainda adicionalmente um método de con- trole de insetos que compreende o fornecimento do material vegetal derivado do CTC75064-3 no local em que os ditos insetos se alimen- tam e a aplicação de outros reagentes agroquímicos ou biológicos ao dito material vegetal tais como herbicidas, fungicidas e outros. [00192] The present invention further provides a method of controlling insects that comprises the provision of plant material derived from event CTC75064-3 in a place where said insects feed. The invention still further provides a method of controlling insects which comprises providing plant material derived from CTC75064-3 at the place where said insects feed and the application of other agrochemical or biological reagents to said plant material such as herbicides, fungicides and others.
[00193] Em um outro escopo, a invenção descreve um método para produzir uma planta de cana de açúcar geneticamente modificada ( Saccharum spp.) do evento CTC75064-3, compreendendo introduzir uma modificação genética a uma planta de cana de açúcar ( Sac charum spp.) compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 22 para produzir uma planta de cana de açúcar ( Saccharum spp.) geneticamente modi- ficada do evento CTC75064-3, onde a planta de cana de açúcar ( Sac charum spp.) geneticamente modificada possui resistência a insetos melhorada quando comparada a uma planta de cana de açúcar ( Sac charum spp.) sem a modificação genética. Em um escopo adicional, a invenção fornece um método para cultivo de uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada do evento CTC75064-3, compreendendo crescer uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 22 sob condições compreendendo infestação de insetos, onde a planta de cana de açúcar (Saccharum spp.) genetica- mente modificada possui resistência a insetos aumentada quando comparada com uma planta de cana de açúcar (Saccharum spp.) sem a modificação genética crescendo sob as mesmas condições. A inven- ção também fornece uma planta de cana de açúcar (Saccharum spp.) geneticamente modificada caracterizada por compreender pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. Em um aspecto adicional, a invenção contempla uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 12 e SEQ ID NO 13. Ainda em um escopo relacionado, a invenção apresenta uma planta de cana de açúcar ( Saccharum spp .) geneticamente modificada compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 22, onde a planta é resistente a inseto. Preferi- velmente, a planta de cana de açúcar ( Saccharum spp.) geneticamen- te modificada é do evento CTC75064-3. [00193] In another scope, the invention describes a method for producing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3, comprising introducing a genetic modification to a sugarcane plant ( Saccharum spp. .) comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22 to produce a genetically modified sugar cane plant ( Saccharum spp.) from event CTC75064-3, where the sugarcane plant (Saccharum spp.) genetically modified sugar cane ( Sac charum spp.) has improved insect resistance when compared to a sugar cane plant ( Sac charum spp.) without the genetic modification. In a further scope, the invention provides a method for growing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3, comprising growing a genetically modified sugarcane plant ( Saccharum spp.) comprising at least a sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22 under conditions comprising insect infestation, wherein the genetically modified sugar cane plant (Saccharum spp.) has increased insect resistance compared to a sugarcane plant (Saccharum spp.) without genetic modification growing under the same conditions. The invention also provides a genetically modified sugar cane plant (Saccharum spp.) characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19. In a further aspect, the invention contemplates a genetically modified sugarcane plant ( Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO 12 and SEQ ID NO 13. Still in a related scope, the invention features a genetically modified sugar cane plant ( Saccharum spp .) comprising at least one sequence selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 22, where the plant is insect resistant. Preferably, the genetically modified sugarcane plant (Saccharum spp.) is from event CTC75064-3.
Descrição da Cana de açúcar Transqênica CTC75064-3 [00194] As plantas do evento transgênico de cana de açúcar 'CTC75064-3' são substancialmente equivalentes geneticamente e fe- notipicamente similares a variedade parental 'RB 867515' (Certificado de proteção de cultivar Ne 271), mas com uma nova e particular carac- terística (CrylAc expression.), a qual garante a resistência ao inseto da broca da cana de açúcar, Diatrea saccharalis (Lepidoptera). Da mesma forma que a sua variedade parental RB 867515, a CTC75064- 3 é um híbrido moderno de cana de açúcar que possui muitas caracte- rísticas agronómicas desejáveis como por exemplo, potencial genético para alto vigor de brotação de cana-soca, alta produtividade, excelente perfilhamento, maturidade de média-tardia, alto conteúdo de sacarose e tolerâncias a escaldadura, ferrugem alaranjada e mosaico da cana- de-açúcar. Description of Transgenic Sugarcane CTC75064-3 [00194] The plants of the transgenic sugarcane event 'CTC75064-3' are substantially genetically equivalent and phenotypically similar to the parental variety 'RB 867515' (Certificate of protection of cultivar Ne 271 ), but with a new and particular characteristic (CrylAc expression.), which guarantees resistance to the sugarcane borer, Diatrea saccharalis (Lepidoptera). Like its parent variety RB 867515, CTC75064-3 is a modern sugarcane hybrid that has many desirable agronomic characteristics such as genetic potential for high ratoon cane sprouting vigor, high productivity, excellent tillering, medium-late maturity, high sucrose content and tolerances to scald, blight and sugarcane mosaic.
[00195] Resumidamente, as plantas do evento 'CTC75064-3' são caracterizadas por pelos colmos de coloração roxa quando exposto ao sol e verde-púrpura quando na sombra. As plantas 'CTC75064-3' exi- bem entrenós curvos de tamanho médio a longo e anéis de crescimen- to amarelo esverdeados de largura média. Os entrenós são de aspecto liso e sem fissuras de crescimento, com cerosidade média. As plantas 'CTC75064-3' exibem gemas de formato obovado com uma pubescên- cia na posição apical da gema. A arquitetura da folha é ereta com pon- tas curvadas. A aurícula média é lanceolada, apresentando lígula em forma de crescente. [00195] Briefly, the plants of the event 'CTC75064-3' are characterized by purple culms when exposed to the sun and purple-green when in the shade. 'CTC75064-3' plants exhibit medium to long curved internodes and medium width greenish yellow growth rings. The internodes are smooth in appearance and without growth cracks, with medium waxiness. Plants 'CTC75064-3' exhibit obovate-shaped buds with pubescence in the apical position of the bud. The leaf architecture is erect with curved tips. The middle auricle is lanceolate, with a ligule in crescent shape.
[00196] Características agronómicas e fenotípicas de plantas do evento CTC75064-3 foram avaliadas em comparação à variedade pa- rental RB '867515' e três cultivares referências comerciais, em 6 locais representativos da área de cultivo da variedade parental. A média da altura da planta (medidas realizadas a 330 Dias após plantio - DAP, exceto em Juazeiro, onde a medida foi realizada a 210 DAP), diâmetro do colmo (medidas realizadas a 330 Dias após plantio - DAP, exceto em Juazeiro, onde a medida foi realizada a 210 DAP); número de per- filhos (medidas realizadas a 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 e 330 DAP; ensaio não realizado em Juazeiro-BA), peso da parce- la (medidas realizadas a 330 Dias após plantio - DAP, exceto em Jua- zeiro, onde a medida foi realizada a 210 DAP), conteúdo de açúcar (BRIX %; medidas realizadas a 330 Dias após plantio - DAP, exceto em Juazeiro, onde a medida foi realizada a 210 DAP), florescimento (observações durante todo o ciclo de desenvolvimento até 330 DAP, exceto em Juazeiro, onde as observações foram realizadas até 210 DAP) e toneladas de pol% (% de sacarose no suco da cana) por hec- tare (TPH; medidas realizadas a 330 Dias após plantio - DAP, exceto em Juazeiro, onde a medida foi realizada a 210 DAP) foram avaliadas. O TPH é calculado de acordo com a fórmula:
Figure imgf000073_0002
[00196] Agronomic and phenotypic characteristics of plants of event CTC75064-3 were evaluated in comparison to the parental variety RB ' 867515' and three commercial reference cultivars, in 6 representative locations of the parental variety's cultivation area. The average plant height (measurements performed at 330 days after planting - DAP, except in Juazeiro, where the measurement was performed at 210 DAP), stem diameter (measurements performed at 330 days after planting - DAP, except in Juazeiro, where the measurement was performed at 210 DAP); number of offspring (measurements carried out at 30, 60, 90, 120, 150, 180, 210, 240, 270, 300 and 330 DAP; test not carried out in Juazeiro-BA), plot weight (measurements carried out at 330 Days after planting - DAP, except in Juazeiro, where the measurement was carried out at 210 DAP), sugar content (BRIX %; measurements carried out at 330 Days after planting - DAP, except in Juazeiro, where the measurement was carried out at 210 DAP), flowering (observations throughout the development cycle up to 330 DAP, except in Juazeiro, where observations were carried out up to 210 DAP) and tons of pol% (% sucrose in sugarcane juice) per hectare (TPH ; measurements performed at 330 days after planting - DAP, except in Juazeiro, where the measurement was performed at 210 DAP) were evaluated. TPH is calculated according to the formula:
Figure imgf000073_0002
[00197] Para cada conjunto de dados, os dados de todos os locais foram combinados para análise estatística. A Análise combinada foi realizada através do seguinte modelo estatístico:
Figure imgf000073_0001
onde y,jk medida da repetição j no local / para o tratamento k; μ é a média geral; Si efeito do local /, / = 1 a 6; Bj efeito da repetição j, j = 1 a 4; B(S)íj efeito da repetição j dentro do local / (j=1 a 4); Gk é o efeito do tratamento k, k = 1 a 7; (SG)ik interação entre o local / e o tratamento k; Sijk é erro do resíduo experimental.
[00197] For each dataset, data from all sites were combined for statistical analysis. The combined analysis was performed using the following statistical model:
Figure imgf000073_0001
where y, jk measure of repetition j at site / for treatment k; μ is the general mean; If local effect /, / = 1 to 6; B j effect of repetition j, j = 1 to 4; B(S) ij effect of repetition j within site / (j=1 to 4); G k is the effect of treatment k, k = 1 to 7; (SG)i k interaction between site / and treatment k; Sijk is experimental residual error.
[00198] As principais análises de efeito e modelos de interação são realizadas conforme descrito Kuznetsova et al. (2017). Todas as in- formações foram analisadas usando modelo linear misto através do Ime4 (Bates et al., 2015). [00198] The main effect analyzes and interaction models are performed as described Kuznetsova et al. (2017). All information was analyzed using a mixed linear model through Ime4 (Bates et al., 2015).
[00199] Os resultados da análise das características agronómicas e fenotípicas são mostrados na tabela abaixo e corroboram a conclusão de que o evento 'CTC75064-3' é similar à sua variedade parental ('RB867515'). [00199] The results of the analysis of agronomic and phenotypic traits are shown in the table below and corroborate the conclusion that the event 'CTC75064-3' is similar to its parental variety ( ' RB867515 ' ).
TABELA 01. Comparação de médias para as características agronó- micas e fenotípicas para OTC75064-3' e 'RB867515' (parental). Análi- se combinada para os locais Barrinha-SP, Piracicaba-SP, Valparaíso- SP, Quirinópolis-GO, Mandaguaçu-PR e Juazeiro-BA. Os resultados de Juazeiro - BA foram coletados a 210 DAP, enquanto que nas ou- tras localidades as coletas foram realizadas a 330 DAP.
Figure imgf000074_0001
TABLE 01. Comparison of means for agronomic and phenotypic traits for OTC75064-3' and 'RB867515' (parental). Combined analysis for the locations Barrinha-SP, Piracicaba-SP, Valparaíso-SP, Quirinópolis-GO, Mandaguaçu-PR and Juazeiro-BA. The results of Juazeiro - BA were collected at 210 DAP, while in the other locations the collections were carried out at 330 DAP.
Figure imgf000074_0001
*Diferença significativa entre o evento transgênico e a variedade pa- rental pelo teste t ao nível de 5% (p < 0,05). **lntervalo: Valores mé- dios mínimos e máximos de 3 variedades comerciais de referência. † Não avaliado em Juazeiro (BA). * Significant difference between the transgenic event and the parental variety by the t test at the 5% level (p < 0.05). ** Interval: Minimum and maximum average values of 3 reference commercial varieties. † Not rated in Juazeiro (BA).
[00200] Outros estudos composicionais foram realizados e também demonstram que 'CTC75064-3' é similar a sua variedade parental ('RB 867515') [parâmetros composicionais relacionados a nutrição e uso da cana de açúcar na dieta, conforme definido pelo guia OECD Guidance Document (OECD, 2011)]. Baseado nos resultados da análise conjun- ta (6 localização representativas de regiões de cultivo de cana de açú- car no Brasil), sugere-se que a presença das proteínas CrylAc e Nptll presentes nas amostras analisadas não interferem significativamente na composição bromatológica do evento CTC75064-3 comparada com a variedade parental RB 867515, e que a equivalência composicional observada para os 11 parâmetros avaliados corroboram coma premis- sa de que há uma alta similaridade entre o evento CTC75064-3 e a sua variedade parental RB 867515. [00200] Other compositional studies were carried out and also demonstrate that 'CTC75064-3' is similar to its parental variety ('RB 867515') [compositional parameters related to nutrition and use of sugar cane in the diet, as defined by the OECD Guidance Document (OECD, 2011)]. Based on the results of the joint analysis (6 representative locations of sugarcane growing regions in Brazil), it is suggested that the presence of CrylAc and Nptll proteins present in the analyzed samples do not significantly interfere in the bromatological composition of the event CTC75064 -3 compared to the parental variety RB 867515, and that the compositional equivalence observed for the 11 evaluated parameters corroborate the premise that there is a high similarity between the event CTC75064-3 and its parental variety RB 867515.
TABELA 02. Valores médios dos parâmetros composicionais medidos no evento geneticamente modificado 'CTC75064-3' e sua variedade parental convencional 'RB 867515'.
Figure imgf000075_0001
TABLE 02. Mean values of the compositional parameters measured in the genetically modified event 'CTC75064-3' and its conventional parental variety 'RB 867515'.
Figure imgf000075_0001
1 Resultados são expressos com base no peso seco; 2Valores expres- sos com base no colmo de cana de açúcar; *Diferença significativa en- tre o evento transgênico e a variedade parental pelo teste t ao nível de 5% (p < 0,05). **lntervalo: Valores médios mínimos e máximos de 3 variedades comerciais de referência. † Não avaliado em Juazeiro (BA).EP: Erro Padrão; Exemplos 1 Results are expressed on a dry weight basis; 2 Values expressed based on sugar cane stalk; * Significant difference between the transgenic event and the parental variety by the t test at the 5% level (p < 0.05). ** Interval: Minimum and maximum average values of 3 reference commercial varieties. † Not evaluated in Juazeiro (BA).EP: Standard Error; Examples
Exemplo 1. Geração do Evento CTC75064-3 - Transformação por Agrobacterium. Example 1. Generation of Event CTC75064-3 - Transformation by Agrobacterium.
[00201] O evento CTC75064-3 foi obtido por transformação genéti- ca mediada por Agrobacterium tumefasciens da cultivar RB 867515. [00202] A cultivar RB 867515 é um híbrido comercial que é doador do genótipo para o evento CTC75064-3 (background genético); desta forma, ela representa a variedade não transformada de referência para o evento CTC75064-3. Essa cultivar possui maturação média a tardia e tem sido plantada especialmente no centro-sul do Brasil. Assim, co- mo os outros híbridos comerciais, é um material com alta ploidia e com muitos cromossomos derivados de duas variedades parentais: S. offi- cinarum e S. spontaneum (DANIELS e ROACH, 1987; SREENIVASAN et al., 1987). [00201] Event CTC75064-3 was obtained by genetic transformation mediated by Agrobacterium tumefasciens of the cultivar RB 867515. [00202] The cultivar RB 867515 is a commercial hybrid that is a genotype donor for event CTC75064-3 (genetic background) ; thus, it represents the reference untransformed manifold for event CTC75064-3. This cultivar has medium to late maturation and has been planted especially in south-central Brazil. Thus, like other commercial hybrids, it is a material with high ploidy and many chromosomes derived from two parental varieties: S. officinarum and S. spontaneum (DANIELS and ROACH, 1987; SREENIVASAN et al., 1987).
[00203] O evento CTC75064-3 possui o gene crylAc, que expressa uma toxina para controle da D. saccharalis, e o gene nptll, utilizado como marcador de seleção durante o processo de modificação genéti- ca. O desenvolvimento do evento CTC75064-3 foi proposto para con- trole da broca da cana. É esperado que após a eclosão das larvas dos ovos nas folhas do evento CTC75064-3, as larvas jovens comecem a se alimentar e, ao ingerirem a proteína CrylAc, sejam controladas an- tes de penetrarem no colmo das plantas do evento CTC75064-3, evi- tando o dano económico da praga ao cultivo. A expressão do gene crylAc é regulada pela região promotora compreendendo promotor CaMV 35s com enhacer duplicado (2xCaMV35s), sequência líder L- Cab de trigo, íntron de Actina de arroz (OsACTI) e sequência Kosak 5' upstream do sítio de início da transcrição. A expressão do gene nptll é regulada pelo promotor do gene da ubiquitina do milho - UBI-1 (que possui um intron endógeno). O cassete de expressão do crylAc utiliza o terminador CaMV 35S e o cassete do nptll usa o terminador da no- palina sintase de Agrobacterium tumefaciens (nos). [00203] Event CTC75064-3 has the crylAc gene, which expresses a toxin to control D. saccharalis, and the nptll gene, used as a selection marker during the genetic modification process. The development of event CTC75064-3 was proposed to control the sugarcane borer. It is expected that after the hatching of the larvae from the eggs in the leaves of the event CTC75064-3, the young larvae begin to feed and, when ingesting the CrylAc protein, they are controlled before penetrating the stem of the plants of the event CTC75064-3, avoiding the economic damage of the pest to the crop. The crylAc gene expression is regulated by the promoter region comprising CaMV 35s promoter with duplicated enhacer (2xCaMV35s), wheat L-Cab leader sequence, rice actin intron (OsACTI) and Kosak sequence 5' upstream from the transcription start site. The expression of the nptll gene is regulated by the corn ubiquitin gene promoter - UBI-1 (which has an endogenous intron). The crylAc expression cassette uses the CaMV 35S terminator and the nptll cassette uses the no- paline synthase from Agrobacterium tumefaciens (nos).
1.1 Desenvolvimento da Construção contendo os genes crvIAc e notll (Figura 5: SEQ ID NO 14). 1.1 Development of the Construct containing the crvIAc and notII genes (Figure 5: SEQ ID NO 14).
[00204] Técnicas convencionais de clonagem genica, utilizando plasmídeos bacterianos comerciais e digestão e ligação de fragmentos através do uso de enzimas de restrição e ligases foram utilizadas para construir a construção da presente invenção (Figura 5). [00204] Conventional gene cloning techniques using commercial bacterial plasmids and digestion and ligation of fragments through the use of restriction enzymes and ligases were used to construct the construct of the present invention (Figure 5).
[00205] A construção da presente invenção foi desenvolvida por meio da junção dos cassetes 2xCaMV35s-cry1Ac-T35s e UBI-nptlI- TNOS. O T-DNA contendo ambos os cassetes, foi transferido por clo- nagem tradicional para o plasmídeo base (Figura 4; vetor plasmidial binário, que contém em seu espectro de hospedeiro as bactérias Es- cherichia coli e Agrobacterium tumefaciens ), gerando o plasmídeo bi- nário contendo a construção da presente invenção (Figura 5; SEQ ID NO 14). [00205] The construction of the present invention was developed by joining the 2xCaMV35s-cry1Ac-T35s and UBI-nptlITNOS cassettes. The T-DNA containing both cassettes was transferred by traditional cloning to the base plasmid (Figure 4; binary plasmid vector, which contains the bacteria Escherichia coli and Agrobacterium tumefaciens in its host spectrum), generating the plasmid bi - nary containing the construct of the present invention (Figure 5; SEQ ID NO 14).
[00206] Após a clonagem final da construção (SEQ ID NO 14), a mesma foi inserida por choque térmico na cepa de Escherichia coli TOP10. Uma colónia isolada contendo a construção, a qual foi inocu- lada em meio LB líquido suplementado com 150 μg/mL de espectino- micina e incubada a 37°C, com agitação de 250 rpm por um período de 16 horas. Preparou-se, então, estoques contendo suspensão bacte- riana e glicerol 10% (v/v) que foram armazenados em ultrafreezer - 80°C. [00206] After the final cloning of the construct (SEQ ID NO 14), it was inserted by heat shock into the Escherichia coli TOP10 strain. An isolated colony containing the construct, which was inoculated in liquid LB medium supplemented with 150 μg/mL of spectinomycin and incubated at 37°C, with agitation of 250 rpm for a period of 16 hours. Stocks containing bacterial suspension and 10% glycerol (v/v) were then prepared and stored in an ultrafreezer at 80°C.
[00207] A construção da presente invenção foi então transferida de E. coli para a cepa EHA105 de Agrobacterium tumefaciens através do isolamento e purificação do DNA plasmidial e transformação da Agrobacterium por eletroporação. Uma colónia isolada de agrobactéria contendo o vetor desejado foi inoculada em meio LB líquido suplemen- tado com 100 μg/ml de espectinomicina e 50 μg/ml de rifampicina e incubada a 28°C, com agitação de 200 rpm por um período de 24 ho- ras. Preparou-se, então, estoques contendo suspensão bacteriana e glicerol 10% (v/v) que foram armazenados em ultrafreezer -80°C. Es- ses estoques foram utilizados nos experimentos de transformação ge- nética que deram origem ao evento CTC75064-3. [00207] The construct of the present invention was then transferred from E. coli to Agrobacterium tumefaciens strain EHA105 by isolating and purifying the plasmid DNA and transforming the Agrobacterium by electroporation. An isolated colony of agrobacteria containing the desired vector was inoculated into liquid LB medium supplemented with 100 μg/ml of spectinomycin and 50 μg/ml of rifampicin and incubated at 28°C, with agitation at 200 rpm for a period of 24 h. - ras. Stocks containing bacterial suspension and 10% glycerol (v/v) were then prepared and stored in an ultrafreezer -80°C. These stocks were used in the genetic transformation experiments that gave rise to event CTC75064-3.
1.2 Transformação das plantas mediada por Aarobacterium [00208] Para obtenção de calos embriogênicos, folhas jovens enro- ladas (palmitos) de cana-de-açúcar da variedade RB 867515, desen- volvidas no campo ou casa de vegetação por até 12 meses, foram co- letadas para isolamento dos explantes iniciais. 1.2 Transformation of plants mediated by Aarobacterium [00208] To obtain embryogenic callus, young curled leaves (palm hearts) of sugarcane variety RB 867515, grown in the field or in a greenhouse for up to 12 months, were collected for isolation of initial explants.
[00209] Após desinfecção superficial, secções transversais com cerca de 0,05-5mm de espessura foram cortadas da região acima do meristema, em condições assépticas. As secções foram colocadas na superfície do meio de cultura de indução de calos [Sais MS - Murashi- ge e Skoog, 1962; sacarose, vitaminas B5, aminoácidos selecionados do grupo compreendendo prolina, hidrolisado de caseína, ácido cítrico, manitol, sulfato de cobre, glicina, agente gelificante, 2,4D] As culturas foram mantidas no escuro à temperatura de 26°C± 2°C, sendo subcul- tivado a cada 15 dias, por três a cinco ciclos de 7-28 dias cada. Uma semana antes da transformação, os calos foram novamente selecio- nados para as características embriogênicas (nodular, compacto, opa- co e ligeiramente amarelado). [00209] After surface disinfection, cross-sections about 0.05-5mm thick were cut from the region above the meristem under aseptic conditions. Sections were placed on the surface of callus-inducing culture medium [Salts MS - Murashige and Skoog, 1962; sucrose, vitamins B5, amino acids selected from the group comprising proline, casein hydrolyzate, citric acid, mannitol, copper sulfate, glycine, gelling agent, 2,4D] Cultures were kept in the dark at a temperature of 26°C± 2°C , being subcultured every 15 days, for three to five cycles of 7-28 days each. One week before transformation, the calluses were again selected for embryogenic characteristics (nodular, compact, opaque and slightly yellow).
[00210] A cultura de Agrobacterium, compreendendo a cepa EHA105 transformada com o plasmídeo binário da presente invenção, foi iniciada a partir de um estoque de glicerol e mantida no escuro a 28°C por dois a três dias. A suspensão de Agrobacterium para infectar o material vegetal foi preparada ressuspendendo a cultura em meio líquido MS acrescido de acetoseringona, ajustando para uma ODeoo final de 0, 1-1,0 (sais MS, sacarose e vitaminas B5). [00210] The Agrobacterium culture, comprising the EHA105 strain transformed with the binary plasmid of the present invention, was started from a glycerol stock and kept in the dark at 28°C for two to three days. The Agrobacterium suspension to infect the plant material was prepared by resuspending the culture in MS liquid medium plus acetosyringone, adjusting to a final ODeoo of 0.1-1.0 (MS salts, sucrose and vitamins B5).
[00211] Os calos com características embriogênicas foram selecio- nados visualmente e diretamente transferidos para a suspensão de Agrobacterium, onde permaneceram por 30 minutos, no escuro com agitação constante de 50 rpm. [00211] The calluses with embryogenic characteristics were visually selected and directly transferred to the suspension of Agrobacterium, where they remained for 30 minutes, in the dark with constant agitation at 50 rpm.
[00212] Após esse período, os calos foram separados da suspen- são de Agrobacterium e o excesso da suspensão foi removido. Em se- guida, os calos foram cultivados por 1 -5 dias em semissólido (sais MS, sacarose, vitaminas B5, ácido cítrico, agente gelificante, 2,4D e acetoseringona) a 22°C no escuro. [00212] After this period, the calluses were separated from the Agrobacterium suspension and the excess suspension was removed. Then, the calluses were cultured for 1-5 days in semi-solid (MS salts, sucrose, vitamins B5, citric acid, gelling agent, 2,4D and acetosyringone) at 22°C in the dark.
[00213] Após o co-cultivo, os calos foram transferidos para meio de descanso DT (Sais MS; sacarose, vitaminas B5, aminoácidos selecio- nados do grupo compreendendo prolina e asparagina, hidrolisado de caseína, ácido cítrico, sulfato de cobre, glicina, agente gelificante, 2,4D, timetina]) e mantidos por 5-14 dias a 26°C no escuro. [00213] After co-cultivation, the calluses were transferred to DT resting medium (MS salts; sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, citric acid, copper sulfate, glycine , gelling agent, 2,4D, thimetine]) and kept for 5-14 days at 26°C in the dark.
[00214] As células transformadas foram selecionadas por sucessi- vos subcultivos em meio de cultura de seleção contendo fitorregulado- res e o agente seletivo, geneticina (meio de seleção com geneticina, Sais MS; sacarose, vitaminas B5, aminoácidos selecionados do grupo compreendendo prolina e asparagina, hidrolisado de caseína, sulfato de cobre, glicina, agente gelificante, 2,4D, timetina). Os calos perma- neceram nesta condição por 21 dias a 26°C no escuro. Em seguida, os calos foram transferidos para o meio de regeneração (equivalente ao meio de seleção com ausência de 2,4D) e posteriormente para o meio de elongação (Sais MS; sacarose, vitaminas B5, hidrolisado de caseí- na, agente gelificante, timetina), e para um fotoperíodo de 16 horas a 4.000 lux. Plantas regeneradas na presença do antibiótico utilizado como agente seletivo foram multiplicadas, enraizadas e aclimatadas antes da transferência para casa-de-vegetação, dentre elas, o clone que posteriormente originou o evento CTC75064-3, para o qual abaixo descreve-se os métodos para sua caracterização. [00214] The transformed cells were selected by successive subcultures in a selection culture medium containing phytoregulators and the selective agent, geneticin (selection medium with geneticin, MS Salts; sucrose, vitamins B5, amino acids selected from the group comprising proline and asparagine, casein hydrolyzate, copper sulfate, glycine, gelling agent, 2,4D, thimetine). The calluses remained in this condition for 21 days at 26°C in the dark. Then, the calluses were transferred to the regeneration medium (equivalent to the selection medium without 2,4D) and later to the elongation medium (MS salts; sucrose, vitamins B5, casein hydrolyzate, gelling agent, timetine), and for a photoperiod of 16 hours at 4000 lux. Plants regenerated in the presence of the antibiotic used as a selective agent were multiplied, rooted and acclimatized before being transferred to a greenhouse, including the clone that later gave rise to event CTC75064-3, for which the methods for its characterization.
Exemplo 2. Caracterização Molecular do evento CTC75064-3 Example 2. Molecular Characterization of event CTC75064-3
2.1 Extração de DNA. [00215] Foi utilizado aproximadamente 10 mg de tecido foliar do evento CTC75064-3. A extração do DNA genômico foi realizada no extrator de ácidos nucleicos BioSprint 96 (Quiagen, GER) com o kit de extração BioSprint 96 DNA Plant Kit (Quiagen, GER), de acordo com as instruções do fabricante. O DNA obtido foi normalizado para a con- centração de 10 ng/μL em espectrômetro Multiskan GO (Thermo Sci- entific, EUA). 2.1 DNA Extraction. [00215] Approximately 10 mg of leaf tissue from event CTC75064-3 was used. Genomic DNA extraction was performed in the BioSprint 96 nucleic acid extractor (Quiagen, GER) with the BioSprint 96 DNA Plant Kit (Quiagen, GER) extraction kit, according to the manufacturer's instructions. The DNA obtained was normalized to a concentration of 10 ng/μL in a Multiskan GO spectrometer (Thermo Scientific, USA).
2.2 Determinação do número de cópias do transgene inseridas no germoplasma da planta hospedeira. 2.2 Determination of the number of copies of the transgene inserted into the germplasm of the host plant.
[00216] O número de cópias dos genes crylAc e nptll inseridos no evento CTC75064-3 foi avaliado inicialmente por meio de PCR quanti- tativo via Taqman® (qPCR/Taqman®), sendo seus resultados confir- mados posteriormente via Southern blot e/ou sequenciamento. [00216] The number of copies of genes crylAc and nptll inserted in event CTC75064-3 was initially evaluated by quantitative PCR via Taqman ® (qPCR/Taqman ®), and its results were later confirmed via Southern blot and/or or sequencing.
[00217] As reações de PCR em tempo real via Taqman® foram rea- lizadas utilizando o equipamento 7500 Real-Time PCR System (Appli- ed Biosystems, EUA) em seu modo Fast. Os conjuntos de primers e sondas utilizados encontram-se descritos na TABELA 3. [00217] Real-time PCR reactions via Taqman ® were performed using the 7500 Real-Time PCR System equipment (Applied Biosystems, USA) in its Fast mode. The sets of primers and probes used are described in TABLE 3.
TABELA 3: Primers e sondas (Taqman®) utilizadas para a determina- ção do número de cópias via qPCR. TABLE 3: Primers and probes (Taqman®) used to determine the number of copies via qPCR.
Ensaio Iniciadores I sondas Sequências 5' - 3' AmpliconAssay Primers I probes Sequences 5' - 3' Amplicon
_ (Pb) crylAc - 0 pCTC001_Cry1Ac.F GAGGTGCCAATCCACTTCCC 82
Figure imgf000080_0002
crylAc - 1 cry1AcF.1_SB CAT CCCAT ACAACTGCCT GAG 103
_ (Pb) crylAc - 0 pCTC001_Cry1Ac.F GAGGTGCCAATCCACTTCCC 82
Figure imgf000080_0002
crylAc - 1 cry1AcF.1_SB CAT CCCAT ACAACTGCCT GAG 103
SEQ ID NO 43 cry 1 AcR .1 _SB CTGGGTCAAGGACAGGGAGAT
Figure imgf000080_0001
sonda1_cry1Ac_SB CCGGTTACACCCCC
SEQ ID NO 43 cry 1 AcR .1 _SB CTGGGTCAAGGACAGGGAGAT
Figure imgf000080_0001
probe1_cry1Ac_SB CCGGTTACACCCCC
SEQ ID NO 45 Ensaio Iniciadores I sondas Sequências 5' - 3' Amplicon
Figure imgf000081_0002
sonda2_cry1Ac_SB TCTCCGCGAGGAAA
SEQ ID NO 45 Assay Primers I probes Sequences 5' - 3' Amplicon
Figure imgf000081_0002
probe2_cry1Ac_SB TCTCCGCGAGGAAA
SEQ ID NO 48 crylAc - 3 cry1AcF.3_SB CACCGTGCTGGACATT GT GT 77 SEQ ID NO 48 crylAc - 3 cry1AcF.3_SB CACCGTGCTGGACATT GT GT 77
SEQ ID NO 49 cry1AcR.3_SB T GAGTTGGG ACACGGT GC SEQ ID NO 49 cry1AcR.3_SB T GAGTTGGG ACACGGT GC
SEQ ID NO 50 sonda3_cry1Ac_SB CTCTT CCCG AACT ACG ACT SEQ ID NO 50 probe3_cry1Ac_SB CTCTT CCCG AACT ACG ACT
SEQ ID NO 51 crylAc - 4 cry1AcF.4_SB ACCCTGTCCTCCACCCTGTA 107
Figure imgf000081_0001
Ensaio Iniciadores I sondas Sequências 5' - 3' Amplicon
SEQ ID NO 51 crylAc - 4 cry1AcF.4_SB ACCCTGTCCTCCACCCTGTA 107
Figure imgf000081_0001
Assay Primers I probes Sequences 5' - 3' Amplicon
(Pb)(Pb)
(, backbo - c-StaA.R CCGCCGACCTGGTGGA ne) SEQ ID N065 c-StaA_BB_probe FAM-CGTGACCTCAATGCG-MGB
Figure imgf000082_0001
aad-A aad-A_BB_F CACAATCGTCACCTCAACCG 75
(, backbo - c-StaA.R CCGCCGACCTGGTGGA ne) SEQ ID N065 c-StaA_BB_probe FAM-CGTGACCTCAATGCG-MGB
Figure imgf000082_0001
aad-A aad-A_BB_F CACAATCGTCACCTCAACCG 75
SEQ ID NO 67 SEQ ID NO 67
(backbo- aad-A_BB_R AT CAACG ACCTT CTGGAAACG ne) SEQ ID NO 68 aad-A_BB_probe N ED-CGCAGGATTTCGCTCTCG-(backbo-aad-A_BB_R AT CAACG ACCTT CTGGAAACG ne) SEQ ID NO 68 aad-A_BB_probe N ED-CGCAGGATTTCGCTCTCG-
MGBMGB
SEQ ID NO 69 SEQ ID NO 69
[00218] Como controle endógeno das reações para crylAc e nptll, visando confirmar a presença e qualidade do DNA utilizado, bem como a efetividade da reação, foi utilizado o gene da poliubiquitina de cana- de-açúcar [Iniciador sense: 5 'ACCATTACCCTGGAGGTTGAGA 3 ' (SEQ ID NO: 15); antisense primer: 5 'GTCCT GGAT CTT CGCCTT CA 3' (SEQ ID NO: 16); sonda: VIC -5 'CTCTGACACCATCGAC 3'-MGB (SEQ ID NO:17)], em um modo multiplex. [00218] As endogenous control of the reactions for crylAc and nptll, in order to confirm the presence and quality of the DNA used, as well as the effectiveness of the reaction, the sugarcane polyubiquitin gene was used [Initiator sense: 5 'ACCATTACCCTGGAGGTTGAGA 3 ' (SEQ ID NO: 15); antisense primer: 5' GTCCT GGAT CTT CGCCTT CA 3' (SEQ ID NO: 16); probe: VIC -5 'CTCTGACACCATCGAC 3'-MGB (SEQ ID NO:17)], in a multiplex mode.
[00219] As reações de qPCR utilizaram 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, EUA), 300 nM de cada iniciador e 200 nM das sondas correspondentes. A ciclagem utilizada foi: um ciclo de 50°C por 2 minutos para ativação da uracil-N-glicosilase, um ciclo de 95°C por 20 segundos para ativação da DNA polimerase, 40 ciclos de 95°C por 3 segundos (desnaturação) e 60°C por 30 segundos (ane- lamento e extensão). [00219] The qPCR reactions used 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 300 nM of each primer and 200 nM of the corresponding probes. The cycling used was: one cycle of 50°C for 2 minutes for activation of uracil-N-glycosylase, one cycle of 95°C for 20 seconds for activation of DNA polymerase, 40 cycles of 95°C for 3 seconds (denaturation) and 60°C for 30 seconds (annealing and extension).
[00220] A análise de dados foi realizada pela inserção manual do limiar ( threshold) na fase exponencial da curva de amplificação. Para os genes crylAc e nptll, o número de cópias foi inferido a partir da análise de DeltaCt (dCt), na qual o Ct (ciclo no qual o sinal de fluores- cência emitido pelo produto da amplificação atinge o limiar) do gene endógeno é subtraído do Ct do gene alvo. Neste tipo de análise, con- sidera-se que o número de cópias dobra a cada Ct e toma-se como referência o número de cópias de controles da mesma variedade cujo valor é conhecido. Adicionalmente, o número de cópias para o gene crylAc foi confirmado pelo cálculo de delta-Ct (dCt), utilizando como referência controles internos da própria variedade, cujo resultado é ex- presso em números exponenciais (1, 2, 4, 8, 16 cópias). [00220] Data analysis was performed by manually entering the threshold (threshold) in the exponential phase of the amplification curve. For the crylAc and nptll genes, the copy number was inferred from the analysis of DeltaCt (dCt), in which the Ct (cycle in which the fluorescence signal emitted by the amplification product reaches the threshold) of the endogenous gene is subtracted from the Ct of the target gene. In this type of analysis, it is considered that the number of copies doubles for each Ct and is taken as reference the number of copies of controls of the same variety whose value is known. Additionally, the number of copies for the crylAc gene was confirmed by calculating delta-Ct (dCt), using as a reference internal controls of the variety itself, whose result is expressed in exponential numbers (1, 2, 4, 8, 16 copies).
[00221] Os resultados dos ensaios indicam a presença de 1 cópia do gene crylAc e 1 cópia do gene nptll presentes no genoma do even- to CTC75064-3. [00221] The results of the assays indicate the presence of 1 copy of the crylAc gene and 1 copy of the nptll gene present in the genome of the CTC75064-3 event.
[00222] Para o ensaio de Southern blot, 10 μg do DNA genômico do evento CTC75064-3 foi digerido separadamente com enzimas de res- trição distintas (EcoRV, Hindlll e Shpl), seguido pelo procedimento de marcação a frio da sonda (Digoxigenin - DIG). Resumidamente, os DNAs genômicos do evento CTC75064-3 e da variedade parental RB 867515 foram extraídos usando NucleoSpin® Plant II kit em tubos, se- guindo as recomendações do fabricante (Macherey-Nagel GmbH & Co. KG,Germany). A qualidade do DNA extraído foi verificada em gel de agarose a 1% em tampão TAE 1X (Tris-Acetate EDTA) e 10 μg de DNA foram digeridos usando 100 unidades da enzima de restrição (10 U/μg de gDNA) por amostra, em um volume final de 400 pl de reação. [00223] A reação enzimática foi realizada de acordo com as instru- ções do fabricante (Thermo Fisher, USA). O produto da digestão foi precipitado em 2 volumes de etanol e 10% 7,5 M acetato de amónio, e incubado por 48 h a -20 °C. O DNA precipitado foi centrifugado a 14,000 x g por 30 min e o pellet formado foi resuspendido em 35 pl de água milli-Q até a dissolução completa. A qualidade da digestãofoi vi- sualizada em gel de agarose 1% com tampão 1X TAE (Tris-Acetato - EDTA). As enzimas EcoRV e Hindlll foram usadas para detectar os cassetes contendo crylAc e nptll genes (Figura 23 A). A enzima Sphl foi usada para detectar o backbone do vector (Figura 23 B). [00222] For the Southern blot assay, 10 μg of genomic DNA from event CTC75064-3 was digested separately with different restriction enzymes (EcoRV, Hindlll and Shpl), followed by the probe cold labeling procedure (Digoxigenin - DIG). Briefly, genomic DNAs from event CTC75064-3 and from the parental variety RB 867515 were extracted using NucleoSpin® Plant II kit in tubes, following the manufacturer's recommendations (Macherey-Nagel GmbH & Co. KG, Germany). The quality of the extracted DNA was verified on a 1% agarose gel in 1X TAE buffer (Tris-Acetate EDTA) and 10 μg of DNA was digested using 100 units of restriction enzyme (10 U/μg of gDNA) per sample, in a final volume of 400 µl of reaction. [00223] The enzymatic reaction was performed according to the manufacturer's instructions (Thermo Fisher, USA). The digestion product was precipitated in 2 volumes of ethanol and 10% 7.5M ammonium acetate, and incubated for 48 h at -20°C. The precipitated DNA was centrifuged at 14,000 x g for 30 min and the formed pellet was resuspended in 35 µl milli-Q water until complete dissolution. Digestion quality was visualized on 1% agarose gel with 1X TAE buffer (Tris-Acetate - EDTA). EcoRV and Hindlll enzymes were used to detect cassettes containing crylAc and nptll genes (Figure 23 A). The Sphl enzyme was used to detect the vector backbone (Figure 23B).
[00224] Sondas foram desenhadas para detectar o gene crylAc (sonda CrylAc - 1,079 bp), nptll gene (sonda nptll 579 bp), e região promotora CaMV 35s (promotor CaMV 35s e íntron de OsACT; sonda 35S - 904 bp), presentes no evento CTC75064-3. As sondas para de- tectar fragmentos do vetor (backbone) foram desenhadas através do vetor, cobrindo ~ 98% do backbone (sonda BB1 - 1.875 bp; sonda BB2 -2.305 bp; sonda BB3 -2.282 bp; Figura 23 B). As sondas foram preparadas e usadas para detectar alvos usando os reagentes do PCR DIG Probe Synthesis Kit (Roche, cat # 11636090910, Switzerland). Cerca de 100 μg do vetor linearizado foram usados como molde para a amplificação de regiões de interesse e incorporação da molécula de digoxigenin (DIG; marcação) por PCR para uso como sonda. Os inici- adores usados para a produção das sondas, as temperaturas de hibri- dização (Thyb) e o tamanho esperado de cada amplicon são listados na Tabela 04. [00224] Probes were designed to detect the crylAc gene (CrylAc probe - 1.079 bp), nptII gene (nptII probe 579 bp), and CaMV 35s promoter region (CaMV 35s promoter and OsACT intron; 35S probe - 904 bp), present in event CTC75064-3. The probes to detect fragments of the vector (backbone) were designed through the vector, covering ~98% of the backbone (probe BB1 - 1875 bp; probe BB2 -2305 bp; probe BB3 -2282 bp; Figure 23 B). Probes were prepared and used to detect targets using PCR reagents from the DIG Probe Synthesis Kit (Roche, cat # 11636090910, Switzerland). About 100 μg of the linearized vector were used as a template for amplification of regions of interest and incorporation of the digoxigenin molecule (DIG; labeling) by PCR for use as a probe. The primers used to produce the probes, the annealing temperatures (Thyb) and the expected size of each amplicon are listed in Table 04.
[00225] O DNA da variedade RB 867515 foi usado como controle negativo. Como controle positivo, o DNA plasmidial contendo a cons- trução usada para obter o evento CTC75064-3 foi adicionado ao DNA genômico da RB 867515. O DNA plasmidial foi previamente lineariza- do com a enzima de restrição usada em cada ensaio. [00225] DNA from the RB 867515 variety was used as a negative control. As a positive control, plasmid DNA containing the construct used to obtain event CTC75064-3 was added to the genomic DNA of RB 867515. The plasmid DNA was previously linearized with the restriction enzyme used in each assay.
Tabela 04. Lista de iniciadores usados na síntese de sondas marcadas com DIG.
Figure imgf000084_0001
Figure imgf000085_0001
Table 04. List of primers used in the synthesis of probes labeled with DIG.
Figure imgf000084_0001
Figure imgf000085_0001
[00226] A transferência do DNA digerido para a membrana de nylon foi realizada de acordo com protocolos bem estabelecidos. Resumi- damente, a eletroforese de DNA digerido em agarose gel 1% com tampão TAE 1X for realizado a 40 V por aproximadamente 20 horas, usando SYBR Safe DNA gel stain (Invitrogen # S33102, USA) como agente intercalante. Posteriormente, o gel de agarose foi tratado com quatro diferentes soluções na seguinte ordem: [00226] The transfer of the digested DNA to the nylon membrane was performed according to well-established protocols. Briefly, electrophoresis of DNA digested on 1% agarose gel with 1X TAE buffer is performed at 40 V for approximately 20 hours, using SYBR Safe DNA gel stain (Invitrogen # S33102, USA) as an intercalating agent. Subsequently, the agarose gel was treated with four different solutions in the following order:
• Solução de Depurinação (1,1% HCL); 10-15 min; • Depuration Solution (1.1% HCL); 10-15 min;
• Solução de Denaturação (0,5 N NaOH; 1,5 M NaCI); 30-40 min; • Denaturation Solution (0.5 N NaOH; 1.5 M NaCI); 30-40 min;
• Solução de Neutralização (1,5 M NaCI; 0,5 M Tris); 30-40 min; • Neutralization Solution (1.5 M NaCI; 0.5 M Tris); 30-40 min;
• SSC 20x (Citrato de sódio salino); 20 min [00227] A transferência do DNA para a membrana de nylon foi rea- lizada usando TurboBlotter Transfer System 20 x 25 (Sigma # WHA1 0416324, USA) de acordo com instruções do fabricante. A membrana com as amostras do DNA transferido foi colocada em um equipamento UV Crosslinker (UVP- Analytik-Jena, Germany) para fi- xação do DNA (2 ciclos de 700 x 100 μJ/cm2). Pré-hibridização e hibri- dização foram então realizadas. • SSC 20x (Saline Sodium Citrate); 20 min [00227] Transfer of DNA to nylon membrane was performed using TurboBlotter Transfer System 20 x 25 (Sigma # WHA1 0416324, USA) according to manufacturer's instructions. The membrane with the transferred DNA samples was placed in a UV Crosslinker equipment (UVP-Analytik-Jena, Germany) for DNA fixation (2 cycles of 700 x 100 μJ/cm 2 ). Prehybridization and hybridization were then performed.
[00228] O tratamento de Prehibridização consiste em incubação da membrana com solução DIG Easy Hyb (Roche # 11603558001, Swit- zerland) a 40 °C por 3 horas, com DNA de esperma de salmão desna- turado na concentração final de 100 μg.ml_-1 e rotação constante (0,5 x g). Após, a hibridização foi realizada com a mesma solução de Pre- hibridização (DIG Easy Hyb com DNA de esperma de salmão) adicio- nada à sonda marcada com DIG e desnaturada. A concentração usa- da para as sonda foi de 65 μg.ml_-1. A temperatura de hibridização foi 50 °C. [00228] The Prehybridization treatment consists of incubating the membrane with DIG Easy Hyb solution (Roche # 11603558001, Switzerland) at 40 °C for 3 hours, with denatured salmon sperm DNA at a final concentration of 100 μg. ml_-1 and constant rotation (0.5 x g). Afterwards, hybridization was performed with the same Prehybridization solution (DIG Easy Hyb with salmon sperm DNA) added to the DIG-labeled and denatured probe. The concentration used for the probes was 65 μg.ml_-1. The annealing temperature was 50°C.
[00229] A hibridização foi realizada em um forno de hibridização de aproximadamente 16 horas com rotação constante (0,5 x g). As mem- branas hibridizadas foram lavadas e bloqueadas. Após, a solução de bloqueio foi descartada e a membrana foi encoberta com uma nova solução de bloqueio com Anti-Digoxigenin AP fragments (Roche # 11093274910, Switzerland) diluídos em uma razão de 1:20.000. A membrana foi então incubada por 30 min a temperatura ambiente e suavemente agitada. A solução de anticorpo foi descartada e a mem- brana foi lavada e incubada com o tampão de detecção Detection buf- fer (Roche # 11585762001, Switzerland) plus CDP-Star ready to use (Roche # 12041677001, Switzerland) em uma concentração final de 1X, de acordo com instruções do fabricante. Um filme fotográfico foi adicionado para detectar quimiluminescência (Roche # 11666657001, Switzerland), mantido em contato com a membrana por pelo menos 16 hours e posteriormente imerso em 1x Developing Solution (Kodak # 1900943, USA) para visualização das bandas. A solução de fixação (1x) (Kodak # 1901875, USA) foi usada para fixar as imagens das bandas detectadas. [00230] Na hibridização com as sondas CrylAc e 35S, para os ma- teriais digeridos com Hindlll, uma única banda com cerca de 8,5 kb é observada em todas as amostras do evento CTC75064-3 (Figura 24 - esquerda; Figura 25 - direita). Para as mesmas sondas, as amostras digeridas com EcoRV apresentam fragmentos com cerca de 2,79 kb em todas as amostras do evento CTC75064-3 (Figura 24 - direita; Fi- gura 25 - esquerda). A hibridização com a sonda nptll, em materiais digeridos com Hindlll, um fragmento com tamanho esperado de ~ 3,5 kb é observado em todas as amostras do evento CTC75064-3 (Figura 26 - esquerda). Para a enzima EcoRV, um fragmento > 12 kb é obser- vado (Figura 26 - direita). [00229] Hybridization was performed in a hybridization oven for approximately 16 hours with constant rotation (0.5 xg). Hybridized membranes were washed and blocked. Afterwards, the blocking solution was discarded and the membrane was covered with a new blocking solution with Anti-Digoxigenin AP fragments (Roche # 11093274910, Switzerland) diluted in a ratio of 1:20,000. The membrane was then incubated for 30 min at room temperature and gently shaken. The antibody solution was discarded and the membrane was washed and incubated with Detection buffer (Roche # 11585762001, Switzerland) plus CDP-Star ready to use (Roche # 12041677001, Switzerland) at a final concentration of 1X, according to the manufacturer's instructions. A photographic film was added to detect chemiluminescence (Roche # 11666657001, Switzerland), kept in contact with the membrane for at least 16 hours and then immersed in 1x Developing Solution (Kodak # 1900943, USA) to visualize the bands. Fixation solution (1x) (Kodak # 1901875, USA) was used to fix the images of the detected bands. [00230] In the hybridization with the probes CrylAc and 35S, for the materials digested with Hindlll, a single band with about 8.5 kb is observed in all samples of event CTC75064-3 (Figure 24 - left; Figure 25 - right). For the same probes, samples digested with EcoRV show fragments of about 2.79 kb in all samples of event CTC75064-3 (Figure 24 - right; Figure 25 - left). Hybridization with the nptII probe, in materials digested with HindIII, a fragment with expected size of ~3.5 kb is observed in all samples from event CTC75064-3 (Figure 26 - left). For the EcoRV enzyme, a fragment > 12 kb is observed (Figure 26 - right).
[00231] Os resultados de Southern blot, usando as enzimas EcoRV e Hindlll em combinação com as sondas que reconhecem os genes crylAc, nptll e o promotor 35s, confirmam os resultados obtidos usan- do qPCR, os quais indicam que o evento CTC75064-3 possui apenas uma única integração do T-DNA, com uma única cópia do gene crylAc e uma única cópia do gene nptll no genoma. Adicionalmente, a pre- sença dos mesmos fragmentos em todas as gerações do evento CTC75064-3, de amostras provenientes de gerações vegetativas con- secutivas (T0 - T3; Figuras 24, 25 e 26), confirmam a estabilidade ge- nética da inserção do evento ao longo de 4 gerações de multiplicação vegetativa. Sequências do backbone do vetor não foram detectadas no evento CTC75064-3 (Figura 27). [00231] The results of the Southern blot, using the enzymes EcoRV and Hindlll in combination with the probes that recognize the genes crylAc, nptll and the 35s promoter, confirm the results obtained using qPCR, which indicate that the event CTC75064-3 it has only a single T-DNA integration, with a single copy of the crylAc gene and a single copy of the nptll gene in the genome. Additionally, the presence of the same fragments in all generations of event CTC75064-3, from samples from consecutive vegetative generations (T0 - T3; Figures 24, 25 and 26), confirm the genetic stability of the insertion of the event over 4 generations of vegetative multiplication. Vector backbone sequences were not detected in event CTC75064-3 (Figure 27).
2.3 Definição das sequências flanqueadoras. 2.3 Definition of flanking sequences.
[00232] Para isolar as regiões flanqueadoras às extremidades dos insertos de T-DNA presentes no evento CTC75064-3, foram realizados vários experimentos de sequenciamento de DNA. O mapa da inserção genética presente no evento CTC75064-3 resultante dos dados gera- dos por estes experimentos é apresentado na FIGURA 3. [00232] To isolate the flanking regions at the ends of the T-DNA inserts present in event CTC75064-3, several DNA sequencing experiments were performed. The genetic insertion map present in event CTC75064-3 resulting from the data generated by these experiments is shown in FIGURE 3.
[00233] Ensaios de PCR reverso (iPCR) foram realizados para am- bas extremidades do T-DNA com o objetivo de isolar e clonar as regi- ões flanqueadoras do inserto. A metodologia de iPCR é baseada na digestão do DNA genômico utilizando enzimas que clivam a sequência do T-DNA e uma sequência aleatória do genoma do evento. Os produ- tos da clivagem são circularizados e submetidos a múltiplos ciclos de PCR aninhadas ( nested PCR), utilizando primers para regiões conhe- cidas do T-DNA (TABELA 5). A partir do isolamento, sequenciamento e análise das bandas amplificadas nas reações de iPCR por metodo- logia Sanger, uma sequência consenso das regiões flanqueadoras foi definida (SEQ ID NO: 23 e SEQ ID NO: 24). [00233] Reverse PCR (iPCR) assays were performed for am- at the ends of the T-DNA in order to isolate and clone the flanking regions of the insert. The iPCR methodology is based on the digestion of genomic DNA using enzymes that cleave the T-DNA sequence and a random sequence of the event's genome. The cleavage products are circularized and subjected to multiple cycles of nested PCR (nested PCR), using primers for known regions of the T-DNA (TABLE 5). From the isolation, sequencing and analysis of the amplified bands in the iPCR reactions by Sanger methodology, a consensus sequence of the flanking regions was defined (SEQ ID NO: 23 and SEQ ID NO: 24).
TABELA 5. Enzimas de restrição e sequências de iniciadores utiliza- dos para a realização das reações de iPCR e condições das reações de amplificação.
Figure imgf000088_0001
Figure imgf000089_0001
TABLE 5. Restriction enzymes and primer sequences used to carry out the iPCR reactions and conditions of the amplification reactions.
Figure imgf000088_0001
Figure imgf000089_0001
Número de Desnaturação Anelamento Extensão ciclos Number of Denaturation Annealing Extension cycles
1st 94 °C, 5 min 1st 94°C, 5 min
2-36th 94 °C, 30 sec 50 °C 45 sec 72 °C, 3 min2-36th 94 °C, 30 sec 50 °C 45 sec 72 °C, 3 min
37th - - 72 °C, 7 min37th - - 72°C, 7 min
[00234] Em paralelo, como não há atualmente nenhum genoma completamente sequenciado que pudesse ser utilizado como referên- cia para o germoplasma RB 867515, uma metodologia de sequencia- mento por captura foi adotada como forma de esforço adicional para o isolamento do T-DNA inserido no evento CTC75064-3 e de suas regi- ões flanqueadoras. Nesta estratégia, pequenos fragmentos de polinu- cleotídeos sobrepostos (sondas) foram desenvolvidos de modo a co- brir toda a sequência do T-DNA. Essas sondas foram hibridizadas com o DNA genômico fracionado de ambas cultivares, RB 867515 e CTC75064-3, e as sequências híbridas foram isoladas. Os fragmentos isolados foram então sequenciados utilizando tecnologia lllumina® de acordo com protocolo padrão. Os dados obtidos foram alinhados com a sequência de T-DNA presente no vetor de transformação e, em con- junto com os dados obtidos por iPCR mencionados anteriormente, a sequência consenso da inserção de T-DNA (SEQ ID NO 2) presente no evento CTC75064-3 foi definida, bem como as suas sequências flanqueadoras (SEQ ID NO: 23, SEQ ID NO: 24) e as sequências da junção entre as extremidades dos insertos e o genoma de cana de açúcar do evento CTC75064-3 (SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 18, SEQ ID NO 19). Desta forma, as sequências consenso do evento CTC75064-3 foram definidas (SEQ ID NO 5 e SEQ ID NO 22). 2.4 Método de deteccão e caracterização do evento CTC75064-3 - en- saio evento-específico. [00234] In parallel, as there is currently no fully sequenced genome that could be used as a reference for the RB 867515 germplasm, a capture sequencing methodology was adopted as an additional effort for the isolation of T-DNA inserted in event CTC75064-3 and its flanking ions. In this strategy, small overlapping polynucleotide fragments (probes) were developed in order to cover the entire T-DNA sequence. These probes were hybridized with fractionated genomic DNA from both cultivars, RB 867515 and CTC75064-3, and the hybrid sequences were isolated. The isolated fragments were then sequenced using lllumina® technology according to standard protocol. The data obtained were aligned with the T-DNA sequence present in the transformation vector and, together with the data obtained by iPCR mentioned above, the consensus sequence of the T-DNA insertion (SEQ ID NO 2) present in the event CTC75064-3 was defined, as well as its flanking sequences (SEQ ID NO: 23, SEQ ID NO: 24) and the sequences of the junction between the ends of the inserts and the sugarcane genome of event CTC75064-3 (SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 18, SEQ ID NO 19). In this way, the consensus sequences of event CTC75064-3 were defined (SEQ ID NO 5 and SEQ ID NO 22). 2.4 Method of detection and characterization of event CTC75064-3 - event-specific assay.
[00235] Para a validação da metodologia, foram utilizadas amostras de folha do evento oriundas de Piracicaba) Como controles experimen- tais, foram utilizados outros eventos geneticamente modificados que possuem a mesma construção e plantas controles não transformados (WT). A extração do DNA ocorreu conforme descrito acima. [00235] For the validation of the methodology, leaf samples from the event from Piracicaba were used) As experimental controls, other genetically modified events that have the same construction and untransformed control plants (WT) were used. DNA extraction took place as described above.
[00236] A partir da caracterização molecular das sequências flan- queadoras da inserção do T-DNA no genoma no evento CTC75064-3 de cana-de-açúcar geneticamente modificada, foi possível desenhar e validar ensaios de PCR em tempo real para a identificação inequívoca do evento. Para o desenvolvimento de metodologia de detecção espe- cífica optou-se pela técnica de PCR em tempo real (qPCR) conhecida como "Plus-Minus" ou "Presença-Ausência", sendo validadas as duas variações da metodologia: via SYBR GREEN e via tecnologia Taqman®. Dois pares de iniciadores de amplificação ( primers ) especí- ficos foram desenhados para gerar informação a respeito das inser- ções do T-DNA em ambas metodologias, de modo que, para cada par de primer, um iniciador se ancora na região espaçadora e um segundo iniciador se ancora no genoma. Para o uso da tecnologia Taqman®, sondas específicas foram desenhadas entre os iniciadores. [00236] From the molecular characterization of the sequences flanking the insertion of the T-DNA in the genome in the event CTC75064-3 of genetically modified sugarcane, it was possible to design and validate real-time PCR assays for the unequivocal identification of the event. For the development of a specific detection methodology, the real-time PCR (qPCR) technique known as "Plus-Minus" or "Presence-Absence" was chosen, both of which were validated. Methodology variations: via SYBR GREEN and via Taqman ® technology. Two specific amplification primers (primers) were designed to generate information about the T-DNA insertions in both methodologies, so that, for each primer pair, one primer anchors in the spacer region and one second primer anchors in the genome. For the use of Taqman ® technology, specific probes were designed between the primers.
[00237] Em uma modalidade preferida da invenção, os iniciadores desenhados são caracterizados conforme definidos nas SEQ ID Nos: 6 a 9, onde o Iniciador SEQ ID NO: 6 é o iniciador senso da borda direita e o iniciador de sequência SEQ ID NO: 7 é o iniciador antissenso da borda direita, o iniciador SEQ ID NO: 8 é o iniciador senso da borda esquerda e o iniciador de sequência SEQ ID NO: 9 é o iniciador antis- senso da borda esquerda (Tabela 06). [00237] In a preferred embodiment of the invention, the primers designed are characterized as defined in SEQ ID Nos: 6 to 9, where Primer SEQ ID NO: 6 is the right edge sense primer and the sequence primer SEQ ID NO: 7 is the right edge antisense primer, the SEQ ID NO: 8 primer is the left edge sense primer, and the sequence primer SEQ ID NO: 9 is the left edge antisense primer (Table 06).
[00238] Em uma modalidade preferida da invenção, a sonda em- pregada no PCR via tecnologia Taqman® para identificação do evento CTC75064-3 compreende a SEQ ID NO: 10 na borda direita (RB bor- der) e/ou a SEQ ID NO: 11 na borda esquerda (LB border). [00238] In a preferred embodiment of the invention, the probe employed in the PCR via Taqman ® technology to identify the CTC75064-3 event comprises the SEQ ID NO: 10 in the right border (RB border) and/or the SEQ ID NO: 11 on the left border (LB border).
[00239] As reações de PCR em tempo real via Taqman® foram rea- lizadas utilizando o equipamento 7500 Real-Time PCR System (Appli- ed Biosystems, USA) em seu modo Fast. [00239] Real-time PCR reactions via Taqman ® were performed using the 7500 Real-Time PCR System equipment (Applied Biosystems, USA) in its Fast mode.
[00240] Como controle endógeno de reação, visando confirmar a presença e qualidade do DNA utilizado, foi utilizado o gene da poli- ubiquitina de cana-de-açúcar (iniciador senso: SEQ ID NO: 15; inicia- dor anti-senso: SEQ ID NO: 16; sonda: SEQ ID NO: 17) em multiplex com o ensaio desenvolvido para o evento. TABELA 6. Sequências de iniciadores e sondas desenvolvidas na presente invenção para identificação específica do evento (Real-time PCR).
Figure imgf000092_0001
[00240] As an endogenous reaction control, in order to confirm the presence and quality of the DNA used, the sugarcane poly-ubiquitin gene was used (sense primer: SEQ ID NO: 15; antisense primer: SEQ ID NO: 16; probe: SEQ ID NO: 17) multiplexed with the assay developed for the event. TABLE 6. Sequences of primers and probes developed in the present invention for event-specific identification (Real-time PCR).
Figure imgf000092_0001
[00241] As reações de qPCR utilizaram 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 150 nM de cada iniciador específico para o evento da invenção e 100 nM da sonda correspon- dente, 300 nM dos iniciadores para o gene endógeno poli-ubiquitina e 200 nM da sua sonda, 100-200 ng de DNA e água suficiente para completar o volume de 20 μL. A ciclagem utilizada foi: um ciclo de 50°C por 2 minutos para ativação da uracil-N-glicosilase, um ciclo de 95°C por 20 segundos para ativação da DNA polimerase, 40 ciclos de 95°C por 3 segundos (desnaturação) e 60°C por 1 minuto (anelamento e extensão). [00241] The qPCR reactions used 1X TaqMan® Fast PCR Master Mix II (Applied Biosystems, USA), 150 nM of each specific primer for the event of the invention and 100 nM of the corresponding probe, 300 nM of the primers for the gene endogenous poly-ubiquitin and 200 nM of your probe, 100-200 ng of DNA and enough water to complete the volume of 20 μL. The cycling used was: one cycle of 50°C for 2 minutes for activation of uracil-N-glycosylase, one cycle of 95°C for 20 seconds for activation of DNA polymerase, 40 cycles of 95°C for 3 seconds (denaturation) and 60°C for 1 minute (annealing and extension).
[00242] As reações de qPCR utilizando SYBR GREEN foram reali- zadas também utilizando o equipamento 7500 Real-Time PCR System (Applied Biosystems, USA), em seu modo padrão para esse tipo de ensaio. As reações foram realizadas utilizando 1 X o QuantiFast SYBR Green PCR Kit (QIAGEN™), 150 nM do primer sense e 150 nM do primer anti-sense, 20 ng de DNA e água em quantidade suficiente para um volume final de 25 μL . Foram realizadas utilizando o evento da in- venção e, como controles negativos, os outros eventos transformados com a mesma construção do evento da invenção (controles negati- vos), além de amostras de cana-de-açúcar selvagem (WT) e controles experimentais (branco de extração e reação). [00242] The qPCR reactions using SYBR GREEN were also performed using the 7500 Real-Time PCR System equipment (Applied Biosystems, USA), in its standard mode for this type of assay. Reactions were performed using 1X the QuantiFast SYBR Green PCR Kit (QIAGEN™), 150 nM sense primer and 150 nM antisense primer, 20 ng DNA and enough water for a final volume of 25 μL. They were performed using the event of the invention and, as negative controls, the other events transformed with the same construction of the event of the invention (negative controls), in addition to samples of wild sugarcane (WT) and experimental controls. (extraction and reaction blank).
[00243] Os parâmetros de ciclagem utilizados foram: um ciclo de desnaturação do DNA a 95°C por 5 minutos, 35 ciclos de anelamento dos iniciadores e amplificação a 95°C por 15 segundos e 60°C por 1 minuto e um ciclo de dissociação para geração do "pico de melting" (95°C por 15 seg, 60°C por 1 min, 95°C por 15 seg). A reação com SYBR safe não permite a utilização de multiplex, sendo necessário o preparo de nova reação de amplificação de gene endógeno, utilizando o mesmo DNA, para a eliminação de falsos negativos. [00243] The cycling parameters used were: a cycle of DNA denaturation at 95°C for 5 minutes, 35 cycles of primer annealing and amplification at 95°C for 15 seconds and 60°C for 1 minute and a cycle of dissociation to generate the "melting peak" (95°C for 15 sec, 60°C for 1 min, 95°C for 15 sec). The reaction with SYBR safe does not allow the use of multiplex, requiring the preparation of a new endogenous gene amplification reaction, using the same DNA, to eliminate false negatives.
[00244] Como resultado, foi possível validar a reação de detecção específica para o evento da invenção via Taqman® com alta acurácia, como ilustrado na Figura 6. As sondas da tecnologia Taqman® se li- gam especificamente ao DNA e são liberadas durante a amplificação do DNA, gerando um sinal de fluorescência capturado pelo equipa- mento durante o processo. [00244] As a result, it was possible to validate the specific detection reaction for the event of the invention via Taqman ® with high accuracy, as illustrated in Figure 6. Taqman® technology probes specifically bind to DNA and are released during DNA amplification, generating a fluorescence signal captured by the equipment during the process.
[00245] Reações de qPCR multiplex, compreendendo os iniciadores e sondas de todas as regiões flanqueadoras que caracterizam o even- to, assim como o controle endógeno da poli-ubiqutitina, podem ser rea- lizadas para a identificação do evento. Da mesma forma que também são suficientes para identificar de forma inequívoca o evento as rea- ções específicas para cada região flanqueadora realizadas apenas em multiplex com o gene de poli-ubiquitina. [00245] Multiplex qPCR reactions, comprising primers and probes from all flanking regions that characterize the event, as well as the endogenous control of poly-ubiqutitin, can be performed to identify the event. In the same way, the specific reactions for each flanking region performed only in multiplex with the poly-ubiquitin gene are also sufficient to unequivocally identify the event.
[00246] As amostras correspondentes ao evento da invenção apre- sentaram amplificação específica, com formação de curva de amplifi- cação bem definida, com formato sigmoide característico, enquanto as amostras dos outros eventos, bem como WT e brancos da extração e reação, não apresentaram amplificação de evento-específico. O con- trole endógeno apresentou amplificação para todas as amostras, exce- to brancos de extração e reação, como esperado, evidenciando a qua- lidade do DNA utilizado na reação, bem como a qualidade da reação e ciclagem. [00246] The samples corresponding to the event of the invention presented specific amplification, with formation of an amplification curve. well-defined formation, with a characteristic sigmoid shape, while the samples from the other events, as well as WT and blanks from the extraction and reaction, showed no event-specific amplification. The endogenous control showed amplification for all samples, except for extraction and reaction blanks, as expected, evidencing the quality of the DNA used in the reaction, as well as the quality of the reaction and cycling.
[00247] O ensaio via SYBR GREEN™, por sua vez, apresentou amplificação específica das amostras do evento da invenção na tem- peratura de melting esperada. As amostras dos demais eventos, bem como WT e brancos não apresentaram pico de amplificação (Figura 7). Exemplo 3. Reconstrução do evento CTC75064-3 através de técnicas de inserção sítio dirigido (Edição Genômica). [00247] The assay via SYBR GREEN™, in turn, showed specific amplification of the samples from the event of the invention at the expected melting temperature. The samples from the other events, as well as WT and blanks, showed no amplification peak (Figure 7). Example 3. Reconstruction of event CTC75064-3 using site-directed insertion techniques (Genomic Editing).
[00248] O evento CTC75064-3 pode ser gerado utilizando ferra- mentas de edição genômica (EG), recriando o evento inicialmente de- senvolvido através de método de transformação genética mediados por Agrobacterium, conforme apresentado pela presente invenção. [00249] Desse modo, o evento CTC75064-3 é recriado através da inserção do gene CrylAc na mesma localização no genoma da cultivar RB 867515 conforme descrição apresentada para o evento CTC75064-3. A expressão do gene CrylAc é regulada por um promo- tor ou uma região promotora e um terminador capaz de dirigir a ex- pressão da proteína CrylAc a níveis suficientes para controlar a infes- tação da praga alvo. Adicionalmente, um gene marcador ou um siste- ma de seleção também é inserido (transientemente ou estavelmente) para permitir a seleção do evento. Preferivelmente, o T-DNA da pre- sente invenção (SEQ ID NO: 2) é inserido no(s) sítio específico do ge- noma conforme descrito para o evento CTC75064-3. Desta forma, o evento CTC75064-3 é recriado com a inserção do gene crylAc gene, o qual expressa a toxina que controla D. saccharalis, e o gene nptll. A expressão de crylAc pela região promotora compreendendo promotor CaMV35s com enhancer duplicado, sequência líder L-Cab de trigo, intron de OsACTI e sequência Kosak 5' upstream do sítio de início da transcrição. A expressão dos genes nptll é regulada pelo promotor de milho ubiquitina 1 (UBI-1), o qual possui um intron endógeno. O casse- te de expressão do crylAc possui o terminador CaMV35s (T35s) e o cassete de expressão do nptll usa terminador de nopalina sintase de Agrobacterium tumefaciens (nos). [00248] The CTC75064-3 event can be generated using genomic editing (GE) tools, recreating the event initially developed through an Agrobacterium-mediated genetic transformation method, as presented by the present invention. [00249] In this way, the event CTC75064-3 is recreated by inserting the CrylAc gene at the same location in the genome of the cultivar RB 867515 as described for the event CTC75064-3. The expression of the CrylAc gene is regulated by a promoter or a promoter region and a terminator capable of driving the expression of the CrylAc protein to levels sufficient to control the infestation of the target pest. Additionally, a marker gene or a selection system is also inserted (transiently or stably) to allow selection of the event. Preferably, the T-DNA of the present invention (SEQ ID NO: 2) is inserted into the genome-specific site(s) as described for event CTC75064-3. In this way, the CTC75064-3 event is recreated with the insertion of the crylAc gene, which expresses the toxin that controls D. saccharalis, and the nptll gene. THE crylAc expression by the promoter region comprising CaMV35s promoter with duplicated enhancer, wheat L-Cab leader sequence, OsACTI intron and Kosak sequence 5' upstream from the transcription start site. The expression of nptll genes is regulated by the maize ubiquitin 1 (UBI-1) promoter, which has an endogenous intron. The crylAc expression cassette has CaMV35s terminator (T35s) and the nptII expression cassette uses Agrobacterium tumefaciens nopaline synthase terminator (nos).
[00250] Caso a estratégia de EG definida para a geração do evento CTC75064-3 resultar em uma baixa eficiência de integração do T-DNA no sítio específico de inserção do CTC75064-3, genes de desenvolvi- mento, morfogenes ou outros elementos reguladores podem ser utili- zados em conjunto com os reagentes de Edição Genômica (EG) para melhoria da eficiência de integração. [00250] If the GE strategy defined for the generation of the CTC75064-3 event results in a low efficiency of T-DNA integration at the specific insertion site of CTC75064-3, developmental genes, morphogens or other regulatory elements may be used in conjunction with Genomic Editing (GE) reagents to improve integration efficiency.
3.1 Desenvolvimento das Construções 3.1 Development of Constructions
[00251] Técnicas de clonagem gênica convencionais utilizando plasmídeos comerciais, digestão por enzimas de restrição, ligação de fragmentos através de ligases e outras metodologias conhecidas são usadas para desenvolver as construções (plasmídeos) da presente invenção. [00251] Conventional gene cloning techniques using commercial plasmids, restriction enzyme digestion, ligation of fragments through ligases and other known methodologies are used to develop the constructs (plasmids) of the present invention.
[00252] Os reagentes de GE podem ser entregues em múltiplas construções (plasmídeos), cada um compreendendo um elemento do complexo enzimático (endonuclease, crRNA ou RNA guia, e o templa- te de recombinação homóloga- HR). [00252] GE reagents can be delivered in multiple constructs (plasmids), each comprising an element of the enzyme complex (endonuclease, crRNA or guide RNA, and the homologous recombination template-HR).
[00253] Em uma modalidade da presente invenção, a construção do molde de recombinação homóloga (RH ou HR) compreende o T-DNA (SEQ ID NO 2), flanqueado por fragmentos de DNA homólogos às se- quências flanqueadoras do evento CTC75064-3 (SEQ ID Nos: 23 e SEQ ID Nos: 24), localizados em ambos os lados do T-DNA. Assim, é um aspecto da presente invenção uma construção compreendendo a sequência de T-DNA selecionada do grupo consistindo em SEQ ID NO: 2 e flanqueada nas extremidades 5' e 3' por sequências de DNA homologas as sequências flanqueadoras que caracterizam o evento CTC75064-3, as quais são selecionadas do grupo consistindo em SEQ ID Nos: 23 e SEQ ID Nos: 24. A orientação das sequências é de- finida pela orientação do T-DNA no genoma do evento CTC75064-3 de tal forma que o molde de recombinação homóloga caracteriza-se por compreender sequência idêntica ou substancialmente idêntica à SEQ ID NO 22. Em um escopo preferido a construção do molde de recom- binação homóloga (HR) compreende a SEQ ID NO: 26 (Figura 21). [00254] A invenção também compreende uma segunda construção compreendendo um cassete de expressão de uma endonuclease. Em um escopo preferido, o cassete de expressão da endonuclease com- preende a sequência de uma endonuclease Cas9. Em um escopo ain- da mais preferido a sequência da endonuclease é códon otimizada pa- ra expressão em cana de açúcar. Uma terceira construção também está contemplada na presente invenção compreendendo apenas o cassete de expressão do RNA guia/crRNA também está contemplada na presente invenção. Em um aspecto alternativo da invenção, a cons- trução contendo a endonuclease Cas 9 compreende adicionalmente a sequência do RNA guia/crRNA. Preferencialmente, a construção de Cas 9 compreende a sequência crRNA SEQ ID NO: 28. Em um esco- po mais específico, a construção do Cas9 compreende a SEQ ID NO: 27 (Figura 20). Uma terceira construção compreendendo apenas o cassete de expressão do RNA guia também está contemplada na pre- sente invenção e compreende a SEQ ID NO: 28 [00255] Em um escopo adicional, os reagentes de edição genômica podem ser entregues em um único plasmídeo (construção) o qual compreende os cassetes de expressão da endonuclease, do RNA guia (sgRNA) e do molde de recombinação homóloga contendo a(s) se- quências de interesse. Em um escopo da invenção, a construção única compreende a sequência de T-DNA da presente invenção (SEQ ID NO: 2), flanqueada nas extremidades 5' e 3' por sequências de DNA homólogas as sequências flanqueadoras que caracterizam o evento CTC75064-3, as quais são selecionadas do grupo consistindo em SEQ ID Nos: 23 e SEQ ID No 24 localizadas em ambas as extremida- des do T-DNA. Em um escopo preferido, a construção compreende a SEQ ID NO: 25 (Figura 22). A orientação das sequências é definida pela orientação do T-DNA no genoma do evento CTC75064-3 de tal forma que o molde de recombinação homóloga caracteriza-se por compreender sequência idêntica ou substancialmente idêntica à se- quência selecionada do grupo consistindo em SEQ ID NO 22. [00253] In one embodiment of the present invention, the construct of the homologous recombination (RH or HR) template comprises the T-DNA (SEQ ID NO 2), flanked by DNA fragments homologous to the flanking sequences of event CTC75064-3 (SEQ ID Nos: 23 and SEQ ID Nos: 24), located on both sides of the T-DNA. Thus, it is an aspect of the present invention a construction comprising the T-DNA sequence selected from the group consisting of SEQ ID NO: 2 and flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences characterizing event CTC75064-3, which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID Nos: 24. The orientation of the sequences is defined by the orientation of the T-DNA in the genome of the event CTC75064-3 such that the homologous recombination template is characterized by comprising an identical or substantially identical sequence. to SEQ ID NO 22. In a preferred scope the homologous recombination (HR) template construct comprises SEQ ID NO: 26 (Figure 21). [00254] The invention also comprises a second construct comprising an endonuclease expression cassette. In a preferred scope, the endonuclease expression cassette comprises the sequence of a Cas9 endonuclease. In an even more preferred scope the endonuclease sequence is codon optimized for expression in sugar cane. A third construct is also contemplated by the present invention comprising only the guide RNA/crRNA expression cassette is also contemplated by the present invention. In an alternative aspect of the invention, the Cas 9 endonuclease-containing construct additionally comprises the guide RNA/crRNA sequence. Preferably, the Cas9 construct comprises the crRNA sequence SEQ ID NO: 28. In a more specific scope, the Cas9 construct comprises SEQ ID NO: 27 (Figure 20). A third construct comprising only the guide RNA expression cassette is also contemplated in the present invention and comprises SEQ ID NO: 28 [00255] ) which comprises the endonuclease expression cassettes, the guide RNA (sgRNA) and the homologous recombination template containing the sequence(s) sequences of interest. In a scope of the invention, the single construct comprises the T-DNA sequence of the present invention (SEQ ID NO: 2), flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences that characterize event CTC75064-3 , which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID No 24 located at both ends of the T-DNA. In a preferred scope, the construct comprises SEQ ID NO: 25 (Figure 22). The orientation of the sequences is defined by the orientation of the T-DNA in the genome of event CTC75064-3 such that the homologous recombination template is characterized by comprising sequence identical or substantially identical to the sequence selected from the group consisting of SEQ ID NO 22.
[00256] Opcionalmente, as construções também compreendem marcadores de seleção/fluorescentes e/ou outros sistemas de enge- nharia genética para remoção dos marcadores de seleção e/ou dos cassetes de nucleases, como por exemplo, o sistema de recombina- ção homóloga Cre/loxP do bacteriófago P1. Nesse caso, o cassete de expressão do marcador/nuclease, o qual deve ser deletado, é flanque- ado por regiões LoxP, enquanto a Cre recombinase remove esse fra- gmento durante a sua expressão transiente. [00256] Optionally, the constructs also comprise selection/fluorescent markers and/or other genetic engineering systems for removing selection markers and/or nuclease cassettes, such as the Cre homologous recombination system /loxP of bacteriophage P1. In this case, the marker/nuclease expression cassette, which must be deleted, is flanked by LoxP regions, while the Cre recombinase removes this fragment during its transient expression.
3.2 Entrega Direta 3.2 Direct Delivery
[00257] Em um aspecto, o evento da invenção é gerado usando metodologias para a entrega direta de proteínas, RNA ou plasmídeos. As metodologias para entrega direta são selecionadas do grupo con- sistindo em bombardeamento de partículas, eletroporação, lipofecção e transfecção de protoplastos; entretanto, outras metodologias conhe- cidas por um técnico no assunto também podem ser usadas. [00257] In one aspect, the event of the invention is generated using methodologies for the direct delivery of proteins, RNA or plasmids. Methodologies for direct delivery are selected from the group consisting of particle bombardment, electroporation, lipofection and protoplast transfection; however, other methodologies known to one skilled in the art may also be used.
3.2.1 Entrega Direta - estratégia RNP ( ribonucleoproteína ) 3.2.1 Direct Delivery - RNP (ribonucleoprotein) strategy
[00258] Em uma modalidade preferida, o evento da presente inven- ção pode ser gerado utilizando ribonucleoproteínas (RNP) ou a entre- ga direta de sgRNA para a células ou tecido vegetal a ser transforma- do. Dentre as metodologias preferidas para a entrega direta do com- plexo RNP/sgRNA estão o bombardeamento de partículas de calos de cana de açúcar e a transfecção de protoplastos, sem, no entanto, esta- rem limitadas a estas, sendo possível o uso de outras metodologias para o transporte transmembrana de moléculas, como é de conheci- mento no Estado da Técnica. Além disso, outros tipos de celulares po- dem ser usados para transformação, incluindo, sem estar limitado a: discos foliares, meristema, calo e células em suspensão. [00258] In a preferred embodiment, the event of the present invention can be generated using ribonucleoproteins (RNP) or the direct delivery of sgRNA to the cells or plant tissue to be transformed. Among the preferred methodologies for the direct delivery of the RNP/sgRNA complex are the bombardment of sugarcane callus particles and the transfection of protoplasts, without, however, being limited to these, being possible to use other methods. methodologies for the transmembrane transport of molecules, as is known in the State of the Art. In addition, other cell types can be used for transformation, including, but not limited to: leaf discs, meristem, callus, and suspension cells.
[00259] Nessa modalidade, as endonucleases e o crRNA ou o RNA guia são entregues diretamente à célula vegetal na forma de uma RNP, separadas do molde de recombinação homóloga (RH), o qual é entregue através de um plasmídeo. [00259] In this modality, the endonucleases and the crRNA or guide RNA are delivered directly to the plant cell in the form of an RNP, separated from the homologous recombination (RH) template, which is delivered through a plasmid.
[00260] O RNA guia deve ser preliminarmente produzido por trans- crição in vitro ou ser quimicamente sintetizado como um ribooligonu- cleotídeo, enquanto a nuclease correspondente pode ser produzida in vivo e posteriormente purificada (expressão bacteriana) ou adquirida de fabricante desses produtos. Em um escopo da invenção, a nu- clease é a Cas9. [00260] The guide RNA must be preliminarily produced by in vitro transcription or be chemically synthesized as a ribooligonucleotide, while the corresponding nuclease can be produced in vivo and later purified (bacterial expression) or purchased from the manufacturer of these products. In one scope of the invention, the nuclease is Cas9.
[00261] O complexo ribonucleoproteico pronto para uso (RNP) con- sistindo da nuclease correspondente e do RNA guia, e o plasmídeo contendo o molde de RH são absorvidos em partículas de ouro e en- tregues diretamente ás células ou tecidos. [00261] The ready-to-use ribonucleoprotein (RNP) complex consisting of the corresponding nuclease and guide RNA, and the plasmid containing the RH template are absorbed into gold particles and delivered directly to cells or tissues.
3.2.2 Entrega Direta - Plasmídeos 3.2.2 Direct Delivery - Plasmids
[00262] Em uma outra modalidade, o evento CTC75064-3 é recria- do através da entrega direta de plasmídeos contendo as sequências necessárias para a expressão dos componentes dos sistemas CRISPR-Cas e disponibilização do molde para a recombinação homó- loga utilizando a maquinaria da própria célula/tecido vegetal, os quais devem ser expressos de maneira transiente para a síntese do comple- xo enzimático capaz de realizar a clivagem sítio específica para a re- combinação homóloga. As metodologias para a entrega dos plasmí- deos são selecionadas do grupo consistindo em bombardeamento de partículas (biolística) de calos de cana de açúcar e transformação de protoplastos com polietilenoglicol; entretanto, outras metodologias de transformação conhecidas no Estado da técnica podem ser utilizadas, assim como podem ser utilizados outros tecidos além de calos como por exemplo: protoplastos, discos foliares, meristemas, células finas em suspensão, entre outras. [00262] In another embodiment, event CTC75064-3 is recreated through the direct delivery of plasmids containing the sequences necessary for the expression of the components of CRISPR-Cas systems and provision of the template for homologous recombination using the machinery of the cell/plant tissue itself, which must be expressed transiently for the synthesis of the complement. enzyme capable of performing site-specific cleavage for homologous recombination. The methodologies for the delivery of plasmids are selected from the group consisting of particle bombardment (biolistics) of sugarcane callus and transformation of protoplasts with polyethylene glycol; however, other transformation methodologies known in the state of the art can be used, as well as other tissues besides callus, such as: protoplasts, leaf discs, meristems, fine cells in suspension, among others.
[00263] Ainda em uma modalidade adicional, o evento da invenção pode ser gerado através do uso de plasmídeos, onde os componentes do complexo enzimática encontram-se estavelmente inseridos no ge- noma do organismo receptor (RB 867515), sendo expressos e neces- sariamente excisados após a transformação através, por exemplo, do uso de sistema do tipo Cre/Lox ou equivalente. A escolha dessa alter- nativa pode gerar a permanência de sítios LoxP inseridos no genoma da planta. Outras estratégias de excisão do DNA conhecidas do Esta- do da Técnica podem ser utilizadas para a remoção do reagente de EG do DNA do genoma da planta do evento CTC75064-3. Os reagen- tes de edição genômica podem ser entregues em múltiplos plasmí- deos, mas, preferivelmente são entregues em um único plasmídeo, o qual compreende sítios LoxP, um marcador de seleção, a sequência da endonuclease, sgRNA, e o molde de recombinação homóloga. [00263] Still in an additional modality, the event of the invention can be generated through the use of plasmids, where the components of the enzymatic complex are stably inserted in the genome of the recipient organism (RB 867515), being expressed and needed. excised after transformation through, for example, the use of a Cre/Lox system or equivalent. The choice of this alternative can generate the permanence of LoxP sites inserted in the plant genome. Other DNA excision strategies known from the prior art can be used to remove the EG reagent from the DNA of the plant genome of event CTC75064-3. Genome editing reagents can be delivered in multiple plasmids, but are preferably delivered in a single plasmid, which comprises LoxP sites, a selection marker, the endonuclease sequence, sgRNA, and the homologous recombination template. .
3.3 Entrega indireta 3.3 Indirect delivery
[00264] Em um escopo, o evento da presente invenção é gerado usando metodologias de entrega indireta de plasmídeos, como por exemplo, transformação mediada por Agrobacterium. Agrobacterium tumefaciens e Agrobacterium rhizogenes podem ser usadas. Vírus de plantas também podem ser usados para a entrega indireta dos plas- mídeos às células de plantas e tecidos. Por exemplo, geminivirus ge- neicamente modificados possibilitam alcançar uma alta eficiência de trasnformação, especialmente se a estratégia considerada não com- templar a inserção estável das construções no genoma. Além disso, diferentes tecidos e tipos celulares podem ser usados para transfor- mação incluindo, mas não se limitando a: calus, protoplastos, discos foliares, meristemas, e células em suspensão derivados de calus. [00265] Em um escopo preferido, a transformação mediada por Agrobacterium é realizada como descrita no Exemplo 1. [00264] In one scope, the event of the present invention is generated using indirect plasmid delivery methodologies, such as, for example, Agrobacterium-mediated transformation. Agrobacterium tumefaciens and Agrobacterium rhizogenes can be used. Plant viruses can also be used for indirect delivery of plasmids to plant cells and tissues. For example, geminivirus ge- netically modified genes make it possible to achieve a high efficiency of transformation, especially if the considered strategy does not contemplate the stable insertion of the constructs in the genome. In addition, different tissues and cell types can be used for transformation including, but not limited to: calus, protoplasts, leaf discs, meristems, and calus-derived suspension cells. [00265] In a preferred scope, Agrobacterium-mediated transformation is carried out as described in Example 1.
[00266] Em um outro escopo preferido, o evento da invenção é ge- rado através da entrega do plasmídeo pela transformação mediada por Agrobacterium, onde os reagentes de EG são expressos de uma ma- neira transiente, alcançando a integração sítio-dirigida do CTC75064-3 sem a integração de transgenes adicionais associados com a estraté- gia de EG. [00266] In another preferred scope, the event of the invention is generated through delivery of the plasmid by Agrobacterium-mediated transformation, where the EG reagents are expressed in a transient manner, achieving site-directed integration of CTC75064 -3 without the integration of additional transgenes associated with the EG strategy.
[00267] Os reagentes de EG podem ser entregues em múltiplos plasmídeos, mas preferivelmente, em um único plasmídeo. Em um es- copo preferido, a construção é a SEQ ID NO: 25 e compreende um marcador de seleção, uma nuclease, o RNA guia/crRNA, e o molde de recombinação homóloga (RH; Figura 22). O molde de recombinação homóloga compreende uma sequência de T-DNA selecionada do gru- po consistindo em SEQ ID NO: 2 e flanqueada nas extremidades 5' e 3' por sequências de DNA homologas as sequências flanqueadoras que caracterizam o evento CTC75064-3, as quais são selecionadas do grupo consistindo em SEQ ID Nos: 23 e SEQ ID Nos: 24 e localizadas em ambos os lados do T-DNA. A orientação das sequências é definida pela orientação do T-DNA no genoma do evento CTC75064-3 de tal forma que o molde de recombinação homóloga caracteriza-se por compreender sequência idêntica ou substancialmente idêntica à se- quência selecionada do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24. [00268] Em um escopo, o evento da invenção é gerado usando a entrega indireta através de plasmídeos onde os reagentes de EG são estavelmente expressos, assim, necessitam da excisão dos reagentes de EG e/ou dos marcadores de seleção integrados através, por exem- plo do sistema Cre/Lox. A escolha dessa alternativa pode gerar a per- manência de sítios LoxP inseridos no genoma da planta. Outras estra- tégias de excisão do DNA conhecidas do Estado da Técnica podem ser utilizadas para a remoção do reagente de EG do DNA do genoma da planta do evento CTC75064-3. [00267] EG reagents can be delivered on multiple plasmids, but preferably, on a single plasmid. In a preferred scope, the construct is SEQ ID NO: 25 and comprises a selectable marker, a nuclease, the guide RNA/crRNA, and the homologous recombination template (RH; Figure 22). The homologous recombination template comprises a T-DNA sequence selected from the group consisting of SEQ ID NO: 2 and flanked at the 5' and 3' ends by DNA sequences homologous to the flanking sequences that characterize event CTC75064-3, the which are selected from the group consisting of SEQ ID Nos: 23 and SEQ ID Nos: 24 and located on either side of the T-DNA. The orientation of the sequences is defined by the orientation of the T-DNA in the genome of event CTC75064-3 such that the homologous recombination template is characterized by comprising sequence identical or substantially identical to the sequence selected from the group consisting of SEQ ID NO 23 and SEQ ID NO 24. [00268] In one scope, the event of the invention is generated using indirect delivery through plasmids where EG reagents are stably expressed, thus necessitating excision of EG reagents and/or selection markers integrated through, for example - by the Cre/Lox system. The choice of this alternative can generate the permanence of LoxP sites inserted in the plant genome. Other DNA excision strategies known from the prior art can be used to remove the EG reagent from the plant genome DNA of event CTC75064-3.
[00269] Genes morfogenéticos ou outros elementos regulatórios podem estar contemplados em qualquer uma das estratégias acima descritas, possibilitando melhorias da eficiência de transformação (en- trega e integração genômica). [00269] Morphogenetic genes or other regulatory elements can be included in any of the strategies described above, enabling improvements in transformation efficiency (delivery and genomic integration).
[00270] Considerando qualquer um dos processos de transforma- ção descrito acima, as células transformadas resultantes serão rege- neradas para formar uma planta idêntica ou substancialmente idêntica ao evento da presente invenção. [00270] Considering any of the transformation processes described above, the resulting transformed cells will be regenerated to form a plant identical or substantially identical to the event of the present invention.
3.4 Caracterização Molecular 3.4 Molecular Characterization
[00271] O evento gerado através do uso de Edição genômica, é avaliado pela incorporação exata do T-DNA nos sítios de inserção que caracterizam o evento CTC75064-3, através dos iniciadores (SEQ ID NO: 6-9) e sondas (SEQ ID NO: 10-11) descritos na presente invenção. [00272] Pares de iniciadores desenhados para amplificar sequên- cias próximas aos sítios de inserção do molde de recombinação homó- loga podem ser utilizados para confirmar a integridade do sítio de re- combinação (Tabela 7, Figura 28). Adicionalmente, reações de amplifi- cação utilizando iniciadores específicos para a amplificação das se- quências dos reagentes de edição genômica deve ser realizada para confirmar a ausência desses componentes do genoma da planta rege- nerada. TABELA 7. Pares de iniciadores desenhados para as sequências fla- queadoras do CTC75064-3.
Figure imgf000102_0001
Figure imgf000103_0001
[00271] The event generated through the use of Genomic Editing, is evaluated by the exact incorporation of the T-DNA in the insertion sites that characterize the CTC75064-3 event, through the primers (SEQ ID NO: 6-9) and probes (SEQ ID NO: 10-11) described in the present invention. [00272] Pairs of primers designed to amplify sequences close to the insertion sites of the homologous recombination template can be used to confirm the integrity of the recombination site (Table 7, Figure 28). Additionally, amplification reactions using specific primers for the amplification of the sequences of the genomic editing reagents should be performed to confirm the absence of these components from the genome of the regenerated plant. TABLE 7. Primer pairs designed for the flanking sequences of CTC75064-3.
Figure imgf000102_0001
Figure imgf000103_0001
[00273] Reações de PCR usam 0,2 mM dos iniciadores (Tabela 7), 20ng de DNA, 1X Dream Taq- Thermo Fisher buffer (Thermo Fisher Scientific Inc - USA), Taq polymerase (final volume 20 mI_). Condições de reação: 1 ciclo a 94°C por 1 min; 35 ciclos a 94°C por 30 segundos, 65°C por 45 segundos e 72°C por 3 min; e 1 ciclo de extensão a 72°C por 7 minutos. Para Amplicons com mais de 2kb, as reações são reali- zadas com 1U de Takara LA Taq enzima - Takara (Takara Bio Inc- USA), 1 X LA PCR Buffer (Takara Bio Inc - USA), 2,5 mM MgCI2, 2,5mM dNTP, 0,5 mM de iniciadores e 200 ng de DNA (volume final de 50 pL). [00273] PCR reactions use 0.2 mM primers (Table 7), 20ng DNA, 1X Dream Taq- Thermo Fisher buffer (Thermo Fisher Scientific Inc - USA), Taq polymerase (final volume 20 mI_). Reaction conditions: 1 cycle at 94°C for 1 min; 35 cycles at 94°C for 30 seconds, 65°C for 45 seconds and 72°C for 3 min; and 1 extension cycle at 72°C for 7 minutes. For Amplicons with more than 2kb, the reactions are performed with 1U of Takara LA Taq enzyme - Takara (Takara Bio Inc- USA), 1 X LA PCR Buffer (Takara Bio Inc - USA), 2.5 mM MgCl2, 2 .5 mM dNTP, 0.5 mM primers and 200 ng DNA (50 µl final volume).
[00274] Os amplicons obtidos pelas reações de PCR com a combi- nação dos iniciadores “T-DNA” e “Regiões flanqueadoras” da TABELA 07, devem ser submetidos posteriormente ao sequenciamento, por exemplo sequenciamento Sanger, usando os pares de iniciadores de- senhados nas regiões internas do T-DNA do evento CTC75064-3 para, após o alinhamento e geração da sequência consenso final, confirmar a integridade da região genômica modificada e das sequências inseri- das (TABELA 08). [00274] The amplicons obtained by PCR reactions with the combination of primers “T-DNA” and “Flanking Regions” of TABLE 07, must be submitted later to sequencing, for example Sanger sequencing, using the primer pairs de- coded in the internal regions of the T-DNA of event CTC75064-3 to, after alignment and generation of the final consensus sequence, confirm the integrity of the modified genomic region and the inserted sequences (TABLE 08).
TABELA 8. Pares de iniciadores desenhados para as regiões internas do T-DNA do evento CTC75064-3.
Figure imgf000104_0001
evento da invenção.
TABLE 8. Primer pairs designed for the inner regions of the T-DNA of event CTC75064-3.
Figure imgf000104_0001
invention event.
[00275] O produto da expressão dos genes no evento da presente invenção foi detalhadamente caracterizado por meio do emprego de metodologia ELISA, para determinação da concentração das proteínas CrylAc e Nptll, e Western blot, para comprovação das identidades dessas proteínas heterólogas. A expressão dos genes crylAc e nptll no evento CTC75064-3 foi caracterizada em diferentes tecidos, está- gios de desenvolvimento da cultura e localidades de plantio. [00275] The product of gene expression in the event of the present The invention was characterized in detail through the use of ELISA methodology, to determine the concentration of CrylAc and Nptll proteins, and Western blot, to prove the identities of these heterologous proteins. The expression of crylAc and nptll genes in event CTC75064-3 was characterized in different tissues, stages of crop development and planting locations.
ELISA (Enzvme-Linked Immunosorbent Assav) ELISA (Enzvme-Linked Immunosorbent Assav)
[00276] Para a produção das amostras de tecidos do evento CTC75064-3 e do controle (variedade parental) para realização dos ensaios ELISA, foram realizados experimentos em localidades repre- sentativas das áreas de cultivo da cultivar parental RB 867515, a sa- ber, Piracicaba, Barrinha e Valparaíso (SP), Quirinópolis (GO) e Jua- zeiro (BA) e Mandaguaçu (PR) (TABELA 09). Em cada local, os expe- rimentos foram conduzidos em delineamento em blocos completos ca- sualizados com 4 repetições. As parcelas foram compostas por 10 li- nhas de 8 metros, com espaçamento de 1 ,5 metros entre as linhas.[00276] For the production of tissue samples from the event CTC75064-3 and the control (parental variety) for carrying out the ELISA assays, experiments were carried out in representative locations of the cultivation areas of the parental cultivar RB 867515, namely , Piracicaba, Barrinha and Valparaíso (SP), Quirinópolis (GO) and Juazeiro (BA) and Mandaguaçu (PR) (TABLE 09). At each site, the experiments were conducted in a randomized complete block design with 4 repetitions. The plots were composed of 10 lines of 8 meters, with a spacing of 1.5 meters between the lines.
TABELA 09. Informações dos ensaios onde as coletas de amostras para análise da expressão de crylAc e nptll produzido pelo evento da invenção foram realizadas. (Dias após plantio- DAP)
Figure imgf000105_0001
Figure imgf000106_0001
TABLE 09. Information of the assays where the collections of samples for analysis of the expression of crylAc and nptll produced by the event of the invention were carried out. (Days after planting - DAP)
Figure imgf000105_0001
Figure imgf000106_0001
[00277] A análise de expressão das proteínas CrylAc e Nptll no evento CTC75064-3 foi investigada em diferentes tecidos e em dife- rentes períodos do desenvolvimento dos ciclos de cultivo. Os tecidos e tempos avaliados (± 5 dias) foram: [00277] The analysis of the expression of the proteins CrylAc and Nptll in the event CTC75064-3 was investigated in different tissues and in different periods of the development of the culture cycles. The tissues and times evaluated (± 5 days) were:
1) Folhas ao longo do ciclo de cultivo do evento CTC75064-3 (100, 200 e 300 Dias Após o Plantio (DAP); 1) Leaves throughout the crop cycle of event CTC75064-3 (100, 200 and 300 Days After Planting (DAP);
2) Folhas, colmos e raízes ao final do ciclo de cultivo (330 DAP) do primeiro corte da cana. Em Juazeiro o material foi avaliado aos 210DAP. 2) Leaves, stems and roots at the end of the crop cycle (330 DAP) of the first sugarcane cut. In Juazeiro, the material was evaluated at 210DAP.
[00278] A amostras de folhas foram coletadas nas parcelas dos tra- tamentos experimentais nos ensaios de AGRO/PHENO a 100, 200, 300 e 330DAP. Colmos e raízes foram coletados somente a 330 DAP. As amostras de 330DAP foram coletadas aos 210 DAP em Juazeiro. Após a coleta, as amostras foram enviadas para a análise de ELISA para determinar a expressão das proteínas CrylAc e Nptll no evento CTC75064-3. [00278] Leaf samples were collected in plots of experimental treatments in AGRO/PHENO trials at 100, 200, 300 and 330DAP. Stems and roots were collected only at 330 DAP. The 330DAP samples were collected at 210 DAP in Juazeiro. After collection, samples were sent for ELISA analysis to determine the expression of CrylAc and Nptll proteins in event CTC75064-3.
[00279] Amostras de Folhas: foram coletados 30 cm de tecidos a partir da ponta de 5 a 10 folhas "diagnóstico" nas linhas 2 e 3 em zi- guezague evitando folhas doentes. Após a retirada da nervura central as folhas foram picadas em pedaços, homogeneizadas e acondiciona- das em sacos plásticos tipo "ziplock" previamente identificados. [00279] Leaf Samples: 30 cm of tissue were collected from the tip of 5 to 10 "diagnosis" leaves in lines 2 and 3 in a zigzag pattern, avoiding diseased leaves. After removing the midrib, the leaves were chopped into pieces, homogenized and placed in previously identified plastic ziplock bags.
[00280] Amostras de Colmos: foram coletadas 10 canas inteiras em ziguezague. Após retiras as folhas secas e ponteiros, as canas foram cortadas em pequenos toletes, homogeneizadas e acondicionadas em embalagens previamente identificadas. [00280] Stem samples: 10 whole canes were collected in a zigzag pattern. After removing the dry leaves and shoots, the canes were cut into small pieces, homogenized and packed in previously identified packages.
[00281] Amostras de Raízes: foi coletada uma touceira representa- tiva das linhas 2 e 3 da parcela experimental. O solo foi esboroado e as raízes lavadas com água limpa para a retirada do excesso de solo. Em seguida, as raízes limpas foram picadas em pedaços, homogenei- zadas e acondicionadas em sacos plásticos previamente identificados. [00282] Todas as amostras de tecidos (folha, colmo e raízes) foram transferidas para a caixa de isopor com gelo seco em até 15 min após a coleta. A identidade genética de todas as touceiras amostradas foi confirmada por meio de ensaio evento-específico conforme descrito na presente invenção. [00281] Root samples: a representative clump of lines 2 and 3 of the experimental plot was collected. The soil was crumbled and the roots washed with clean water to remove excess soil. Then, the clean roots were chopped into pieces, homogenized and placed in previously identified plastic bags. [00282] All tissue samples (leaf, stem and roots) were transferred to the styrofoam box with dry ice within 15 min after collection. The genetic identity of all clumps sampled was confirmed by an event-specific assay as described in the present invention.
[00283] Para a análise da proteína CrylAc foram utilizados 30 ± 1 mg de folha, 200 ± 1 mg de colmo e 20 ± 1 mg de raízes congelados em gelo seco ou nitrogénio líquido. A maceração foi realizada no equi- pamento TissueLyser. Ao tecido macerado de folha adicionaram-se 750 pl_ de tampão de extração fosfato salino (PBS) suplementado com Tween20 (NaCI 0,138 M; KCI 0,027 mM; Tween200,05%, pH 7,4) dilu- ído de acordo com as instruções do fabricante (Envirologix™ EUA). No caso de colmo foram utilizados 375 mI_, e para raízes 1 ,500 mI_, do mesmo tampão. [00283] For the analysis of CrylAc protein, 30 ± 1 mg of leaf, 200 ± 1 mg of stem and 20 ± 1 mg of roots frozen in dry ice or liquid nitrogen were used. Maceration was performed on the TissueLyser equipment. To the leaf macerated tissue was added 750 µl of phosphate saline extraction buffer (PBS) supplemented with Tween20 (0.138 M NaCl; 0.027 mM KCl; 200.05% Tween, pH 7.4) diluted according to the instructions of the manufacturer (Envirologix™ USA). In the case of stems, 375 ml of the same buffer were used, and for roots 1,500 ml of the same buffer.
[00284] Para análise da proteína Nptll em folhas foram pesados 40 ±1 mg do tecido macerado, e para colmo e raiz foram pesados 200 ±1 mg. Similarmente, nas amostras de tecido foliar foram adicionados 750 mI_ do tampão de extração; enquanto nas amostras de colmo e raiz foram adicionados 1 ,500 mI_. O tampão de extração utilizado neste ca- so foi o PEB1 1x (pH 7,0), que acompanha o kit utilizado para a quanti- ficação da proteína NPTII: PathoScreen® Kit for NPT II (Agdia, EUA). [00285] Em todos os casos, após a adição do tampão nas amostras de folha, efetuou-se a homogeneização com vortex. A homogeneíza- ção foi seguida por centrifugação por 20 minutos a 4000 *g. O sobre- nadante resultante foi coletado e seguiu para a etapa de quantificação de proteínas totais pelas metodologias de Bradford (CrylAc) ou BCA (NPTII). [00284] For analysis of Nptll protein in leaves, 40 ±1 mg of the macerated tissue were weighed, and 200 ±1 mg of stem and root were weighed. Similarly, 750 ml of extraction buffer was added to leaf tissue samples; while in the stem and root samples 1,500 mI_ were added. The extraction buffer used in this case was PEB1 1x (pH 7.0), which accompanies the kit used for the quantification of NPTII protein: PathoScreen® Kit for NPT II (Agdia, USA). [00285] In all cases, after adding the buffer to the leaf samples, homogenization was performed with vortexing. The homogenization This was followed by centrifugation for 20 minutes at 4000 *g. The resulting supernatant was collected and proceeded to the step of quantification of total proteins by the Bradford (CrylAc) or BCA (NPTII) methodologies.
[00286] Os padrões utilizados para a obtenção da curva de calibra- ção para quantificação das proteínas foram os padrões comerciais já previamente diluídos (Albumin Standard Thermo Scientific, cat#23209). Calibradores na concentração de 2000, 1000, 500, 250, 125 e 0 μg/mL (preparados em tampão PBST) foram usados. 10 pL de cada calibrador padrão foi adicionado em triplicada aos poços nas pla- cas. No total, 6 curvas foram geradas de diluições independentes. Pa- ra as amostras, 10pL de 3 extrações de proteínas individuais foram usados em cada poço. Posteriormente, 200pL de Coomassie Plus Re- agent Solution foi adicionado em cada poço contendo os calibradores e as amostras. As placas foram cobertas e incubadas por 5 minutos a temperatura ambiente. Absorbância foi lida a 595 nanometros (nm) usando SoftmaxPro 7.0 software (Molecular Device, US). [00286] The standards used to obtain the calibration curve for protein quantification were commercial standards already diluted (Albumin Standard Thermo Scientific, cat#23209). Calibrators at the concentration of 2000, 1000, 500, 250, 125 and 0 μg/mL (prepared in PBST buffer) were used. 10 pL of each calibrator standard was added in triplicate to the wells on the plates. In total, 6 curves were generated from independent dilutions. For the samples, 10pL of 3 individual protein extractions were used in each well. Subsequently, 200pL of Coomassie Plus Reagent Solution was added to each well containing the calibrators and samples. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device, US).
[00287] As proteínas totais foram obtidas em triplicatas para cada amostra estudada. Após a quantificação de proteínas totais, escolheu- se a amostra com menor variação do valor mediano da quantificação. Após a quantificação, as amostras de folhas foram diluídas como se- gue: amostras de folhas para análise de CrylAc foram diluídas 2.500x, exceto as amostras de 100 DAP que foram diluídas 3.500x; as amos- tras de colmos para análise de CrylAc foram diluídas 2,500x; enquan- to, amostras de raízes para análise de CrylAc foram diluídas 200x. Todas as amostras (folha, raiz, e colmo) para análise de Nptll foram diluídas 8x. [00287] Total proteins were obtained in triplicates for each sample studied. After the quantification of total proteins, the sample with the smallest variation of the median value of the quantification was chosen. After quantification, the leaf samples were diluted as follows: leaf samples for CrylAc analysis were diluted 2500x, except for the 100 DAP samples which were diluted 3500x; stem samples for CrylAc analysis were diluted 2,500x; while root samples for CrylAc analysis were diluted 200x. All samples (leaf, root, and stem) for Nptll analysis were diluted 8x.
[00288] A obtenção de resultados para as proteínas CrylAc e Nptll foi feita por espectrometria em placas de 96 poços com leitura em dois comprimentos de onda diferentes: 450 nm e 630 nm em leitora de Pia- ca SpectraMax (Molecular Devices, EUA). Para a detecção e quantifi- cação da proteína CrylAc foi utilizado o kit AP003 CRBS (Envirologix, EUA), seguindo as recomendações do fabricante. Para a detecção e quantificação da proteína Nptll foi utilizado o kit PathoScreen® Kit for NPT II (Agdia, EUA), seguindo as recomendações do fabricante. [00289] A análise baseou-se na associação dos valores de absor- bâncias das amostras testes com os valores preditos em uma equação estimada pela medida de absorbância de uma curva padrão. As prote- ínas sintéticas foram diluídas para as concentrações desejadas em tampão PBST. As análises foram realizadas em duplicata experimental para cada amostra. As concentrações das proteínas CrylAc e Nptll foram apresentadas com base em Proteína Total (μg/mg), Peso Fres- co - PF (μg/g) e Peso Seco - PS (μg/g). [00288] Obtaining results for CrylAc and Nptll proteins was done by spectrometry in 96-well plates with reading at two different wavelengths: 450 nm and 630 nm in a Pia-reader. ca SpectraMax (Molecular Devices, USA). For the detection and quantification of CrylAc protein, the AP003 CRBS kit (Envirologix, USA) was used, following the manufacturer's recommendations. For the detection and quantification of Nptll protein, the PathoScreen® Kit for NPT II (Agdia, USA) was used, following the manufacturer's recommendations. [00289] The analysis was based on the association of the absorbance values of the test samples with the predicted values in an equation estimated by the absorbance measurement of a standard curve. Synthetic proteins were diluted to desired concentrations in PBST buffer. Analyzes were performed in experimental duplicate for each sample. The concentrations of CrylAc and Nptll proteins were presented based on Total Protein (μg/mg), Fresh Weight - FP (μg/g) and Dry Weight - PS (μg/g).
[00290] Os resultados das análises estatísticas de quantificação as proteínas CrylAc e Nptll são encontrados nas Tabelas 10 e 11, res- pectivamente. Os resultados de expressão de proteína foram obtidos da média de quatro replicatas biológicas (parcelas experimentais) em duplicata. Tabela 10 apresenta os resultados das análises individuais e conjuntas por localidade para a expressão da proteína CrylAc, em fo- lhas de cana de açúcar coletadas ao longo de 1 ano de cultivo (100, 200 e 300 DAP). Tabela 11 demonstra os resultados das análises para a proteína Nptll, nas mesmas condições. [00290] The results of statistical analyzes of quantification of proteins CrylAc and Nptll are found in Tables 10 and 11, respectively. Protein expression results were obtained from the average of four biological replicates (experimental plots) in duplicate. Table 10 presents the results of individual and joint analyzes by locality for the expression of CrylAc protein in sugarcane leaves collected during 1 year of cultivation (100, 200 and 300 DAP). Table 11 shows the results of the analyzes for the Nptll protein under the same conditions.
TABELA 10: Comparação das médias de expressão de CrylAc em folhas do evento CTC75064-3 ao longo de um ano de cultivo de cana- planta (100 DAP, 200 DAP e 300 DAP). Análise estatística individual e conjunta para os 6 locais ensaiados. Resultados não disponíveis para Juazeiro (BA) Em 300DAP. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. Ep: Erro Padrão. TABLE 10: Comparison of means of CrylAc expression in leaves of event CTC75064-3 throughout a year of sugarcane cultivation (100 DAP, 200 DAP and 300 DAP). Individual and joint statistical analysis for the 6 tested sites. Results not available for Juazeiro (BA) At 300DAP. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. Ep: Standard Error.
Figure imgf000110_0001
Figure imgf000110_0001
TABELA 11: Comparação das médias de expressão de Nptll em fo- lhas do evento CTC75064-3 ao longo de um ano de cultivo de cana- planta (100 DAP, 200 DAP e 300 DAP). Análise estatística individual e conjunta para os 6 locais ensaiados. Resultados não disponíveis para Juazeiro (BA) a 300DAP. Médias seguidas pela mesma letra não dife- rem entre si pelo Teste t ao nível de p < 0,05. Ep: Erro Padrão. TABLE 11: Comparison of means of Nptll expression in leaves of event CTC75064-3 over a year of sugarcane cultivation (100 DAP, 200 DAP and 300 DAP). Individual and joint statistical analysis for the 6 tested sites. Results not available for Juazeiro (BA) at 300DAP. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. Ep: Standard Error.
Figure imgf000111_0001
Figure imgf000111_0001
[00291] Os resultados da análise conjunta para 6 localidades, refe- rentes à expressão de CrylAc em folha (μg/g Tecido Fresco e Seco) ao longo do ciclo de 1 ano de cultivo estão apresentados na TABELA 10 e FIGURA 8 (μg proteína /g tecido fresco) e FIGURA 9 (μg proteí- na/g tecido seco). Os resultados da análise conjunta para 6 localida- des, referentes à expressão de Nptll em folha (μg/g Tecido Fresco e Seco) ao longo do ciclo de 1 ano de cultivo estão apresentados na TABELA 11 e FIGURA 11 (μg proteína /g tecido fresco) e FIGURA 12 (μg proteína/g tecido seco). [00291] The results of the joint analysis for 6 localities, referring to the expression of CrylAc in leaves (μg/g Fresh and Dry Tissue) throughout the 1-year cultivation cycle are shown in TABLE 10 and FIGURE 8 (μg protein /g fresh tissue) and FIGURE 9 (μg protein/g dry tissue). The results of the joint analysis for 6 sites, referring to the expression of Nptll in leaf (μg/g Fresh and Dry Tissue) throughout the 1-year cultivation cycle are shown in TABLE 11 and FIGURE 11 (μg protein /g tissue fresh) and FIGURE 12 (μg protein/g dry tissue).
[00292] A expressão média da proteína CrylAc em folhas do even- to CTC75064-3 ao longo do ciclo de 1 ano de cultivo da cana de açú- car em todas as localidades (com exceção de Juazeiro à 300DAP - sem resultados) foi de 125,18 μg/g de tecido fresco e 423,75 μg/g de tecido seco. Para Nptll, expressão média da proteína em folhas do evento CTC75064-3 ao longo do ciclo de 1 ano de cultivo da cana de açúcar em todas as localidades (com exceção de Juazeiro à 300DAP - sem resultados) foi 1,401 μg/g de tecido fresco e de 6,370 μg/g de tecido seco. [00292] The average expression of CrylAc protein in leaves from event CTC75064-3 over the 1-year cycle of sugarcane cultivation in all locations (except for Juazeiro at 300DAP - no results) was 125.18 μg/g of fresh tissue and 423.75 μg/g of dry tissue. For Nptll, mean protein expression in leaves from event CTC75064-3 over the 1-year cycle of sugarcane cultivation in all locations (with the exception of Juazeiro at 300DAP - no results) was 1,401 μg/g of fresh tissue and 6,370 μg/g dry tissue.
[00293] Os resultados de expressão da proteína CrylAc em folhas do evento CTC75064-3 coletada a 330 DAP (210 DAP para Juazeiro) são apresentados na TABELA 12 e Figura 10 (em μg proteína/g tecido fresco e seco). [00293] The results of CrylAc protein expression in leaves from event CTC75064-3 collected at 330 DAP (210 DAP for Juazeiro) are presented in TABLE 12 and Figure 10 (in μg protein/g fresh and dry tissue).
TABELA 12. Comparação das médias de expressão de CrylAc em folhas do evento CTC75064-3 coletado a 330 DAP (* 210 DAP ara Ju- azeiro). Análise estatística individual e conjunta para os 6 locais ensai- ados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. NA: não avaliado. EP: Erro Padrão.
Figure imgf000112_0001
evento CTC75064-3 coletadas a 330 DAP (210 DAP para Juazeiro) são apresentados na Tabela 13 e Figura 13 (μg proteína/g de tecido fresco e seco).
TABLE 12. Comparison of means of CrylAc expression in leaves from event CTC75064-3 collected at 330 DAP ( * 210 DAP for Juazeiro). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. NA: not evaluated. EP: Standard Error.
Figure imgf000112_0001
event CTC75064-3 collected at 330 DAP (210 DAP for Juazeiro) are shown in Table 13 and Figure 13 (μg protein/g of fresh and dry tissue).
TABELA 13: Comparação das médias de expressão de Nptll em fo- lhas do evento CTC75064-3 a 330 DAP (*210 DAP para Juazeiro). Análise estatística individual e conjunta para os 6 locais ensaiados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. EP: Erro Padrão.
Figure imgf000113_0001
TABLE 13: Comparison of Nptll expression means in leaves from event CTC75064-3 at 330 DAP ( * 210 DAP for Juazeiro). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. EP: Standard Error.
Figure imgf000113_0001
[00295] Os resultados da expressão da proteína CrylAc em colmo de amostras do evento CTC75064-3 coletadas a 330 DAP são apre- sentados na Tabela 14 e Figura 10 (μg/g tecido fresco e seco). TABELA 14: Comparação das médias de expressão de CrylAc em colmo do evento CTC75064-3 a 330 DAP (*210 DAP). Análise estatís- tica individual e conjunta para os 6 locais ensaiados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. EP: Erro Padrão.
Figure imgf000113_0002
[00295] The results of CrylAc protein expression in the stem of samples from event CTC75064-3 collected at 330 DAP are presented in Table 14 and Figure 10 (μg/g fresh and dry tissue). TABLE 14: Comparison of means of CrylAc expression in stem from event CTC75064-3 at 330 DAP ( * 210 DAP). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. EP: Standard Error.
Figure imgf000113_0002
Figure imgf000114_0001
Figure imgf000114_0001
[00296] Os resultados da expressão da proteína Nptll em colmo de amostras do evento CTC75064-3 coletadas a 330 DAP são apresen- tados na Tabela 15 e Figura 13 (μg/g tecido fresco e seco). [00296] The results of Nptll protein expression in stem of samples from event CTC75064-3 collected at 330 DAP are presented in Table 15 and Figure 13 (μg/g fresh and dry tissue).
TABELA 15: Comparação das médias de expressão de Nptll em col- mo do evento CTC75064-3 a 330 DAP (*210 DAP). Análise estatística individual e conjunta para os 6 locais ensaiados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. EP: Erro Padrão.
Figure imgf000114_0002
TABLE 15: Comparison of Nptll expression means in the stem of event CTC75064-3 at 330 DAP ( * 210 DAP). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. EP: Standard Error.
Figure imgf000114_0002
[00297] Os resultados da expressão da proteína CrylAc em raiz de amostras do evento CTC75064-3 coletadas a 330 DAP são apresen- tados na Tabela 16 e Figura 10 (μg/g tecido fresco e seco).[00297] The results of CrylAc protein expression in root of event CTC75064-3 samples collected at 330 DAP are presented. shown in Table 16 and Figure 10 (μg/g fresh and dry tissue).
TABELA 16: Comparação das médias de expressão de CrylAc em raízes do evento CTC75064-3 a 330 DAP (*210 DAP). Análise estatís- tica individual e conjunta para os 6 locais ensaiados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. EP: Erro Padrão.
Figure imgf000115_0001
y
TABLE 16: Comparison of means of CrylAc expression in roots of event CTC75064-3 at 330 DAP ( * 210 DAP). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. EP: Standard Error.
Figure imgf000115_0001
and
[00298] Os resultados da expressão da proteína Nptll em raiz de amostras do evento CTC75064-3 coletadas a 330 DAP são apresen- tados na Tabela 17 e Figura 13 (μg/g tecido fresco e seco). [00298] The results of Nptll protein expression in root samples from event CTC75064-3 collected at 330 DAP are presented in Table 17 and Figure 13 (μg/g fresh and dry tissue).
TABELA 17: Comparação das médias de expressão de Nptll em raízes do evento CTC75064-3 a 330 DAP (*210 DAP). Análise estatís- tica individual e conjunta para os 6 locais ensaiados. Médias seguidas pela mesma letra não diferem entre si pelo Teste t ao nível de p < 0,05. EP: Erro Padrão.
Figure imgf000115_0002
TABLE 17: Comparison of Nptll expression means in roots of event CTC75064-3 at 330 DAP ( * 210 DAP). Individual and joint statistical analysis for the 6 tested sites. Means followed by the same letter do not differ from each other by the t test at the level of p < 0.05. EP: Standard Error.
Figure imgf000115_0002
Figure imgf000116_0001
Figure imgf000116_0001
[00299] A expressão média da proteína CrylAc em colmos do evento CTC75064-3 nas localidades avaliadas foi de 42,94 μg/g de tecido fresco e 173,54 μg/g de tecido seco. Para Nptll, a expressão média em colmos do CTC75064-3 em todas as localidades foi de 0,138 μg/g de tecido fresco e de 0,558 μg/g de tecido seco. [00299] The average expression of CrylAc protein in stems from event CTC75064-3 in the evaluated locations was 42.94 μg/g of fresh tissue and 173.54 μg/g of dry tissue. For Nptll, the mean expression in stems of CTC75064-3 in all localities was 0.138 μg/g of fresh tissue and 0.558 μg/g of dry tissue.
[00300] A expressão média da proteína CrylAc em raízes do even- to CTC75064-3 nas localidades avaliadas foi de 10,21 μg/g de tecido fresco e 46,30 μg/g tecido seco. Para Nptll, a expressão média em raí- zes do CTC75064-3 em todas as localidades foi de 0,092 μg/g tecido fresco e de 0,422 μg/g tecido seco. [00300] The average expression of CrylAc protein in roots of event CTC75064-3 in the evaluated locations was 10.21 μg/g of fresh tissue and 46.30 μg/g of dry tissue. For Nptll, the mean root expression of CTC75064-3 in all localities was 0.092 μg/g fresh tissue and 0.422 μg/g dry tissue.
[00301] Os resultados obtidos em folha, colmo e raízes indicam que o evento da invenção possui níveis de expressão da proteína CrylAc muito maiores do que a expressão de Nptll. [00301] The results obtained in leaf, stem and roots indicate that the event of the invention has expression levels of the CrylAc protein much higher than the expression of NptII.
[00302] A concentração média de CrylAc em folhas do evento da invenção a 100 DAP é mais baixa do que a concentração média a 200 e 300 DAP. Para Nptll, a expressão média em folhas ao longo do ciclo da cana de açúcar permanece constante. [00302] The average concentration of CrylAc in sheets of the event of the invention at 100 DAP is lower than the average concentration at 200 and 300 DAP. For Nptll, the average expression in leaves throughout the sugarcane cycle remains constant.
[00303] Os níveis de expressão das proteínas CrylAc e Nptll no evento CTC75064-3 a 330 DAP foram muito maiores em folhas do que em colmos e raízes. Os resultados de expressão da proteína CrylAc também apresentaram diferenças significativas entre colmos e raízes, com raízes demonstrando a expressão proteica mais baixa. Para Nptll, a expressão média da proteína em colmos e raízes não difere signifi- cativamente. [00303] The expression levels of proteins CrylAc and Nptll in event CTC75064-3 at 330 DAP were much higher in leaves than in stems and roots. The CrylAc protein expression results also showed significant differences between stems and roots, with roots demonstrating the lowest protein expression. For Nptll, the average expression of the protein in stems and roots did not differ significantly.
[00304] Observa-se que os níveis de expressão das proteínas CrylAc e Nptll do evento da invenção foram caracterizados em dife- rentes idades de cultivo, tecidos e localidades. Para CrylAc, os níveis de expressão proteica, especialmente em folhas do evento da inven- ção, mantêm-se altos ao longo de todo o ciclo de cultivo, garantindo o efeito desejado de resistência a infestação por Diatraea saccharalis. Western blot [00304] It is observed that the expression levels of the proteins CrylAc and Nptll of the event of the invention were characterized in different culture ages, tissues and localities. For CrylAc, protein expression levels, especially in leaves from the event of the invention, remain high throughout the entire cultivation cycle, ensuring the desired effect of resistance to infestation by Diatraea saccharalis. western blot
[00305] Para identificação das proteínas heterólogas expressas no evento da invenção, foram utilizadas 50 mg (±0,5 mg) de folha conge- ladas em nitrogénio líquido para CrylAc e 300mg (±0,5 mg) para Nptll. A maceração foi realizada no equipamento TissueLyser, durante 1 mi- nutos à 25 Hz, com a adição de três esferas de aço (3 mm - Qiagen). Ao tecido macerado, adicionou-se 500 μL do tampão de extração fos- fato salino (PBS) suplementado com Tween 20 (NaCI 0,138 M; KCI - 0,027 mM; Tween 20 - 0,05%, pH 7,4) diluído de acordo com as ins- truções do fabricante ( Envirologix ™, EUA). Após a adição do tampão efetuou-se a homogeneização com vortex e centrifugação por 20 mi- nutos, a 4.000rpm a 4°C. O sobrenadante resultante foi coletado e se- guiu para a etapa de quantificação de proteínas totais. [00305] To identify the heterologous proteins expressed in the event of the invention, 50 mg (±0.5 mg) of leaf frozen in liquid nitrogen were used for CrylAc and 300mg (±0.5 mg) for NptII. Maceration was performed in the TissueLyser equipment for 1 minute at 25 Hz, with the addition of three steel balls (3 mm - Qiagen). To the macerated tissue, 500 μL of phosphate saline extraction buffer (PBS) supplemented with Tween 20 (NaCI 0.138 M; KCI - 0.027 mM; Tween 20 - 0.05%, pH 7.4) diluted according to with the manufacturer's instructions ( Envirologix ™, USA). After the addition of the buffer, homogenization was carried out with a vortex and centrifuged for 20 minutes at 4,000 rpm at 4°C. The resulting supernatant was collected and proceeded to the step of total protein quantification.
[00306] A quantificação adotada para as análises das proteínas CrylAc e Nptll foi executada de acordo com as recomendações do ThermoScientific ™ Coomassie Plus ( Bradford) Protein Assay Kit (23236) - Procedimento em microplaca e BCA. Para a proteína Nptll, utilizou-se o método de quantificação de proteínas totais denominado BCA. A quantificação com o método BCA foi executada de acordo com as recomendações do fabricante do kit: PierceTM BCA Protein Assay Kit (23225). Assim, os padrões utilizados para a obtenção da curva de calibração foram os padrões comerciais já diluídos de BSA (Pré- Diluted Protein Assay Standards: Bovine Serum Albumin (BSA) set- 23208, (Thermo Scientific, EUA) na concentração de 2,000, 1 ,500, 1000, 750, 500, 250, 125 e 0 μg/mL, preparados em tampão PBST. Foram adicionados 10 mI_ de cada calibrador padrão em poços triplica- dos na placa. As placas foram cobertas e incubadas durante 5 minutos à temperatura ambiente. A absorbância foi lida em 595 nanômetros (nm) usando o software SoftmaxPro 7.0 ( Molecular Devicé). Após a extração de proteínas totais, 3 μg de extrato proteico foram misturadas ao tampão de amostra 2X Laemmli Sample Buffer ( Bio-Rad , EUA) e submetidos à desnaturação via aquecimento à 100°C por 5 minutos para identificação da proteína CrylAc presente na amostra. No caso da detecção e identificação da proteína Nptll, primeiro foi realizada a concentração do extrato de proteínas totais utilizando colunas Ami- con® Ultra-0.5 Centrifugal Filter Devices (3000 NMWL) seguindo as recomendações do fabricante. Foram utilizados 40 μg de extrato pro- teico, misturados com o tampão de amostras como descrito para CrylAc. [00306] The quantification adopted for the analysis of CrylAc and Nptll proteins was performed according to the recommendations of the ThermoScientific ™ Coomassie Plus (Bradford) Protein Assay Kit (23236) - Procedure in microplate and BCA. For the Nptll protein, the method of quantification of total proteins called BCA was used. Quantification with the BCA method was performed according to the kit manufacturer's recommendations: PierceTM BCA Protein Assay Kit (23225). Thus, the standards used to obtain the calibration curve were commercial standards already diluted of BSA (Pre- Diluted Protein Assay Standards: Bovine Serum Albumin (BSA) set-23208, (Thermo Scientific, USA) at a concentration of 2,000, 1,500, 1000, 750, 500, 250, 125 and 0 µg/ml, prepared in PBST buffer. 10 ml of each calibrator standard was added in triplicate wells on the plate. The plates were covered and incubated for 5 minutes at room temperature. Absorbance was read at 595 nanometers (nm) using SoftmaxPro 7.0 software (Molecular Device). After the extraction of total proteins, 3 μg of protein extract were mixed with the 2X sample buffer Laemmli Sample Buffer (Bio-Rad, USA) and subjected to denaturation via heating at 100°C for 5 minutes to identify the CrylAc protein present in the sample. . In the case of the detection and identification of the Nptll protein, the concentration of the extract of total proteins was first performed using Amicon® Ultra-0.5 Centrifugal Filter Devices columns (3000 NMWL) following the manufacturer's recommendations. 40 μg of protein extract were used, mixed with the sample buffer as described for CrylAc.
[00307] Para o controle negativo da presença das proteínas heteró- logas, foram utilizados 3 μg de extrato proteico extraído da variedade convencional parental RB 867515 foi usado nos experimentos com CrylAc e 40 μg para os ensaios de Nptll. Adicionalmente, foram pre- parados controles positivos para detectar as proteínas CrylAc e Nptll, sendo 0,5 ng das proteínas CrylAc de ~69 kDa (GenScript, USA) ou Nptll de ~29 kDa (Bon Opus Biosciences, USA) purificadas, diluídos na solução de proteínas totais extraídas de folhas de plantas da varie- dade convencional RB 867515. O segundo controle positivo foi obtido através da diluição de 1ng da proteína CrylAc purificada ou 5ng da proteína Nptll puirificada em tampão de extração PBST. [00307] For the negative control of the presence of heterologous proteins, 3 μg of protein extract extracted from the conventional parental variety RB 867515 was used in the experiments with CrylAc and 40 μg for the Nptll assays. Additionally, positive controls were prepared to detect CrylAc and Nptll proteins, with 0.5 ng of ~69 kDa CrylAc proteins (GenScript, USA) or ~29 kDa Nptll (Bon Opus Biosciences, USA) purified, diluted in total protein solution extracted from plant leaves of the conventional variety RB 867515. The second positive control was obtained by diluting 1ng of purified CrylAc protein or 5ng of purified Nptll protein in PBST extraction buffer.
[00308] As amostras foram desnaturadas e aplicadas em gel de po- liacrilamida 4-20% ( Mini-PROTEAN ® TGXTM Precast Gel ) submerso em tampão Tris/glycine/SDS running buffer ( Bio-Rad , EUA) e separa- das por eletroforese a 50 V por 5 minutos e depois a 120 V por, apro- ximadamente, 90 minutos. Na sequência, os géis de poliacrilamida fo- ram equilibrados em Tampão de Transferência Trís/Glycine Buffer (Bio-Rad, EUA), o qual foi adicionado de 20% de metanol, por 10 - 15 minutos. A membrana de PVDF foi tratada com metanol absoluto. O sistema para transferência foi montado em cuba preenchida com o Tampão de Transferência gelado para a transferência sob imersão ("transferência molhada"), à voltagem constante de 50V durante 3 ho- ras. Após concluída a transferência, a membrana foi bloqueada duran- te 16 horas a 4°C, sob agitação constante, em solução de bloqueio [5% de leite em pó desnatado ( Bio-Rad , EUA) e TBS/T (20mM Tris, 150mM NaCI, 1% Tween20] para prevenir possíveis ligações inespecí- ficas à membrana. [00308] The samples were denatured and applied in a 4-20% polyacrylamide gel (Mini-PROTEAN ® TGXTM Precast Gel) submerged in Tris/glycine/SDS running buffer (Bio-Rad, USA) and separated by electrophoresis at 50 V for 5 minutes and then at 120 V for approximately 90 minutes. Next, the polyacrylamide gels were equilibrated in Tris/Glycine Buffer Transfer Buffer (Bio-Rad, USA), to which 20% methanol was added for 10 - 15 minutes. The PVDF membrane was treated with absolute methanol. The transfer system was mounted in a vat filled with ice-cold Transfer Buffer for immersion transfer ("wet transfer"), at a constant voltage of 50V for 3 hours. After the transfer was completed, the membrane was blocked for 16 hours at 4°C, under constant agitation, in blocking solution [5% skimmed milk powder (Bio-Rad, USA) and TBS/T (20mM Tris, 150mM NaCI, 1% Tween20] to prevent possible unspecific binding to the membrane.
[00309] Na etapa seguinte, a membrana foi incubada com o anti- corpo primário durante 90 minutos para detecção e confirmação da presença e integridade das proteínas CrylAc e Nptll. Os anticorpos policlonais utilizados neste ensaio foram o Anti-Cry1Ab ( Fitzgerald , EUA) produzido em coelho e que reage com as proteínas CrylAc e CrylAb; e o Anti-Nptll (Rhea, BRA IM0770-18088), também produzido em coelho, e que reage com a proteína Nptll, diluídos na concentração de 1:500 em TBS/T (v/v). [00309] In the next step, the membrane was incubated with the primary antibody for 90 minutes to detect and confirm the presence and integrity of the CrylAc and Nptll proteins. The polyclonal antibodies used in this assay were Anti-Cry1Ab (Fitzgerald, USA) produced in rabbit and which reacts with CrylAc and CrylAb proteins; and Anti-NptII (Rhea, BRA IM0770-18088), also produced in rabbit, and which reacts with NptII protein, diluted at a concentration of 1:500 in TBS/T (v/v).
[00310] A membrana foi lavada em 3 ciclos de 5 minutos (3x5) em TBS/T e incubada com anticorpo secundário Anti-Rabbit conjugado com HRP produzido em cabras (Sigma), na concentração de 1:20.000 ou Fitzgerald, na concentração de 1 :5.000 - v/v) por 60 minutos. Após as incubações, a membrana foi novamente lavada com TBS/T (3x5 minutos) e a reação imunoenzimática verificada em filmes de raio-X Amersham Hyperfilm ECL (GE Healthcare, EUA) através da reação com substrato Clarit Western ECL Substrate Kit (Biorad, EUA), de acordo com as instruções do fabricante. A exposição do filme de raio-X a membrana variou de 15 segundos até 3 minutos. [00310] The membrane was washed in 3 cycles of 5 minutes (3x5) in TBS/T and incubated with secondary Anti-Rabbit antibody conjugated to HRP produced in goats (Sigma), at a concentration of 1:20,000 or Fitzgerald, at a concentration of 1:5,000 - v/v) for 60 minutes. After the incubations, the membrane was washed again with TBS/T (3x5 minutes) and the enzyme immunoreaction was verified on Amersham Hyperfilm ECL X-ray films (GE Healthcare, USA) by reacting with Clarit Western ECL Substrate Kit (Biorad, USA), from according to the manufacturer's instructions. Exposure of the X-ray film to the membrane ranged from 15 seconds to 3 minutes.
[00311] Os resultados revelaram que o perfil de expressão da prote- ína CrylAc se apresenta como uma banda imunorreativas de peso molecular ~66 kDa (Figura 14). Ambas as amostras (R1-R4) são repe- tições biológicas do evento da invenção CTC75064-3, obtidas de qua- tro parcelas experimentais distintas no Polo Piracicaba. Como espera- do, o controle negativo (WT) não apresentou imunoreatividade. O con- trole negativo consistiu em amostras de proteínas totais extraídas da variedade parental RB 867515 não transformada. O controle positivo (WT+CP) onde a proteína CrylAc foi adicionada ao extrato proteico total da variedade RB 867515 convencional apresentou duas bandas reativas. Nesse caso (WT+CP), é comumente conhecido como doublet e aceito como um produto clivagens proteolíticas intracelulares da pro- teína Cry em folhas de plantas geralmente produzidas através da re- moção de resíduos de aminoácidos terminais por proteases liberadas durante o processamento do tecido vegetal, assim como as outras bandas de pesos moleculares menores (~20 e 10 kDa) visualizadas nas amostras. [00311] The results revealed that the CrylAc protein expression profile is presented as an immunoreactive band of molecular weight ~66 kDa (Figure 14). Both samples (R1-R4) are biological repetitions of the event of the invention CTC75064-3, obtained from four different experimental plots at the Piracicaba Pole. As expected, the negative control (WT) did not show immunoreactivity. The negative control consisted of total protein samples extracted from the untransformed parental variety RB 867515. The positive control (WT+CP) where CrylAc protein was added to the total protein extract of the conventional RB 867515 variety showed two reactive bands. In this case (WT+CP), it is commonly known as doublet and is accepted as a product of intracellular proteolytic cleavages of Cry protein in plant leaves, usually produced through the removal of terminal amino acid residues by proteases released during tissue processing. vegetal, as well as the other bands of smaller molecular weights (~20 and 10 kDa) visualized in the samples.
[00312] A detecção da proteína expressa pelo gene de seleção nptll também foi realizada pelo ensaio de Western blot. Mesmo sendo ex- pressa em níveis mais baixos do que a proteína CrylAc, os ensaios de Western blot demonstraram a presença de uma banda imunorreativa no tamanho esperado de ~29 kDa, em todas as repetições biológicas utilizadas do evento CTC75064-3 (FIGURA 15). Dois controles positivo e um controle negativo foram adicionados à membrana. O controle po- sitivo (CP) corresponde a 0,5 ng de proteína Nptll purificada (~29 kDa, Bon Opus Biosciences, USA), e um segundo controle positivo (WT+CP) correspondendo a 0,5 ng de proteína Nptll purificada e diluí- da em extrato proteico de cana-de-açúcar convencional (RB 867515). O Controle negativo corresponde ao extrato proteico da variedade pa- rental. A banda diagnóstico correspondente a proteína Nptll está pre- sente no controle positivo na altura esperada e é idêntica à banda pre- sente no evento CTC75064-3, confirmando a identidade da mesma. [00313] Os resultados dos ensaios de Western blot confirmaram a presença e integridade das ambas as proteínas CrylAc e Nptll e a au- sência de formas alternativas não esperadas dessas proteínas, no evento geneticamente modificado CTC75064-3. [00312] The detection of the protein expressed by the nptll selection gene was also performed by the Western blot assay. Even though it is expressed at lower levels than the CrylAc protein, Western blot assays demonstrated the presence of an immunoreactive band of the expected size of ~29 kDa, in all biological repeats used for event CTC75064-3 (FIGURE 15) . Two positive controls and one negative control were added to the membrane. The positive control (CP) corresponds to 0.5 ng of purified Nptll protein (~29 kDa, Bon Opus Biosciences, USA), and a second positive control (WT+CP) corresponds to 0.5 ng of purified Nptll protein. and diluted in conventional sugarcane protein extract (RB 867515). The Negative Control corresponds to the protein extract of the parental variety. The diagnostic band corresponding to the Nptll protein is present in the positive control at the expected time and is identical to the band present in event CTC75064-3, confirming its identity. [00313] The results of the Western blot assays confirmed the presence and integrity of both CrylAc and Nptll proteins and the absence of unexpected alternative forms of these proteins, in the genetically modified event CTC75064-3.
[00314] Conclui-se que a identidade das proteínas CrylAc e Nptll expressas pelo evento da invenção foi confirmada por meio de western blot. As proteínas expressas pelo evento da invenção apresentam o tamanho esperado e não foi encontrado evidências de proteínas trun- cadas/fusionadas sendo expressas pelo referido evento. [00314] It is concluded that the identity of CrylAc and Nptll proteins expressed by the event of the invention was confirmed by western blot. The proteins expressed by the event of the invention have the expected size and no evidence was found of truncated/fused proteins being expressed by said event.
Exemplo 5. Ensaios biológicos: Resistência à broca-da-cana (D. sac- charalis) Example 5. Biological assays: Resistance to sugarcane borer (D. saccharalis)
[00315] Ensaios Biológicos (bioensaios) com a praga alvo da cultu- ra, D. saccharalis (broca-da-cana), também podem ser utilizados para a detecção e caracterização do evento CTC75064-3, demonstrando a eficácia de controle proporcionada pela proteína inseticida CrylAc ex- pressa. Diferentes Bioensaios podem ser contemplados no escopo da presente invenção, como por exemplo, Ensaio de Disco Foliar, Ensai- os de Eficácia em Telado, Ensaios de Diluição em Tecido, entre ou- tros. [00315] Biological Assays (bioassays) with the target pest of the crop, D. saccharalis (sugarcane borer), can also be used for the detection and characterization of event CTC75064-3, demonstrating the control effectiveness provided by the CrylAc insecticidal protein expressed. Different Bioassays can be contemplated within the scope of the present invention, such as, for example, Leaf Disc Assay, Telado Efficacy Assays, Tissue Dilution Assays, among others.
[00316] No caso de ensaio de disco foliar, amostras de folhas do evento CTC75064-3 são coletadas, cortadas em discos e em seguida mantidas úmidas. Em seguida, os discos foliares são distribuídos em placas de cultura contendo meio sólido (ágar), infestados com lagartas neonatas (0-24h de idade) de D. saccharalis e incubadas a uma tem- peratura de 27±1°C, umidade relativa 60±10% e fotoperíodo 12:12 (luz:escuro), por um período de 7 dias. Ao final da incubação, avalia-se a mortalidade das larvas e a inibição do desenvolvimento larval dos indivíduos sobreviventes, sendo calculado a partir disso a eficácia rela- tiva através da fórmula:
Figure imgf000122_0001
[00316] In the case of leaf disc test, leaf samples from event CTC75064-3 are collected, cut into discs and then kept moist. Then, the leaf discs are distributed in culture plates containing solid medium (agar), infested with neonatal caterpillars (0-24h of age) of D. saccharalis and incubated at a temperature of 27±1°C, relative humidity 60±10% and photoperiod 12:12 (light:dark), for a period of 7 days. At the end of incubation, evaluate larval mortality and inhibition of larval development of surviving individuals, and the relative efficiency is calculated from this using the formula:
Figure imgf000122_0001
Legenda: Eficácia relativa de LDA, larvas vivas do evento, larvas vivas do controle) Caption: Relative efficacy of LDA, live event larvae, live control larvae)
[00317] As larvas sobreviventes são submetidas a análise de ima- gem para avaliação do estágio larval baseado no tamanho da cápsula cefálica. As larvas que não alcançam o primeiro instar são considera- das mortas. Variedades de cana de açúcar não transgênica genetica- mente muito similares ao evento transgênico da invenção podem ser usadas como controles do ensaio. [00317] Surviving larvae are subjected to image analysis to assess larval stage based on head capsule size. Larvae that do not reach the first instar are considered dead. Non-transgenic sugarcane varieties genetically very similar to the transgenic event of the invention can be used as assay controls.
[00318] Para caracterizar a eficácia do evento no controle da D. saccharalis em laboratório, ensaios de disco foliar foram realizados em tecido vegetal foliar do evento CTC75064-3 (30 DAP). A cana de açú- car não transgênica RB 867515 foi usada como controle (CTC75-TC). O desenho experimental foi completamente randomizado com 4 repli- catas por tratamento. Uma média de 98,2% de taxa de mortalidade foi observada quando comparadas a variedade convencional (CT75-TC) e o evento CTC75064-3 após 7 dias de alimentação com os discos folia- res. Baseado nas medidas de tamanho da cápsula cefálica, foi obser- vado que 100% dos indivíduos sobreviventes não se desenvolvem além do primeiro instar, evidenciando uma alta supressão no desen- volvimento de D. saccharalis após alimentação com o evento transgê- nico (Figura 18). [00318] To characterize the effectiveness of the event in the control of D. saccharalis in the laboratory, leaf disc assays were performed on leaf plant tissue from event CTC75064-3 (30 DAP). The non-transgenic sugarcane RB 867515 was used as a control (CTC75-TC). The experimental design was completely randomized with 4 replicates per treatment. An average of 98.2% mortality rate was observed when comparing the conventional variety (CT75-TC) and the event CTC75064-3 after 7 days of feeding with leaf discs. Based on head capsule size measurements, it was observed that 100% of surviving individuals do not develop beyond the first instar, evidencing a high suppression in D. saccharalis development after feeding with the transgenic event (Figure 18). ).
[00319] Para ensaios de diluição em tecido, as folhas do evento CTC75064-3 foram amostradas em campos de ensaio Agro/pheno em Piracicaba, Valparaíso, Barrinha (SP) e Quirinópolis (GO), com pontos de coleta em 100, 200 e 300 DAP. Essas amostras foram cortadas, desidratadas, congeladas e então maceradas para obter um pó verde uniforme. Para preparar as placas dos bioensaios, cada quadrante com 16 células recebeu uma amostra diluída 25x com dieta MS (Multi- ple Species), preenchendo aproximadamente 1 ml_ por célula. Para infestação, 2 larvas neonatas (0-24h de idade) foram transferidas em cada célula (32 larvas por quadrante). As placas foram identificadas e incubadas a temperatura de 27 ± 1 ° C, umidade relativa de 60 ± 10% e fotoperíodo de 12:12 (claro: escuro), por um período de 10 dias. No final da incubação, cada quadrante foi avaliado para cálculo da morta- lidade efetiva e média de massa de larvas. A mortalidade efetiva foi calculada através da equação:
Figure imgf000123_0001
[00319] For tissue dilution tests, the leaves of event CTC75064-3 were sampled in Agro/pheno test fields in Piracicaba, Valparaíso, Barrinha (SP) and Quirinópolis (GO), with collection points at 100, 200 and 300 DAP. These samples were cut, dehydrated, frozen and then macerated to obtain a green powder. uniform. To prepare bioassay plates, each 16-cell quadrant received a sample diluted 25x with MS diet (Multiple Species), filling approximately 1 ml per cell. For infestation, 2 neonate larvae (0-24h of age) were transferred into each cell (32 larvae per quadrant). The plates were identified and incubated at a temperature of 27 ± 1 °C, relative humidity of 60 ± 10% and a photoperiod of 12:12 (light: dark), for a period of 10 days. At the end of incubation, each quadrant was evaluated to calculate the effective mortality and mean larval mass. Effective mortality was calculated using the equation:
Figure imgf000123_0001
Legenda: Mortalidade efetiva, n larvas mortas + n larvas no primeiro instar / número total de larvas vivas Caption: Effective mortality, n dead larvae + n first instar larvae / total number of live larvae
[00320] A eficácia relativa para os testes de diluição foi calculada através da equação:
Figure imgf000123_0002
[00320] The relative effectiveness for the dilution tests was calculated using the equation:
Figure imgf000123_0002
Legenda: Eficácia relativa na diluição, Larvas vivas do evento, larvas vivas do controle Caption: Relative dilution efficacy, Live event larvae, Live control larvae
[00321] Através da análise de diluição de tecidos de amostras dos campos de Agro/pheno, foi possível verificar a eficácia, tanto a morta- lidade efetiva e a redação de massa de larvas, é 51% e 94%, respecti- vamente. [00321] Through the analysis of tissue dilution of samples from the Agro/pheno fields, it was possible to verify the effectiveness, both the effective mortality and the larval mass redaction, is 51% and 94%, respectively.
[00322] Já no ensaio de Eficácia em Telado, mudas do evento transgênico são plantadas em um viveiro telado, onde as plantas são plantadas no solo e ficam em condições ambientais compatíveis com as condições naturais, porém com restrição a entrada ou saída de formas biológicas, como Diatraea saccharalis, garantir a não ocorrên- cia de infestações naturais. São realizadas pelo menos 5 infestações, contendo de 20-35 ovos de Diatraea saccharalis por perfilho. As avali- ações ocorrem quando todos os colmos infectados são colhidos e ra- chados longitudinalmente para quantificar o dano. A intensidade de infestação é calculada dividindo o número de entrenós com dano pelo número de entrenós totais e o resultado é multiplicado por 100 (Inten- sidade de Infestação). A porcentagem de dano efetivo foi calculada considerando o total de entrenós com dano causado pelo inseto dividi- do pelo número total de colmos avaliados na parcela. [00322] In the Efficacy test in Telado, seedlings of the transgenic event are planted in a screened nursery, where the plants are planted in the soil and are kept in environmental conditions compatible with natural conditions, but with restriction to the entry or exit of biological forms , such as Diatraea saccharalis, guarantee the non-occurrence of natural infestations. At least 5 infestations are carried out, containing 20-35 Diatraea saccharalis eggs per tiller. The evaluations Actions occur when all infected stalks are harvested and split lengthwise to quantify the damage. Infestation intensity is calculated by dividing the number of damaged internodes by the number of total internodes and the result is multiplied by 100 (Infestation Intensity). The percentage of effective damage was calculated considering the total internodes with damage caused by the insect divided by the total number of culms evaluated in the plot.
[00323] Os ensaios em telado foram realizadas para caracterizar a eficácia do evento CTC75064-3 no controle do ataque da broca em comparação com a sua variedade parental RB 867515 (WT; não- transgênica) em um desenho experimental em blocos randomizados, com 4 replicatas. Cada parcela experimental foi composta por oito tou- ceiras de cana-planta que receberam 10 infestações artificiais com aproximadamente 30 ovos de D. saccharalis a cada 15 dias. Após oito meses, o índice de infestação e o dano efetivo para ambas as varie- dades foi calculado. A eficácia relativa foi calculada de acordo com a fórmula abaixo:
Figure imgf000124_0001
[00323] Screening trials were performed to characterize the effectiveness of event CTC75064-3 in controlling the borer attack compared to its parental variety RB 867515 (WT; non-transgenic) in a randomized block design with 4 replicates. Each experimental plot consisted of eight clumps of sugarcane that received 10 artificial infestations with approximately 30 eggs of D. saccharalis every 15 days. After eight months, the infestation index and the effective damage for both varieties were calculated. The relative effectiveness was calculated according to the formula below:
Figure imgf000124_0001
Legenda: eficácia relativa, média do evento, média dos controles [00324] Sobre infestação artificial o evento CTC75064-3 apresentou eficácia relativa no controle da infestação por D. saccharalis de 98,8% e controle do dano nos colmos (comprimento) superior a 99,9% em relação a variedade parental não transgênica RB 867515 (Controle). O dano causado pela D. saccharalis nos colmos do evento CTC75064-3 foi visivelmente menor do que na cana de açúcar não transgênica con- vencional RB 867515. Há diferenças estatísticas significativas (t-test, P < 0,05) entre CTC75064-3 e a variedade não transgênica RB 867515 em ambos os parâmetros avaliados (df = 16; P < 0,0001), demons- trando que sob infestação massiva com D. Saccharalis o evento impe- de os danos causados por essa praga (Figura 16). [00325] Nos plantios comerciais de cana de açúcar D. saccharalis é considerado controlada quando a intensidade de infestação está abai- xo de 3% (Gallo et al., 2002). Para CTC75064-3, a intensidade de in- festação foi inferior a 0,01%, reforçando a eficácia do evento no con- trole dessa praga. Caption: relative efficacy, average of the event, average of the controls [00324] On artificial infestation, event CTC75064-3 presented relative efficacy in the control of infestation by D. saccharalis of 98.8% and control of damage to the stems (length) greater than 99.9% in relation to the non-transgenic parental variety RB 867515 (Control). The damage caused by D. saccharalis in the culms of event CTC75064-3 was noticeably lower than in conventional non-transgenic sugarcane RB 867515. There are statistically significant differences (t-test, P < 0.05) between CTC75064-3 and the non-transgenic variety RB 867515 in both parameters evaluated (df = 16; P < 0.0001), demonstrating that under massive infestation with D. Saccharalis the event prevents the damage caused by this pest (Figure 16) . [00325] In commercial sugarcane plantations, D. saccharalis is considered controlled when the infestation intensity is below 3% (Gallo et al., 2002). For CTC75064-3, the infestation intensity was less than 0.01%, reinforcing the event's effectiveness in controlling this pest.
[00326] A observação e análise das infestações artificiais ou natu- rais em áreas de plantio também permitem a caracterização da eficá- cia dos materiais contra D. saccharalis. A l.l (Intensidade de infesta- ção), por exemplo, pode ser calculado através da avaliação de infesta- ções naturais através da definição de uma área experimental para co- leta dos colmos e abertura longitudinal para contagem dos entrenós totais e os entrenós brocados (com danos causados pela broca), ob- tendo-se assim o índice de infestação (l.l). [00326] The observation and analysis of artificial or natural infestations in planting areas also allow the characterization of the effectiveness of materials against D. saccharalis. The l.l (Intensity of infestation), for example, can be calculated through the evaluation of natural infestations by defining an experimental area for the collection of culms and longitudinal opening to count the total internodes and the brocade internodes ( with damage caused by the borer), thus obtaining the infestation index (l.l).
[00327] Para caracterizar a eficácia do evento CTC75064-3 contra a praga alvo em campo, foram instalados experimentos em 4 localidades (Piracicaba-SP, Barrinha-SP, Valparaíso-SP e Quirinópolis-GO). Os campos foram delineados em 4 parcelas por evento testado em blocos casualizados. A variedade convencional RB 867515 (parental; não trasngênica) foi usada como controle. Esse ensaio ilustra a resistência do evento CTC75064-3 a infestação por D. saccharalis em compara- ção com a variedade parental (RB 867515): foi observado uma menor intensidade de infestação para plantas do evento CTC75064-3 em comparação com a variedade parental (RB 867515) em todas as qua- tro áreas experimentais (Análise conjunta; Figura 17). O evento CTC75064-3 eficácia relativa no controle da infestação por D. saccha- ralis de 100% em todas as localidades, exceto para Valparaiso, a qual demonstrou 99,1% eficácia, muito próximo de 100%. Assim, o evento da presente invenção foi, em média nas 4 localidades, 99,7% mais efetivo do que a plantas não transgênicas (materiais convencionais), para controle de Diatrea saccharallis (Figura 17). [00328] Os exemplos descritos representam os escopos preferidos, devendo ser compreendido que o escopo da presente invenção con- templa outras variações possíveis, sendo limitado apenas pelo conte- údo das reivindicações, incluindo os equivalentes possíveis. [00327] To characterize the effectiveness of event CTC75064-3 against the target pest in the field, experiments were installed in 4 locations (Piracicaba-SP, Barrinha-SP, Valparaíso-SP and Quirinópolis-GO). The fields were designed in 4 plots per event tested in randomized blocks. The conventional variety RB 867515 (parental; non-transgenic) was used as a control. This assay illustrates the resistance of event CTC75064-3 to infestation by D. saccharalis compared to the parental variety (RB 867515): a lower intensity of infestation was observed for plants of event CTC75064-3 compared to the parental variety ( RB 867515) in all four experimental areas (Joint analysis; Figure 17). The event CTC75064-3 relative efficacy in the control of infestation by D. saccharalis of 100% in all locations, except for Valparaiso, which demonstrated 99.1% efficacy, very close to 100%. Thus, the event of the present invention was, on average in the 4 localities, 99.7% more effective than non-transgenic plants (conventional materials) to control Diatrea saccharallis (Figure 17). [00328] The examples described represent the preferred scopes, it being understood that the scope of the present invention contemplates other possible variations, being limited only by the content of the claims, including possible equivalents.

Claims

REIVINDICAÇÕES
1. Polinucleotídeo, caracterizado pelo fato de que compre- ende pelo menos 14 nucleotídeos contíguos da SEQ ID NO: 18. 1. Polynucleotide, characterized in that it comprises at least 14 contiguous nucleotides of SEQ ID NO: 18.
2. Polinucleotídeo, de acordo com a reivindicação 1 , ca- racterizado pelo fato de que compreende pelo menos 15 nucleotídeos contíguos da SEQ ID NO: 18. 2. Polynucleotide, according to claim 1, characterized in that it comprises at least 15 contiguous nucleotides of SEQ ID NO: 18.
3. Polinucleotídeo, de acordo com a reivindicação 1 , ca- racterizado pelo fato de que compreende pelo menos 16 nucleotídeos contíguos da SEQ ID NO 18. 3. Polynucleotide, according to claim 1, characterized in that it comprises at least 16 contiguous nucleotides of SEQ ID NO 18.
4. Polinucleotídeo, de acordo com a reivindicação 1 , ca- racterizado pelo fato de que compreende a SEQ I D NO 18. 4. Polynucleotide, according to claim 1, characterized by the fact that it comprises SEQ ID NO 18.
5. Polinucleotídeo, de acordo com qualquer uma das rei- vindicações 1 a 4, caracterizado pelo fato de que compreende a SEQ ID NO 13. 5. Polynucleotide according to any one of claims 1 to 4, characterized in that it comprises SEQ ID NO 13.
6. Polinucleotídeo, caracterizado pelo fato de que compre- ende pelo menos 14 nucleotídeos contíguos da SEQ ID NO 19. 6. Polynucleotide, characterized in that it comprises at least 14 contiguous nucleotides of SEQ ID NO 19.
7. Polinucleotídeo, de acordo com a reivindicação 6, ca- racterizado pelo fato de que compreende pelo menos 15 nucleotídeos contíguos da SEQ ID NO 19. 7. Polynucleotide, according to claim 6, characterized in that it comprises at least 15 contiguous nucleotides of SEQ ID NO 19.
8. Polinucleotídeo, de acordo com a reivindicação 6, ca- racterizado pelo fato de que compreende pelo menos 16 nucleotídeos contíguos da SEQ ID NO 19. 8. Polynucleotide, according to claim 6, characterized in that it comprises at least 16 contiguous nucleotides of SEQ ID NO 19.
9. Polinucleotídeo, de acordo com a reivindicação 6, ca- racterizado pelo fato de que compreende a SEQ I D NO 19. 9. Polynucleotide, according to claim 6, characterized by the fact that it comprises SEQ ID NO 19.
10. Polinucleotídeo, de acordo com qualquer uma das rei- vindicações 6 a 9, caracterizado pelo fato de que compreende a SEQ ID NO 12. 10. A polynucleotide according to any one of claims 6 to 9, characterized in that it comprises SEQ ID NO 12.
11. Polinucleotídeo, de acordo com qualquer uma das rei- vindicações 1 a 10, caracterizado pelo fato de que compreende pelo menos 80% de identidade com a SEQ ID NO 5. 11. A polynucleotide according to any one of claims 1 to 10, characterized in that it comprises at least 80% identity with SEQ ID NO 5.
12. Polinucleotídeo, de acordo com qualquer uma das rei- vindicações 1 a 11 , caracterizado pelo fato de que compreende pelo menos 80% de identidade com a SEQ ID NO 22. 12. A polynucleotide according to any one of claims 1 to 11, characterized in that it comprises at least 80% identity with SEQ ID NO 22.
13. Pares de Iniciadores, caracterizados pelo fato de que o iniciador senso possui pelo menos 80% de identidade com a SEQ ID NO: 6 e o iniciador antissenso possui pelo menos 80% de identidade com a SEQ ID NO: 7 e/ou o iniciador senso possui pelo menos 80% de identidade com a SEQ ID NO: 8 e o iniciador antissenso possui pelo menos 80% de identidade com a SEQ ID NO:9. 13. Primer Pairs, characterized in that the sense primer has at least 80% identity with SEQ ID NO: 6 and the antisense primer has at least 80% identity with SEQ ID NO: 7 and/or the sense primer has at least 80% identity to SEQ ID NO:8 and the antisense primer has at least 80% identity to SEQ ID NO:9.
14. Método de detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3, caracterizado pelo fato que compreende as etapas de: a) obter uma amostra de material vegetal para análise; b) extrair o DNA da amostra; c) fornecer pares de iniciadores compreendendo pelo me- nos um iniciador senso e outro antissenso; d) amplificar a região que fica entre os sítios em que os iniciadores se ligam; e e) detectar a presença de produto da amplificação. 14. Method for detecting plant material derived from a genetically modified sugarcane plant of event CTC75064-3, characterized in that it comprises the steps of: a) obtaining a sample of plant material for analysis; b) extracting DNA from the sample; c) providing primer pairs comprising at least one sense and one antisense primer; d) amplifying the region that lies between the sites where the primers bind; and e) detecting the presence of amplification product.
15. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que compreende o fornecimento de pares de iniciado- res na etapa c) planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo menos um dos iniciadores compreende nucleotídeos contí- guos de sequência selecionada do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. 15. Method according to claim 14, characterized in that it comprises providing primer pairs in step c) designed to bind to at least one polynucleotide that comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one of the primers comprises contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
16. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que compreende o fornecimento de pares de iniciado- res na etapa c) planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO: 22 e SEQ ID NO: 29, onde pelo menos um par de iniciadores consiste em um primeiro inici- ador que compreende nucleotídeos contíguos de uma sequência sele- cionada do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31 e um segundo iniciador que compre- ende nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 2 e SEQ ID NO 36. 16. Method, according to claim 14, characterized in that it comprises the provision of primer pairs in step c) designed to bind to at least one polynu- cleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 22 and SEQ ID NO: 29, wherein at least one pair of primers consists of a first primer comprising contiguous nucleotides of a selected sequence from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31 and a second primer comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 2 and SEQ ID NO 36.
17. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que compreende o fornecimento de pares de iniciado- res na etapa c) planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um par de iniciadores compreende nucleotídeos con- tíguos de sequência selecionada do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39. 17. Method according to claim 14, characterized in that it comprises providing primer pairs in step c) designed to bind to at least one polynucleotide that comprises contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one pair of primers comprises contiguous nucleotides of sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39.
18. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que compreende o fornecimento de pares de iniciado- res na etapa c) planejados para se ligarem a pelo menos um polinu- cleotídeo que compreende nucleotídeos contíguos de sequências se- lecionadas do grupo consistindo em SEQ ID NO: 5 e SEQ ID NO: 37, onde pelo menos um par de iniciadores consiste em um primeiro inici- ador que compreende nucleotídeos contíguos de uma sequência sele- cionada do grupo consistindo em SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 38 e SEQ ID NO: 39 e um segundo iniciador que compreende nucleotídeos contíguos de uma sequência selecionada do grupo con- sistindo em SEQ ID NO 2 e SEQ ID NO 36. 18. Method according to claim 14, characterized in that it comprises providing primer pairs in step c) designed to bind to at least one polynucleotide comprising contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO: 5 and SEQ ID NO: 37, wherein at least one pair of primers consists of a first primer comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 3 , SEQ ID NO: 4, SEQ ID NO: 38 and SEQ ID NO: 39 and a second primer comprising contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 2 and SEQ ID NO 36.
19. Método de acordo com a reivindicação 14, caracteriza- do pelo fato de que compreende pares de iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende núcleo- tídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde, o produto de amplificação de- tectado na etapa e) compreende nucleotídeos contíguos de uma se- quência selecionada do grupo consistindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 e SEQ ID NO 33. 19. Method according to claim 14, characterized in that it comprises primer pairs designed to bind to at least one polynucleotide comprising nucleus- contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein, the amplification product detected in step e) comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 32 and SEQ ID NO 33.
20. Método, de acordo com a reivindicação 19, caracteriza- do pelo fato de que o produto de amplificação detectado na etapa e) compreende nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38 e SEQ ID NO 39. 20. Method according to claim 19, characterized in that the amplification product detected in step e) comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 38 and SEQ ID NO 39.
21. Método, de acordo com a reivindicação 14, em que os pares de iniciadores utilizados na etapa c) são caracterizados pelo fato de que são selecionados do grupo consistindo em sequências com pelo menos 80% de identidade com as SEQ ID NO: 6 e SEQ ID NO: 7; SEQ ID NO: 8 e SEQ ID NO: 9. 21. Method according to claim 14, wherein the primer pairs used in step c) are characterized in that they are selected from the group consisting of sequences with at least 80% identity with SEQ ID NO: 6 and SEQ ID NO: 7; SEQ ID NO: 8 and SEQ ID NO: 9.
22. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que os produtos da amplificação obtidos são selecio- nados do grupo consistindo em SEQ ID NO 12 e SEQ ID NO 13. 22. Method according to claim 14, characterized in that the amplification products obtained are selected from the group consisting of SEQ ID NO 12 and SEQ ID NO 13.
23. Método, de acordo com a reivindicação 14, caracteriza- do pelo fato de que a detecção do produto da amplificação é realizada através da hibridização de sonda selecionada do grupo consistindo em SEQ ID NO 10 e SEQ ID NO 11. 23. Method according to claim 14, characterized in that the detection of the amplification product is carried out through the hybridization of a probe selected from the group consisting of SEQ ID NO 10 and SEQ ID NO 11.
24. Método de detecção de material vegetal derivado de uma planta de cana de açúcar geneticamente modificada do evento CTC75064-3, caracterizado pelo fato de que compreende as etapas de: a) obter uma amostra de material vegetal para análise; b) extrair o DNA ou RNA da amostra; c) fornecer uma sonda planejada ou uma combinação de sondas planejadas para se ligar a pelo menos um polinucleotídeo que compreende nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 e SEQ ID NO 39; d) hibridizar a dita sonda com o material extraído da amos- tra da etapa (b), e e) detectar a sonda hibridizada. 24. Method for detecting plant material derived from a genetically modified sugarcane plant of event CTC75064-3, characterized in that it comprises the steps of: a) obtaining a sample of plant material for analysis; b) extracting DNA or RNA from the sample; c) provide a probe designed or a combination of probes designed to bind to at least one polynucleotide that comprises contiguous nucleotides from sequences selected from the group consisting of SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 12, SEQ ID NO 13, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO 22, SEQ ID NO 23, SEQ ID NO 24, SEQ ID NO 29, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO 36, SEQ ID NO 37, SEQ ID NO 38 and SEQ ID NO 39; d) hybridizing said probe with the material extracted from the sample of step (b), and ee) detecting the hybridized probe.
25. Construção genética, caracterizada pelo fato de que compreende uma sequência de nucleotídeos possuindo pelo menos 80% de identidade com a SEQ ID NO: 1. 25. Genetic construct, characterized in that it comprises a nucleotide sequence having at least 80% identity with SEQ ID NO: 1.
26. Construção genética, caracterizada pelo fato de que compreende uma sequência de nucleotídeos de SEQ ID NO: 2 26. Genetic construct, characterized in that it comprises a nucleotide sequence of SEQ ID NO: 2
27. Construção genética de acordo com as reinvindicações 25 e 26, caracterizada pelo fato de que compreende uma sequência de nucleotídeos possuindo pelo menos 80% de identidade com a SEQ ID NO:14. 27. The genetic construct of claims 25 and 26, characterized in that it comprises a nucleotide sequence having at least 80% identity to SEQ ID NO:14.
28. Kit para detecção da presença de uma amostra de ma- terial vegetal de uma cana de açúcar transgênica compreendendo uma proteína CrylAc (evento CTC75064-3), caracterizado pelo fato de que compreende um meio para detecção da presença de um polinucleotí- deo que compreende pelo menos 14 nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO. 32, SEQ ID NO 33 e/ou uma proteína cristal pesticida (Cry). 28. Kit for detecting the presence of a sample of plant material from a transgenic sugarcane comprising a CrylAc protein (event CTC75064-3), characterized in that it comprises a means for detecting the presence of a polynucleotide that comprises at least 14 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO. 32, SEQ ID NO 33 and/or a pesticidal crystal protein (Cry).
29. Kit de acordo com a reivindicação 28, caracterizado pe- lo fato de que o meio para detecção compreende pares de iniciadores planejados para se ligarem a pelo menos um polinucleotídeo que compreende nucleotídeos contíguos de sequências selecionadas do grupo consistindo em SEQ ID NO 22 e SEQ ID NO 29, onde pelo me- nos um dos iniciadores compreende nucleotídeos contíguos de uma sequência selecionada do grupo consistindo em SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 e SEQ ID NO: 31. 29. Kit according to claim 28, characterized in that the means for detection comprises pairs of primers designed to bind to at least one polynucleotide comprising contiguous nucleotides of selected sequences from the group consisting of SEQ ID NO 22 and SEQ ID NO 29, wherein at least one of the primers comprises contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 30 and SEQ ID NO: 31.
30. Kit de acordo com a reivindicação 28, caracterizado pe- lo fato de que o meio para detecção compreende uma sonda_selecio- nada do grupo consistindo em SEQ ID NO 10 e SEQ ID NO 11. 30. Kit according to claim 28, characterized in that the means for detection comprises a probe selected from the group consisting of SEQ ID NO 10 and SEQ ID NO 11.
31. Planta de cana de açúcar ( Saccharum spp ) genetica- mente modificada, caracterizada pelo fato de que compreende pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. 31. A genetically modified sugarcane plant (Saccharum spp), characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
32. Planta de cana de açúcar ( Saccharum spp ) genetica- mente modificada, caracterizada pelo fato de que compreende pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 12 e SEQ ID NO 13. 32. A genetically modified sugarcane plant (Saccharum spp), characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 12 and SEQ ID NO 13.
33. Planta de cana de açúcar (Saccharum spp) genetica- mente modificada, caracterizada pelo fato de que compreende pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 22, onde a planta é resistente a inseto. 33. A genetically modified sugarcane plant (Saccharum spp), characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22, where the plant is insect resistant.
34. Evento CTC75064-3, caracterizado pelo fato de que é uma variedade de cana-de-açúcar ( Saccharum spp.) compreendendo pelo menos 14 nucleotídeos contíguos das sequências selecionadas do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. 34. Event CTC75064-3, characterized in that it is a variety of sugarcane (Saccharum spp.) comprising at least 14 contiguous nucleotides of sequences selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
35. Evento CTC75064-3, caracterizado pelo fato de que é uma variedade de cana-de-açúcar ( Saccharum spp.) compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 22. 35. Event CTC75064-3, characterized in that it is a variety of sugarcane (Saccharum spp.) comprising at least one sequence selected from the group consisting of SEQ ID NO 5 and SEQ ID NO 22.
36. Planta resistente a insetos, caracterizada pelo fato de que é uma variedade de cana-de-açúcar ( Saccharum spp.) compreen- dendo pelo menos 14 nucleotídeos contíguos das sequências selecio- nadas do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. 36. Insect resistant plant, characterized by the fact that it is a variety of sugarcane ( Saccharum spp.) comprising at least 14 contiguous nucleotides of selected sequences. nothing from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
37. Planta resistente a insetos, de acordo com a reivindica- ção 36, caracterizada pelo fato de que compreende pelo menos uma sequência selecionada do grupo consistindo em sequências com pelo menos 80% de identidade com as SEQ ID NO 5 e SEQ ID NO 22. 37. Insect resistant plant according to claim 36, characterized in that it comprises at least one sequence selected from the group consisting of sequences with at least 80% identity with SEQ ID NO 5 and SEQ ID NO 22 .
38. Parte de planta, célula de planta, tecido de planta ou semente de uma planta de cana de açúcar ( Saccharum spp ) geneti- camente modificada, caracterizada pelo fato de que compreende, pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. 38. Plant part, plant cell, plant tissue or seed of a genetically modified sugarcane plant ( Saccharum spp ) characterized in that it comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
39. Cultura de tecidos, caracterizada pelo fato de que é de uma planta de cana de açúcar (Saccharum spp) geneticamente modi- ficada como definida na reivindicação 31. 39. Tissue culture, characterized by the fact that it is from a genetically modified sugarcane plant (Saccharum spp) as defined in claim 31.
40. Planta de cana de açúcar ( Saccharum spp.) genetica- mente modificada regenerada a partir de uma cultura de tecidos como definida na reivindicação 39, caracterizada pelo fato de que a planta regenerada compreende pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 18 e SEQ ID NO 19. 40. Genetically modified sugarcane plant (Saccharum spp.) regenerated from a tissue culture as defined in claim 39, characterized in that the regenerated plant comprises at least one sequence selected from the group consisting of SEQ ID NO 18 and SEQ ID NO 19.
41. Produto de comódite, caracterizado pelo fato de que é produzido a partir de uma planta de cana-de-açúcar como definida na reivindicação 31. 41. Commodity product, characterized in that it is produced from a sugarcane plant as defined in claim 31.
42. Método para produzir uma planta de cana-de-açúcar re- sistente a inseto, caracterizado pelo fato de que compreende cruzar uma primeira planta de cana-de-açúcar com uma segunda planta de cana-de-açúcar compreendendo o evento CTC75064-3, produzindo uma prole de plantas de cana de açúcar resistente a inseto. 42. Method for producing an insect resistant sugarcane plant, characterized in that it comprises crossing a first sugarcane plant with a second sugarcane plant comprising event CTC75064- 3, producing an offspring of insect resistant sugarcane plants.
43. Parte de planta, células de planta, tecido de planta ou semente de uma planta de cana de açúcar, caracterizada pelo fato de que é produzida de acordo com o método da reivindicação 42. 43. Plant part, plant cells, plant tissue or seed of a sugarcane plant, characterized in that it is produced according to the method of claim 42.
44. Método para produzir uma planta de cana de açúcar (Saccharum spp) geneticamente modificada resistente a inseto, carac- terizado pelo fato de que compreende as etapas: a) introduzir uma construção genética compreendendo SEQ ID NO 20 e SEQ I D NO 21 em uma cepa de Agrobacterium, b) obter de calos embriogênicos de palmitos de uma varie- dade de cana-de-açúcar ( Saccharum spp.), c) co-cultivar os calos embriogênicos com a Agrobacterium da etapa a); d) selecionar as células transformadas que contém o fra- gmento funcional em meio de cultura contendo antibióticos aminogli- cosídicos; e e) regenerar as plantas de cana-de-açúcar geneticamente modificadas compreendendo as SEQ ID NO 20 e SEQ ID NO 21. 44. Method for producing a sugarcane plant (Saccharum spp) genetically modified insect resistant, characterized by the fact that it comprises the steps: a) introducing a genetic construct comprising SEQ ID NO 20 and SEQ ID NO 21 into an Agrobacterium strain, b) obtaining from embryogenic callus of palm hearts of a variety of sugarcane (Saccharum spp.), c) co-cultivate the embryogenic callus with the Agrobacterium from step a); d) select the transformed cells that contain the functional fragment in a culture medium containing aminoglycosidic antibiotics; and e) regenerating the genetically modified sugarcane plants comprising SEQ ID NO 20 and SEQ ID NO 21.
45. Parte de planta, células de planta, tecido de planta ou semente de uma planta de cana de açúcar, caracterizada pelo fato de que é produzida de acordo com o método da reivindicação 44. 45. Plant part, plant cells, plant tissue or seed of a sugarcane plant, characterized in that it is produced according to the method of claim 44.
46. Método para produzir uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada do evento CTC75064-3, caracterizado pelo fato de que compreende introduzir uma modificação genética a uma planta de cana de açúcar compreendendo pelo menos uma sequência selecionada do grupo consistindo em SEQ ID NO 5 e SEQ ID NO 22, onde a planta de cana de açúcar geneticamente modi- ficada possui resistência a inseto melhorada quando comparada com a cana de açúcar sem modificação genética. 46. Method for producing a genetically modified sugarcane plant ( Saccharum spp.) of event CTC75064-3, characterized in that it comprises introducing a genetic modification to a sugarcane plant comprising at least one sequence selected from the group consisting in SEQ ID NO 5 and SEQ ID NO 22, wherein the genetically modified sugar cane plant has improved insect resistance when compared to the unmodified sugar cane.
47. Método para produzir uma planta de cana de açúcar ( Saccharum spp.) geneticamente modificada resistente a inseto, carac- terizado pelo fato de que compreende a inserção de um fragmento de T DNA em sítio específico do genoma compreendido entre as sequên- cias selecionadas do grupo consistindo em SEQ ID NO 23 e SEQ ID NO 24 através de recombinação homóloga. 47. Method for producing a genetically modified insect-resistant sugarcane plant ( Saccharum spp.), characterized by the fact that it comprises the insertion of a fragment of T DNA in a specific site of the genome comprised between the selected sequences from the group consisting of SEQ ID NO 23 and SEQ ID NO 24 via homologous recombination.
48. Parte de planta, células de planta, tecido de planta ou semente de planta de cana de açúcar ( Saccharum spp.) geneticamen- te modificada resistente a inseto, caracterizada pelo fato de que é pro- duzida pelo método como definido em qualquer uma das reivindica- ções 46 e 47. 48. Plant part, plant cells, plant tissue or seed of a genetically modified insect resistant sugarcane plant ( Saccharum spp.), characterized in that it is produced by the method as defined in any of claims 46 and 47.
49. Método de cultivo de uma planta de cana de açúcar ge- neticamente modificada ( Saccharum ssp.), caracterizado pelo fato de que compreende crescer uma planta de cana de açúcar compreen- dendo a SEQ ID NO 2 sob condições de infestação de insetos, onde a cana de açúcar geneticamente modificada possui uma resistência a insetos aumentada em relação à cana de açúcar sem a modificação genética crescendo sob as mesmas condições. 49. Method of growing a genetically modified sugar cane plant ( Saccharum ssp.), characterized in that it comprises growing a sugar cane plant comprising SEQ ID NO 2 under insect infestation conditions, where the genetically modified sugarcane has an increased insect resistance compared to sugarcane without the genetic modification growing under the same conditions.
50. Uso de uma planta, célula de planta, parte de planta ou semente de uma planta de cana de açúcar ( Saccharum spp.) geneti- camente modificada como definida nas reivindicações 42, 44, 46 e 46, caracterizado pelo fato de que é para regenerar uma planta, plantar, produzir sementes, crescer ou cultivar um campo de plantas ou produ- zir um produto de planta. 50. Use of a genetically modified plant, plant cell, plant part or seed of a sugarcane plant (Saccharum spp.) as defined in claims 42, 44, 46 and 46, characterized in that it is to regenerate a plant, plant, produce seeds, grow or cultivate a field of plants, or produce a plant product.
51. Método para controle de insetos, caracterizado pelo fato de que compreende disponibilizar uma planta, tecido, parte da planta, células ou semente de uma cana de açúcar geneticamente modificada, definida por compreende a SEQ ID NO 2, para alimentação do inseto. 51. Method for controlling insects, characterized in that it comprises providing a plant, tissue, plant part, cells or seed of a genetically modified sugarcane, defined by comprising SEQ ID NO 2, for feeding the insect.
52. Método de acordo com a reivindicação 51, caracteriza- do pelo fato de que compreende planta, tecido, parte da planta, células ou sementes de uma planta de cana de açúcar geneticamente modifi- cada do evento CTC75064-3. 52. Method according to claim 51, characterized in that it comprises plant, tissue, plant part, cells or seeds of a genetically modified sugarcane plant of event CTC75064-3.
53. Método, de acordo com a reivindicação 51, caracteriza- do pelo fato de que os insetos são da espécie Diatrea saccharalis. 53. Method, according to claim 51, characterized by the fact that the insects are of the species Diatrea saccharalis.
54. Método para aumentar a produção de cana de açúcar no campo, caracterizado pelo fato de que compreende cultivar uma planta de cana de açúcar geneticamente modificada definida por com- preender a SEQ ID NO 2. 54. Method to increase the production of sugar cane in the field, characterized by the fact that it comprises cultivating a genetically modified sugarcane plant defined by comprising SEQ ID NO 2.
55. Método de acordo com a reivindicação 54, caracteriza- do pelo fato de que compreende uma planta de cana de açúcar gene- ticamente modificada do evento CTC75064-3. 55. Method according to claim 54, characterized in that it comprises a genetically modified sugarcane plant from event CTC75064-3.
PCT/BR2022/050142 2021-04-27 2022-04-27 Polynucleotide, pairs of primers, methods for detecting plant material, gene construct, kit for detecting presence in a sample of plant material, event ctc75064-3, insect-resistant plant, commodity product, method for producing an insect-resistant sugarcane plant and use of a plant, plant cell, part of a plant or seed WO2022226617A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRBR102021008065-5 2021-04-27
BR102021008065-5A BR102021008065A2 (en) 2021-04-27 2021-04-27 POLYNUCLEOTIDE, PRIMER PAIRS, METHODS FOR DETECTION OF PLANT MATERIAL, GENETIC CONSTRUCTION, KIT FOR DETECTING THE PRESENCE IN A SAMPLE OF PLANT MATERIAL, EVENT CTC75064-3, INSECT RESISTANT PLANT, COMMODITE PRODUCT, METHOD FOR PRODUCING A CANE PLAN- INSECT RESISTANT SUGAR AND USE OF A PLANT, PLANT CELL, PLANT PART OR SEED

Publications (1)

Publication Number Publication Date
WO2022226617A1 true WO2022226617A1 (en) 2022-11-03

Family

ID=83848866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2022/050142 WO2022226617A1 (en) 2021-04-27 2022-04-27 Polynucleotide, pairs of primers, methods for detecting plant material, gene construct, kit for detecting presence in a sample of plant material, event ctc75064-3, insect-resistant plant, commodity product, method for producing an insect-resistant sugarcane plant and use of a plant, plant cell, part of a plant or seed

Country Status (2)

Country Link
BR (1) BR102021008065A2 (en)
WO (1) WO2022226617A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114457088A (en) * 2020-11-10 2022-05-10 巴西甘蔗技术中心 Event CTC75064-3, insect-resistant sugarcane plants, methods of producing and detecting insect-resistant sugarcane plants
EP3995583A1 (en) * 2020-11-10 2022-05-11 Centro de Tecnologia Canavieira S.A Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc75064-3, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114457088A (en) * 2020-11-10 2022-05-10 巴西甘蔗技术中心 Event CTC75064-3, insect-resistant sugarcane plants, methods of producing and detecting insect-resistant sugarcane plants
EP3995583A1 (en) * 2020-11-10 2022-05-11 Centro de Tecnologia Canavieira S.A Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc75064-3, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ADRIANA C. GIANOTTO, MOISES S. ROCHA, LUCAS CUTRI, FRANCISCO C. LOPES, WILLIAM DAL'ACQUA, JERRY J. HJELLE, RON P. LIRETTE, WLADECI: "The insect-protected CTC91087-6 sugarcane event expresses Cry1Ac protein preferentially in leaves and presents compositional equivalence to conventional sugarcane", GM CROPS & FOOD, LANDES BIOSCIENCE, vol. 10, no. 4, 2 October 2019 (2019-10-02), pages 208 - 219, XP055766948, ISSN: 2164-5698, DOI: 10.1080/21645698.2019.1651191 *

Also Published As

Publication number Publication date
BR102021008065A2 (en) 2022-11-08

Similar Documents

Publication Publication Date Title
Ye et al. Development of insect‐resistant transgenic rice with Cry1C*‐free endosperm
CN109868273B (en) Nucleic acid sequence for detecting corn plant DBN9501 and detection method thereof
WO2016173361A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
WO2024060732A1 (en) Transgenic zea mays l. event lp026-2 and detection method therefor
WO2016173362A1 (en) Maize plant dbn9978 and method for use in detecting nucleic acid sequence thereof
JP7443491B2 (en) Nucleic acid sequence for detecting soybean plant DBN8002 and detection method therefor
Ivo et al. Biolistic-mediated genetic transformation of cowpea (Vigna unguiculata) and stable Mendelian inheritance of transgenes
US11653609B2 (en) Generating maize plants with enhanced resistance to northern leaf blight
CN113151533B (en) Transgenic corn event LP007-6 and detection method thereof
BR112018001306B1 (en) NUCLEIC ACID MOLECULE, METHOD FOR DETECTING THE PRESENCE OF DNA FROM A DBN9004 TRANSGENIC SOYBEAN EVENT, DNA, CELL OR PLANT PART DETECTION KIT, METHOD FOR PRODUCING OR CULTIVING A SOYBEAN PLANT TOLERANT TO A GLYPHOSATE HERBICIDE AND /OR A GLUFOSINATE HERBICIDE, METHOD FOR PROTECTING A PLANT AGAINST DAMAGE CAUSED BY A HERBICIDE AND/OR CONTROLLING WEEDS IN A FIELD, METHOD FOR DELAYING RESISTANCE TO INSECT AND AGRICULTURAL PRODUCT OR COMMODITY
EP3696188A1 (en) Gene for resistance to plant disease
JP7375028B2 (en) Genes for resistance to plant diseases
CN110881367A (en) Corn event Ttrans-4 and methods of use thereof
EP3995583A1 (en) Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc75064-3, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed
WO2016173360A1 (en) Maize plant dbn9927 and method for use in detecting nucleic acid sequence thereof
WO2022226617A1 (en) Polynucleotide, pairs of primers, methods for detecting plant material, gene construct, kit for detecting presence in a sample of plant material, event ctc75064-3, insect-resistant plant, commodity product, method for producing an insect-resistant sugarcane plant and use of a plant, plant cell, part of a plant or seed
EP4001418A1 (en) Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc79005-2, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed
CN114457088A (en) Event CTC75064-3, insect-resistant sugarcane plants, methods of producing and detecting insect-resistant sugarcane plants
Woo et al. Generation and molecular characterization of marker-free Bt transgenic rice plants by selectable marker-less transformation
US20220235370A1 (en) Polynucleotides, primers, and methods for detection of transgenic event, genetic construct, kit for detection material from a plant sample, event ctc91087-6, insect-resistant sugarcane plant, and method for producing an insect-resistant sugarcane plant, plant cell, plant part or seed
BR102021012709A2 (en) POLYNUCLEOTIDES, PRIMER PAIRS, PLANT MATERIAL DETECTION METHODS, GENETIC CONSTRUCTIONS, KIT FOR PRESENCE DETECTION IN A PLANT MATERIAL SAMPLE, GENETICALLY MODIFIED SUGARCANE PLANTS, CTC79005-02 EVENTS, INSECT RESISTANT PLANT, PARTS OF PLANT, PLANT CELL, PLANT TISSUES OR SEEDS OF A PLANT, TISSUE CULTURE, COMMODITE PRODUCT, METHODS FOR PRODUCING AN INSECT RESISTANT SUGAR CANE PLANT AND FOR PRODUCING AN EVENT SUGAR CANE PLANT CTC79005-2, METHODS OF CULTIVATION OF A SUGARCANE PLANT, USE OF A PLANT AND METHODS TO CONTROL INSECTS AND TO INCREASE SUGARCANE PRODUCTION IN THE FIELD
BR102021014763A2 (en) POLYNUCLEOTIDES, PRIMER PAIRS, PLANT MATERIAL DETECTION METHODS, GENETIC CONSTRUCTIONS, KIT, GENETICALLY MODIFIED SUGARCANE, CTC95019-5 EVENT, INSECT RESISTANT PLANT, PLANT PARTS, PLANT CELL, PLANT TISSUES OR SEEDS, FABRIC CULTIVATION, COMMODITE PRODUCT, METHODS TO PRODUCE SUGAR CANE AND PRODUCE THE CTC95019-5 EVENT, SUGAR CANE CULTIVATION METHODS, USE OF A PLANT AND METHODS TO CONTROL INSECTS AND INCREASE CANE PRODUCTION -OF SUGAR
EP3567111A1 (en) Gene for resistance to a pathogen of the genus heterodera
BR102020005666A2 (en) POLYNUCLEOTIDE, PAIRS OF INITIATORS, VEGETABLE MATERIAL DETECTION METHODS, GENETIC CONSTRUCTION, KIT FOR DETECTION OF THE PRESENCE IN A VEGETABLE MATERIAL SAMPLE, EVENT CTC93209-4, INSECT RESISTANT PLANT, COMODITE PRODUCT- A PLANT TO PRODUCE DE-SUGAR RESISTANT TO INSECT AND USE OF A PLANT, PLANT CELL, PART OF PLANT OR SEED
CN116694626B (en) Transgenic corn event LP035-2 and detection method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22794120

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112023022165

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22794120

Country of ref document: EP

Kind code of ref document: A1